{"PMC7380242": [["IntroductionThis chapter will discuss the fundamental concepts, terminology, and practice of pathology as the discipline dedicated to the understanding of causes, mechanisms, and effects of diseases.", [["pathology", "TEST", 93, 102], ["diseases", "PROBLEM", 190, 198]]], ["A section on key terms, definitions, and concepts is followed by sections on historical human approaches to diseases, an overview of current diagnostic practice, and a vision for new interface with applied molecular biology.Terms, definitions, and concepts", [["human", "ORGANISM", 88, 93], ["human", "SPECIES", 88, 93], ["human", "SPECIES", 88, 93]]]], "903855991f270aa6220f378ee1ee7dfc1db140dd": [["There are several problems of mathematical physics in which the only available analytic solution is a divergent and/or truncated power series expansion.", [["several", "OBSERVATION_MODIFIER", 10, 17]]], ["Over the past decade, a new approach has evolved to overcome the convergence barrier in series solutions.", [["a new approach", "TREATMENT", 22, 36], ["the convergence barrier in series solutions", "TREATMENT", 61, 104], ["new", "OBSERVATION_MODIFIER", 24, 27]]], ["An asymptotic approximant is a closed-form expression whose expansion in one region is exact up to a specified order and whose asymptotic equivalence in another region is enforced.", [["asymptotic", "OBSERVATION_MODIFIER", 3, 13], ["closed", "OBSERVATION_MODIFIER", 31, 37], ["expansion", "OBSERVATION_MODIFIER", 60, 69]]], ["The remarkable feature of asymptotic approximants is their ability to attain uniform accuracy not only in these two regions, but also at all points in-between, as demonstrated thus far for problems in thermodynamics, astrophysics, and fluid dynamics [1] [2] [3] [4] [5] [6] [7] .", [["[1] [2] [3] [4] [5] [6]", "CHEMICAL", 250, 273], ["[1] [2] [3] [4] [5] [6] [7]", "SIMPLE_CHEMICAL", 250, 277], ["fluid dynamics", "TEST", 235, 249], ["asymptotic", "OBSERVATION", 26, 36]]], ["The current need to model and predict viral epidemics motivates us to extend the application of asymptotic approximants to the commonly used Susceptible-Infected-Recovered (SIR) model.", [["viral epidemics", "PROBLEM", 38, 53]]], ["Although no exact analytic solution has yet been found for the SIR model, a convergent series solution may be formulated via the homotopy analysis method 8 .", [["a convergent series solution", "TREATMENT", 74, 102], ["the homotopy analysis method", "TEST", 125, 153], ["no", "UNCERTAINTY", 9, 11]]], ["Here, we provide an alternative and simple analytic approach.", [["an alternative and simple analytic approach", "TREATMENT", 17, 60]]], ["Interestingly, the SIR model shares the same asymptotic features as boundary layer flow over a moving flat plate, for which asymptotic approximants have already been applied 4 .", [["boundary layer flow", "PROBLEM", 68, 87], ["a moving flat plate", "TREATMENT", 93, 112], ["boundary", "OBSERVATION_MODIFIER", 68, 76], ["layer", "OBSERVATION_MODIFIER", 77, 82], ["flow", "OBSERVATION_MODIFIER", 83, 87]]], ["Model parameters may be extracted for available COVID-19 data via a least squares (or equivalent) technique without the need for an embedded numerical scheme.", [["available COVID", "TEST", 38, 53], ["an embedded numerical scheme", "TREATMENT", 129, 157]]], ["The SIR epidemic model considers the time-evolution of a susceptible population, S(t), interacting with an infected population, I(t), where t is time.", [["a susceptible population", "PROBLEM", 55, 79], ["infected", "OBSERVATION", 107, 115]]]], "e4d6c7b63c33ac798572f0e53ab6b53a2f71b452": [["The Basic Reproduction NumberThe basic reproduction number, R 0 , of an infectious disease is the average number of secondary cases generated by a single primary case in a fully susceptible population [1] .", [["infectious disease", "DISEASE", 72, 90], ["an infectious disease", "PROBLEM", 69, 90], ["infectious", "OBSERVATION", 72, 82]]], ["R 0 is the most widely used epidemiological measurement of the transmission potential in a given population.", [["R 0", "GENE_OR_GENE_PRODUCT", 0, 3], ["most widely", "OBSERVATION_MODIFIER", 11, 22]]], ["Statistical estimation of R 0 has been performed for various infectious diseases [2, 3] , aiming towards understanding the dynamics of transmission and evolution, and designing effective public health OPEN ACCESS intervention strategies.", [["infectious diseases", "DISEASE", 61, 80], ["Statistical estimation of R 0", "TEST", 0, 29], ["various infectious diseases", "PROBLEM", 53, 80], ["OPEN ACCESS intervention strategies", "TREATMENT", 201, 236], ["infectious", "OBSERVATION", 61, 71]]], ["In particular, R 0 has been used for determining the minimum coverage of immunization, because the threshold condition to prevent a major epidemic in a randomly-mixing population is given by 1-1/R 0 [4] .", [["R 0", "GENE_OR_GENE_PRODUCT", 15, 18], ["immunization", "TREATMENT", 73, 85], ["the threshold condition", "PROBLEM", 95, 118], ["a major epidemic", "PROBLEM", 130, 146]]], ["In addition, R 0 gives an estimate of the so-called final size, i.e., the proportion of the population that will experience infection by the end of an epidemic [5, 6] .Statistical Estimation of R 0Methodological discussions concerning the statistical inference of R 0 are still in progress, and it is recognized that the estimate is very sensitive to dispersal (or underlying epidemiological assumptions) of the progression of a disease [7] .", [["infection", "DISEASE", 124, 133], ["infection", "PROBLEM", 124, 133], ["a disease", "PROBLEM", 427, 436], ["size", "OBSERVATION_MODIFIER", 58, 62], ["infection", "OBSERVATION", 124, 133], ["progression", "OBSERVATION_MODIFIER", 412, 423]]], ["When one estimates R 0 using epidemic data of an emerging (or exotic) disease, the exponential growth rate, r, of infections during the initial phase of the epidemic is used [8, 9] .", [["infections", "DISEASE", 114, 124], ["exotic) disease", "PROBLEM", 62, 77], ["the exponential growth rate", "TEST", 79, 106], ["infections", "PROBLEM", 114, 124], ["infections", "OBSERVATION", 114, 124]]], ["Assuming that the generation time, i.e., the time from infection of a primary case to infection of a secondary case generated by the primary case [10] , is known (or separately estimated from other empirical data), the growth rate r is transformed to R 0 using that knowledge (see below).", [["infection", "DISEASE", 55, 64], ["infection", "DISEASE", 86, 95], ["infection", "PROBLEM", 55, 64], ["empirical data", "TEST", 198, 212], ["the growth rate", "TEST", 215, 230]]], ["That is, the conventional estimation technique has required two statistical steps, namely, first estimate r and then convert r to R 0 .Statistical Estimation of R 0The estimation method can be illustrated by employing a simple renewal process which adheres to the original definition of R 0 [1] .", [["a simple renewal process", "TREATMENT", 218, 242]]], ["Let j(t) be the number of new infections (i.e., incidence) at calendar time t.", [["infections", "DISEASE", 30, 40], ["new infections", "PROBLEM", 26, 40], ["new", "OBSERVATION_MODIFIER", 26, 29], ["infections", "OBSERVATION", 30, 40]]], ["Supposing that each infected individual on average generates secondary cases at a rate A(\uf074) at time \uf074 since infection (where \uf074 is referred to as the \"infection-age\" hereafter), j(t) is written as:Statistical Estimation of R 0Since R 0 represents the total number of secondary cases that a primary case generates during the entire course of infection, the estimate is given by ( [11] ):Statistical Estimation of R 0When j(t) follows an exponential growth path, it is easy to extract the integral of A(\uf074) from equation (1) .", [["infection", "DISEASE", 108, 117], ["infection", "DISEASE", 150, 159], ["infection", "DISEASE", 340, 349], ["infection", "PROBLEM", 108, 117], ["infection", "PROBLEM", 340, 349], ["infected", "OBSERVATION_MODIFIER", 20, 28], ["infection", "OBSERVATION", 108, 117], ["infection", "OBSERVATION", 150, 159], ["infection", "OBSERVATION", 340, 349]]], ["Supposing that the incidence grows exponentially at a rate r, we have j(t) = kexp(rt)Statistical Estimation of R 0where k is a constant, and moreover, j(t \u2212 \uf074) = kexp(rt)exp(\u2212r\uf074).", [["kexp", "TEST", 162, 166]]], ["This simplifies (1) to the so-called Euler-Lotka equation:Statistical Estimation of R 0Since the density function of the generation time, g(\uf074), represents the frequency of secondary transmissions relative to infection-age \uf074, we can write g(\uf074) as:Statistical Estimation of R 0Replacing A(\uf074) in the right-hand side of (3) by that of (4), an estimator of R 0 is obtained [9] :Statistical Estimation of R 0The estimation of R 0 is achieved by measuring the exponential growth rate r from the incidence data and also by assuming that g(\uf074) is known (or separately estimated from empirical observation such as contact tracing data [12, 13] ).", [["right-hand", "ANATOMY", 297, 307], ["infection", "DISEASE", 208, 217], ["secondary transmissions", "PROBLEM", 172, 195], ["infection", "PROBLEM", 208, 217], ["Statistical Estimation", "TEST", 373, 395], ["empirical observation", "TEST", 573, 594], ["density", "OBSERVATION", 97, 104], ["infection", "OBSERVATION", 208, 217], ["right", "ANATOMY_MODIFIER", 297, 302], ["hand", "ANATOMY", 303, 307]]], ["Moreover, equation (5) may not be easily used by non-experts, e.g., an epidemiologist who wishes to estimate R 0 using her/his own data.Statistical Estimation of R 0The purpose of the present study is to offer an improved framework for estimating R 0 from early epidemic growth data, which may be slightly more tractable among non-experts as compared with the above mentioned estimator (5) .", [["the present study", "TEST", 180, 197], ["early epidemic growth data", "PROBLEM", 256, 282], ["may be", "UNCERTAINTY", 290, 296], ["slightly", "OBSERVATION_MODIFIER", 297, 305], ["more tractable", "OBSERVATION_MODIFIER", 306, 320]]], ["A likelihood-based approach is proposed to permit derivation of the uncertainty bounds of R 0 .", [["A likelihood-based approach", "TREATMENT", 0, 27]]], ["For an exposition of the proposed method, the incidence data of the HIV epidemic in Europe is explored.Actual Reproduction NumberIn addition to R 0 , a different measurement of the transmission potential using widely available epidemiological data, the actual reproduction number, R a , has been proposed for HIV/AIDS [14] .", [["HIV/AIDS", "DISEASE", 309, 317], ["HIV", "SPECIES", 68, 71], ["HIV", "SPECIES", 309, 312], ["the HIV epidemic", "PROBLEM", 64, 80], ["HIV/AIDS", "TREATMENT", 309, 317]]], ["The concept of R a is much simpler than R 0 in that R a is defined as a product of the mean duration of infectiousness and the ratio of incidence to prevalence [15] .", [["infectiousness", "PROBLEM", 104, 118], ["R", "ANATOMY_MODIFIER", 15, 16]]], ["The prevalence p(t) at calendar time t is written as:Actual Reproduction Numberwhere \uf047(\uf074) is the survivorship of infectiousness, or probability of being infectious, at infection-age \uf074.Actual Reproduction NumberLetting \uf062(\uf074) be the transmission rate, which depends primarily on the frequency of contact and infectiousness at infection-age \uf074, the above mentioned A(\uf074), the rate of secondary transmission per single primary case at \uf074, under an assumption of a Kermack and McKendrick type model, is decomposed as ( [16] ):Actual Reproduction NumberThe actual reproduction number R a is written as:Actual Reproduction Numberwhere D is the mean generation time (or what was previously described as the mean duration of infectiousness [14, 15] ).", [["infection", "DISEASE", 168, 177], ["infection", "DISEASE", 323, 332], ["infectiousness", "PROBLEM", 113, 127], ["infectiousness at infection", "PROBLEM", 305, 332], ["infectiousness", "PROBLEM", 712, 726], ["infectious", "OBSERVATION", 153, 163]]], ["If the transmission rate \uf062(\uf074) is constant \uf062 (i.e., independent of infection-age), R a = \uf062D. Moreover, from equation (2), R 0 is given by: Figure 1 .", [["infection", "DISEASE", 66, 75], ["the transmission rate", "TEST", 3, 24], ["infection", "PROBLEM", 66, 75]]], ["The relative frequency of secondary transmissions of HIV as a function of the time since infection.", [["HIV", "DISEASE", 53, 56], ["infection", "DISEASE", 89, 98], ["HIV", "ORGANISM", 53, 56], ["HIV", "SPECIES", 53, 56], ["HIV", "SPECIES", 53, 56], ["HIV", "PROBLEM", 53, 56], ["infection", "PROBLEM", 89, 98], ["infection", "OBSERVATION", 89, 98]]], ["A step function is employed to approximately model the frequency of secondary transmissions relative to infection-age.", [["infection", "DISEASE", 104, 113], ["A step function", "TEST", 0, 15], ["secondary transmissions", "PROBLEM", 68, 91], ["infection", "PROBLEM", 104, 113], ["infection", "OBSERVATION", 104, 113]]], ["For d 1 years shortly after infection, the frequency g 1 is very high.", [["infection", "DISEASE", 28, 37], ["infection", "PROBLEM", 28, 37], ["infection", "OBSERVATION", 28, 37], ["very", "OBSERVATION_MODIFIER", 60, 64], ["high", "OBSERVATION", 65, 69]]], ["Subsequently, for d 2 years (i.e., during the asymptomatic period), g 2 is persistently low, followed by a time period with high infectiousness g 3 for d 3 years until death or no secondary transmission due to AIDS.", [["death", "DISEASE", 168, 173], ["AIDS", "DISEASE", 210, 214], ["death", "PROBLEM", 168, 173], ["secondary transmission", "PROBLEM", 180, 202], ["AIDS", "PROBLEM", 210, 214]]], ["Following a statistical study [20] , d 1 , R a coincides with R 0 as long as \uf062(\uf074) is constant.", [["a statistical study", "TEST", 10, 29], ["constant", "OBSERVATION_MODIFIER", 85, 93]]], ["Nevertheless, in many instances, the contact frequency and infectiousness (which may be partly reflected, for example, in the viral load distribution of the infected host) vary as a function of infection-age \uf074.", [["infection", "DISEASE", 194, 203], ["infectiousness", "PROBLEM", 59, 73], ["infection", "PROBLEM", 194, 203], ["viral load", "OBSERVATION", 126, 136], ["infection", "OBSERVATION", 194, 203]]], ["The variation in \uf062(\uf074) is particularly the case for HIV infection.", [["HIV infection", "DISEASE", 51, 64], ["HIV", "ORGANISM", 51, 54], ["HIV", "SPECIES", 51, 54], ["HIV", "SPECIES", 51, 54], ["HIV infection", "PROBLEM", 51, 64], ["variation", "OBSERVATION_MODIFIER", 4, 13], ["infection", "OBSERVATION", 55, 64]]], ["Thus, although the usefulness of the incidence-to-prevalence ratio and R a has been emphasized to have an application in HIV/AIDS [15] , R a tends to yield a biased estimate (if R a is regarded as a proxy for R 0 ), and the estimate of R a is not as robust as that is obtained with equation (5) to objectively interpret the transmission potential [17, 18] .Correcting R aHere, the above mentioned negative aspect of R a is reconsidered by correcting the definition of R a .", [["AIDS", "DISEASE", 125, 129], ["HIV", "SPECIES", 121, 124], ["HIV/AIDS", "TREATMENT", 121, 129]]], ["The disease of interest in the present study is HIV.", [["HIV", "ORGANISM", 48, 51], ["HIV", "SPECIES", 48, 51], ["HIV", "SPECIES", 48, 51], ["The disease of interest", "PROBLEM", 0, 23], ["HIV", "PROBLEM", 48, 51], ["disease", "OBSERVATION", 4, 11]]], ["The frequency of secondary transmissions relative to infection-age \uf074 (i.e., the generation time distribution), approximated by a step function, is shown in Figure 1 .", [["infection", "DISEASE", 53, 62], ["secondary transmissions", "PROBLEM", 17, 40], ["infection", "PROBLEM", 53, 62], ["secondary transmissions", "OBSERVATION", 17, 40], ["infection", "OBSERVATION", 53, 62]]], ["As has been known for some time [19] , the frequency of secondary transmissions is very high shortly after infection (for a duration d 1 = 0.24 years), followed by a long asymptomatic period with a low frequency of secondary transmissions (for d 2 = 8.38 years) [20] .", [["infection", "DISEASE", 107, 116], ["secondary transmissions", "PROBLEM", 56, 79], ["infection", "PROBLEM", 107, 116], ["high", "OBSERVATION_MODIFIER", 88, 92]]], ["Subsequently, the frequency rises sharply again resulting in a substantial number of secondary cases for a duration d 3 = 0.75 years until death or until the infected individual ceases risky sexual contact due to AIDS [20] [21] [22] .", [["death", "DISEASE", 139, 144], ["AIDS", "DISEASE", 213, 217], ["substantial", "OBSERVATION_MODIFIER", 63, 74]]], ["Assuming that the contact frequency does not vary as a function of infection-age, g 1 , g 2 and g 3 have been estimated at 1.30, 0.05 and 0.36 per year [20] .", [["infection", "DISEASE", 67, 76], ["infection", "PROBLEM", 67, 76], ["infection", "OBSERVATION", 67, 76]]], ["Here, g(\uf074) is the density function of the generation time, with a mean of 3.79 years.Correcting R aHere the concept of R a is corrected.", [["density", "OBSERVATION", 18, 25], ["R", "ANATOMY_MODIFIER", 119, 120], ["corrected", "OBSERVATION", 126, 135]]], ["The equation (8) is rewritten as:Correcting R aThe numerator represents the number of new infections at calendar time t, while the denominator was originally intended to represent \"the total number of infectious individuals\" who can potentially be primary cases with an equal chance at time t.", [["infections", "DISEASE", 90, 100], ["new infections", "PROBLEM", 86, 100], ["new", "OBSERVATION_MODIFIER", 86, 89], ["infections", "OBSERVATION", 90, 100]]], ["Therefore, the corrected R a is better written as:Correcting R awhere g(\uf074), in the renewal equation with the Kermack and McKendrick type assumption, is written as the normalized density of secondary transmissions, i.e.,:Correcting R aReplacing g(\uf074) in the right-hand side of (11) by that of (12), we get:Correcting R aThus, the estimator of corrected R a in (11) is identical to that of R 0 .", [["right-hand", "ANATOMY", 256, 266], ["the Kermack", "TREATMENT", 105, 116], ["secondary transmissions", "OBSERVATION", 189, 212], ["right", "ANATOMY_MODIFIER", 256, 261], ["hand", "ANATOMY", 262, 266]]], ["In other words, R 0 can be estimated from the incidence data and the generation time without assuming exponential growth of cases during the early phase of an epidemic.", [["R 0", "GENE_OR_GENE_PRODUCT", 16, 19], ["exponential growth of cases", "PROBLEM", 102, 129]]], ["It should be noted that the ratio of prevalence to mean generation time p(t)/D in the denominator of the right-hand side of (10) has been replaced by \"the total number of effective contacts that have equal potential to generate secondary cases\".DataHere the epidemic data of HIV/AIDS in three European countries: France, the Western part of Germany (i.e., the former Western Germany) and the United Kingdom (UK) are investigated [23] .", [["right-hand", "ANATOMY", 105, 115], ["HIV/AIDS", "DISEASE", 275, 283], ["HIV", "SPECIES", 275, 278], ["HIV", "SPECIES", 275, 278], ["the ratio", "TEST", 24, 33], ["HIV/AIDS", "PROBLEM", 275, 283], ["right", "ANATOMY_MODIFIER", 105, 110]]], ["During the observation period, a total of 23,243, 13,126 and 11,491 AIDS cases were diagnosed in France, Western Germany and the UK, respectively.", [["AIDS", "DISEASE", 68, 72]]], ["Although the time of HIV infection is not directly observable, the HIV incidence has been estimated by employing a back-calculation technique and using the AIDS incidence and the incubation period distribution of AIDS [23] .", [["HIV infection", "DISEASE", 21, 34], ["AIDS", "DISEASE", 156, 160], ["AIDS", "DISEASE", 213, 217], ["HIV", "ORGANISM", 21, 24], ["HIV", "SPECIES", 21, 24], ["HIV", "SPECIES", 67, 70], ["HIV infection", "PROBLEM", 21, 34], ["a back-calculation technique", "TREATMENT", 113, 141], ["the AIDS incidence", "TREATMENT", 152, 170], ["infection", "OBSERVATION", 25, 34]]], ["The present study does not discuss the details of back-calculation, but explanatory guides can be found elsewhere [24] [25] [26] .", [["The present study", "TEST", 0, 17], ["back-calculation", "TEST", 50, 66]]], ["Figure 2B shows the enlarged HIV incidence curve during the initial phase of an epidemic.", [["HIV", "SPECIES", 29, 32], ["the enlarged HIV incidence curve", "PROBLEM", 16, 48], ["an epidemic", "PROBLEM", 77, 88], ["enlarged", "OBSERVATION_MODIFIER", 20, 28], ["HIV", "OBSERVATION", 29, 32], ["epidemic", "OBSERVATION", 80, 88]]], ["For the purpose of an exposition of the proposed method, the HIV incidence is assumed to have been in a single homogeneously-mixing population.Statistical AnalysisR 0 is estimated using two different methods, one employing the estimator (5) and another using the corrected R a .", [["HIV", "ORGANISM", 61, 64], ["HIV", "SPECIES", 61, 64], ["the proposed method", "TREATMENT", 36, 55], ["the HIV incidence", "PROBLEM", 57, 74]]], ["For the former approach, the exponential growth rate is estimated via a pure birth process [27] .", [["the exponential growth rate", "TEST", 25, 52]]], ["Given that the cumulative incidence from year 0 to t \u2212 1 is observed, the conditional likelihood of observing the cumulative incidence J t cases in year t is proportional to ( [28] ):Statistical Analysisfrom which the maximum likelihood estimate and the 95% confidence intervals (CI) of r (per year) are obtained.", [["t \u2212 1", "DNA", 51, 56], ["CI", "TEST", 280, 282]]], ["Given a fixed generation time distribution g(\uf074), the uncertainty bound of R 0 mirrors the uncertainty in the estimate of r.", [["R 0", "PROTEIN", 74, 77], ["r.", "SPECIES", 121, 123]]], ["The translation of r into R 0 via (5) is made by using g(\uf074) in Figure 1 .Statistical AnalysisThe latter method, proposed in the present study, employs the estimator of corrected R a in (11) .", [["R 0", "DNA", 26, 29], ["Statistical Analysis", "TEST", 73, 93], ["the present study", "TEST", 124, 141]]], ["Since the data are yearly, the equation (11) needs to be rewritten in discrete-time: (15) where the discrete density function of the generation time, g s is assumed to be given by g s = G(s + 1) \u2212 G(s), where G(s) is the cumulative distribution function of the generation time of length s, but g 0 is calculated as a normalized yearly average, because d 1 is as short as 0.24 years.Statistical AnalysisThe likelihood of estimating R 0 with (15) is proposed as follows.", [["g s", "TEST", 180, 183], ["G(s", "TEST", 186, 189], ["G(s", "TEST", 197, 200], ["length s", "TEST", 280, 288], ["Statistical Analysis", "TEST", 382, 402], ["discrete", "OBSERVATION_MODIFIER", 100, 108], ["density", "OBSERVATION", 109, 116]]], ["First, the inverse of both sides of (15) is taken: The numerator of the right-hand side indicates the total number of effective contacts made by potential primary cases in year t that have an equal probability of resulting in a secondary transmission, and the denominator is the number of secondary cases in year t.", [["right-hand", "ANATOMY", 72, 82], ["right", "ANATOMY_MODIFIER", 72, 77], ["hand", "ANATOMY", 78, 82], ["total", "OBSERVATION_MODIFIER", 102, 107]]], ["1 The intrinsic growth rate during the exponential growth phase; 2 the basic reproduction number estimated using equation (5); 3 the basic reproduction number estimated using equation (17); the 95% confidence intervals are shown in parentheses.Statistical AnalysisThe right-hand side of equation (16) is interpreted as follows.", [["right-hand", "ANATOMY", 268, 278], ["the exponential growth phase", "TEST", 35, 63], ["Statistical Analysis", "TEST", 244, 264], ["intrinsic", "OBSERVATION_MODIFIER", 6, 15], ["growth", "OBSERVATION_MODIFIER", 16, 22], ["rate", "OBSERVATION_MODIFIER", 23, 27], ["right", "ANATOMY_MODIFIER", 268, 273]]], ["A transmission tree of this kind is usually unobserved unless rigorous contact-tracing with microbiological examination is implemented.", [["microbiological examination", "TEST", 92, 119]]], ["This is a simple binomial sampling process.", [["a simple binomial sampling process", "PROBLEM", 8, 42], ["simple", "OBSERVATION_MODIFIER", 10, 16], ["binomial sampling", "OBSERVATION", 17, 34]]], ["In other words, the likelihood function for estimating R 0 is: (17) where T is the most recent time point of observation within an early (linear) epidemic growth stage.", [["epidemic growth stage", "PROBLEM", 146, 167]]], ["The maximum likelihood estimate of R 0 is obtained by minimizing the negative logarithm of (17) , and the 95% CI are derived from the profile likelihood.", [["maximum", "OBSERVATION_MODIFIER", 4, 11]]], ["Table 1 shows the estimates of r and R 0 for HIV in France, Western Germany and the UK.", [["HIV", "SPECIES", 45, 48]]], ["The maximum likelihood estimates of r ranged from 1.15 to 2.15 per year with the smallest estimate in France and the highest in Western Germany.", [["maximum", "OBSERVATION_MODIFIER", 4, 11], ["likelihood", "OBSERVATION_MODIFIER", 12, 22], ["estimates", "OBSERVATION_MODIFIER", 23, 32], ["r", "OBSERVATION_MODIFIER", 36, 37], ["ranged", "OBSERVATION_MODIFIER", 38, 44], ["smallest", "OBSERVATION_MODIFIER", 81, 89], ["highest", "OBSERVATION_MODIFIER", 117, 124]]], ["The 95% CI for Western Germany did not overlap with those of the other two countries, reflecting the steep rise in incidence in this region in Figure 2B .", [["steep", "OBSERVATION_MODIFIER", 101, 106], ["rise", "OBSERVATION_MODIFIER", 107, 111]]], ["Based on the exponential growth assumption in (5), the estimate of R 0 ranged from 3.65-4.08.", [["the exponential growth assumption", "TEST", 9, 42], ["exponential", "OBSERVATION_MODIFIER", 13, 24], ["growth", "OBSERVATION_MODIFIER", 25, 31]]], ["The maximum likelihood estimate of R 0 based on the proposed new method ranged from 3.59 to 3.74.", [["maximum", "OBSERVATION_MODIFIER", 4, 11], ["likelihood", "OBSERVATION_MODIFIER", 12, 22], ["new", "OBSERVATION_MODIFIER", 61, 64]]], ["In particular, although R 0 in Western Germany using the proposed method is smaller than that based on an exponential growth assumption, the 95% CIs of the two methods overlapped.", [["an exponential growth assumption", "TEST", 103, 135], ["smaller", "OBSERVATION_MODIFIER", 76, 83]]], ["The 95% CI based on the proposed method appeared to be wider than those based on exponential growth assumption.", [["the proposed method", "TEST", 20, 39], ["exponential growth assumption", "TEST", 81, 110]]], ["Since HIV is mainly transmitted via sexual contact, the above mentioned estimate may vary with the mixing pattern and contact frequency (thus, there is no general disease-specific R 0 , especially for HIV/AIDS).", [["HIV is mainly transmitted via sexual contact", "DISEASE", 6, 50], ["HIV/AIDS", "DISEASE", 201, 209], ["HIV", "ORGANISM", 6, 9], ["HIV", "SPECIES", 6, 9], ["HIV", "SPECIES", 6, 9], ["HIV", "SPECIES", 201, 204], ["general disease", "PROBLEM", 155, 170], ["HIV/AIDS", "TREATMENT", 201, 209], ["no", "UNCERTAINTY", 152, 154]]], ["At least, compared with a previous estimate of R 0 as ranging from 13.9 to 54.5 in the USA, based on an exponential growth assumption that adopted a mean infectious period of 10 years [32] , R 0 in the present study appeared to be much smaller using a precise estimate of the generation time distribution.Results and DiscussionThe present study proposed the use of the corrected actual reproduction number, R a , for statistical inference of R 0 based on incidence and known relative frequency of secondary transmissions (i.e., the generation time distribution) during the early growth phase of an epidemic.", [["secondary transmissions", "PROBLEM", 497, 520], ["an epidemic", "PROBLEM", 595, 606], ["infectious", "OBSERVATION_MODIFIER", 154, 164], ["smaller", "OBSERVATION_MODIFIER", 236, 243], ["secondary transmissions", "OBSERVATION", 497, 520], ["epidemic", "OBSERVATION", 598, 606]]], ["The previously available method using (5) forced us to adopt an exponential growth assumption, and moreover, an additional step towards the estimation of r (i.e., the translation of r to R 0 ) was required [9] .", [["an exponential growth assumption", "TEST", 61, 93]]], ["The proposed method does not necessarily require an exponential growth assumption and provides a \"short-cut\" to estimate R 0 from incidence data.", [["incidence data", "TEST", 130, 144], ["does not necessarily require", "UNCERTAINTY", 20, 48]]], ["The simple likelihood function employing a binomial distribution was also proposed to yield an appropriate uncertainty bound of R 0 .", [["simple", "OBSERVATION_MODIFIER", 4, 10], ["likelihood function", "OBSERVATION", 11, 30]]], ["It should be noted that given the knowledge of g s and readily available incidence data, equation (15) permits calculation of the expected value of R 0 without likelihood.", [["g s", "PROBLEM", 47, 50]]], ["However, it appears that R a does not precisely capture the secondary transmission if the transmission rate \uf062(\uf074) varies with infection-age \uf074 [18] , and moreover, the cohort-and period-reproduction numbers directly derived from the renewal equation have been suggested to be more accurate figures in capturing the underlying transmission dynamics [17, 33] .", [["infection", "DISEASE", 125, 134], ["the transmission rate", "TEST", 86, 107], ["infection", "PROBLEM", 125, 134], ["infection", "OBSERVATION", 125, 134]]], ["In the present study, replacing the denominator (i.e., prevalence) of R a by the total number of potential contacts, it was shown that the R 0 derived from the renewal equation coincides with the corrected actual reproduction number, R a , and also that the likelihood can be quite easily derived.", [["the present study", "TEST", 3, 20]]], ["Most importantly, the estimation of R 0 from early epidemic growth data for a heterogeneously-mixing population is called for.", [["R 0", "GENE_OR_GENE_PRODUCT", 36, 39], ["early epidemic growth data", "PROBLEM", 45, 71]]], ["R 0 in the present study can even be interpreted as R 0 for a heterogeneously-mixing population (i.e., the dominant eigenvalue of the nextgeneration matrix), provided that the early growth rate is the same among sub-populations (though it is not the case if the growth rate varies across sub-populations) [34, 35] .", [["matrix", "CELLULAR_COMPONENT", 149, 155], ["the present study", "TEST", 7, 24], ["a heterogeneously-mixing population", "PROBLEM", 60, 95], ["the early growth rate", "TEST", 172, 193], ["the growth rate", "TEST", 258, 273], ["dominant", "OBSERVATION_MODIFIER", 107, 115]]], ["Analyzing heterogeneous transmission among approximately-aggregated discrete groups, the estimate of the next-generation matrix would give more detailed insights into the epidemic dynamics, including the most important target host for intervention [36] .", [["matrix", "CELLULAR_COMPONENT", 121, 127], ["Analyzing heterogeneous transmission", "PROBLEM", 0, 36], ["the next-generation matrix", "TREATMENT", 101, 127], ["heterogeneous", "OBSERVATION_MODIFIER", 10, 23], ["approximately", "OBSERVATION_MODIFIER", 43, 56]]], ["As discussed in a modeling study in this special issue of the International Journal of Environmental Research and Public Health [37] , understanding the implications of sexual partnerships and their variations as a function of calendar time as well as infection-age is also of utmost importance.", [["infection", "DISEASE", 252, 261], ["a modeling study", "TEST", 16, 32]]], ["As the next step for a similar estimation framework, methods for estimating robust R 0 and the next-generation matrix from structured data (i.e., data stratified by age-and/or risk-groups) will be useful.", [["matrix", "CELLULAR_COMPONENT", 111, 117], ["structured data", "TEST", 123, 138]]], ["Despite the future challenges, I believe the present study at least satisfies a need to offer a likelihood-based approach to estimate R 0 from early epidemic growth data, while being easily tractable and calculable among general epidemiologists.", [["the present study", "TEST", 41, 58], ["early epidemic growth data", "PROBLEM", 143, 169]]]], "174f63ff45fc7bbecf0f559200761ad76691b6fb": [["IntroductionCassiae semen, also known as \u02bbJuemingzi\u02bc in Chinese, is the dry and mature seed of Cassia obtusifolia L. or C. tora L., which belong to the Cassia genus of Leguminosae (1) .", [["semen", "ORGANISM_SUBSTANCE", 20, 25], ["seed", "ORGANISM_SUBDIVISION", 87, 91], ["Cassia obtusifolia L.", "ORGANISM", 95, 116], ["C. tora L.", "ORGANISM", 120, 130], ["Cassia genus", "ORGANISM", 152, 164], ["Leguminosae", "ORGANISM", 168, 179], ["Cassia obtusifolia", "SPECIES", 95, 113], ["L.", "SPECIES", 114, 116], ["C. tora", "SPECIES", 120, 127], ["L.", "SPECIES", 128, 130], ["Cassia", "SPECIES", 152, 158], ["Cassia obtusifolia L.", "SPECIES", 95, 116], ["C. tora L.", "SPECIES", 120, 130], ["Cassia obtusifolia L.", "PROBLEM", 95, 116], ["Cassia genus", "ANATOMY", 152, 164], ["Leguminosae", "ANATOMY", 168, 179]]], ["It is cultivated in Korea, Japan and China, and is commonly consumed as a roasted tea (2, 3) .", [["tea", "ORGANISM_SUBDIVISION", 82, 85], ["cultivated", "OBSERVATION_MODIFIER", 6, 16], ["China", "ANATOMY", 37, 42]]], ["In traditional Chinese medicine, it has been used in treatments for hyperlipemia, diabetes mellitus, Alzheimer's disease, acute liver injury, inflammation, photophobia, headache, dizziness and hypertension (4) (5) (6) .IntroductionPhytochemical investigations have isolated and identified >70 compounds, including anthraquinones, naphthopyrones, volatile oils and sterols (7, 8) .", [["liver", "ANATOMY", 128, 133], ["volatile oils", "ANATOMY", 346, 359], ["hyperlipemia", "DISEASE", 68, 80], ["diabetes mellitus", "DISEASE", 82, 99], ["Alzheimer's disease", "DISEASE", 101, 120], ["acute liver injury", "DISEASE", 122, 140], ["inflammation", "DISEASE", 142, 154], ["photophobia", "DISEASE", 156, 167], ["headache", "DISEASE", 169, 177], ["dizziness", "DISEASE", 179, 188], ["hypertension", "DISEASE", 193, 205], ["anthraquinones", "CHEMICAL", 314, 328], ["naphthopyrones", "CHEMICAL", 330, 344], ["sterols", "CHEMICAL", 364, 371], ["anthraquinones", "CHEMICAL", 314, 328], ["naphthopyrones", "CHEMICAL", 330, 344], ["sterols", "CHEMICAL", 364, 371], ["liver", "ORGAN", 128, 133], ["anthraquinones", "SIMPLE_CHEMICAL", 314, 328], ["naphthopyrones", "SIMPLE_CHEMICAL", 330, 344], ["volatile oils", "SIMPLE_CHEMICAL", 346, 359], ["sterols", "SIMPLE_CHEMICAL", 364, 371], ["hyperlipemia", "PROBLEM", 68, 80], ["diabetes mellitus", "PROBLEM", 82, 99], ["Alzheimer's disease", "PROBLEM", 101, 120], ["acute liver injury", "PROBLEM", 122, 140], ["inflammation", "PROBLEM", 142, 154], ["photophobia", "PROBLEM", 156, 167], ["headache", "PROBLEM", 169, 177], ["dizziness", "PROBLEM", 179, 188], ["hypertension", "PROBLEM", 193, 205], ["IntroductionPhytochemical investigations", "TEST", 219, 259], ["anthraquinones", "TREATMENT", 314, 328], ["naphthopyrones", "TREATMENT", 330, 344], ["hyperlipemia", "OBSERVATION", 68, 80], ["diabetes mellitus", "OBSERVATION", 82, 99], ["acute", "OBSERVATION_MODIFIER", 122, 127], ["liver", "ANATOMY", 128, 133], ["injury", "OBSERVATION", 134, 140], ["inflammation", "OBSERVATION", 142, 154], ["photophobia", "OBSERVATION", 156, 167], ["hypertension", "OBSERVATION", 193, 205]]], ["Among these, anthraquinones are the primary functional components and possess a wide spectrum of pharmacological properties (9) (10) (11) , including antihyperlipidemic, neuroprotective, hepatoprotective, antibacterial and antimutagenic activities (12) (13) (14) .", [["anthraquinones", "CHEMICAL", 13, 27], ["anthraquinones", "CHEMICAL", 13, 27], ["anthraquinones", "SIMPLE_CHEMICAL", 13, 27], ["9) (10) (11)", "SIMPLE_CHEMICAL", 125, 137], ["antihyperlipidemic", "TREATMENT", 150, 168], ["neuroprotective", "TREATMENT", 170, 185], ["hepatoprotective", "TREATMENT", 187, 203], ["antibacterial", "TREATMENT", 205, 218], ["antimutagenic activities", "TEST", 223, 247]]], ["Naphthopyrones, other primary components, exhibit antidiabetic (15, 16) , antimicrobial (17) , antiestrogenic (18) , antiallergic (19) and anthelmintic effects (20) .", [["Naphthopyrones", "CHEMICAL", 0, 14], ["Naphthopyrones", "CHEMICAL", 0, 14], ["Naphthopyrones", "SIMPLE_CHEMICAL", 0, 14], ["Naphthopyrones", "TREATMENT", 0, 14], ["antidiabetic", "TREATMENT", 50, 62], ["antimicrobial", "TREATMENT", 74, 87], ["antiestrogenic", "TREATMENT", 95, 109], ["antiallergic", "TREATMENT", 117, 129], ["anthelmintic effects", "TREATMENT", 139, 159]]], ["At present, the Pharmacopoeia of the People's Republic of China recommends the use of chrysophanol and aurantio-obtusin as the indicator components, and the quality of Cassiae semen is evaluated primarily by assessing the content of these two compounds (1) .IntroductionThe purpose of the present review is to provide comprehensive information on the ethnobotany, phytochemistry and pharmacology of Cassiae semen collated from previous studies, in order to facilitate the further study and application of Cassiae semen, as well as generate a novel basis for the associations between structure and activity, and their molecular mechanisms of action. pairs and are glaucous, membranous, glabrous or pubescent, and have obcordate or obovate oblong morphology (2-6 cm long x 1.5-2.5 cm wide); the base is somewhat oblique, usually rounded and there are 8-10 pairs of main nerves.", [["semen", "ANATOMY", 513, 518], ["glaucous", "ANATOMY", 663, 671], ["membranous", "ANATOMY", 673, 683], ["glabrous", "ANATOMY", 685, 693], ["nerves", "ANATOMY", 868, 874], ["chrysophanol", "CHEMICAL", 86, 98], ["-obtusin", "CHEMICAL", 111, 119], ["chrysophanol", "CHEMICAL", 86, 98], ["aurantio-obtusin", "CHEMICAL", 103, 119], ["chrysophanol", "SIMPLE_CHEMICAL", 86, 98], ["aurantio-obtusin", "SIMPLE_CHEMICAL", 103, 119], ["Cassiae", "ORGANISM", 505, 512], ["semen", "ORGANISM_SUBSTANCE", 513, 518], ["glabrous", "TISSUE", 685, 693], ["nerves", "MULTI-TISSUE_STRUCTURE", 868, 874], ["People", "SPECIES", 37, 43], ["chrysophanol and aurantio-obtusin", "TREATMENT", 86, 119], ["previous studies", "TEST", 427, 443], ["the further study", "TEST", 468, 485], ["Cassiae semen", "TREATMENT", 505, 518], ["membranous, glabrous or pubescent", "PROBLEM", 673, 706], ["obcordate or obovate oblong morphology", "PROBLEM", 717, 755], ["somewhat oblique", "PROBLEM", 801, 817], ["glaucous", "OBSERVATION", 663, 671], ["membranous", "OBSERVATION_MODIFIER", 673, 683], ["glabrous", "OBSERVATION_MODIFIER", 685, 693], ["pubescent", "OBSERVATION_MODIFIER", 697, 706], ["obovate", "OBSERVATION_MODIFIER", 730, 737], ["oblong", "OBSERVATION_MODIFIER", 738, 744], ["morphology", "OBSERVATION_MODIFIER", 745, 755], ["2-6 cm long x 1.5-2.5 cm", "OBSERVATION_MODIFIER", 757, 781], ["base", "ANATOMY_MODIFIER", 793, 797], ["somewhat", "OBSERVATION_MODIFIER", 801, 809], ["oblique", "OBSERVATION", 810, 817], ["rounded", "OBSERVATION_MODIFIER", 827, 834], ["8-10 pairs", "OBSERVATION_MODIFIER", 849, 859], ["main nerves", "ANATOMY", 863, 874]]], ["The petiolules are 1.5-2 mm in length and their stipules are linear, pilose and caducous.", [["petiolules", "ANATOMY", 4, 14], ["stipules", "ANATOMY", 48, 56], ["petiolules", "CANCER", 4, 14], ["stipules", "CANCER", 48, 56], ["The petiolules", "TEST", 0, 14], ["length", "TEST", 31, 37], ["1.5-2 mm", "OBSERVATION_MODIFIER", 19, 27], ["stipules", "OBSERVATION_MODIFIER", 48, 56], ["linear", "OBSERVATION_MODIFIER", 61, 67]]], ["Flowers are usually in subsessile pairs in leaf axils, the pedicels are filiform and are 1-1.5 cm in length.", [["leaf axils", "ANATOMY", 43, 53], ["pedicels", "ANATOMY", 59, 67], ["filiform", "ANATOMY", 72, 80], ["leaf axils", "MULTI-TISSUE_STRUCTURE", 43, 53], ["pedicels", "TISSUE", 59, 67], ["leaf axils", "OBSERVATION", 43, 53], ["filiform", "OBSERVATION_MODIFIER", 72, 80], ["1-1.5 cm", "OBSERVATION_MODIFIER", 89, 97]]], ["Calyces are ovate, glabrous, membranous and comprised of five-parts; there are five petals, which are pale yellow, oblong, obtuse and the upper petal (standard) is two-lobed.", [["Calyces", "ANATOMY", 0, 7], ["glabrous", "ANATOMY", 19, 27], ["membranous", "ANATOMY", 29, 39], ["petals", "ANATOMY", 84, 90], ["petal", "ANATOMY", 144, 149], ["petals", "ORGAN", 84, 90], ["upper", "ORGANISM_SUBDIVISION", 138, 143], ["petal", "ORGAN", 144, 149], ["pale yellow", "PROBLEM", 102, 113], ["glabrous", "OBSERVATION_MODIFIER", 19, 27], ["membranous", "OBSERVATION", 29, 39], ["five petals", "OBSERVATION", 79, 90], ["pale", "OBSERVATION_MODIFIER", 102, 106], ["yellow", "OBSERVATION", 107, 113], ["oblong", "OBSERVATION_MODIFIER", 115, 121], ["obtuse", "OBSERVATION_MODIFIER", 123, 129], ["upper", "ANATOMY_MODIFIER", 138, 143], ["petal", "ANATOMY_MODIFIER", 144, 149]]], ["The flowers have 10 stamens, while the upper three are reduced to minute staminodes.", [["flowers", "ANATOMY", 4, 11], ["stamens", "ANATOMY", 20, 27], ["flowers", "ORGANISM_SUBDIVISION", 4, 11], ["flowers", "OBSERVATION_MODIFIER", 4, 11], ["10 stamens", "OBSERVATION_MODIFIER", 17, 27], ["upper", "ANATOMY_MODIFIER", 39, 44], ["reduced", "OBSERVATION", 55, 62], ["minute staminodes", "OBSERVATION", 66, 83]]], ["The pods are slender, puberulous, subtetragonous, obliquely septate and, are ~15 cm in length and 3-4 mm in width.IntroductionHowever, the seeds of C. obtusifolia are a dark brown or green-brown, rhombohedral or short cylindrical, and are 3-7 mm in length and 2-4 mm in width.", [["pods", "ANATOMY", 4, 8], ["septate", "ANATOMY", 60, 67], ["pods", "ORGANISM_SUBDIVISION", 4, 8], ["C. obtusifolia", "ORGANISM", 148, 162], ["C. obtusifolia", "SPECIES", 148, 162], ["C. obtusifolia", "SPECIES", 148, 162], ["slender, puberulous, subtetragonous, obliquely septate", "PROBLEM", 13, 67], ["length", "TEST", 87, 93], ["C. obtusifolia", "PROBLEM", 148, 162], ["a dark brown or green-brown, rhombohedral or short cylindrical", "PROBLEM", 167, 229], ["length", "TEST", 249, 255], ["pods", "OBSERVATION_MODIFIER", 4, 8], ["slender", "OBSERVATION_MODIFIER", 13, 20], ["subtetragonous", "OBSERVATION_MODIFIER", 34, 48], ["obliquely", "OBSERVATION_MODIFIER", 50, 59], ["septate", "OBSERVATION", 60, 67], ["~15 cm", "OBSERVATION_MODIFIER", 77, 83], ["length", "OBSERVATION_MODIFIER", 87, 93], ["3-4 mm", "OBSERVATION_MODIFIER", 98, 104], ["width", "OBSERVATION_MODIFIER", 108, 113], ["C. obtusifolia", "OBSERVATION", 148, 162], ["dark", "OBSERVATION_MODIFIER", 169, 173], ["brown", "OBSERVATION_MODIFIER", 174, 179], ["green", "OBSERVATION_MODIFIER", 183, 188], ["brown", "OBSERVATION_MODIFIER", 189, 194], ["rhombohedral", "OBSERVATION_MODIFIER", 196, 208], ["short cylindrical", "OBSERVATION_MODIFIER", 212, 229], ["3-7 mm", "OBSERVATION_MODIFIER", 239, 245], ["length", "OBSERVATION_MODIFIER", 249, 255], ["2-4 mm", "OBSERVATION_MODIFIER", 260, 266], ["width", "OBSERVATION_MODIFIER", 270, 275]]], ["While C. tora seeds are a light brown, shiny, short cylindrical, and are 3-5 mm in length and 2-3 mm in width (1, 21) .IntroductionC. obtusifolia is cultivated in multiple provinces of China, including Henan, Hubei, Shanxi, Sichuan, Zhejiang and Anhui, and also other countries, including Korea, India and Japan.", [["obtusifolia", "CHEMICAL", 134, 145], ["C. tora seeds", "ORGANISM", 6, 19], ["obtusifolia", "ORGANISM", 134, 145], ["C. tora", "SPECIES", 6, 13], ["obtusifolia", "SPECIES", 134, 145], ["C. tora", "SPECIES", 6, 13], ["obtusifolia", "SPECIES", 134, 145], ["a light brown, shiny, short cylindrical", "PROBLEM", 24, 63], ["length", "TEST", 83, 89], ["width", "TEST", 104, 109], ["obtusifolia", "PROBLEM", 134, 145], ["light brown", "OBSERVATION_MODIFIER", 26, 37], ["shiny", "OBSERVATION_MODIFIER", 39, 44], ["short cylindrical", "OBSERVATION_MODIFIER", 46, 63], ["3-5 mm", "OBSERVATION_MODIFIER", 73, 79], ["length", "OBSERVATION_MODIFIER", 83, 89], ["2-3 mm", "OBSERVATION_MODIFIER", 94, 100], ["width", "OBSERVATION_MODIFIER", 104, 109], ["cultivated", "OBSERVATION_MODIFIER", 149, 159], ["multiple", "OBSERVATION_MODIFIER", 163, 171], ["provinces", "OBSERVATION_MODIFIER", 172, 181]]], ["It is primarily distributed in moist and sunny places, in hillside shrubs and in the sandy soil of river banks (21) .IntroductionAs a widely used traditional Chinese medicine, there are some adulterants of this plant, including the seeds of C. occidentalis (Leguminosae), C. sophera (Leguminosae) and Sesbania aculeata Pers (Papilionaceae) (22) (23) (24) .", [["C. occidentalis", "ORGANISM", 241, 256], ["Leguminosae)", "ORGANISM", 258, 270], ["C. sophera", "ORGANISM", 272, 282], ["Leguminosae", "ORGANISM", 284, 295], ["Sesbania aculeata", "ORGANISM", 301, 318], ["Pers", "ORGANISM", 319, 323], ["C. occidentalis", "SPECIES", 241, 256], ["C. sophera", "SPECIES", 272, 282], ["Sesbania aculeata", "SPECIES", 301, 318], ["C. occidentalis", "SPECIES", 241, 256], ["C. sophera", "SPECIES", 272, 282], ["Sesbania aculeata", "SPECIES", 301, 318], ["traditional Chinese medicine", "TREATMENT", 146, 174], ["this plant", "TREATMENT", 206, 216], ["C. occidentalis", "PROBLEM", 241, 256], ["C. sophera (Leguminosae)", "PROBLEM", 272, 296], ["primarily", "OBSERVATION_MODIFIER", 6, 15], ["distributed", "OBSERVATION_MODIFIER", 16, 27], ["moist", "OBSERVATION_MODIFIER", 31, 36], ["Leguminosae", "ANATOMY", 284, 295]]], ["To date, a number of methods have been developed to identify and distinguish these, including experiential identification, morphological identification, ultraviolet spectrophotometry, the thin layer chromatography method, high performance liquid chromatography (HPLC), HPLC-coupled with time-of-flight and ion trap mass spectrometry, and SDS-PAGE (25) (26) (27) (28) .", [["experiential identification", "TEST", 94, 121], ["morphological identification", "TEST", 123, 151], ["ultraviolet spectrophotometry", "TEST", 153, 182], ["the thin layer chromatography method", "TEST", 184, 220], ["high performance liquid chromatography", "TEST", 222, 260], ["HPLC", "TEST", 262, 266], ["HPLC", "TEST", 269, 273], ["ion trap mass spectrometry", "TEST", 306, 332], ["SDS", "TEST", 338, 341]]], ["Among these methods, the HPLC method is regarded as the most popular method for evaluating the quality and authenticity of Cassiae semen.", [["semen", "ANATOMY", 131, 136], ["Cassiae", "ORGANISM", 123, 130], ["semen", "ORGANISM_SUBSTANCE", 131, 136], ["the HPLC method", "TEST", 21, 36]]], ["Chrysophanol and aurantio-obtusin are used as the indicator compounds to characterize the quality of this plant and the minimum contents are defined as 0.20 and 0.080%, respectively, in the Pharmacopoeia of the People's Republic of China (1).PhytochemistryA number of compounds, including anthraquinones, naphthopyrones, volatile oils and sterols, have been isolated from Cassiae semen.", [["volatile oils", "ANATOMY", 321, 334], ["semen", "ANATOMY", 380, 385], ["Chrysophanol", "CHEMICAL", 0, 12], ["-obtusin", "CHEMICAL", 25, 33], ["anthraquinones", "CHEMICAL", 289, 303], ["naphthopyrones", "CHEMICAL", 305, 319], ["sterols", "CHEMICAL", 339, 346], ["Chrysophanol", "CHEMICAL", 0, 12], ["aurantio-obtusin", "CHEMICAL", 17, 33], ["anthraquinones", "CHEMICAL", 289, 303], ["naphthopyrones", "CHEMICAL", 305, 319], ["sterols", "CHEMICAL", 339, 346], ["Chrysophanol", "SIMPLE_CHEMICAL", 0, 12], ["aurantio-obtusin", "SIMPLE_CHEMICAL", 17, 33], ["anthraquinones", "SIMPLE_CHEMICAL", 289, 303], ["naphthopyrones", "SIMPLE_CHEMICAL", 305, 319], ["volatile oils", "SIMPLE_CHEMICAL", 321, 334], ["sterols", "SIMPLE_CHEMICAL", 339, 346], ["Cassiae", "ORGANISM", 372, 379], ["semen", "ORGANISM_SUBSTANCE", 380, 385], ["People", "SPECIES", 211, 217], ["Chrysophanol", "TREATMENT", 0, 12], ["aurantio-obtusin", "TREATMENT", 17, 33], ["anthraquinones", "TREATMENT", 289, 303], ["naphthopyrones", "TREATMENT", 305, 319], ["volatile oils", "TREATMENT", 321, 334], ["sterols", "TREATMENT", 339, 346]]], ["Anthraquinones and naphthopyrones, which exhibit multiple pharmacological activities, are considered the primary active ingredients of Cassiae semen.", [["semen", "ANATOMY", 143, 148], ["Anthraquinones", "CHEMICAL", 0, 14], ["naphthopyrones", "CHEMICAL", 19, 33], ["Anthraquinones", "CHEMICAL", 0, 14], ["naphthopyrones", "CHEMICAL", 19, 33], ["Anthraquinones", "SIMPLE_CHEMICAL", 0, 14], ["naphthopyrones", "SIMPLE_CHEMICAL", 19, 33], ["Cassiae", "ORGANISM", 135, 142], ["semen", "ORGANISM_SUBSTANCE", 143, 148], ["Anthraquinones", "TREATMENT", 0, 14], ["naphthopyrones", "TREATMENT", 19, 33], ["multiple", "OBSERVATION_MODIFIER", 49, 57], ["pharmacological activities", "OBSERVATION", 58, 84]]], ["All compounds isolated from Cassiae semen are listed in Table I, Anthraquinones.", [["semen", "ANATOMY", 36, 41], ["Anthraquinones", "CHEMICAL", 65, 79], ["Cassiae", "ORGANISM", 28, 35], ["semen", "ORGANISM_SUBSTANCE", 36, 41], ["Anthraquinones", "SIMPLE_CHEMICAL", 65, 79]]], ["Cassiae semen contains structurally diverse and biologically active anthraquinones.", [["anthraquinones", "CHEMICAL", 68, 82], ["anthraquinones", "SIMPLE_CHEMICAL", 68, 82], ["structurally", "OBSERVATION_MODIFIER", 23, 35], ["diverse", "OBSERVATION_MODIFIER", 36, 43]]], ["Thus far, ~53 anthraquinones have been isolated and identified.", [["anthraquinones", "CHEMICAL", 14, 28], ["anthraquinones", "SIMPLE_CHEMICAL", 14, 28]]], ["The predominant anthraquinones are emodin-type anthraquinones, which include emodin, chrysophanol, physcion, aloe-emodin, rhein, obtusin, chryso-obtusin, aurantio-obtusin, obtusifolin, questin, 1-desmethylaurantio-obtusin, 1-desmethylobtusin, 1-desmethylchryso-obtusin, chrysophanol-10,10'-bianthrone, 1, 2-dihydroxyanthraquinone, 2-hydroxyemodin-1-methylether, alaternin, 1,3-dihydroxy-6-methoxy-7-methyl anthraquinone, 1-hydroxy-3,7-diformyl anthraquinone, chrysarobin, 8-O-methylchrysophanol, 1-O-methylemodin, 1,2-dimethoxy-8-hydroxy-3-methyl-9 ,10-anthraquinone and l,2,7-trimethoxyl-6,8-dihydroxy-3-methylanthraquinone (compounds 1-24, respectively; Fig. 1 ); these have all been isolated from Cassiae semen (29) (30) (31) (32) (33) (34) (35) (36) (37) (38) .", [["anthraquinones", "CHEMICAL", 16, 30], ["emodin-type anthraquinones", "CHEMICAL", 35, 61], ["emodin", "CHEMICAL", 77, 83], ["chrysophanol", "CHEMICAL", 85, 97], ["physcion", "CHEMICAL", 99, 107], ["aloe-emodin", "CHEMICAL", 109, 120], ["rhein", "CHEMICAL", 122, 127], ["obtusin", "CHEMICAL", 129, 136], ["chryso-obtusin", "CHEMICAL", 138, 152], ["aurantio-obtusin", "CHEMICAL", 154, 170], ["obtusifolin", "CHEMICAL", 172, 183], ["questin", "CHEMICAL", 185, 192], ["1-desmethylaurantio-obtusin", "CHEMICAL", 194, 221], ["1-desmethylobtusin", "CHEMICAL", 223, 241], ["1-desmethylchryso-obtusin", "CHEMICAL", 243, 268], ["chrysophanol-10,10'-bianthrone", "CHEMICAL", 270, 300], ["1, 2-dihydroxyanthraquinone", "CHEMICAL", 302, 329], ["2-hydroxyemodin-1-methylether", "CHEMICAL", 331, 360], ["alaternin", "CHEMICAL", 362, 371], ["1,3-dihydroxy-6-methoxy-7-methyl anthraquinone", "CHEMICAL", 373, 419], ["1-hydroxy-3,7-diformyl anthraquinone", "CHEMICAL", 421, 457], ["chrysarobin", "CHEMICAL", 459, 470], ["8-O-methylchrysophanol", "CHEMICAL", 472, 494], ["1-O-methylemodin", "CHEMICAL", 496, 512], ["1,2-dimethoxy-8-hydroxy-3-methyl-9 ,10-anthraquinone", "CHEMICAL", 514, 566], ["2,7-trimethoxyl-6,8-dihydroxy-3-methylanthraquinone", "CHEMICAL", 573, 624], ["compounds 1-24", "CHEMICAL", 626, 640], ["anthraquinones", "CHEMICAL", 16, 30], ["emodin", "CHEMICAL", 35, 41], ["anthraquinones", "CHEMICAL", 47, 61], ["emodin", "CHEMICAL", 77, 83], ["chrysophanol", "CHEMICAL", 85, 97], ["physcion", "CHEMICAL", 99, 107], ["aloe-emodin", "CHEMICAL", 109, 120], ["rhein", "CHEMICAL", 122, 127], ["obtusin", "CHEMICAL", 129, 136], ["chryso-obtusin", "CHEMICAL", 138, 152], ["aurantio-obtusin", "CHEMICAL", 154, 170], ["obtusifolin", "CHEMICAL", 172, 183], ["questin", "CHEMICAL", 185, 192], ["1-desmethylaurantio-obtusin", "CHEMICAL", 194, 221], ["1-desmethylobtusin", "CHEMICAL", 223, 241], ["1-desmethylchryso-obtusin", "CHEMICAL", 243, 268], ["chrysophanol-10,10'-bianthrone", "CHEMICAL", 270, 300], ["1, 2-dihydroxyanthraquinone", "CHEMICAL", 302, 329], ["2-hydroxyemodin-1-methylether", "CHEMICAL", 331, 360], ["alaternin", "CHEMICAL", 362, 371], ["1,3-dihydroxy-6-methoxy-7-methyl anthraquinone", "CHEMICAL", 373, 419], ["1-hydroxy-3,7-diformyl anthraquinone", "CHEMICAL", 421, 457], ["chrysarobin", "CHEMICAL", 459, 470], ["8-O-methylchrysophanol", "CHEMICAL", 472, 494], ["1-O-methylemodin", "CHEMICAL", 496, 512], ["1,2-dimethoxy-8-hydroxy-3-methyl-9 ,10-anthraquinone", "CHEMICAL", 514, 566], ["l,2,7-trimethoxyl-6,8-dihydroxy-3-methylanthraquinone", "CHEMICAL", 571, 624], ["anthraquinones", "SIMPLE_CHEMICAL", 16, 30], ["emodin-type anthraquinones", "SIMPLE_CHEMICAL", 35, 61], ["emodin", "SIMPLE_CHEMICAL", 77, 83], ["chrysophanol", "SIMPLE_CHEMICAL", 85, 97], ["physcion", "SIMPLE_CHEMICAL", 99, 107], ["aloe-emodin", "SIMPLE_CHEMICAL", 109, 120], ["rhein", "SIMPLE_CHEMICAL", 122, 127], ["obtusin", "SIMPLE_CHEMICAL", 129, 136], ["chryso-obtusin", "SIMPLE_CHEMICAL", 138, 152], ["aurantio-obtusin", "SIMPLE_CHEMICAL", 154, 170], ["obtusifolin", "SIMPLE_CHEMICAL", 172, 183], ["questin", "SIMPLE_CHEMICAL", 185, 192], ["1-desmethylaurantio-obtusin", "SIMPLE_CHEMICAL", 194, 221], ["1-desmethylobtusin", "SIMPLE_CHEMICAL", 223, 241], ["1-desmethylchryso-obtusin", "SIMPLE_CHEMICAL", 243, 268], ["chrysophanol-10,10'-bianthrone, 1, 2-dihydroxyanthraquinone", "SIMPLE_CHEMICAL", 270, 329], ["2-hydroxyemodin-1-methylether", "SIMPLE_CHEMICAL", 331, 360], ["alaternin", "SIMPLE_CHEMICAL", 362, 371], ["1,3-dihydroxy-6-methoxy-7-methyl anthraquinone", "SIMPLE_CHEMICAL", 373, 419], ["1-hydroxy-3,7-diformyl anthraquinone", "SIMPLE_CHEMICAL", 421, 457], ["chrysarobin", "SIMPLE_CHEMICAL", 459, 470], ["8-O-methylchrysophanol", "SIMPLE_CHEMICAL", 472, 494], ["1-O-methylemodin", "SIMPLE_CHEMICAL", 496, 512], ["1,2-dimethoxy-8-hydroxy-3-methyl-9 ,10-anthraquinone", "SIMPLE_CHEMICAL", 514, 566], ["l,2,7-trimethoxyl-6,8-dihydroxy-3-methylanthraquinone", "SIMPLE_CHEMICAL", 571, 624], ["compounds 1-24", "SIMPLE_CHEMICAL", 626, 640], ["The predominant anthraquinones", "TREATMENT", 0, 30], ["emodin-type anthraquinones", "TREATMENT", 35, 61], ["emodin", "TREATMENT", 77, 83], ["physcion", "TREATMENT", 99, 107], ["aloe-emodin", "TREATMENT", 109, 120], ["rhein", "TREATMENT", 122, 127], ["obtusin", "TREATMENT", 261, 268], ["chrysophanol", "TREATMENT", 270, 282], ["bianthrone", "TREATMENT", 290, 300], ["dihydroxyanthraquinone", "TREATMENT", 307, 329], ["hydroxyemodin", "TREATMENT", 333, 346], ["methylether", "TREATMENT", 349, 360], ["alaternin", "TREATMENT", 362, 371], ["dihydroxy", "TEST", 377, 386], ["methoxy", "TREATMENT", 389, 396], ["methyl anthraquinone", "TREATMENT", 399, 419], ["hydroxy", "TEST", 423, 430], ["diformyl anthraquinone", "TREATMENT", 435, 457], ["chrysarobin", "TREATMENT", 459, 470], ["methylchrysophanol", "TREATMENT", 476, 494], ["methylemodin", "TREATMENT", 500, 512], ["dimethoxy", "TEST", 518, 527], ["anthraquinone", "TREATMENT", 553, 566], ["trimethoxyl", "TREATMENT", 577, 588], ["dihydroxy-3-methylanthraquinone (compounds", "TREATMENT", 593, 635], ["predominant", "OBSERVATION_MODIFIER", 4, 15], ["anthraquinones", "OBSERVATION", 16, 30]]], ["There are also many combined anthraquinones (compounds 25-46; Fig. 1 ), which have been isolated from the seeds of C. obtusifolia or C. tora (3, 7, 30, 36, (39) (40) (41) (42) (43) (44) (45) (46) .PhytochemistryNaphthopyrones.", [["anthraquinones", "CHEMICAL", 29, 43], ["compounds 25-46", "CHEMICAL", 45, 60], ["3, 7, 30, 36,", "CHEMICAL", 142, 155], ["Naphthopyrones", "CHEMICAL", 211, 225], ["anthraquinones", "CHEMICAL", 29, 43], ["Naphthopyrones", "CHEMICAL", 211, 225], ["anthraquinones", "SIMPLE_CHEMICAL", 29, 43], ["compounds 25-46", "SIMPLE_CHEMICAL", 45, 60], ["Fig. 1 )", "SIMPLE_CHEMICAL", 62, 70], ["C. obtusifolia", "ORGANISM", 115, 129], ["C. tora", "ORGANISM", 133, 140], ["(39) (40) (41) (42) (43) (44) (45", "SIMPLE_CHEMICAL", 156, 189], ["Naphthopyrones", "SIMPLE_CHEMICAL", 211, 225], ["C. obtusifolia", "SPECIES", 115, 129], ["C. tora", "SPECIES", 133, 140], ["C. obtusifolia", "SPECIES", 115, 129], ["C. tora", "SPECIES", 133, 140], ["C. obtusifolia", "PROBLEM", 115, 129], ["C. tora", "TEST", 133, 140], ["PhytochemistryNaphthopyrones", "TREATMENT", 197, 225]]], ["Naphthopyrones are the other characteristic components in Cassiae semen.", [["semen", "ANATOMY", 66, 71], ["Naphthopyrones", "CHEMICAL", 0, 14], ["Naphthopyrones", "CHEMICAL", 0, 14], ["Naphthopyrones", "SIMPLE_CHEMICAL", 0, 14], ["Cassiae semen", "ORGANISM_SUBSTANCE", 58, 71], ["Naphthopyrones", "TREATMENT", 0, 14]]], ["In 1969, torachrysone, rubrofusarin and rubrofusarin-6-O-\u03b2-D-gentiobioside were isolated from C. tora seeds (compounds 47-49, respectively; Fig. 2 ) (47, 48) .", [["torachrysone", "CHEMICAL", 9, 21], ["rubrofusarin", "CHEMICAL", 23, 35], ["rubrofusarin-6-O-\u03b2-D-gentiobioside", "CHEMICAL", 40, 74], ["torachrysone", "CHEMICAL", 9, 21], ["rubrofusarin", "CHEMICAL", 23, 35], ["rubrofusarin-6-O-\u03b2-D-gentiobioside", "CHEMICAL", 40, 74], ["torachrysone", "SIMPLE_CHEMICAL", 9, 21], ["rubrofusarin", "SIMPLE_CHEMICAL", 23, 35], ["rubrofusarin-6-O-\u03b2-D-gentiobioside", "SIMPLE_CHEMICAL", 40, 74], ["C. tora seeds", "ORGANISM", 94, 107], ["C. tora", "SPECIES", 94, 101], ["C. tora", "SPECIES", 94, 101], ["torachrysone", "TREATMENT", 9, 21], ["rubrofusarin", "TREATMENT", 23, 35], ["rubrofusarin", "TREATMENT", 40, 52], ["gentiobioside", "TREATMENT", 61, 74]]], ["Subsequently, toralactone, rubrofusarin triglucoside, cassiaside, nor-rubrofusarin gentiobioside, cassiaside B, cassiaside C, torachrysone apiglucoside, torachrysone gentiobioside, torachrysone tetraglucoside, cassiatoroside, demethylflavasperone gentiobioside and cassialactone gentiobioside were isolated from C. tora seeds (compounds 50-61, respectively; Fig. 2 ) (17, 28, (49) (50) (51) .", [["toralactone", "CHEMICAL", 14, 25], ["rubrofusarin triglucoside, cassiaside, nor-rubrofusarin gentiobioside, cassiaside B, cassiaside C, torachrysone apiglucoside", "CHEMICAL", 27, 151], ["torachrysone gentiobioside", "CHEMICAL", 153, 179], ["torachrysone tetraglucoside", "CHEMICAL", 181, 208], ["cassiatoroside", "CHEMICAL", 210, 224], ["demethylflavasperone gentiobioside", "CHEMICAL", 226, 260], ["cassialactone gentiobioside", "CHEMICAL", 265, 292], ["toralactone", "CHEMICAL", 14, 25], ["rubrofusarin triglucoside", "CHEMICAL", 27, 52], ["cassiaside", "CHEMICAL", 54, 64], ["nor-rubrofusarin gentiobioside", "CHEMICAL", 66, 96], ["cassiaside B", "CHEMICAL", 98, 110], ["cassiaside C", "CHEMICAL", 112, 124], ["torachrysone apiglucoside", "CHEMICAL", 126, 151], ["torachrysone gentiobioside", "CHEMICAL", 153, 179], ["torachrysone tetraglucoside", "CHEMICAL", 181, 208], ["cassiatoroside", "CHEMICAL", 210, 224], ["demethylflavasperone gentiobioside", "CHEMICAL", 226, 260], ["cassialactone gentiobioside", "CHEMICAL", 265, 292], ["toralactone", "SIMPLE_CHEMICAL", 14, 25], ["rubrofusarin triglucoside", "SIMPLE_CHEMICAL", 27, 52], ["cassiaside", "SIMPLE_CHEMICAL", 54, 64], ["nor-rubrofusarin gentiobioside", "SIMPLE_CHEMICAL", 66, 96], ["cassiaside B", "SIMPLE_CHEMICAL", 98, 110], ["cassiaside C", "SIMPLE_CHEMICAL", 112, 124], ["torachrysone apiglucoside", "SIMPLE_CHEMICAL", 126, 151], ["torachrysone gentiobioside", "SIMPLE_CHEMICAL", 153, 179], ["torachrysone tetraglucoside", "SIMPLE_CHEMICAL", 181, 208], ["cassiatoroside", "SIMPLE_CHEMICAL", 210, 224], ["demethylflavasperone gentiobioside", "SIMPLE_CHEMICAL", 226, 260], ["cassialactone gentiobioside", "SIMPLE_CHEMICAL", 265, 292], ["C. tora seeds", "ORGANISM", 312, 325], ["C. tora", "SPECIES", 312, 319], ["C. tora", "SPECIES", 312, 319], ["toralactone", "TREATMENT", 14, 25], ["rubrofusarin triglucoside", "TREATMENT", 27, 52], ["cassiaside", "TREATMENT", 54, 64], ["nor-rubrofusarin gentiobioside", "TREATMENT", 66, 96], ["cassiaside C", "TREATMENT", 112, 124], ["torachrysone apiglucoside", "TREATMENT", 126, 151], ["torachrysone gentiobioside", "TREATMENT", 153, 179], ["torachrysone tetraglucoside", "TREATMENT", 181, 208], ["cassiatoroside", "TREATMENT", 210, 224], ["demethylflavasperone gentiobioside", "TREATMENT", 226, 260], ["cassialactone gentiobioside", "TREATMENT", 265, 292]]], ["In addition, cassiaside B and cassiaside C were identified in the seeds of C. obtusifolia (52) .", [["seeds", "ANATOMY", 66, 71], ["cassiaside B", "CHEMICAL", 13, 25], ["cassiaside C", "CHEMICAL", 30, 42], ["cassiaside B", "CHEMICAL", 13, 25], ["cassiaside C", "CHEMICAL", 30, 42], ["cassiaside B", "SIMPLE_CHEMICAL", 13, 25], ["cassiaside C", "SIMPLE_CHEMICAL", 30, 42], ["C. obtusifolia", "ORGANISM", 75, 89], ["C. obtusifolia", "SPECIES", 75, 89], ["C. obtusifolia", "SPECIES", 75, 89], ["C. obtusifolia", "PROBLEM", 75, 89]]], ["Other naphthopyrones, including torosachrysone, isotoralactone, cassialactone, cassiaside B 2 , cassiaside C 2 , nor-rubrofusarin Volatile oils.", [["naphthopyrones", "CHEMICAL", 6, 20], ["torosachrysone", "CHEMICAL", 32, 46], ["isotoralactone", "CHEMICAL", 48, 62], ["cassialactone", "CHEMICAL", 64, 77], ["cassiaside B 2 , cassiaside C 2 , nor-rubrofusarin", "CHEMICAL", 79, 129], ["naphthopyrones", "CHEMICAL", 6, 20], ["torosachrysone", "CHEMICAL", 32, 46], ["isotoralactone", "CHEMICAL", 48, 62], ["cassialactone", "CHEMICAL", 64, 77], ["cassiaside B", "CHEMICAL", 79, 91], ["cassiaside C", "CHEMICAL", 96, 108], ["nor-rubrofusarin", "CHEMICAL", 113, 129], ["naphthopyrones", "SIMPLE_CHEMICAL", 6, 20], ["torosachrysone", "SIMPLE_CHEMICAL", 32, 46], ["isotoralactone", "SIMPLE_CHEMICAL", 48, 62], ["cassialactone", "SIMPLE_CHEMICAL", 64, 77], ["cassiaside B 2", "SIMPLE_CHEMICAL", 79, 93], ["cassiaside C 2", "SIMPLE_CHEMICAL", 96, 110], ["nor-rubrofusarin Volatile oils", "SIMPLE_CHEMICAL", 113, 143], ["Other naphthopyrones", "TREATMENT", 0, 20], ["torosachrysone", "TREATMENT", 32, 46], ["isotoralactone", "TREATMENT", 48, 62], ["cassialactone", "TREATMENT", 64, 77]]], ["Li (56) extracted the volatile oils from Cassiae semen by steam distillation, and subsequently identified 37 components according to the gas chromatography/mass spectrometry analysis.", [["volatile oils", "ANATOMY", 22, 35], ["semen", "ANATOMY", 49, 54], ["Li", "CHEMICAL", 0, 2], ["Li (56)", "CHEMICAL", 0, 7], ["Cassiae semen", "ORGANISM_SUBSTANCE", 41, 54], ["the gas chromatography", "TEST", 133, 155], ["mass spectrometry analysis", "TEST", 156, 182]]], ["Among these peaks, the major volatile components were 9-octadecenoic acid (E) (22.15%), n-hexadecanoic acid (12.53%), 9,10-anthracenedione, 1,8-dihydroxy-3-methyl (7.66%), octadecanoic acid (4.56%) and 13-octadecenoic acid methyl ester (Z) (3.84%) (56) .PhytochemistryOther compounds.", [["9-octadecenoic acid", "CHEMICAL", 54, 73], ["n-hexadecanoic acid", "CHEMICAL", 88, 107], ["9,10-anthracenedione", "CHEMICAL", 118, 138], ["1,8-dihydroxy-3-methyl", "CHEMICAL", 140, 162], ["octadecanoic acid", "CHEMICAL", 172, 189], ["13-octadecenoic acid methyl ester", "CHEMICAL", 202, 235], ["9-octadecenoic acid", "CHEMICAL", 54, 73], ["n-hexadecanoic acid", "CHEMICAL", 88, 107], ["9,10-anthracenedione", "CHEMICAL", 118, 138], ["1,8-dihydroxy-3-methyl", "CHEMICAL", 140, 162], ["octadecanoic acid", "CHEMICAL", 172, 189], ["13-octadecenoic acid methyl ester", "CHEMICAL", 202, 235], ["9-octadecenoic acid", "SIMPLE_CHEMICAL", 54, 73], ["E", "SIMPLE_CHEMICAL", 75, 76], ["n-hexadecanoic acid", "SIMPLE_CHEMICAL", 88, 107], ["9,10-anthracenedione", "SIMPLE_CHEMICAL", 118, 138], ["1,8-dihydroxy-3-methyl", "SIMPLE_CHEMICAL", 140, 162], ["octadecanoic acid", "SIMPLE_CHEMICAL", 172, 189], ["13-octadecenoic acid methyl ester", "SIMPLE_CHEMICAL", 202, 235], ["the major volatile components", "TEST", 19, 48], ["n-hexadecanoic acid", "TEST", 88, 107], ["dihydroxy", "TEST", 144, 153], ["octadecanoic acid", "TREATMENT", 172, 189], ["octadecenoic acid methyl ester (Z)", "TREATMENT", 205, 239], ["peaks", "OBSERVATION_MODIFIER", 12, 17]]], ["A range of other components have been isolated from Cassiae semen, including malvalic acid, sterculic acid, mandelic acid, campesterol, aspidinol and 5,7-dihydroxychromone (compounds 69-74, respectively; Fig. 3 ) (5, 57, 58) .", [["semen", "ANATOMY", 60, 65], ["malvalic acid", "CHEMICAL", 77, 90], ["sterculic acid", "CHEMICAL", 92, 106], ["mandelic acid", "CHEMICAL", 108, 121], ["campesterol", "CHEMICAL", 123, 134], ["aspidinol", "CHEMICAL", 136, 145], ["5,7-dihydroxychromone", "CHEMICAL", 150, 171], ["malvalic acid", "CHEMICAL", 77, 90], ["sterculic acid", "CHEMICAL", 92, 106], ["mandelic acid", "CHEMICAL", 108, 121], ["campesterol", "CHEMICAL", 123, 134], ["aspidinol", "CHEMICAL", 136, 145], ["5,7-dihydroxychromone", "CHEMICAL", 150, 171], ["Cassiae", "ORGANISM", 52, 59], ["semen", "ORGANISM_SUBSTANCE", 60, 65], ["malvalic acid", "SIMPLE_CHEMICAL", 77, 90], ["sterculic acid", "SIMPLE_CHEMICAL", 92, 106], ["mandelic acid", "SIMPLE_CHEMICAL", 108, 121], ["campesterol", "SIMPLE_CHEMICAL", 123, 134], ["aspidinol", "SIMPLE_CHEMICAL", 136, 145], ["5,7-dihydroxychromone", "SIMPLE_CHEMICAL", 150, 171], ["Cassiae semen", "TREATMENT", 52, 65], ["malvalic acid", "TREATMENT", 77, 90], ["sterculic acid", "TREATMENT", 92, 106], ["mandelic acid", "TEST", 108, 121], ["campesterol", "TREATMENT", 123, 134], ["aspidinol", "TREATMENT", 136, 145], ["dihydroxychromone", "TREATMENT", 154, 171], ["range", "OBSERVATION_MODIFIER", 2, 7]]], ["In addition, the four f lavonoid compounds, chrysin, chrysin-7-O-\u03b2-D-glucoside, galangin and cyanidenon, were also obtained and identified from Cassiae semen (compounds 75-78, respectively; Fig. 3 ) (58).PharmacologyCassiae semen exerts a great variety of pharmacological activities due to its complex bioactive compounds.", [["semen", "ANATOMY", 224, 229], ["chrysin", "CHEMICAL", 44, 51], ["chrysin-7-O-\u03b2-D-glucoside", "CHEMICAL", 53, 78], ["galangin", "CHEMICAL", 80, 88], ["cyanidenon", "CHEMICAL", 93, 103], ["lavonoid", "CHEMICAL", 24, 32], ["chrysin", "CHEMICAL", 44, 51], ["chrysin-7-O-\u03b2-D-glucoside", "CHEMICAL", 53, 78], ["galangin", "CHEMICAL", 80, 88], ["cyanidenon", "CHEMICAL", 93, 103], ["f lavonoid compounds", "SIMPLE_CHEMICAL", 22, 42], ["chrysin", "SIMPLE_CHEMICAL", 44, 51], ["chrysin-7-O-\u03b2-D-glucoside", "SIMPLE_CHEMICAL", 53, 78], ["galangin", "SIMPLE_CHEMICAL", 80, 88], ["cyanidenon", "SIMPLE_CHEMICAL", 93, 103], ["Cassiae", "ORGANISM", 144, 151], ["semen", "ORGANISM_SUBSTANCE", 152, 157], ["semen", "ORGANISM_SUBSTANCE", 224, 229], ["chrysin", "TREATMENT", 44, 51], ["chrysin", "TEST", 53, 60], ["galangin", "TREATMENT", 80, 88], ["cyanidenon", "TREATMENT", 93, 103], ["PharmacologyCassiae semen", "TREATMENT", 204, 229], ["pharmacological activities", "TREATMENT", 256, 282], ["bioactive compounds", "OBSERVATION", 302, 321]]], ["An overview of the pharmacological studies on Cassiae semen is presented in detail in the following sections.PharmacologyAntihyperlipidemic activity.", [["semen", "ANATOMY", 54, 59], ["sections", "ANATOMY", 100, 108], ["Cassiae", "ORGANISM", 46, 53], ["semen", "ORGANISM_SUBSTANCE", 54, 59], ["the pharmacological studies", "TEST", 15, 42], ["PharmacologyAntihyperlipidemic activity", "TREATMENT", 109, 148]]], ["In traditional Chinese herbal medicine, Cassiae semen is used for the prevention and Alaternin-1-O-\u03b2-D-glucopyranoside (7) 33PharmacologyAlaternin-2-O-\u03b2-D-glucopyranoside (29) 34PharmacologyAurantio-obtusin-6-O-\u03b2-D-glucopyranoside (43) 35PharmacologyChryso-obtusin-2-O-\u03b2-D-glucopyranoside (7) 36PharmacologyObtusifolin Rubrofusarin (47) 49 RubrofusarinPharmacologytreatment of hyperlipidemia.", [["Cassiae", "CHEMICAL", 40, 47], ["Alaternin-1-O-\u03b2-D-glucopyranoside", "CHEMICAL", 85, 118], ["Alaternin-2-O-\u03b2-D-glucopyranoside", "CHEMICAL", 137, 170], ["34PharmacologyAurantio-obtusin-6-O-\u03b2-D-glucopyranoside", "CHEMICAL", 176, 230], ["obtusin-2-O-\u03b2-D-glucopyranoside", "CHEMICAL", 257, 288], ["Rubrofusarin", "CHEMICAL", 319, 331], ["hyperlipidemia", "DISEASE", 377, 391], ["Alaternin-1-O-\u03b2-D-glucopyranoside", "CHEMICAL", 85, 118], ["Alaternin-2-O-\u03b2-D-glucopyranoside", "CHEMICAL", 137, 170], ["34PharmacologyAurantio-obtusin-6-O-\u03b2-D-glucopyranoside", "CHEMICAL", 176, 230], ["Chryso-obtusin-2-O-\u03b2-D-glucopyranoside", "CHEMICAL", 250, 288], ["Rubrofusarin", "CHEMICAL", 319, 331], ["Rubrofusarin", "CHEMICAL", 340, 352], ["Cassiae", "ORGANISM", 40, 47], ["semen", "ORGANISM_SUBSTANCE", 48, 53], ["Alaternin-1-O-\u03b2-D-glucopyranoside (7) 33PharmacologyAlaternin-2-O-\u03b2-D-glucopyranoside (29) 34PharmacologyAurantio-obtusin-6-O-\u03b2-D-glucopyranoside (43) 35PharmacologyChryso-obtusin-2-O-\u03b2-D-glucopyranoside (7) 36PharmacologyObtusifolin Rubrofusarin (47) 49", "SIMPLE_CHEMICAL", 85, 339], ["Rubrofusarin", "SIMPLE_CHEMICAL", 340, 352], ["traditional Chinese herbal medicine", "TREATMENT", 3, 38], ["Cassiae semen", "TREATMENT", 40, 53], ["Alaternin", "TEST", 85, 94], ["Alaternin", "TEST", 137, 146], ["glucopyranoside", "TREATMENT", 215, 230], ["Chryso-obtusin", "TREATMENT", 250, 264], ["glucopyranoside", "TREATMENT", 273, 288], ["Rubrofusarin", "TREATMENT", 319, 331], ["hyperlipidemia", "PROBLEM", 377, 391], ["hyperlipidemia", "OBSERVATION", 377, 391]]], ["Several Chinese herbal formulations containing Cassiae semen is available in the Chinese market for preventing the formation of atherosclerotic plaques (59) .", [["atherosclerotic plaques", "ANATOMY", 128, 151], ["Cassiae", "CHEMICAL", 47, 54], ["atherosclerotic plaques", "DISEASE", 128, 151], ["Cassiae", "ORGANISM", 47, 54], ["semen", "ORGANISM_SUBSTANCE", 55, 60], ["atherosclerotic plaques", "PATHOLOGICAL_FORMATION", 128, 151], ["Several Chinese herbal formulations", "TREATMENT", 0, 35], ["Cassiae semen", "TREATMENT", 47, 60], ["atherosclerotic plaques", "PROBLEM", 128, 151], ["atherosclerotic", "OBSERVATION_MODIFIER", 128, 143], ["plaques", "OBSERVATION", 144, 151]]], ["In certain Asian countries, including China and Korea, it is also commonly drunk as a roasted tea to reduce body weight (60, 61) .", [["tea", "ANATOMY", 94, 97], ["body", "ANATOMY", 108, 112], ["roasted tea", "CHEMICAL", 86, 97], ["tea", "ORGANISM_SUBDIVISION", 94, 97], ["body", "ORGANISM_SUBDIVISION", 108, 112], ["a roasted tea", "TREATMENT", 84, 97], ["body weight", "TEST", 108, 119]]], ["Previous studies using mice have evaluated the reductions in blood lipid contents induced by different Cassiae semen extracts obtained through different methods, including supercritical fluid extraction, systematic solvents (petroleum ether, ethyl acetate, n-butanol, 70% ethanol and water) and ethanol precipitation following water extraction.", [["blood", "ANATOMY", 61, 66], ["extracts", "ANATOMY", 117, 125], ["petroleum ether, ethyl acetate, n-butanol", "CHEMICAL", 225, 266], ["ethanol", "CHEMICAL", 272, 279], ["ethanol", "CHEMICAL", 295, 302], ["petroleum ether", "CHEMICAL", 225, 240], ["ethyl acetate", "CHEMICAL", 242, 255], ["n-butanol", "CHEMICAL", 257, 266], ["ethanol", "CHEMICAL", 272, 279], ["ethanol", "CHEMICAL", 295, 302], ["mice", "ORGANISM", 23, 27], ["blood", "ORGANISM_SUBSTANCE", 61, 66], ["lipid", "SIMPLE_CHEMICAL", 67, 72], ["semen extracts", "ORGANISM_SUBSTANCE", 111, 125], ["petroleum ether", "SIMPLE_CHEMICAL", 225, 240], ["ethyl acetate", "SIMPLE_CHEMICAL", 242, 255], ["n-butanol", "SIMPLE_CHEMICAL", 257, 266], ["ethanol", "SIMPLE_CHEMICAL", 272, 279], ["water", "SIMPLE_CHEMICAL", 284, 289], ["ethanol", "SIMPLE_CHEMICAL", 295, 302], ["water", "SIMPLE_CHEMICAL", 327, 332], ["mice", "SPECIES", 23, 27], ["mice", "SPECIES", 23, 27], ["Previous studies", "TEST", 0, 16], ["the reductions in blood lipid contents", "PROBLEM", 43, 81], ["different Cassiae semen extracts", "TREATMENT", 93, 125], ["supercritical fluid extraction", "TREATMENT", 172, 202], ["systematic solvents (petroleum ether", "TREATMENT", 204, 240], ["ethyl acetate", "TREATMENT", 242, 255], ["n-butanol", "TREATMENT", 257, 266], ["ethanol precipitation", "TREATMENT", 295, 316], ["water extraction", "TREATMENT", 327, 343]]], ["The results revealed that the n-butanol and ethyl acetate extracts were the most effective (62, 63) .", [["extracts", "ANATOMY", 58, 66], ["n-butanol", "CHEMICAL", 30, 39], ["ethyl acetate", "CHEMICAL", 44, 57], ["n-butanol", "CHEMICAL", 30, 39], ["ethyl acetate", "CHEMICAL", 44, 57], ["n-butanol", "SIMPLE_CHEMICAL", 30, 39], ["ethyl acetate", "SIMPLE_CHEMICAL", 44, 57], ["extracts", "ORGANISM_SUBSTANCE", 58, 66], ["the n-butanol and ethyl acetate extracts", "TREATMENT", 26, 66]]], ["In addition, the ethanol and aqueous extracts of Cassiae emen significantly decreased the serum levels of total cholesterol (TC), triglyceride (TG) and low-density lipoprotein cholesterol (LDL-C), however, they increased the levels of high-density lipoprotein cholesterol (HDL-C) (13, 64, 65) .", [["extracts", "ANATOMY", 37, 45], ["serum", "ANATOMY", 90, 95], ["ethanol", "CHEMICAL", 17, 24], ["Cassiae", "CHEMICAL", 49, 56], ["cholesterol", "CHEMICAL", 112, 123], ["triglyceride", "CHEMICAL", 130, 142], ["cholesterol", "CHEMICAL", 176, 187], ["cholesterol", "CHEMICAL", 260, 271], ["ethanol", "CHEMICAL", 17, 24], ["cholesterol", "CHEMICAL", 112, 123], ["triglyceride", "CHEMICAL", 130, 142], ["cholesterol", "CHEMICAL", 176, 187], ["cholesterol", "CHEMICAL", 260, 271], ["ethanol", "SIMPLE_CHEMICAL", 17, 24], ["aqueous extracts", "ORGANISM_SUBSTANCE", 29, 45], ["Cassiae emen", "ORGANISM", 49, 61], ["serum", "ORGANISM_SUBSTANCE", 90, 95], ["cholesterol", "SIMPLE_CHEMICAL", 112, 123], ["TC", "SIMPLE_CHEMICAL", 125, 127], ["triglyceride", "SIMPLE_CHEMICAL", 130, 142], ["TG", "SIMPLE_CHEMICAL", 144, 146], ["low-density lipoprotein cholesterol", "SIMPLE_CHEMICAL", 152, 187], ["LDL-C", "SIMPLE_CHEMICAL", 189, 194], ["high-density lipoprotein cholesterol", "SIMPLE_CHEMICAL", 235, 271], ["HDL-C", "SIMPLE_CHEMICAL", 273, 278], ["LDL", "PROTEIN", 189, 192], ["HDL", "PROTEIN", 273, 276], ["the serum levels", "TEST", 86, 102], ["total cholesterol", "TEST", 106, 123], ["triglyceride", "TEST", 130, 142], ["TG", "TEST", 144, 146], ["low-density lipoprotein cholesterol", "TEST", 152, 187], ["LDL", "TEST", 189, 192], ["HDL", "TEST", 273, 276]]], ["Similarly, He et al (66) reported that treatment with the water extract form of C. obtusifolia seeds decreased the blood-lipid level by inhibiting cholesterol synthesis.", [["blood", "ANATOMY", 115, 120], ["cholesterol", "CHEMICAL", 147, 158], ["cholesterol", "CHEMICAL", 147, 158], ["C. obtusifolia seeds", "ORGANISM", 80, 100], ["blood", "ORGANISM_SUBSTANCE", 115, 120], ["lipid", "SIMPLE_CHEMICAL", 121, 126], ["cholesterol", "SIMPLE_CHEMICAL", 147, 158], ["C. obtusifolia", "SPECIES", 80, 94], ["C. obtusifolia", "SPECIES", 80, 94], ["treatment", "TREATMENT", 39, 48], ["the water extract", "TREATMENT", 54, 71], ["C. obtusifolia seeds", "PROBLEM", 80, 100], ["the blood-lipid level", "TEST", 111, 132], ["inhibiting cholesterol synthesis", "PROBLEM", 136, 168], ["cholesterol synthesis", "OBSERVATION", 147, 168]]], ["Cho et al (67) demonstrated that soluble fibers from C. tora seeds markedly decreased liver TC and TG levels in rats fed with a high-cholesterol diet.", [["fibers", "ANATOMY", 41, 47], ["liver", "ANATOMY", 86, 91], ["cholesterol", "CHEMICAL", 133, 144], ["cholesterol", "CHEMICAL", 133, 144], ["fibers", "CELLULAR_COMPONENT", 41, 47], ["C. tora seeds", "ORGANISM", 53, 66], ["liver", "ORGAN", 86, 91], ["TC", "MULTI-TISSUE_STRUCTURE", 92, 94], ["TG", "SIMPLE_CHEMICAL", 99, 101], ["rats", "ORGANISM", 112, 116], ["C. tora", "SPECIES", 53, 60], ["rats", "SPECIES", 112, 116], ["C. tora", "SPECIES", 53, 60], ["soluble fibers", "TREATMENT", 33, 47], ["markedly decreased liver TC", "PROBLEM", 67, 94], ["TG levels", "TEST", 99, 108], ["a high-cholesterol diet", "TREATMENT", 126, 149], ["decreased", "OBSERVATION_MODIFIER", 76, 85], ["liver", "ANATOMY", 86, 91]]], ["The underlying mechanism may be mediated by increasing fecal bile acid excretion and downregulating the production of lipogenic enzymes (67) .", [["fecal bile", "ANATOMY", 55, 65], ["bile acid", "CHEMICAL", 61, 70], ["bile acid", "CHEMICAL", 61, 70], ["bile acid", "SIMPLE_CHEMICAL", 61, 70], ["lipogenic enzymes", "GENE_OR_GENE_PRODUCT", 118, 135], ["lipogenic enzymes", "PROTEIN", 118, 135], ["67", "PROTEIN", 137, 139], ["increasing fecal bile acid excretion", "PROBLEM", 44, 80], ["lipogenic enzymes", "TEST", 118, 135], ["may be", "UNCERTAINTY", 25, 31], ["increasing", "OBSERVATION_MODIFIER", 44, 54], ["fecal bile", "OBSERVATION", 55, 65], ["acid excretion", "OBSERVATION", 66, 80]]], ["In addition, soluble fibers decreased the serum levels of TC, TG and LDL-C in patients with type II diabetes without serious adverse effects (2).", [["fibers", "ANATOMY", 21, 27], ["serum", "ANATOMY", 42, 47], ["type II diabetes", "DISEASE", 92, 108], ["fibers", "CELLULAR_COMPONENT", 21, 27], ["serum", "ORGANISM_SUBSTANCE", 42, 47], ["TC", "SIMPLE_CHEMICAL", 58, 60], ["TG", "SIMPLE_CHEMICAL", 62, 64], ["LDL-C", "SIMPLE_CHEMICAL", 69, 74], ["patients", "ORGANISM", 78, 86], ["TC", "PROTEIN", 58, 60], ["LDL", "PROTEIN", 69, 72], ["patients", "SPECIES", 78, 86], ["the serum levels", "TEST", 38, 54], ["TC", "TEST", 58, 60], ["TG", "TEST", 62, 64], ["LDL", "TEST", 69, 72], ["type II diabetes", "PROBLEM", 92, 108], ["serious adverse effects", "PROBLEM", 117, 140], ["LDL", "ANATOMY", 69, 72]]], ["Liu et al (68) revealed that the ethanol extract of Cassiae semen upregulated the expression levels of peroxisome proliferator-activated receptor (PPAR)-\u03b3, sterol regulatory element-binding protein-1c, hormone-sensitive lipase and triacylglycerol hydrolase, however, tumor necrosis factor receptor superfamily member 6 was downregulated in adipose tissue.", [["adipose tissue", "ANATOMY", 340, 354], ["ethanol", "CHEMICAL", 33, 40], ["Cassiae", "CHEMICAL", 52, 59], ["tumor", "DISEASE", 267, 272], ["ethanol", "CHEMICAL", 33, 40], ["sterol", "CHEMICAL", 156, 162], ["triacylglycerol", "CHEMICAL", 231, 246], ["ethanol", "SIMPLE_CHEMICAL", 33, 40], ["Cassiae semen", "ORGANISM", 52, 65], ["peroxisome proliferator-activated receptor (PPAR)-\u03b3", "GENE_OR_GENE_PRODUCT", 103, 154], ["sterol regulatory element-binding protein-1c", "GENE_OR_GENE_PRODUCT", 156, 200], ["hormone-sensitive lipase", "GENE_OR_GENE_PRODUCT", 202, 226], ["triacylglycerol hydrolase", "GENE_OR_GENE_PRODUCT", 231, 256], ["tumor necrosis factor receptor superfamily member 6", "GENE_OR_GENE_PRODUCT", 267, 318], ["adipose tissue", "TISSUE", 340, 354], ["peroxisome proliferator-activated receptor (PPAR)-\u03b3", "PROTEIN", 103, 154], ["sterol regulatory element-binding protein-1c", "PROTEIN", 156, 200], ["hormone-sensitive lipase", "PROTEIN", 202, 226], ["triacylglycerol hydrolase", "PROTEIN", 231, 256], ["tumor necrosis factor receptor superfamily member 6", "PROTEIN", 267, 318], ["the ethanol extract", "TREATMENT", 29, 48], ["peroxisome proliferator", "TEST", 103, 126], ["activated receptor (PPAR)", "TEST", 127, 152], ["sterol regulatory element", "TEST", 156, 181], ["binding protein", "TEST", 182, 197], ["hormone", "TEST", 202, 209], ["lipase", "TEST", 220, 226], ["triacylglycerol hydrolase", "TREATMENT", 231, 256], ["tumor necrosis factor", "PROBLEM", 267, 288], ["peroxisome proliferator", "OBSERVATION", 103, 126], ["tumor", "OBSERVATION_MODIFIER", 267, 272], ["necrosis", "OBSERVATION", 273, 281], ["adipose tissue", "OBSERVATION", 340, 354]]], ["The anti-hyperlipidemia activity of Cassiae semen is primarily due to its antioxidant components, such as anthraquinones and polysaccharides.", [["Cassiae", "CHEMICAL", 36, 43], ["anthraquinones", "CHEMICAL", 106, 120], ["anthraquinones", "CHEMICAL", 106, 120], ["Cassiae", "ORGANISM", 36, 43], ["semen", "ORGANISM_SUBSTANCE", 44, 49], ["anthraquinones", "SIMPLE_CHEMICAL", 106, 120], ["polysaccharides", "SIMPLE_CHEMICAL", 125, 140], ["Cassiae semen", "TREATMENT", 36, 49], ["its antioxidant components", "PROBLEM", 70, 96], ["anthraquinones", "TREATMENT", 106, 120], ["polysaccharides", "TREATMENT", 125, 140]]], ["There are a variety of bioactive anthraquinone components in Cassiae semen, including chrysophanol, physcion, aurantio-obtusin, obtusifolin and emodin, which have been observed to decrease the levels of TC and TG (69, 70) .", [["semen", "ANATOMY", 69, 74], ["anthraquinone", "CHEMICAL", 33, 46], ["chrysophanol", "CHEMICAL", 86, 98], ["aurantio-obtusin", "CHEMICAL", 110, 126], ["obtusifolin", "CHEMICAL", 128, 139], ["emodin", "CHEMICAL", 144, 150], ["TG", "DISEASE", 210, 212], ["anthraquinone", "CHEMICAL", 33, 46], ["chrysophanol", "CHEMICAL", 86, 98], ["aurantio-obtusin", "CHEMICAL", 110, 126], ["obtusifolin", "CHEMICAL", 128, 139], ["emodin", "CHEMICAL", 144, 150], ["anthraquinone", "SIMPLE_CHEMICAL", 33, 46], ["Cassiae", "ORGANISM", 61, 68], ["semen", "ORGANISM_SUBSTANCE", 69, 74], ["chrysophanol", "SIMPLE_CHEMICAL", 86, 98], ["physcion", "SIMPLE_CHEMICAL", 100, 108], ["aurantio-obtusin", "SIMPLE_CHEMICAL", 110, 126], ["obtusifolin", "SIMPLE_CHEMICAL", 128, 139], ["emodin", "SIMPLE_CHEMICAL", 144, 150], ["TC", "SIMPLE_CHEMICAL", 203, 205], ["TG", "SIMPLE_CHEMICAL", 210, 212], ["bioactive anthraquinone components", "TREATMENT", 23, 57], ["chrysophanol", "TREATMENT", 86, 98], ["physcion", "TREATMENT", 100, 108], ["aurantio", "TREATMENT", 110, 118], ["obtusin", "TREATMENT", 119, 126], ["obtusifolin", "TREATMENT", 128, 139], ["emodin", "TREATMENT", 144, 150], ["TG", "TEST", 210, 212], ["variety", "OBSERVATION_MODIFIER", 12, 19], ["bioactive anthraquinone components", "OBSERVATION", 23, 57]]], ["Previous studies have demonstrated that anthraquinones isolated from Cassiae semen Rubrofusarin triglucoside (17) 52 Cassiaside (50) 53 Nor-rubrofusarin gentiobioside (17) 54 Cassiaside B (50) 55PharmacologyCassiaside C (50) 56 Torachrysone apiglucoside (17) 57 Torachrysone gentiobioside (17) 58 Torachrysone tetraglucoside (17) 59 Cassiatoroside (51) 60 Demethylflavasperone gentiobioside (17) 61 Cassialactone gentiobioside (28) 62 Torosachrysone (53) 63 Isotoralactone (53) 64 Cassialactone (53) 65 Cassiaside (71, 72) .", [["anthraquinones", "CHEMICAL", 40, 54], ["Rubrofusarin triglucoside", "CHEMICAL", 83, 108], ["17) 52 Cassiaside (50) 53 Nor-rubrofusarin gentiobioside (17) 54 Cassiaside B (50) 55PharmacologyCassiaside C (50) 56 Torachrysone apiglucoside (17) 57 Torachrysone gentiobioside (17) 58 Torachrysone tetraglucoside (17) 59 Cassiatoroside (51) 60 Demethylflavasperone gentiobioside (17) 61 Cassialactone gentiobioside (28) 62 Torosachrysone (53) 63 Isotoralactone (53) 64 Cassialactone (53) 65 Cassiaside", "CHEMICAL", 110, 513], ["anthraquinones", "CHEMICAL", 40, 54], ["Rubrofusarin triglucoside", "CHEMICAL", 83, 108], ["Cassiaside", "CHEMICAL", 117, 127], ["Nor-rubrofusarin gentiobioside", "CHEMICAL", 136, 166], ["Cassiaside B", "CHEMICAL", 175, 187], ["Cassiaside C", "CHEMICAL", 207, 219], ["Torachrysone apiglucoside", "CHEMICAL", 228, 253], ["Torachrysone gentiobioside", "CHEMICAL", 262, 288], ["Torachrysone tetraglucoside", "CHEMICAL", 297, 324], ["Cassiatoroside", "CHEMICAL", 333, 347], ["Demethylflavasperone gentiobioside", "CHEMICAL", 356, 390], ["Cassialactone gentiobioside", "CHEMICAL", 399, 426], ["Torosachrysone", "CHEMICAL", 435, 449], ["Isotoralactone", "CHEMICAL", 458, 472], ["Cassialactone", "CHEMICAL", 481, 494], ["Cassiaside", "CHEMICAL", 503, 513], ["anthraquinones", "SIMPLE_CHEMICAL", 40, 54], ["Previous studies", "TEST", 0, 16], ["anthraquinones", "TREATMENT", 40, 54], ["Cassiae semen Rubrofusarin triglucoside", "TREATMENT", 69, 108], ["Torachrysone apiglucoside", "TREATMENT", 228, 253], ["Torachrysone gentiobioside", "TREATMENT", 262, 288], ["Torachrysone tetraglucoside", "TREATMENT", 297, 324], ["Demethylflavasperone gentiobioside", "TREATMENT", 356, 390]]], ["These results were verified by a previous study, which applied an experimental hyperlipidemic rat model to investigate anthraquinone treatment (80 and 20 mg/kg, per os, for 20 days).", [["anthraquinone", "CHEMICAL", 119, 132], ["anthraquinone", "CHEMICAL", 119, 132], ["rat", "ORGANISM", 94, 97], ["anthraquinone", "SIMPLE_CHEMICAL", 119, 132], ["rat", "SPECIES", 94, 97], ["rat", "SPECIES", 94, 97], ["a previous study", "TEST", 31, 47], ["an experimental hyperlipidemic rat model", "TREATMENT", 63, 103], ["anthraquinone treatment", "TREATMENT", 119, 142]]], ["The TC, TG and LDL-C levels were significantly reduced in a dose-dependent manner, however, the levels of HDL-C increased.", [["TC", "SIMPLE_CHEMICAL", 4, 6], ["TG", "SIMPLE_CHEMICAL", 8, 10], ["LDL-C", "SIMPLE_CHEMICAL", 15, 20], ["HDL-C", "SIMPLE_CHEMICAL", 106, 111], ["LDL", "PROTEIN", 15, 18], ["HDL", "PROTEIN", 106, 109], ["The TC", "TEST", 0, 6], ["TG", "TEST", 8, 10], ["LDL", "TEST", 15, 18], ["C levels", "TEST", 19, 27], ["the levels", "TEST", 92, 102], ["HDL", "TEST", 106, 109], ["reduced", "OBSERVATION_MODIFIER", 47, 54], ["increased", "OBSERVATION_MODIFIER", 112, 121]]], ["Inhibition of cholesterol synthesis may be one of the underlying mechanisms involved in decreasing blood lipid levels (73) .", [["blood", "ANATOMY", 99, 104], ["cholesterol", "CHEMICAL", 14, 25], ["cholesterol", "CHEMICAL", 14, 25], ["cholesterol", "SIMPLE_CHEMICAL", 14, 25], ["blood", "ORGANISM_SUBSTANCE", 99, 104], ["lipid", "SIMPLE_CHEMICAL", 105, 110], ["Inhibition of cholesterol synthesis", "TREATMENT", 0, 35], ["blood lipid levels", "TEST", 99, 117]]], ["Water-soluble polysaccharides (WSPs) from Cassiae semen markedly inhibited the activities of \u03b1-amylase and pancreatic lipase, however, protease activity increased.", [["pancreatic", "ANATOMY", 107, 117], ["Water-soluble polysaccharides", "SIMPLE_CHEMICAL", 0, 29], ["WSPs", "SIMPLE_CHEMICAL", 31, 35], ["Cassiae semen", "ORGANISM", 42, 55], ["\u03b1-amylase", "GENE_OR_GENE_PRODUCT", 93, 102], ["pancreatic lipase", "GENE_OR_GENE_PRODUCT", 107, 124], ["\u03b1-amylase", "PROTEIN", 93, 102], ["pancreatic lipase", "PROTEIN", 107, 124], ["protease", "PROTEIN", 135, 143], ["Water-soluble polysaccharides", "TREATMENT", 0, 29], ["\u03b1-amylase", "TEST", 93, 102], ["pancreatic lipase", "TEST", 107, 124], ["pancreatic", "ANATOMY", 107, 117], ["lipase", "ANATOMY", 118, 124]]], ["The results demonstrated that WSPs had the ability to bind to bile acids and reduce the absorption of cholesterol, indicating that WSPs may have potential as an effective herbal ingredient in functional food applications (74) .Antidiabetic activity.A number of studies have demonstrated that Cassiae semen exhibits anti-diabetic activity.", [["semen", "ANATOMY", 300, 305], ["WSPs", "CHEMICAL", 30, 34], ["bile acids", "CHEMICAL", 62, 72], ["cholesterol", "CHEMICAL", 102, 113], ["WSPs", "CHEMICAL", 131, 135], ["Cassiae", "CHEMICAL", 292, 299], ["bile acids", "CHEMICAL", 62, 72], ["cholesterol", "CHEMICAL", 102, 113], ["WSPs", "SIMPLE_CHEMICAL", 30, 34], ["bile acids", "SIMPLE_CHEMICAL", 62, 72], ["cholesterol", "SIMPLE_CHEMICAL", 102, 113], ["WSPs", "SIMPLE_CHEMICAL", 131, 135], ["Cassiae semen", "ORGANISM", 292, 305], ["bile acids", "TEST", 62, 72], ["the absorption of cholesterol", "PROBLEM", 84, 113], ["an effective herbal ingredient", "TREATMENT", 158, 188], ["Cassiae semen", "TREATMENT", 292, 305], ["anti-diabetic activity", "OBSERVATION", 315, 337]]], ["A total of three naphthopyrone glucosides (compounds 49, 52 and 55) isolated from the butanol-soluble extract of Cassia semen have been evaluated for their inhibitory activity on advanced glycation end products (AGEs) formation in vitro.", [["naphthopyrone", "CHEMICAL", 17, 30], ["compounds 49, 52 and 55", "CHEMICAL", 43, 66], ["butanol", "CHEMICAL", 86, 93], ["naphthopyrone glucosides", "CHEMICAL", 17, 41], ["butanol", "CHEMICAL", 86, 93], ["naphthopyrone glucosides", "SIMPLE_CHEMICAL", 17, 41], ["butanol", "SIMPLE_CHEMICAL", 86, 93], ["Cassia semen", "ORGANISM", 113, 125], ["advanced glycation end products", "SIMPLE_CHEMICAL", 179, 210], ["AGEs", "SIMPLE_CHEMICAL", 212, 216], ["AGEs", "PROTEIN", 212, 216], ["Cassia semen", "SPECIES", 113, 125], ["three naphthopyrone glucosides", "TREATMENT", 11, 41], ["the butanol-soluble extract", "TREATMENT", 82, 109], ["Cassia semen", "TREATMENT", 113, 125], ["advanced glycation end products", "TREATMENT", 179, 210]]], ["The results revealed that these compounds possessed more potent inhibitory activity against AGEs compared with the aminoguanidine positive control (15) .", [["AGEs", "CHEMICAL", 92, 96], ["aminoguanidine", "CHEMICAL", 115, 129], ["aminoguanidine", "CHEMICAL", 115, 129], ["AGEs", "SIMPLE_CHEMICAL", 92, 96], ["aminoguanidine", "SIMPLE_CHEMICAL", 115, 129], ["these compounds", "PROBLEM", 26, 41], ["the aminoguanidine positive control", "TREATMENT", 111, 146]]], ["In addition, rubrofusarin-6-O-\u03b2d-gentiobioside (compound 49) and cassiaside (compound 52) significantly inhibited the expression of transforming growth factor (TGF)-1 and extracellular matrix protein in glomerular mesangial cells cultured under diabetic conditions, suggesting that the active compounds in Cassiae semen may be effective in the treatment of renal complications associated with diabetes (16) .", [["extracellular matrix", "ANATOMY", 171, 191], ["glomerular mesangial cells", "ANATOMY", 203, 229], ["semen", "ANATOMY", 314, 319], ["renal", "ANATOMY", 357, 362], ["rubrofusarin-6-O-\u03b2d-gentiobioside", "CHEMICAL", 13, 46], ["compound 49", "CHEMICAL", 48, 59], ["cassiaside", "CHEMICAL", 65, 75], ["compound 52", "CHEMICAL", 77, 88], ["diabetic", "DISEASE", 245, 253], ["renal complications", "DISEASE", 357, 376], ["diabetes", "DISEASE", 393, 401], ["rubrofusarin-6-O-\u03b2d-gentiobioside", "CHEMICAL", 13, 46], ["cassiaside", "CHEMICAL", 65, 75], ["rubrofusarin-6-O-\u03b2d-gentiobioside", "SIMPLE_CHEMICAL", 13, 46], ["compound 49", "SIMPLE_CHEMICAL", 48, 59], ["cassiaside", "SIMPLE_CHEMICAL", 65, 75], ["compound 52", "SIMPLE_CHEMICAL", 77, 88], ["transforming growth factor (TGF)-1", "GENE_OR_GENE_PRODUCT", 132, 166], ["extracellular matrix", "CELLULAR_COMPONENT", 171, 191], ["glomerular mesangial cells", "CELL", 203, 229], ["Cassiae semen", "ORGANISM", 306, 319], ["renal", "ORGAN", 357, 362], ["transforming growth factor (TGF)-1", "PROTEIN", 132, 166], ["extracellular matrix protein", "PROTEIN", 171, 199], ["glomerular mesangial cells", "CELL_TYPE", 203, 229], ["rubrofusarin", "TEST", 13, 25], ["transforming growth factor", "PROBLEM", 132, 158], ["extracellular matrix protein", "TEST", 171, 199], ["glomerular mesangial cells", "TEST", 203, 229], ["diabetic conditions", "PROBLEM", 245, 264], ["the active compounds", "PROBLEM", 282, 302], ["Cassiae semen", "TREATMENT", 306, 319], ["renal complications", "PROBLEM", 357, 376], ["diabetes", "PROBLEM", 393, 401], ["glomerular", "ANATOMY", 203, 213], ["mesangial cells", "OBSERVATION", 214, 229], ["diabetic conditions", "OBSERVATION", 245, 264], ["active", "OBSERVATION_MODIFIER", 286, 292], ["compounds", "OBSERVATION", 293, 302], ["renal", "ANATOMY", 357, 362], ["complications", "OBSERVATION", 363, 376]]], ["Similarly, Kim et al (75) evaluated the preventive effects of the methanol extract of Cassia semen (200 mg/kg/day, for 12 weeks) on the development of diabetic nephropathy in streptozotocin (STZ)-induced diabetic rats.", [["methanol extract of Cassia semen", "CHEMICAL", 66, 98], ["diabetic nephropathy", "DISEASE", 151, 171], ["streptozotocin", "CHEMICAL", 175, 189], ["STZ", "CHEMICAL", 191, 194], ["diabetic", "DISEASE", 204, 212], ["methanol", "CHEMICAL", 66, 74], ["streptozotocin", "CHEMICAL", 175, 189], ["STZ", "CHEMICAL", 191, 194], ["methanol", "SIMPLE_CHEMICAL", 66, 74], ["Cassia semen", "ORGANISM", 86, 98], ["streptozotocin", "SIMPLE_CHEMICAL", 175, 189], ["STZ", "SIMPLE_CHEMICAL", 191, 194], ["rats", "ORGANISM", 213, 217], ["rats", "SPECIES", 213, 217], ["the methanol extract of Cassia semen", "TREATMENT", 62, 98], ["diabetic nephropathy", "PROBLEM", 151, 171], ["streptozotocin (STZ", "TREATMENT", 175, 194], ["induced diabetic rats", "PROBLEM", 196, 217], ["diabetic", "OBSERVATION_MODIFIER", 151, 159], ["nephropathy", "OBSERVATION", 160, 171]]], ["The results indicated that oral treatment with the Cassia semen methanol extract inhibited the development of diabetic nephropathy by inhibiting AGEs accumulation, receptor for advanced glycosylation end product and cyclooxygenase-2 expression in the renal cortex of STZ-diabetic rats (75, 76) .", [["oral", "ANATOMY", 27, 31], ["renal cortex", "ANATOMY", 251, 263], ["Cassia semen methanol extract", "CHEMICAL", 51, 80], ["diabetic nephropathy", "DISEASE", 110, 130], ["STZ", "CHEMICAL", 267, 270], ["diabetic", "DISEASE", 271, 279], ["methanol", "CHEMICAL", 64, 72], ["STZ", "CHEMICAL", 267, 270], ["oral", "ORGANISM_SUBDIVISION", 27, 31], ["Cassia semen", "ORGANISM", 51, 63], ["AGEs", "SIMPLE_CHEMICAL", 145, 149], ["cyclooxygenase-2", "GENE_OR_GENE_PRODUCT", 216, 232], ["renal cortex", "MULTI-TISSUE_STRUCTURE", 251, 263], ["STZ-diabetic rats", "ORGANISM", 267, 284], ["AGEs", "PROTEIN", 145, 149], ["advanced glycosylation end product", "PROTEIN", 177, 211], ["cyclooxygenase-2", "PROTEIN", 216, 232], ["rats", "SPECIES", 280, 284], ["oral treatment", "TREATMENT", 27, 41], ["the Cassia semen methanol extract", "TREATMENT", 47, 80], ["diabetic nephropathy", "PROBLEM", 110, 130], ["inhibiting AGEs accumulation", "PROBLEM", 134, 162], ["receptor", "TREATMENT", 164, 172], ["advanced glycosylation end product", "TREATMENT", 177, 211], ["cyclooxygenase", "TREATMENT", 216, 230], ["diabetic rats", "PROBLEM", 271, 284], ["diabetic nephropathy", "OBSERVATION", 110, 130], ["renal", "ANATOMY", 251, 256], ["cortex", "ANATOMY_MODIFIER", 257, 263]]], ["In addition, Zhu (77) reported that the water extract of Cassia semen exhibited protective activity against STZ-induced renal fibrosis in diabetic rats.", [["renal", "ANATOMY", 120, 125], ["Zhu", "CHEMICAL", 13, 16], ["STZ", "CHEMICAL", 108, 111], ["renal fibrosis", "DISEASE", 120, 134], ["diabetic", "DISEASE", 138, 146], ["STZ", "CHEMICAL", 108, 111], ["Cassia semen", "ORGANISM", 57, 69], ["STZ", "SIMPLE_CHEMICAL", 108, 111], ["renal", "ORGAN", 120, 125], ["rats", "ORGANISM", 147, 151], ["rats", "SPECIES", 147, 151], ["the water extract", "TREATMENT", 36, 53], ["Cassia semen", "TREATMENT", 57, 69], ["STZ", "PROBLEM", 108, 111], ["renal fibrosis in diabetic rats", "PROBLEM", 120, 151], ["renal", "ANATOMY", 120, 125], ["fibrosis", "OBSERVATION", 126, 134], ["diabetic", "OBSERVATION", 138, 146]]], ["The underlying mechanisms may be associated with its ability to downregulate the expression of TGF-\u03b21, connective tissue growth factor and mothers against decapentaplegic homolog 3 (smad3), as well as upregulating the protein expression of smad6 (77) .Antidiabetic activity.Neuroprotective activity.", [["TGF-\u03b21", "GENE_OR_GENE_PRODUCT", 95, 101], ["connective tissue growth factor", "GENE_OR_GENE_PRODUCT", 103, 134], ["mothers against decapentaplegic homolog 3", "GENE_OR_GENE_PRODUCT", 139, 180], ["smad3", "GENE_OR_GENE_PRODUCT", 182, 187], ["smad6 (77)", "GENE_OR_GENE_PRODUCT", 240, 250], ["TGF-\u03b21", "PROTEIN", 95, 101], ["connective tissue growth factor", "PROTEIN", 103, 134], ["decapentaplegic homolog 3", "PROTEIN", 155, 180], ["smad3", "PROTEIN", 182, 187], ["smad6 (77)", "PROTEIN", 240, 250], ["TGF", "TEST", 95, 98], ["connective tissue growth factor", "PROBLEM", 103, 134], ["decapentaplegic homolog", "TREATMENT", 155, 178], ["connective tissue", "ANATOMY", 103, 120], ["activity", "OBSERVATION_MODIFIER", 290, 298]]], ["The ethanolic extract from the seeds of C. obtusifolia has been reported to have a neuroprotective effect in brain disease models.", [["seeds", "ANATOMY", 31, 36], ["brain", "ANATOMY", 109, 114], ["ethanolic extract from the seeds of C. obtusifolia", "CHEMICAL", 4, 54], ["brain disease", "DISEASE", 109, 122], ["seeds", "ORGANISM_SUBDIVISION", 31, 36], ["C. obtusifolia", "ORGANISM", 40, 54], ["brain", "ORGAN", 109, 114], ["C. obtusifolia", "SPECIES", 40, 54], ["C. obtusifolia", "SPECIES", 40, 54], ["The ethanolic extract", "TREATMENT", 0, 21], ["C. obtusifolia", "PROBLEM", 40, 54], ["a neuroprotective effect in brain disease models", "PROBLEM", 81, 129], ["ethanolic extract", "OBSERVATION_MODIFIER", 4, 21], ["C. obtusifolia", "OBSERVATION", 40, 54], ["neuroprotective effect", "OBSERVATION", 83, 105], ["brain", "ANATOMY", 109, 114], ["disease", "OBSERVATION", 115, 122]]], ["Kim et al (6) suggested that C. obtusifolia (25, 50 or 100 mg/kg) significantly attenuated scopolamine or transient bilateral common carotid artery occlusion (2VO)-induced memory impairment.", [["carotid artery", "ANATOMY", 133, 147], ["obtusifolia", "CHEMICAL", 32, 43], ["scopolamine", "CHEMICAL", 91, 102], ["carotid artery occlusion", "DISEASE", 133, 157], ["2VO", "CHEMICAL", 159, 162], ["memory impairment", "DISEASE", 172, 189], ["scopolamine", "CHEMICAL", 91, 102], ["C. obtusifolia", "ORGANISM", 29, 43], ["scopolamine", "SIMPLE_CHEMICAL", 91, 102], ["carotid artery", "MULTI-TISSUE_STRUCTURE", 133, 147], ["C. obtusifolia", "SPECIES", 29, 43], ["C. obtusifolia", "SPECIES", 29, 43], ["C. obtusifolia", "PROBLEM", 29, 43], ["significantly attenuated scopolamine", "PROBLEM", 66, 102], ["transient bilateral common carotid artery occlusion", "PROBLEM", 106, 157], ["induced memory impairment", "PROBLEM", 164, 189], ["bilateral", "ANATOMY_MODIFIER", 116, 125], ["common carotid artery", "ANATOMY", 126, 147], ["occlusion", "OBSERVATION", 148, 157], ["memory impairment", "OBSERVATION", 172, 189]]], ["These effects are mediated by the enhancement of the cholinergic nervous system via acetylcholinesterase inhibition in a dose-dependent manner [half maximal inhibitory concentration (IC 50 )=81.6 \u00b5g/ml] (6).", [["cholinergic nervous system", "ANATOMY", 53, 79], ["cholinergic nervous system", "ANATOMICAL_SYSTEM", 53, 79], ["acetylcholinesterase", "GENE_OR_GENE_PRODUCT", 84, 104], ["acetylcholinesterase", "PROTEIN", 84, 104], ["acetylcholinesterase inhibition", "TREATMENT", 84, 115], ["a dose-dependent manner [half maximal inhibitory concentration (IC", "TREATMENT", 119, 185], ["cholinergic nervous", "ANATOMY", 53, 72]]], ["In addition, C. obtusifolia (10 or 50 mg/kg/day) exhibited a neuroprotective effect in a mouse transient global ischemia model due to its anti-inflammatory properties and the induced upregulated expression of phosphorylated cyclic AMP response element binding protein and brain-derived neurotrophic factor (78).Antidiabetic activity.Drever et al (79) demonstrated that treatment with C. obtusifolia (0.1-10 \u00b5g/ml) significantly attenuated secondary calcium dysregulation and cell death induced by N-methyl-D-aspartate and 3-nitropropionic acid in mouse hippocampal cultures, and no significant effect on cell death was induced by incubation with naturally-secreted oligomers of amyloid (A)\u03b2.", [["cell", "ANATOMY", 475, 479], ["hippocampal cultures", "ANATOMY", 553, 573], ["cell", "ANATOMY", 604, 608], ["obtusifolia", "CHEMICAL", 16, 27], ["ischemia", "DISEASE", 112, 120], ["AMP", "CHEMICAL", 231, 234], ["obtusifolia", "CHEMICAL", 387, 398], ["calcium", "CHEMICAL", 449, 456], ["death", "DISEASE", 480, 485], ["N-methyl-D-aspartate", "CHEMICAL", 497, 517], ["3-nitropropionic acid", "CHEMICAL", 522, 543], ["death", "DISEASE", 609, 614], ["cyclic AMP", "CHEMICAL", 224, 234], ["calcium", "CHEMICAL", 449, 456], ["N-methyl-D-aspartate", "CHEMICAL", 497, 517], ["3-nitropropionic acid", "CHEMICAL", 522, 543], ["C. obtusifolia", "ORGANISM", 13, 27], ["mouse", "ORGANISM", 89, 94], ["cyclic AMP response element binding protein", "GENE_OR_GENE_PRODUCT", 224, 267], ["brain-derived neurotrophic factor", "GENE_OR_GENE_PRODUCT", 272, 305], ["C. obtusifolia", "ORGANISM", 384, 398], ["calcium", "SIMPLE_CHEMICAL", 449, 456], ["cell", "CELL", 475, 479], ["N-methyl-D-aspartate", "SIMPLE_CHEMICAL", 497, 517], ["3-nitropropionic acid", "SIMPLE_CHEMICAL", 522, 543], ["mouse", "ORGANISM", 547, 552], ["hippocampal cultures", "CELL", 553, 573], ["cell", "CELL", 604, 608], ["amyloid (A)\u03b2", "GENE_OR_GENE_PRODUCT", 678, 690], ["phosphorylated cyclic AMP response element binding protein", "PROTEIN", 209, 267], ["brain-derived neurotrophic factor", "PROTEIN", 272, 305], ["mouse hippocampal cultures", "CELL_LINE", 547, 573], ["amyloid (A)\u03b2", "PROTEIN", 678, 690], ["C. obtusifolia", "SPECIES", 13, 27], ["mouse", "SPECIES", 89, 94], ["C. obtusifolia", "SPECIES", 384, 398], ["mouse", "SPECIES", 547, 552], ["C. obtusifolia", "SPECIES", 13, 27], ["mouse", "SPECIES", 89, 94], ["C. obtusifolia", "SPECIES", 384, 398], ["mouse", "SPECIES", 547, 552], ["C. obtusifolia", "PROBLEM", 13, 27], ["a neuroprotective effect", "PROBLEM", 59, 83], ["a mouse transient global ischemia model", "PROBLEM", 87, 126], ["its anti-inflammatory properties", "TREATMENT", 134, 166], ["phosphorylated cyclic AMP response element binding protein", "PROBLEM", 209, 267], ["neurotrophic factor", "TEST", 286, 305], ["C. obtusifolia", "TEST", 384, 398], ["calcium dysregulation", "PROBLEM", 449, 470], ["cell death", "PROBLEM", 475, 485], ["D-aspartate", "TREATMENT", 506, 517], ["nitropropionic acid", "TREATMENT", 524, 543], ["mouse hippocampal cultures", "TEST", 547, 573], ["cell death", "PROBLEM", 604, 614], ["global", "OBSERVATION_MODIFIER", 105, 111], ["ischemia", "OBSERVATION", 112, 120], ["brain", "ANATOMY", 272, 277], ["calcium dysregulation", "OBSERVATION", 449, 470], ["cell death", "OBSERVATION", 475, 485], ["no", "UNCERTAINTY", 579, 581], ["significant", "OBSERVATION_MODIFIER", 582, 593]]], ["Yi et al (80) reported for the first time, that C. obtusifolia (10 \u00b5g/ml) ameliorated the A\u03b2-induced synaptic dysfunction model through anti-inflammatory and protein kinase B (Akt)/glycogen synthase kinase-3\u03b2 pathways.", [["synaptic", "ANATOMY", 101, 109], ["obtusifolia", "CHEMICAL", 51, 62], ["A\u03b2", "CHEMICAL", 90, 92], ["synaptic dysfunction", "DISEASE", 101, 121], ["glycogen", "CHEMICAL", 181, 189], ["C. obtusifolia", "ORGANISM", 48, 62], ["A\u03b2", "SIMPLE_CHEMICAL", 90, 92], ["synaptic", "MULTI-TISSUE_STRUCTURE", 101, 109], ["protein kinase B", "GENE_OR_GENE_PRODUCT", 158, 174], ["Akt", "GENE_OR_GENE_PRODUCT", 176, 179], ["glycogen synthase kinase-3\u03b2", "GENE_OR_GENE_PRODUCT", 181, 208], ["A\u03b2", "PROTEIN", 90, 92], ["protein kinase B", "PROTEIN", 158, 174], ["Akt", "PROTEIN", 176, 179], ["glycogen synthase kinase-3\u03b2", "PROTEIN", 181, 208], ["C. obtusifolia", "SPECIES", 48, 62], ["C. obtusifolia", "SPECIES", 48, 62], ["C. obtusifolia", "PROBLEM", 48, 62], ["the A\u03b2", "PROBLEM", 86, 92], ["synaptic dysfunction model", "PROBLEM", 101, 127], ["protein kinase B", "TEST", 158, 174], ["Akt", "TEST", 176, 179], ["glycogen synthase kinase", "TEST", 181, 205], ["synaptic dysfunction", "OBSERVATION", 101, 121]]], ["The results suggested that the neuroprotective effect may be attributable to obtusifolin (compound 9) and/or alaternin (compound 17) (80) .", [["obtusifolin", "CHEMICAL", 77, 88], ["compound 9", "CHEMICAL", 90, 100], ["alaternin", "CHEMICAL", 109, 118], ["obtusifolin", "CHEMICAL", 77, 88], ["alaternin", "CHEMICAL", 109, 118], ["obtusifolin", "SIMPLE_CHEMICAL", 77, 88], ["alaternin", "SIMPLE_CHEMICAL", 109, 118], ["obtusifolin (compound", "PROBLEM", 77, 98]]], ["In a further experiment, C. obtusifolia (0.1-1 \u00b5g/ml) inhibited cell damage against oxidopamine (6-OHDA)-induced dopaminergic (DA) neural toxicity in PC12 cells through an anti-oxidant and antimitochondrial-mediated apoptosis mechanism.", [["cell", "ANATOMY", 64, 68], ["neural", "ANATOMY", 131, 137], ["PC12 cells", "ANATOMY", 150, 160], ["obtusifolia", "CHEMICAL", 28, 39], ["oxidopamine", "CHEMICAL", 84, 95], ["6-OHDA", "CHEMICAL", 97, 103], ["DA", "CHEMICAL", 127, 129], ["toxicity", "DISEASE", 138, 146], ["oxidopamine", "CHEMICAL", 84, 95], ["6-OHDA", "CHEMICAL", 97, 103], ["C. obtusifolia", "ORGANISM", 25, 39], ["cell", "CELL", 64, 68], ["oxidopamine (6-OHDA", "SIMPLE_CHEMICAL", 84, 103], ["dopaminergic", "CELL", 113, 125], ["DA", "SIMPLE_CHEMICAL", 127, 129], ["neural", "CELL", 131, 137], ["PC12 cells", "CELL", 150, 160], ["PC12 cells", "CELL_LINE", 150, 160], ["C. obtusifolia", "SPECIES", 25, 39], ["C. obtusifolia", "SPECIES", 25, 39], ["C. obtusifolia", "PROBLEM", 25, 39], ["cell damage", "PROBLEM", 64, 75], ["oxidopamine", "TEST", 84, 95], ["dopaminergic (DA)", "TREATMENT", 113, 130], ["neural toxicity in PC12 cells", "PROBLEM", 131, 160], ["an anti-oxidant", "TREATMENT", 169, 184], ["antimitochondrial-mediated apoptosis mechanism", "TREATMENT", 189, 235], ["neural toxicity", "OBSERVATION", 131, 146], ["PC12 cells", "OBSERVATION", 150, 160], ["apoptosis mechanism", "OBSERVATION", 216, 235]]], ["In a mesencephalic DA culture, C. obtusifolia (0.1-1 \u00b5g/ml) protected the DA cells against 6-OHDA-and N-methyl-4-phenylpyridinium iodide-inducedImproves myocardial Water extractIn vivo (107) function and attenuates MI/R-induced injury TC, total cholesterol; TG, triglyceride; LDL-C, low-density lipoprotein cholesterol; HDL-C, high-density lipoprotein cholesterol; PPAR\u03b3, peroxisome proliferator-activated receptor; SREBP-1c, sterol regulatory element-binding protein-1c; HSL, hormone-sensitive lipase; TGH, triacylglycerol hydrolase; FAS, tumor necrosis factor receptor superfamily member 6; AGEs, advanced glycation end products; TGF-1, transforming growth factor-1; ECM, extracellular matrix; RAGE, receptor for advanced glycosylation end product; COX-2, cyclooxygenase-2; CTGF, connective tissue growth factor; Smad3/6, mothers against decapentaplegic homolog 3 and 6; AChE, acetylcholinesterase; pCREB, phosphorylated cyclic AMP response element binding protein; BDNF, brain-derived neurotrophic factor; DA, dopaminergic; MDA, malondialdehyde; MAO, monoamine oxidase; SOD, superoxide dismutase; AST, aspartate transaminase; ALT, alanine transaminase; DPPH, 1-diphenyl-2-picrylhydrazyl; MI/R, myocardial ischemia and reperfusion.Improves myocardial Water extracttoxicities.", [["mesencephalic DA culture", "ANATOMY", 5, 29], ["DA cells", "ANATOMY", 74, 82], ["myocardial", "ANATOMY", 153, 163], ["extracellular matrix", "ANATOMY", 674, 694], ["myocardial", "ANATOMY", 1197, 1207], ["myocardial", "ANATOMY", 1242, 1252], ["DA", "CHEMICAL", 19, 21], ["obtusifolia", "CHEMICAL", 34, 45], ["DA", "CHEMICAL", 74, 76], ["6-OHDA", "CHEMICAL", 91, 97], ["N-methyl-4-phenylpyridinium iodide", "CHEMICAL", 102, 136], ["MI", "CHEMICAL", 215, 217], ["cholesterol", "CHEMICAL", 245, 256], ["triglyceride", "CHEMICAL", 262, 274], ["cholesterol", "CHEMICAL", 307, 318], ["cholesterol", "CHEMICAL", 352, 363], ["necrosis", "DISEASE", 546, 554], ["AMP", "CHEMICAL", 930, 933], ["DA", "CHEMICAL", 1009, 1011], ["malondialdehyde", "CHEMICAL", 1032, 1047], ["superoxide", "CHEMICAL", 1078, 1088], ["aspartate", "CHEMICAL", 1105, 1114], ["alanine", "CHEMICAL", 1134, 1141], ["DPPH", "CHEMICAL", 1156, 1160], ["1-diphenyl-2-picrylhydrazyl", "CHEMICAL", 1162, 1189], ["myocardial ischemia", "DISEASE", 1197, 1216], ["6-OHDA", "CHEMICAL", 91, 97], ["N-methyl-4-phenylpyridinium iodide", "CHEMICAL", 102, 136], ["cholesterol", "CHEMICAL", 245, 256], ["triglyceride", "CHEMICAL", 262, 274], ["cholesterol", "CHEMICAL", 307, 318], ["cholesterol", "CHEMICAL", 352, 363], ["sterol", "CHEMICAL", 426, 432], ["triacylglycerol", "CHEMICAL", 508, 523], ["cyclic AMP", "CHEMICAL", 923, 933], ["MDA", "CHEMICAL", 1027, 1030], ["malondialdehyde", "CHEMICAL", 1032, 1047], ["monoamine", "CHEMICAL", 1054, 1063], ["superoxide", "CHEMICAL", 1078, 1088], ["aspartate", "CHEMICAL", 1105, 1114], ["alanine", "CHEMICAL", 1134, 1141], ["DPPH, 1-diphenyl-2-picrylhydrazyl", "CHEMICAL", 1156, 1189], ["C. obtusifolia", "ORGANISM", 31, 45], ["DA cells", "CELL", 74, 82], ["6-OHDA", "SIMPLE_CHEMICAL", 91, 97], ["N-methyl-4-phenylpyridinium iodide", "SIMPLE_CHEMICAL", 102, 136], ["myocardial", "MULTI-TISSUE_STRUCTURE", 153, 163], ["TC", "SIMPLE_CHEMICAL", 235, 237], ["cholesterol", "SIMPLE_CHEMICAL", 245, 256], ["TG", "SIMPLE_CHEMICAL", 258, 260], ["triglyceride", "SIMPLE_CHEMICAL", 262, 274], ["LDL-C", "SIMPLE_CHEMICAL", 276, 281], ["low-density lipoprotein cholesterol", "SIMPLE_CHEMICAL", 283, 318], ["HDL-C", "SIMPLE_CHEMICAL", 320, 325], ["high-density lipoprotein cholesterol", "SIMPLE_CHEMICAL", 327, 363], ["PPAR\u03b3", "SIMPLE_CHEMICAL", 365, 370], ["peroxisome proliferator-activated receptor", "GENE_OR_GENE_PRODUCT", 372, 414], ["SREBP-1c", "GENE_OR_GENE_PRODUCT", 416, 424], ["sterol regulatory element-binding protein-1c", "GENE_OR_GENE_PRODUCT", 426, 470], ["HSL", "GENE_OR_GENE_PRODUCT", 472, 475], ["hormone-sensitive lipase", "GENE_OR_GENE_PRODUCT", 477, 501], ["TGH", "GENE_OR_GENE_PRODUCT", 503, 506], ["triacylglycerol hydrolase", "GENE_OR_GENE_PRODUCT", 508, 533], ["FAS", "GENE_OR_GENE_PRODUCT", 535, 538], ["tumor necrosis factor receptor superfamily member 6", "GENE_OR_GENE_PRODUCT", 540, 591], ["AGEs", "SIMPLE_CHEMICAL", 593, 597], ["TGF-1", "GENE_OR_GENE_PRODUCT", 632, 637], ["transforming growth factor-1", "GENE_OR_GENE_PRODUCT", 639, 667], ["ECM", "CELLULAR_COMPONENT", 669, 672], ["extracellular matrix", "CELLULAR_COMPONENT", 674, 694], ["RAGE", "GENE_OR_GENE_PRODUCT", 696, 700], ["COX-2", "GENE_OR_GENE_PRODUCT", 751, 756], ["cyclooxygenase-2", "GENE_OR_GENE_PRODUCT", 758, 774], ["CTGF", "GENE_OR_GENE_PRODUCT", 776, 780], ["connective tissue growth factor", "GENE_OR_GENE_PRODUCT", 782, 813], ["Smad3/6", "GENE_OR_GENE_PRODUCT", 815, 822], ["decapentaplegic homolog 3", "GENE_OR_GENE_PRODUCT", 840, 865], ["6", "GENE_OR_GENE_PRODUCT", 870, 871], ["AChE", "GENE_OR_GENE_PRODUCT", 873, 877], ["acetylcholinesterase", "GENE_OR_GENE_PRODUCT", 879, 899], ["pCREB", "GENE_OR_GENE_PRODUCT", 901, 906], ["cyclic AMP response element binding protein", "GENE_OR_GENE_PRODUCT", 923, 966], ["BDNF", "GENE_OR_GENE_PRODUCT", 968, 972], ["brain-derived neurotrophic factor", "GENE_OR_GENE_PRODUCT", 974, 1007], ["DA", "SIMPLE_CHEMICAL", 1009, 1011], ["dopaminergic", "SIMPLE_CHEMICAL", 1013, 1025], ["MDA", "SIMPLE_CHEMICAL", 1027, 1030], ["malondialdehyde", "SIMPLE_CHEMICAL", 1032, 1047], ["MAO", "SIMPLE_CHEMICAL", 1049, 1052], ["monoamine oxidase", "GENE_OR_GENE_PRODUCT", 1054, 1071], ["SOD", "SIMPLE_CHEMICAL", 1073, 1076], ["superoxide dismutase", "GENE_OR_GENE_PRODUCT", 1078, 1098], ["AST", "SIMPLE_CHEMICAL", 1100, 1103], ["aspartate", "SIMPLE_CHEMICAL", 1105, 1114], ["transaminase", "GENE_OR_GENE_PRODUCT", 1115, 1127], ["ALT", "SIMPLE_CHEMICAL", 1129, 1132], ["alanine transaminase", "SIMPLE_CHEMICAL", 1134, 1154], ["DPPH, 1-diphenyl-2-picrylhydrazyl", "SIMPLE_CHEMICAL", 1156, 1189], ["MI/R", "SIMPLE_CHEMICAL", 1191, 1195], ["myocardial", "MULTI-TISSUE_STRUCTURE", 1197, 1207], ["myocardial", "MULTI-TISSUE_STRUCTURE", 1242, 1252], ["mesencephalic DA culture", "CELL_LINE", 5, 29], ["DA cells", "CELL_TYPE", 74, 82], ["LDL", "PROTEIN", 276, 279], ["low-density lipoprotein cholesterol", "PROTEIN", 283, 318], ["HDL-C", "PROTEIN", 320, 325], ["high-density lipoprotein cholesterol", "PROTEIN", 327, 363], ["PPAR\u03b3", "PROTEIN", 365, 370], ["peroxisome proliferator-activated receptor", "PROTEIN", 372, 414], ["SREBP-1c", "PROTEIN", 416, 424], ["sterol regulatory element-binding protein-1c", "PROTEIN", 426, 470], ["HSL", "PROTEIN", 472, 475], ["hormone-sensitive lipase", "PROTEIN", 477, 501], ["TGH", "PROTEIN", 503, 506], ["triacylglycerol hydrolase", "PROTEIN", 508, 533], ["FAS", "PROTEIN", 535, 538], ["tumor necrosis factor receptor superfamily member 6", "PROTEIN", 540, 591], ["AGEs", "PROTEIN", 593, 597], ["advanced glycation end products", "PROTEIN", 599, 630], ["TGF-1", "PROTEIN", 632, 637], ["transforming growth factor-1", "PROTEIN", 639, 667], ["ECM", "PROTEIN", 669, 672], ["RAGE", "PROTEIN", 696, 700], ["receptor for advanced glycosylation end product", "PROTEIN", 702, 749], ["COX-2", "PROTEIN", 751, 756], ["cyclooxygenase-2", "PROTEIN", 758, 774], ["CTGF", "PROTEIN", 776, 780], ["connective tissue growth factor", "PROTEIN", 782, 813], ["Smad3/6", "PROTEIN", 815, 822], ["decapentaplegic homolog 3 and 6", "PROTEIN", 840, 871], ["AChE", "PROTEIN", 873, 877], ["acetylcholinesterase", "PROTEIN", 879, 899], ["pCREB", "PROTEIN", 901, 906], ["phosphorylated cyclic AMP response element binding protein", "PROTEIN", 908, 966], ["BDNF", "PROTEIN", 968, 972], ["brain-derived neurotrophic factor", "PROTEIN", 974, 1007], ["MAO", "PROTEIN", 1049, 1052], ["monoamine oxidase", "PROTEIN", 1054, 1071], ["SOD", "PROTEIN", 1073, 1076], ["superoxide dismutase", "PROTEIN", 1078, 1098], ["AST", "PROTEIN", 1100, 1103], ["ALT", "PROTEIN", 1129, 1132], ["C. obtusifolia", "SPECIES", 31, 45], ["C. obtusifolia", "SPECIES", 31, 45], ["a mesencephalic DA culture", "TEST", 3, 29], ["C. obtusifolia", "TEST", 31, 45], ["the DA cells", "TEST", 70, 82], ["OHDA", "TEST", 93, 97], ["methyl", "TREATMENT", 104, 110], ["phenylpyridinium iodide", "TREATMENT", 113, 136], ["attenuates MI/R-induced injury", "PROBLEM", 204, 234], ["TC", "TEST", 235, 237], ["total cholesterol", "TEST", 239, 256], ["TG", "TEST", 258, 260], ["triglyceride", "TEST", 262, 274], ["LDL", "TEST", 276, 279], ["C", "TEST", 280, 281], ["low", "TEST", 283, 286], ["lipoprotein", "TEST", 295, 306], ["cholesterol", "TEST", 307, 318], ["HDL", "TEST", 320, 323], ["C", "TEST", 324, 325], ["high-density lipoprotein cholesterol", "PROBLEM", 327, 363], ["PPAR\u03b3", "TEST", 365, 370], ["peroxisome proliferator", "TEST", 372, 395], ["activated receptor", "TREATMENT", 396, 414], ["SREBP", "TEST", 416, 421], ["sterol regulatory element", "TEST", 426, 451], ["binding protein", "TEST", 452, 467], ["HSL", "TEST", 472, 475], ["hormone", "TEST", 477, 484], ["lipase", "TEST", 495, 501], ["TGH", "TEST", 503, 506], ["triacylglycerol hydrolase", "TEST", 508, 533], ["FAS", "PROBLEM", 535, 538], ["tumor necrosis", "PROBLEM", 540, 554], ["advanced glycation end products", "TREATMENT", 599, 630], ["TGF", "TEST", 632, 635], ["transforming growth factor", "TEST", 639, 665], ["advanced glycosylation end product", "TREATMENT", 715, 749], ["COX", "TEST", 751, 754], ["cyclooxygenase", "TEST", 758, 772], ["CTGF", "PROBLEM", 776, 780], ["connective tissue growth factor", "TEST", 782, 813], ["Smad3", "TEST", 815, 820], ["decapentaplegic homolog", "TEST", 840, 863], ["AChE", "TEST", 873, 877], ["acetylcholinesterase", "TEST", 879, 899], ["pCREB", "TEST", 901, 906], ["phosphorylated cyclic AMP response element binding protein", "TEST", 908, 966], ["BDNF", "TEST", 968, 972], ["DA", "TREATMENT", 1009, 1011], ["dopaminergic", "TREATMENT", 1013, 1025], ["MDA", "TREATMENT", 1027, 1030], ["malondialdehyde", "TREATMENT", 1032, 1047], ["MAO", "TREATMENT", 1049, 1052], ["monoamine oxidase", "TREATMENT", 1054, 1071], ["SOD", "TREATMENT", 1073, 1076], ["superoxide dismutase", "TEST", 1078, 1098], ["AST", "TEST", 1100, 1103], ["aspartate transaminase", "TEST", 1105, 1127], ["ALT", "TEST", 1129, 1132], ["alanine transaminase", "TEST", 1134, 1154], ["DPPH", "TEST", 1156, 1160], ["diphenyl", "TREATMENT", 1164, 1172], ["picrylhydrazyl", "TREATMENT", 1175, 1189], ["MI", "PROBLEM", 1191, 1193], ["myocardial ischemia", "PROBLEM", 1197, 1216], ["reperfusion", "TREATMENT", 1221, 1232], ["myocardial Water extracttoxicities", "PROBLEM", 1242, 1276], ["mesencephalic", "ANATOMY", 5, 18], ["peroxisome", "ANATOMY", 372, 382], ["tumor necrosis", "OBSERVATION", 540, 554], ["connective tissue", "ANATOMY", 782, 799], ["brain", "ANATOMY", 974, 979], ["R", "ANATOMY", 1194, 1195], ["myocardial", "ANATOMY", 1197, 1207], ["ischemia", "OBSERVATION", 1208, 1216], ["reperfusion", "OBSERVATION", 1221, 1232], ["myocardial", "ANATOMY", 1242, 1252], ["Water extracttoxicities", "OBSERVATION", 1253, 1276]]], ["In addition, C. obtusifolia (50 mg/kg/day for 15 days) significantly protected DA neuronal degeneration in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced mouse Parkinson's disease (PD) model by inhibiting the movement impairment and the loss of DA neurons, indicating that C. obtusifolia may be a useful neuroprotective candidate for PD (81) .", [["neuronal", "ANATOMY", 82, 90], ["DA neurons", "ANATOMY", 253, 263], ["obtusifolia", "CHEMICAL", 16, 27], ["DA", "CHEMICAL", 79, 81], ["neuronal degeneration", "DISEASE", 82, 103], ["1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine", "CHEMICAL", 109, 153], ["Parkinson's disease", "DISEASE", 168, 187], ["PD", "DISEASE", 189, 191], ["movement impairment", "DISEASE", 217, 236], ["DA", "CHEMICAL", 253, 255], ["PD", "DISEASE", 342, 344], ["1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine", "CHEMICAL", 109, 153], ["C. obtusifolia", "ORGANISM", 13, 27], ["DA neuronal", "CELL", 79, 90], ["1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine", "SIMPLE_CHEMICAL", 109, 153], ["mouse", "ORGANISM", 162, 167], ["DA neurons", "CELL", 253, 263], ["C. obtusifolia", "ORGANISM", 281, 295], ["DA neurons", "CELL_TYPE", 253, 263], ["C. obtusifolia", "SPECIES", 13, 27], ["mouse", "SPECIES", 162, 167], ["C. obtusifolia", "SPECIES", 281, 295], ["C. obtusifolia", "SPECIES", 13, 27], ["C. obtusifolia", "SPECIES", 281, 295], ["C. obtusifolia", "TREATMENT", 13, 27], ["significantly protected DA neuronal degeneration", "PROBLEM", 55, 103], ["phenyl", "TEST", 120, 126], ["tetrahydropyridine", "TREATMENT", 135, 153], ["mouse Parkinson's disease (PD) model", "PROBLEM", 162, 198], ["the movement impairment", "PROBLEM", 213, 236], ["the loss of DA neurons", "PROBLEM", 241, 263], ["C. obtusifolia", "PROBLEM", 281, 295], ["PD", "PROBLEM", 342, 344], ["neuronal degeneration", "OBSERVATION", 82, 103], ["Parkinson's", "OBSERVATION", 168, 179]]], ["In addition, protein and anthraquinone glucosides from Cassia semen improved learning and memory capacity, inhibited the malondialdehyde (MDA) and monoamine oxidase levels, and enhanced the level of superoxide dismutase (SOD) in the cerebrum of senile mice (82) .Improves myocardial Water extractHepatoprotective activity.", [["cerebrum", "ANATOMY", 233, 241], ["myocardial", "ANATOMY", 272, 282], ["anthraquinone glucosides", "CHEMICAL", 25, 49], ["malondialdehyde", "CHEMICAL", 121, 136], ["MDA", "CHEMICAL", 138, 141], ["superoxide", "CHEMICAL", 199, 209], ["senile", "DISEASE", 245, 251], ["anthraquinone glucosides", "CHEMICAL", 25, 49], ["malondialdehyde", "CHEMICAL", 121, 136], ["MDA", "CHEMICAL", 138, 141], ["monoamine", "CHEMICAL", 147, 156], ["superoxide", "CHEMICAL", 199, 209], ["anthraquinone glucosides", "SIMPLE_CHEMICAL", 25, 49], ["Cassia semen", "ORGANISM", 55, 67], ["malondialdehyde", "SIMPLE_CHEMICAL", 121, 136], ["MDA", "SIMPLE_CHEMICAL", 138, 141], ["monoamine oxidase", "GENE_OR_GENE_PRODUCT", 147, 164], ["superoxide dismutase", "GENE_OR_GENE_PRODUCT", 199, 219], ["SOD", "GENE_OR_GENE_PRODUCT", 221, 224], ["cerebrum", "ORGAN", 233, 241], ["mice", "ORGANISM", 252, 256], ["myocardial", "MULTI-TISSUE_STRUCTURE", 272, 282], ["monoamine oxidase", "PROTEIN", 147, 164], ["superoxide dismutase", "PROTEIN", 199, 219], ["SOD", "PROTEIN", 221, 224], ["mice", "SPECIES", 252, 256], ["protein", "TEST", 13, 20], ["anthraquinone glucosides", "TREATMENT", 25, 49], ["Cassia semen", "TEST", 55, 67], ["memory capacity", "TEST", 90, 105], ["the malondialdehyde (MDA)", "TEST", 117, 142], ["monoamine oxidase levels", "TEST", 147, 171], ["superoxide dismutase", "TEST", 199, 219], ["superoxide dismutase", "OBSERVATION", 199, 219], ["cerebrum", "ANATOMY", 233, 241], ["myocardial", "ANATOMY", 272, 282], ["Water extract", "OBSERVATION_MODIFIER", 283, 296], ["Hepatoprotective activity", "OBSERVATION", 296, 321]]], ["It was recorded in the Compendium of Materia Medica that Cassiae semen exhibited the functions of nourishing the liver and improving vision (83) .", [["liver", "ANATOMY", 113, 118], ["liver", "ORGAN", 113, 118], ["liver", "ANATOMY", 113, 118]]], ["In Korea, the aqueous extract of C. tora L. seeds has been used for the protection of the liver.", [["aqueous extract", "ANATOMY", 14, 29], ["liver", "ANATOMY", 90, 95], ["aqueous extract of C. tora L.", "CHEMICAL", 14, 43], ["aqueous extract", "ORGANISM_SUBSTANCE", 14, 29], ["C. tora L.", "ORGANISM", 33, 43], ["seeds", "ORGANISM", 44, 49], ["liver", "ORGAN", 90, 95], ["C. tora L.", "SPECIES", 33, 43], ["C. tora L.", "SPECIES", 33, 43], ["the aqueous extract", "TREATMENT", 10, 29], ["C. tora L. seeds", "TREATMENT", 33, 49], ["liver", "ANATOMY", 90, 95]]], ["A weak anti-hepatotoxic activity in CCl 4 -induced mice was observed when the drug was administered orally at a dose of 670 mg/kg (84) .", [["CCl 4", "CHEMICAL", 36, 41], ["CCl 4", "CHEMICAL", 36, 41], ["CCl 4", "SIMPLE_CHEMICAL", 36, 41], ["mice", "ORGANISM", 51, 55], ["mice", "SPECIES", 51, 55], ["mice", "SPECIES", 51, 55], ["A weak anti-hepatotoxic activity", "PROBLEM", 0, 32], ["the drug", "TREATMENT", 74, 82], ["weak", "OBSERVATION_MODIFIER", 2, 6], ["anti-hepatotoxic", "OBSERVATION_MODIFIER", 7, 23], ["activity", "OBSERVATION_MODIFIER", 24, 32]]], ["The methanol extract of C. tora L. seeds exhibited significantly protective effects in primary cultured hepatocytes against CCl 4 and toxicity.", [["hepatocytes", "ANATOMY", 104, 115], ["methanol extract of C. tora L.", "CHEMICAL", 4, 34], ["CCl 4", "CHEMICAL", 124, 129], ["toxicity", "DISEASE", 134, 142], ["methanol", "CHEMICAL", 4, 12], ["CCl 4", "CHEMICAL", 124, 129], ["methanol", "SIMPLE_CHEMICAL", 4, 12], ["C. tora L.", "ORGANISM", 24, 34], ["seeds", "ORGANISM", 35, 40], ["hepatocytes", "CELL", 104, 115], ["primary cultured hepatocytes", "CELL_TYPE", 87, 115], ["C. tora L.", "SPECIES", 24, 34], ["C. tora L.", "SPECIES", 24, 34], ["The methanol extract", "TREATMENT", 0, 20], ["C. tora L. seeds", "TREATMENT", 24, 40], ["primary cultured hepatocytes", "TEST", 87, 115], ["toxicity", "PROBLEM", 134, 142], ["significantly protective", "OBSERVATION_MODIFIER", 51, 75], ["hepatocytes", "ANATOMY", 104, 115]]], ["A total of two anthraquinone glycosides (compounds 44 and 45) and three naphthoypyrone glycosides (compounds 49, 51 and 53) from the methanol extract of C. tora seeds were the primary chemical constituents (42, 50) .", [["anthraquinone", "CHEMICAL", 15, 28], ["compounds 44 and 45", "CHEMICAL", 41, 60], ["naphthoypyrone", "CHEMICAL", 72, 86], ["compounds 49, 51 and 53", "CHEMICAL", 99, 122], ["anthraquinone glycosides", "CHEMICAL", 15, 39], ["naphthoypyrone glycosides", "CHEMICAL", 72, 97], ["methanol", "CHEMICAL", 133, 141], ["anthraquinone glycosides", "SIMPLE_CHEMICAL", 15, 39], ["naphthoypyrone glycosides", "SIMPLE_CHEMICAL", 72, 97], ["methanol", "SIMPLE_CHEMICAL", 133, 141], ["C. tora seeds", "ORGANISM", 153, 166], ["C. tora", "SPECIES", 153, 160], ["C. tora", "SPECIES", 153, 160], ["two anthraquinone glycosides", "TREATMENT", 11, 39], ["three naphthoypyrone glycosides", "TREATMENT", 66, 97], ["the methanol extract", "TREATMENT", 129, 149], ["C. tora seeds", "TREATMENT", 153, 166]]], ["The preventative effects of Cassiae semen on acute liver injury in mice induced by CCl 4 have also been investigated (85, 86) .", [["liver", "ANATOMY", 51, 56], ["Cassiae", "CHEMICAL", 28, 35], ["acute liver injury", "DISEASE", 45, 63], ["CCl 4", "CHEMICAL", 83, 88], ["CCl 4", "CHEMICAL", 83, 88], ["Cassiae", "ORGANISM", 28, 35], ["semen", "ORGANISM_SUBSTANCE", 36, 41], ["liver", "ORGAN", 51, 56], ["mice", "ORGANISM", 67, 71], ["CCl 4", "GENE_OR_GENE_PRODUCT", 83, 88], ["mice", "SPECIES", 67, 71], ["mice", "SPECIES", 67, 71], ["Cassiae semen", "TREATMENT", 28, 41], ["acute liver injury", "PROBLEM", 45, 63], ["acute", "OBSERVATION_MODIFIER", 45, 50], ["liver", "ANATOMY", 51, 56], ["injury", "OBSERVATION", 57, 63]]], ["When compared with the control group, varying concentrations of the aqueous extract of Cassiae semen significantly increased the serum levels of SOD, and decreased the serum levels of aspartate transaminase (AST), alanine transaminase (ALT) and MDA.", [["aqueous extract", "ANATOMY", 68, 83], ["serum", "ANATOMY", 129, 134], ["serum", "ANATOMY", 168, 173], ["Cassiae", "CHEMICAL", 87, 94], ["aspartate", "CHEMICAL", 184, 193], ["alanine", "CHEMICAL", 214, 221], ["MDA", "CHEMICAL", 245, 248], ["aspartate", "CHEMICAL", 184, 193], ["alanine", "CHEMICAL", 214, 221], ["MDA", "CHEMICAL", 245, 248], ["aqueous extract", "ORGANISM_SUBSTANCE", 68, 83], ["Cassiae", "ORGANISM", 87, 94], ["semen", "ORGANISM_SUBSTANCE", 95, 100], ["serum", "ORGANISM_SUBSTANCE", 129, 134], ["SOD", "GENE_OR_GENE_PRODUCT", 145, 148], ["serum", "ORGANISM_SUBSTANCE", 168, 173], ["aspartate transaminase", "GENE_OR_GENE_PRODUCT", 184, 206], ["AST", "SIMPLE_CHEMICAL", 208, 211], ["alanine transaminase", "GENE_OR_GENE_PRODUCT", 214, 234], ["ALT", "SIMPLE_CHEMICAL", 236, 239], ["MDA", "SIMPLE_CHEMICAL", 245, 248], ["SOD", "PROTEIN", 145, 148], ["aspartate transaminase", "PROTEIN", 184, 206], ["AST", "PROTEIN", 208, 211], ["alanine transaminase", "PROTEIN", 214, 234], ["ALT", "PROTEIN", 236, 239], ["the serum levels", "TEST", 125, 141], ["SOD", "PROBLEM", 145, 148], ["the serum levels", "TEST", 164, 180], ["aspartate transaminase", "TEST", 184, 206], ["AST", "TEST", 208, 211], ["alanine transaminase", "TEST", 214, 234], ["ALT", "TEST", 236, 239], ["MDA", "TEST", 245, 248], ["decreased", "OBSERVATION_MODIFIER", 154, 163]]], ["These results indicate that Cassiae semen is potentially beneficial in the treatment or prevention of hepatic damage (85, 86) .", [["hepatic", "ANATOMY", 102, 109], ["hepatic damage", "DISEASE", 102, 116], ["Cassiae", "ORGANISM", 28, 35], ["semen", "ORGANISM_SUBSTANCE", 36, 41], ["hepatic", "ORGAN", 102, 109], ["Cassiae semen", "TREATMENT", 28, 41], ["the treatment", "TREATMENT", 71, 84], ["hepatic damage", "PROBLEM", 102, 116], ["hepatic", "ANATOMY", 102, 109], ["damage", "OBSERVATION", 110, 116]]], ["In addition, the ethanol extract of Cassiae semen has been observed to increase the serum levels of SOD and to decrease the serum levels of TG, TC, MDA, AST and ALT (86).", [["serum", "ANATOMY", 84, 89], ["serum", "ANATOMY", 124, 129], ["ethanol extract", "CHEMICAL", 17, 32], ["Cassiae", "CHEMICAL", 36, 43], ["ethanol", "CHEMICAL", 17, 24], ["MDA", "CHEMICAL", 148, 151], ["ethanol", "SIMPLE_CHEMICAL", 17, 24], ["Cassiae semen", "ORGANISM", 36, 49], ["serum", "ORGANISM_SUBSTANCE", 84, 89], ["SOD", "SIMPLE_CHEMICAL", 100, 103], ["serum", "ORGANISM_SUBSTANCE", 124, 129], ["TG", "SIMPLE_CHEMICAL", 140, 142], ["TC", "SIMPLE_CHEMICAL", 144, 146], ["MDA", "SIMPLE_CHEMICAL", 148, 151], ["AST", "SIMPLE_CHEMICAL", 153, 156], ["ALT", "SIMPLE_CHEMICAL", 161, 164], ["SOD", "PROTEIN", 100, 103], ["AST", "PROTEIN", 153, 156], ["the ethanol extract", "TREATMENT", 13, 32], ["Cassiae semen", "TREATMENT", 36, 49], ["the serum levels", "TEST", 80, 96], ["SOD", "PROBLEM", 100, 103], ["the serum levels", "TEST", 120, 136], ["TG", "TEST", 140, 142], ["TC", "TEST", 144, 146], ["MDA", "TEST", 148, 151], ["AST", "TEST", 153, 156], ["ALT", "TEST", 161, 164]]], ["Total anthraquinones from Cassiae semen exhibited a protective effect on alcohol-induced acute liver injury in mice by regulating fat metabolism, improving liver function and increasing the mRNA and protein expression levels of PPAR-\u03b3 (10, 87) .Improves myocardial Water extractAntibacterial activity.", [["liver", "ANATOMY", 95, 100], ["fat", "ANATOMY", 130, 133], ["liver", "ANATOMY", 156, 161], ["myocardial", "ANATOMY", 254, 264], ["anthraquinones", "CHEMICAL", 6, 20], ["Cassiae", "CHEMICAL", 26, 33], ["alcohol", "CHEMICAL", 73, 80], ["acute liver injury", "DISEASE", 89, 107], ["anthraquinones", "CHEMICAL", 6, 20], ["alcohol", "CHEMICAL", 73, 80], ["anthraquinones", "SIMPLE_CHEMICAL", 6, 20], ["Cassiae semen", "ORGANISM", 26, 39], ["alcohol", "SIMPLE_CHEMICAL", 73, 80], ["liver", "ORGAN", 95, 100], ["mice", "ORGANISM", 111, 115], ["fat", "TISSUE", 130, 133], ["liver", "ORGAN", 156, 161], ["PPAR-\u03b3", "GENE_OR_GENE_PRODUCT", 228, 234], ["myocardial", "MULTI-TISSUE_STRUCTURE", 254, 264], ["PPAR", "PROTEIN", 228, 232], ["mice", "SPECIES", 111, 115], ["mice", "SPECIES", 111, 115], ["Total anthraquinones", "TREATMENT", 0, 20], ["Cassiae semen", "TREATMENT", 26, 39], ["acute liver injury", "PROBLEM", 89, 107], ["protein expression levels", "TEST", 199, 224], ["PPAR", "TEST", 228, 232], ["myocardial Water extract", "TREATMENT", 254, 278], ["acute", "OBSERVATION_MODIFIER", 89, 94], ["liver", "ANATOMY", 95, 100], ["injury", "OBSERVATION", 101, 107], ["liver", "ANATOMY", 156, 161], ["PPAR", "ANATOMY", 228, 232], ["myocardial", "ANATOMY", 254, 264], ["Water extract", "OBSERVATION", 265, 278], ["Antibacterial activity", "OBSERVATION", 278, 300]]], ["Antibacterial activity, an important effect of Cassiae semen, has been comprehensively investigated.", [["semen", "ANATOMY", 55, 60], ["Cassiae semen", "TREATMENT", 47, 60]]], ["Naphthalenes (compounds 47 and 50) and anthraquinones (compounds 1, 4 and 5) isolated from C. tora seeds exhibited significant antibacterial effects on four strains of methicillin-resistant Staphylococcus aureus [minimal inhibitory concentration (MIC) was 2-64 \u00b5g/ml] and a strain of methicillin-sensitive S. aureus.", [["Naphthalenes", "CHEMICAL", 0, 12], ["compounds 47 and 50) and anthraquinones", "CHEMICAL", 14, 53], ["compounds 1, 4 and 5", "CHEMICAL", 55, 75], ["methicillin", "CHEMICAL", 168, 179], ["Staphylococcus aureus", "DISEASE", 190, 211], ["methicillin", "CHEMICAL", 284, 295], ["Naphthalenes", "CHEMICAL", 0, 12], ["anthraquinones", "CHEMICAL", 39, 53], ["methicillin", "CHEMICAL", 168, 179], ["methicillin", "CHEMICAL", 284, 295], ["Naphthalenes", "SIMPLE_CHEMICAL", 0, 12], ["anthraquinones", "SIMPLE_CHEMICAL", 39, 53], ["5", "ORGANISM", 74, 75], ["C. tora seeds", "ORGANISM", 91, 104], ["methicillin-resistant", "SIMPLE_CHEMICAL", 168, 189], ["Staphylococcus aureus", "ORGANISM", 190, 211], ["methicillin", "SIMPLE_CHEMICAL", 284, 295], ["S. aureus", "ORGANISM", 306, 315], ["C. tora", "SPECIES", 91, 98], ["Staphylococcus aureus", "SPECIES", 190, 211], ["S. aureus", "SPECIES", 306, 315], ["C. tora", "SPECIES", 91, 98], ["Staphylococcus aureus", "SPECIES", 190, 211], ["S. aureus", "SPECIES", 306, 315], ["Naphthalenes (compounds", "TREATMENT", 0, 23], ["anthraquinones (compounds", "TREATMENT", 39, 64], ["C. tora seeds", "TREATMENT", 91, 104], ["significant antibacterial effects", "PROBLEM", 115, 148], ["methicillin-resistant Staphylococcus aureus", "PROBLEM", 168, 211], ["minimal inhibitory concentration", "TREATMENT", 213, 245], ["methicillin-sensitive S. aureus", "PROBLEM", 284, 315], ["significant", "OBSERVATION_MODIFIER", 115, 126], ["antibacterial effects", "OBSERVATION", 127, 148], ["Staphylococcus aureus", "OBSERVATION", 190, 211], ["aureus", "OBSERVATION", 309, 315]]], ["In addition, rhein (compound 5) and torachrysone (compound 47) from the seeds of C. tora exhibited antibacterial activity against Escherichia coli K12 with MIC values of 512 and 128 \u00b5g/ml, respectively (17) .", [["seeds", "ANATOMY", 72, 77], ["rhein", "CHEMICAL", 13, 18], ["compound 5", "CHEMICAL", 20, 30], ["torachrysone", "CHEMICAL", 36, 48], ["compound 47", "CHEMICAL", 50, 61], ["rhein", "CHEMICAL", 13, 18], ["torachrysone", "CHEMICAL", 36, 48], ["rhein", "SIMPLE_CHEMICAL", 13, 18], ["compound 5", "SIMPLE_CHEMICAL", 20, 30], ["torachrysone", "SIMPLE_CHEMICAL", 36, 48], ["compound 47", "SIMPLE_CHEMICAL", 50, 61], ["C. tora", "ORGANISM", 81, 88], ["Escherichia coli", "ORGANISM", 130, 146], ["K12", "ORGANISM", 147, 150], ["C. tora", "SPECIES", 81, 88], ["Escherichia coli", "SPECIES", 130, 146], ["C. tora", "SPECIES", 81, 88], ["Escherichia coli", "SPECIES", 130, 146], ["C. tora", "TEST", 81, 88], ["antibacterial activity", "PROBLEM", 99, 121], ["Escherichia coli K12", "PROBLEM", 130, 150], ["MIC values", "TEST", 156, 166], ["rhein", "OBSERVATION_MODIFIER", 13, 18], ["antibacterial activity", "OBSERVATION", 99, 121]]], ["Kim et al (88) were the first to demonstrate that emodin (compound 1) from C. tora seeds has a median lethal dose (LC 50 ) value of 0.102, 0.163, 0.385 and 0.046 g/l against Rhizoctonia solani, Botrytis cinerea, Phytophthora infestans and Erysiphe graminis, respectively, and physcion (compound 3) has an LC 50 value of 0.248, 0.263, 0.518, and 0.073 g/l against R. solani, B. cinerea, P. infestans and E. graminis, respectively.", [["emodin", "CHEMICAL", 50, 56], ["emodin", "CHEMICAL", 50, 56], ["emodin", "SIMPLE_CHEMICAL", 50, 56], ["C. tora seeds", "ORGANISM", 75, 88], ["Rhizoctonia solani", "ORGANISM", 174, 192], ["Botrytis cinerea", "ORGANISM", 194, 210], ["Phytophthora infestans", "ORGANISM", 212, 234], ["Erysiphe graminis", "ORGANISM", 239, 256], ["physcion", "SIMPLE_CHEMICAL", 276, 284], ["R. solani", "ORGANISM", 363, 372], ["B. cinerea", "ORGANISM", 374, 384], ["P. infestans", "ORGANISM", 386, 398], ["E. graminis", "ORGANISM", 403, 414], ["C. tora", "SPECIES", 75, 82], ["Rhizoctonia solani", "SPECIES", 174, 192], ["Botrytis cinerea", "SPECIES", 194, 210], ["Phytophthora infestans", "SPECIES", 212, 234], ["Erysiphe graminis", "SPECIES", 239, 256], ["R. solani", "SPECIES", 363, 372], ["B. cinerea", "SPECIES", 374, 384], ["P. infestans", "SPECIES", 386, 398], ["E. graminis", "SPECIES", 403, 414], ["C. tora", "SPECIES", 75, 82], ["Rhizoctonia solani", "SPECIES", 174, 192], ["Botrytis cinerea", "SPECIES", 194, 210], ["Phytophthora infestans", "SPECIES", 212, 234], ["Erysiphe graminis", "SPECIES", 239, 256], ["R. solani", "SPECIES", 363, 372], ["B. cinerea", "SPECIES", 374, 384], ["P. infestans", "SPECIES", 386, 398], ["E. graminis", "SPECIES", 403, 414], ["C. tora seeds", "TREATMENT", 75, 88], ["LC", "TEST", 115, 117], ["Rhizoctonia solani", "TEST", 174, 192], ["Botrytis cinerea", "TEST", 194, 210], ["Erysiphe graminis", "TEST", 239, 256], ["an LC", "TEST", 302, 307], ["emodin", "OBSERVATION", 50, 56]]], ["In addition, the LC 50 value of rhein (compound 5) is 0.375, 0.478, and 0.047 g/l against R. solani, B. cinerea and P. infestans, respectively (88) .Improves myocardial Water extractIt has been reported that ethanol and aqueous extracts of C. obtusifolia seeds were inhibitory against Helicobacter pylori strains (MIC were 100 and 60 \u00b5g/ml, respectively) (89).", [["myocardial", "ANATOMY", 158, 168], ["aqueous extracts", "ANATOMY", 220, 236], ["rhein", "CHEMICAL", 32, 37], ["compound 5", "CHEMICAL", 39, 49], ["ethanol", "CHEMICAL", 208, 215], ["rhein", "CHEMICAL", 32, 37], ["ethanol", "CHEMICAL", 208, 215], ["rhein", "SIMPLE_CHEMICAL", 32, 37], ["R. solani", "ORGANISM", 90, 99], ["B. cinerea", "ORGANISM", 101, 111], ["P. infestans", "ORGANISM", 116, 128], ["myocardial", "MULTI-TISSUE_STRUCTURE", 158, 168], ["ethanol", "SIMPLE_CHEMICAL", 208, 215], ["aqueous extracts", "ORGANISM_SUBSTANCE", 220, 236], ["C. obtusifolia seeds", "ORGANISM", 240, 260], ["Helicobacter pylori", "ORGANISM", 285, 304], ["strains", "ORGANISM", 305, 312], ["R. solani", "SPECIES", 90, 99], ["B. cinerea", "SPECIES", 101, 111], ["P. infestans", "SPECIES", 116, 128], ["C. obtusifolia", "SPECIES", 240, 254], ["Helicobacter pylori", "SPECIES", 285, 304], ["R. solani", "SPECIES", 90, 99], ["B. cinerea", "SPECIES", 101, 111], ["P. infestans", "SPECIES", 116, 128], ["C. obtusifolia", "SPECIES", 240, 254], ["Helicobacter pylori", "SPECIES", 285, 304], ["the LC", "TEST", 13, 19], ["myocardial Water extract", "TREATMENT", 158, 182], ["aqueous extracts", "TREATMENT", 220, 236], ["C. obtusifolia seeds", "TREATMENT", 240, 260], ["Helicobacter pylori strains", "PROBLEM", 285, 312], ["myocardial", "ANATOMY", 158, 168], ["Water extract", "OBSERVATION", 169, 182]]], ["In addition, 1,2-dihydroxyanthraquinone (compound 15) isolated from C. obtusifolia seeds was revealed to inhibit the growth of Clostridium perfringens and E. coli., indicating that this drug exhibited potent growth-inhibiting activities towards human intestinal bacteria (90) .", [["intestinal", "ANATOMY", 251, 261], ["1,2-dihydroxyanthraquinone", "CHEMICAL", 13, 39], ["compound 15", "CHEMICAL", 41, 52], ["Clostridium perfringens", "DISEASE", 127, 150], ["1,2-dihydroxyanthraquinone", "CHEMICAL", 13, 39], ["1,2-dihydroxyanthraquinone", "SIMPLE_CHEMICAL", 13, 39], ["compound 15", "SIMPLE_CHEMICAL", 41, 52], ["C. obtusifolia", "ORGANISM", 68, 82], ["seeds", "ORGANISM", 83, 88], ["Clostridium perfringens", "ORGANISM", 127, 150], ["E. coli.", "ORGANISM", 155, 163], ["human", "ORGANISM", 245, 250], ["intestinal", "ORGAN", 251, 261], ["C. obtusifolia", "SPECIES", 68, 82], ["Clostridium perfringens", "SPECIES", 127, 150], ["E. coli.", "SPECIES", 155, 163], ["human", "SPECIES", 245, 250], ["C. obtusifolia", "SPECIES", 68, 82], ["Clostridium perfringens", "SPECIES", 127, 150], ["E. coli.", "SPECIES", 155, 163], ["human", "SPECIES", 245, 250], ["dihydroxyanthraquinone (compound", "TREATMENT", 17, 49], ["C. obtusifolia seeds", "PROBLEM", 68, 88], ["Clostridium perfringens", "PROBLEM", 127, 150], ["E. coli.", "PROBLEM", 155, 163], ["potent growth", "PROBLEM", 201, 214], ["human intestinal bacteria", "PROBLEM", 245, 270], ["Clostridium perfringens", "OBSERVATION", 127, 150], ["intestinal", "ANATOMY", 251, 261]]], ["Li et al (91) demonstrated that the chloroform extract of the seeds of C. obtusifolia also exhibited different inhibitory activities against Fusarium oxysporum and B. cinerea (IC 50 values were 0.57 mg/ml and 0.97 mg/ml).Improves myocardial Water extractAntioxidant activity.", [["seeds", "ANATOMY", 62, 67], ["myocardial", "ANATOMY", 230, 240], ["Li", "CHEMICAL", 0, 2], ["chloroform extract of the seeds of C. obtusifolia", "CHEMICAL", 36, 85], ["chloroform", "CHEMICAL", 36, 46], ["chloroform", "SIMPLE_CHEMICAL", 36, 46], ["C. obtusifolia", "ORGANISM", 71, 85], ["Fusarium oxysporum", "ORGANISM", 141, 159], ["B. cinerea", "ORGANISM", 164, 174], ["myocardial", "MULTI-TISSUE_STRUCTURE", 230, 240], ["C. obtusifolia", "SPECIES", 71, 85], ["Fusarium oxysporum", "SPECIES", 141, 159], ["B. cinerea", "SPECIES", 164, 174], ["C. obtusifolia", "SPECIES", 71, 85], ["Fusarium oxysporum", "SPECIES", 141, 159], ["B. cinerea", "SPECIES", 164, 174], ["the chloroform extract", "TREATMENT", 32, 54], ["C. obtusifolia", "PROBLEM", 71, 85], ["Fusarium oxysporum", "PROBLEM", 141, 159], ["C. obtusifolia", "OBSERVATION", 71, 85], ["myocardial", "ANATOMY", 230, 240], ["Water extractAntioxidant", "OBSERVATION", 241, 265]]], ["The water extract of C. tora seeds accelerated the oxidation of deoxyribose induced by Fe 3+ -EDTA/H 2 O 2 and exhibited 94% inhibition of linoleic acid peroxidation at a concentration of 0.2 mg/ml.", [["deoxyribose", "CHEMICAL", 64, 75], ["Fe 3+ -EDTA", "CHEMICAL", 87, 98], ["H 2 O", "CHEMICAL", 99, 104], ["linoleic acid", "CHEMICAL", 139, 152], ["deoxyribose", "CHEMICAL", 64, 75], ["Fe 3+ -EDTA", "CHEMICAL", 87, 98], ["H 2 O 2", "CHEMICAL", 99, 106], ["linoleic acid", "CHEMICAL", 139, 152], ["C. tora seeds", "ORGANISM", 21, 34], ["deoxyribose", "SIMPLE_CHEMICAL", 64, 75], ["Fe 3+ -EDTA", "SIMPLE_CHEMICAL", 87, 98], ["H 2 O 2", "SIMPLE_CHEMICAL", 99, 106], ["linoleic acid", "SIMPLE_CHEMICAL", 139, 152], ["C. tora", "SPECIES", 21, 28], ["C. tora", "SPECIES", 21, 28], ["The water extract", "TREATMENT", 0, 17], ["C. tora seeds", "TREATMENT", 21, 34], ["deoxyribose", "TREATMENT", 64, 75], ["Fe", "TEST", 87, 89], ["EDTA/H", "TEST", 94, 100], ["linoleic acid peroxidation", "TREATMENT", 139, 165]]], ["The underlying mechanisms of this may be mediated by reducing metal ions, scavenging hydroxyl radical and chelating ferrousion (92, 93) .", [["hydroxyl", "CHEMICAL", 85, 93], ["hydroxyl", "CHEMICAL", 85, 93], ["metal ions", "SIMPLE_CHEMICAL", 62, 72], ["hydroxyl radical", "SIMPLE_CHEMICAL", 85, 101], ["chelating ferrousion", "SIMPLE_CHEMICAL", 106, 126], ["metal ions", "TREATMENT", 62, 72], ["scavenging hydroxyl radical", "TREATMENT", 74, 101], ["chelating ferrousion", "TEST", 106, 126], ["hydroxyl radical", "OBSERVATION", 85, 101]]], ["Xv and Hu (94) demonstrated that the water extract of Cassiae semen exhibited a potent ability to scavenge free oxygen radicals [IC 50 values were 2 mg/ml and 2 \u00b5g/ml for hydroxyl radicals (OH -) and hydrogen peroxide (H 2 O 2 ), respectively].", [["Cassiae", "CHEMICAL", 54, 61], ["oxygen", "CHEMICAL", 112, 118], ["hydroxyl", "CHEMICAL", 171, 179], ["OH", "CHEMICAL", 190, 192], ["hydrogen peroxide", "CHEMICAL", 200, 217], ["oxygen", "CHEMICAL", 112, 118], ["hydroxyl", "CHEMICAL", 171, 179], ["OH", "CHEMICAL", 190, 192], ["hydrogen peroxide", "CHEMICAL", 200, 217], ["H 2 O 2", "CHEMICAL", 219, 226], ["Xv", "GENE_OR_GENE_PRODUCT", 0, 2], ["Cassiae semen", "ORGANISM", 54, 67], ["free oxygen radicals", "SIMPLE_CHEMICAL", 107, 127], ["hydroxyl radicals", "SIMPLE_CHEMICAL", 171, 188], ["OH", "SIMPLE_CHEMICAL", 190, 192], ["hydrogen peroxide", "SIMPLE_CHEMICAL", 200, 217], ["H 2 O 2", "SIMPLE_CHEMICAL", 219, 226], ["Hu", "TEST", 7, 9], ["the water extract", "TREATMENT", 33, 50], ["Cassiae semen", "TREATMENT", 54, 67], ["scavenge free oxygen radicals", "TREATMENT", 98, 127], ["hydroxyl radicals", "TREATMENT", 171, 188], ["hydrogen peroxide", "TREATMENT", 200, 217]]], ["WSP from Cassiae semen (0.022 mg/ml) effectively inhibited superoxide radicals (O 2-) induced by pyrogallol autoxidation (95) .", [["superoxide", "CHEMICAL", 59, 69], ["O 2-", "CHEMICAL", 80, 84], ["pyrogallol", "CHEMICAL", 97, 107], ["superoxide", "CHEMICAL", 59, 69], ["O 2-)", "CHEMICAL", 80, 85], ["pyrogallol", "CHEMICAL", 97, 107], ["WSP", "SIMPLE_CHEMICAL", 0, 3], ["Cassiae", "ORGANISM", 9, 16], ["semen", "ORGANISM_SUBSTANCE", 17, 22], ["superoxide radicals", "SIMPLE_CHEMICAL", 59, 78], ["O 2-", "SIMPLE_CHEMICAL", 80, 84], ["pyrogallol", "SIMPLE_CHEMICAL", 97, 107], ["WSP", "PROBLEM", 0, 3], ["Cassiae semen", "TREATMENT", 9, 22]]], ["The inhibitory effects of WSP on serum levels of MDA were used to evaluate its antioxidation capabilities.", [["serum", "ANATOMY", 33, 38], ["MDA", "CHEMICAL", 49, 52], ["MDA", "CHEMICAL", 49, 52], ["WSP", "SIMPLE_CHEMICAL", 26, 29], ["serum", "ORGANISM_SUBSTANCE", 33, 38], ["MDA", "SIMPLE_CHEMICAL", 49, 52], ["WSP", "PROBLEM", 26, 29], ["serum levels", "TEST", 33, 45], ["MDA", "TEST", 49, 52]]], ["The results demonstrated that WSP decreased MDA serum levels with an IC 50 value of 15.80% (96) .", [["MDA serum", "ANATOMY", 44, 53], ["MDA", "CHEMICAL", 44, 47], ["MDA", "CHEMICAL", 44, 47], ["WSP", "SIMPLE_CHEMICAL", 30, 33], ["MDA", "SIMPLE_CHEMICAL", 44, 47], ["serum", "ORGANISM_SUBSTANCE", 48, 53], ["WSP", "PROBLEM", 30, 33], ["MDA serum levels", "TEST", 44, 60], ["an IC", "TEST", 66, 71], ["decreased", "OBSERVATION_MODIFIER", 34, 43]]], ["In another study, Liu et al (97) optimized the extraction conditions for WSP of Cassiae semen (temperature 80\u02daC, extraction time 3.5 h, solid-liquid ratio 1:30) and observed that WSP (94.03 \u00b5g/ml) had the ability to scavenge hydroxyl and superoxide radicals with scavenging rates of 43.32 and 64.97%, respectively.Improves myocardial Water extractIn addition, ethyl acetate fraction and n-butanol fraction of Cassiae semen were evaluated by DPPH radical scavenging activity.", [["semen", "ANATOMY", 88, 93], ["myocardial", "ANATOMY", 323, 333], ["hydroxyl", "CHEMICAL", 225, 233], ["superoxide", "CHEMICAL", 238, 248], ["ethyl acetate", "CHEMICAL", 360, 373], ["n-butanol", "CHEMICAL", 387, 396], ["DPPH", "CHEMICAL", 441, 445], ["hydroxyl", "CHEMICAL", 225, 233], ["superoxide", "CHEMICAL", 238, 248], ["ethyl acetate", "CHEMICAL", 360, 373], ["n-butanol", "CHEMICAL", 387, 396], ["DPPH", "CHEMICAL", 441, 445], ["Cassiae", "ORGANISM", 80, 87], ["semen", "ORGANISM_SUBSTANCE", 88, 93], ["WSP", "SIMPLE_CHEMICAL", 179, 182], ["hydroxyl", "SIMPLE_CHEMICAL", 225, 233], ["superoxide radicals", "SIMPLE_CHEMICAL", 238, 257], ["myocardial", "MULTI-TISSUE_STRUCTURE", 323, 333], ["ethyl acetate", "SIMPLE_CHEMICAL", 360, 373], ["n-butanol", "SIMPLE_CHEMICAL", 387, 396], ["Cassiae", "ORGANISM", 409, 416], ["semen", "ORGANISM_SUBSTANCE", 417, 422], ["DPPH", "SIMPLE_CHEMICAL", 441, 445], ["another study", "TEST", 3, 16], ["the extraction conditions", "TREATMENT", 43, 68], ["WSP", "PROBLEM", 73, 76], ["Cassiae semen", "TREATMENT", 80, 93], ["temperature", "TEST", 95, 106], ["solid-liquid ratio", "TEST", 136, 154], ["WSP", "TEST", 179, 182], ["hydroxyl", "TREATMENT", 225, 233], ["superoxide radicals", "TEST", 238, 257], ["scavenging rates", "TEST", 263, 279], ["myocardial Water extractIn", "TREATMENT", 323, 349], ["ethyl acetate fraction", "TREATMENT", 360, 382], ["n-butanol fraction", "TREATMENT", 387, 405], ["Cassiae semen", "TREATMENT", 409, 422], ["myocardial", "ANATOMY", 323, 333], ["Water extractIn", "OBSERVATION", 334, 349]]], ["The results revealed that the ethyl acetate fraction had a lower IC 50 value of 56.4 g/ml, when compared with the value of 80.6 g/ml for n-butanol fraction.", [["ethyl acetate", "CHEMICAL", 30, 43], ["n-butanol", "CHEMICAL", 137, 146], ["ethyl acetate", "CHEMICAL", 30, 43], ["n-butanol", "CHEMICAL", 137, 146], ["ethyl acetate", "SIMPLE_CHEMICAL", 30, 43], ["n-butanol", "SIMPLE_CHEMICAL", 137, 146], ["the ethyl acetate fraction", "TEST", 26, 52], ["n-butanol fraction", "TEST", 137, 155]]], ["1-Desmethylaurantio-obtusin (compound 11) exhibited good scavenging activity on DPPH with an IC 50 value of 4.5\u00b10.7 g/ml, while aurantio-obtusin-6-O\u03b2-D-glucopyranoside (compound 34) and questin (compound 10) exhibited moderate antioxidant activity, and their IC 50 values were 103.2\u00b11.5 g/ml and 185.2\u00b11.8 g/ml, respectively.", [["1-Desmethylaurantio-obtusin", "CHEMICAL", 0, 27], ["compound 11", "CHEMICAL", 29, 40], ["DPPH", "CHEMICAL", 80, 84], ["aurantio-obtusin-6-O\u03b2-D-glucopyranoside", "CHEMICAL", 128, 167], ["compound 34", "CHEMICAL", 169, 180], ["questin", "CHEMICAL", 186, 193], ["1-Desmethylaurantio-obtusin", "CHEMICAL", 0, 27], ["DPPH", "CHEMICAL", 80, 84], ["aurantio-obtusin-6-O\u03b2-D-glucopyranoside", "CHEMICAL", 128, 167], ["questin", "CHEMICAL", 186, 193], ["1-Desmethylaurantio-obtusin", "SIMPLE_CHEMICAL", 0, 27], ["compound 11", "SIMPLE_CHEMICAL", 29, 40], ["DPPH", "SIMPLE_CHEMICAL", 80, 84], ["aurantio-obtusin-6-O\u03b2-D-glucopyranoside", "SIMPLE_CHEMICAL", 128, 167], ["compound 34", "SIMPLE_CHEMICAL", 169, 180], ["questin", "SIMPLE_CHEMICAL", 186, 193], ["compound 10", "SIMPLE_CHEMICAL", 195, 206], ["Desmethylaurantio", "TEST", 2, 19], ["DPPH", "TEST", 80, 84], ["an IC", "TEST", 90, 95], ["aurantio", "TEST", 128, 136], ["obtusin", "TEST", 137, 144], ["moderate antioxidant activity", "PROBLEM", 218, 247], ["good", "OBSERVATION_MODIFIER", 52, 56], ["scavenging activity", "OBSERVATION", 57, 76], ["moderate", "OBSERVATION_MODIFIER", 218, 226], ["antioxidant activity", "OBSERVATION", 227, 247]]], ["When compared with these results, chryso-obtusin (compound 7) and aurantio-obtusin (compound 8) demonstrated weaker antioxidant activity (IC 50 >200 \u00b5g/ml) (98) .", [["chryso-obtusin", "CHEMICAL", 34, 48], ["aurantio-obtusin", "CHEMICAL", 66, 82], ["compound 8", "CHEMICAL", 84, 94], ["chryso-obtusin", "CHEMICAL", 34, 48], ["aurantio-obtusin", "CHEMICAL", 66, 82], ["chryso-obtusin", "SIMPLE_CHEMICAL", 34, 48], ["compound 7", "SIMPLE_CHEMICAL", 50, 60], ["aurantio-obtusin", "SIMPLE_CHEMICAL", 66, 82], ["compound 8", "SIMPLE_CHEMICAL", 84, 94], ["aurantio", "TEST", 66, 74], ["weaker antioxidant activity", "PROBLEM", 109, 136], ["IC", "TEST", 138, 140]]], ["The methanolic extract of C. tora seeds exhibited a high antioxidant activity on lipid peroxidation (99) .", [["methanolic extract of C. tora", "CHEMICAL", 4, 33], ["C. tora seeds", "ORGANISM", 26, 39], ["lipid", "SIMPLE_CHEMICAL", 81, 86], ["C. tora", "SPECIES", 26, 33], ["C. tora", "SPECIES", 26, 33], ["The methanolic extract", "TREATMENT", 0, 22], ["C. tora seeds", "TREATMENT", 26, 39], ["lipid peroxidation", "TREATMENT", 81, 99], ["methanolic extract", "OBSERVATION_MODIFIER", 4, 22], ["high", "OBSERVATION_MODIFIER", 52, 56], ["antioxidant activity", "OBSERVATION", 57, 77]]], ["Similarly, in another study, Yen et al (12) demonstrated that the methanolic extract of C. tora seeds exerted a greater antioxidant activity than the other organic solvents (n-hexane and ethyl acetate).", [["n-hexane and ethyl acetate", "CHEMICAL", 174, 200], ["n-hexane", "CHEMICAL", 174, 182], ["ethyl acetate", "CHEMICAL", 187, 200], ["C. tora seeds", "ORGANISM", 88, 101], ["n-hexane", "SIMPLE_CHEMICAL", 174, 182], ["ethyl acetate", "SIMPLE_CHEMICAL", 187, 200], ["C. tora", "SPECIES", 88, 95], ["C. tora", "SPECIES", 88, 95], ["another study", "TEST", 14, 27], ["the methanolic extract", "TREATMENT", 62, 84], ["C. tora seeds", "TREATMENT", 88, 101], ["n-hexane and ethyl acetate", "TREATMENT", 174, 200]]], ["Emodin was also revealed to be an antioxidative component (12) .", [["Emodin", "CHEMICAL", 0, 6], ["Emodin", "CHEMICAL", 0, 6], ["Emodin", "SIMPLE_CHEMICAL", 0, 6], ["Emodin", "TREATMENT", 0, 6], ["antioxidative", "OBSERVATION_MODIFIER", 34, 47], ["component", "OBSERVATION_MODIFIER", 48, 57]]], ["In addition, alaternin (compound 17), cassiaside (compound 52) and rubrofusarin-6-O-\u03b2-D-gentiobioside (compound 49) isolated from C. tora seeds exhibited good scavenging activity against DPPH radicals with IC 50 values of 17.59, 32.52 and 18.04 \u00b5g/ml, respectively (100).Improves myocardial Water extractHypotensive activity.", [["myocardial", "ANATOMY", 280, 290], ["alaternin", "CHEMICAL", 13, 22], ["compound 17), cassiaside (compound 52", "CHEMICAL", 24, 61], ["rubrofusarin-6-O-\u03b2-D-gentiobioside", "CHEMICAL", 67, 101], ["compound 49", "CHEMICAL", 103, 114], ["DPPH", "CHEMICAL", 187, 191], ["alaternin", "CHEMICAL", 13, 22], ["cassiaside", "CHEMICAL", 38, 48], ["rubrofusarin-6-O-\u03b2-D-gentiobioside", "CHEMICAL", 67, 101], ["DPPH", "CHEMICAL", 187, 191], ["alaternin", "SIMPLE_CHEMICAL", 13, 22], ["compound 17", "SIMPLE_CHEMICAL", 24, 35], ["cassiaside", "SIMPLE_CHEMICAL", 38, 48], ["compound 52", "SIMPLE_CHEMICAL", 50, 61], ["rubrofusarin-6-O-\u03b2-D-gentiobioside", "SIMPLE_CHEMICAL", 67, 101], ["compound 49", "SIMPLE_CHEMICAL", 103, 114], ["C. tora seeds", "ORGANISM", 130, 143], ["DPPH radicals", "SIMPLE_CHEMICAL", 187, 200], ["myocardial", "MULTI-TISSUE_STRUCTURE", 280, 290], ["C. tora", "SPECIES", 130, 137], ["C. tora", "SPECIES", 130, 137], ["cassiaside", "TEST", 38, 48], ["rubrofusarin", "TEST", 67, 79], ["C. tora seeds", "TEST", 130, 143], ["DPPH radicals", "TEST", 187, 200], ["IC 50 values", "TEST", 206, 218], ["good", "OBSERVATION_MODIFIER", 154, 158], ["scavenging activity", "OBSERVATION", 159, 178], ["myocardial", "ANATOMY", 280, 290], ["Water extractHypotensive activity", "OBSERVATION", 291, 324]]], ["Aqueous and ethanol extracts of Cassiae semen have been reported to possess hypotensive effects (101).", [["extracts", "ANATOMY", 20, 28], ["ethanol", "CHEMICAL", 12, 19], ["hypotensive", "DISEASE", 76, 87], ["ethanol", "CHEMICAL", 12, 19], ["Aqueous", "ORGANISM_SUBSTANCE", 0, 7], ["ethanol extracts", "ORGANISM_SUBSTANCE", 12, 28], ["Cassiae semen", "ORGANISM_SUBSTANCE", 32, 45], ["Aqueous and ethanol extracts", "TREATMENT", 0, 28], ["hypotensive effects", "PROBLEM", 76, 95]]], ["Koo et al (101) reported that the water extract of C. tora seeds (3.75, 7.5, 15, 30, 60 and 250 mg/kg) consistently reduced arterial blood pressure in anesthetized rats.", [["arterial", "ANATOMY", 124, 132], ["blood", "ANATOMY", 133, 138], ["C. tora seeds", "ORGANISM", 51, 64], ["arterial blood", "MULTI-TISSUE_STRUCTURE", 124, 138], ["rats", "ORGANISM", 164, 168], ["C. tora", "SPECIES", 51, 58], ["rats", "SPECIES", 164, 168], ["C. tora", "SPECIES", 51, 58], ["C. tora seeds", "TREATMENT", 51, 64], ["arterial blood pressure", "TEST", 124, 147], ["reduced", "OBSERVATION", 116, 123], ["arterial", "ANATOMY_MODIFIER", 124, 132], ["pressure", "OBSERVATION_MODIFIER", 139, 147]]], ["A potential reflex mechanism of this hypotensive action may involve a vagal reflex, which reciprocally inhibits the peripheral vasomotor tone via a reflex reduction in the sympathetic neural outflow to blood vessels (102) .", [["peripheral vasomotor", "ANATOMY", 116, 136], ["sympathetic neural", "ANATOMY", 172, 190], ["blood vessels", "ANATOMY", 202, 215], ["hypotensive", "DISEASE", 37, 48], ["neural outflow", "MULTI-TISSUE_STRUCTURE", 184, 198], ["blood vessels", "MULTI-TISSUE_STRUCTURE", 202, 215], ["this hypotensive action", "PROBLEM", 32, 55], ["a vagal reflex", "PROBLEM", 68, 82], ["the peripheral vasomotor tone", "PROBLEM", 112, 141], ["a reflex reduction", "TREATMENT", 146, 164], ["reflex mechanism", "OBSERVATION", 12, 28], ["vagal reflex", "OBSERVATION", 70, 82], ["peripheral", "ANATOMY_MODIFIER", 116, 126], ["vasomotor tone", "OBSERVATION", 127, 141], ["reflex reduction", "OBSERVATION", 148, 164], ["sympathetic", "ANATOMY_MODIFIER", 172, 183], ["neural", "ANATOMY_MODIFIER", 184, 190], ["outflow", "ANATOMY_MODIFIER", 191, 198], ["blood vessels", "ANATOMY", 202, 215]]], ["In addition, the media portion of the medullary reticular formation has been revealed to be directly involved in the hypotensive effect of C. tora seeds (103) .", [["medullary reticular", "ANATOMY", 38, 57], ["hypotensive", "DISEASE", 117, 128], ["medullary reticular", "MULTI-TISSUE_STRUCTURE", 38, 57], ["C. tora seeds", "ORGANISM", 139, 152], ["C. tora", "SPECIES", 139, 146], ["C. tora", "SPECIES", 139, 146], ["C. tora seeds", "TREATMENT", 139, 152], ["media", "ANATOMY_MODIFIER", 17, 22], ["medullary", "ANATOMY", 38, 47], ["reticular", "ANATOMY_MODIFIER", 48, 57], ["hypotensive", "OBSERVATION_MODIFIER", 117, 128]]], ["Furthermore, the ethanol extract of Cassiae semen significantly decreased blood pressure in hypertensive rats by inhibiting receptor-controlled calcium channels on vessels and regulating the secretion of nitric oxide and inducible nitric oxide synthase (104) .Improves myocardial Water extractOther activities.", [["blood", "ANATOMY", 74, 79], ["vessels", "ANATOMY", 164, 171], ["myocardial", "ANATOMY", 269, 279], ["ethanol", "CHEMICAL", 17, 24], ["Cassiae", "CHEMICAL", 36, 43], ["hypertensive", "DISEASE", 92, 104], ["calcium", "CHEMICAL", 144, 151], ["nitric oxide", "CHEMICAL", 204, 216], ["nitric oxide", "CHEMICAL", 231, 243], ["ethanol", "CHEMICAL", 17, 24], ["calcium", "CHEMICAL", 144, 151], ["nitric oxide", "CHEMICAL", 204, 216], ["nitric oxide", "CHEMICAL", 231, 243], ["ethanol", "SIMPLE_CHEMICAL", 17, 24], ["Cassiae semen", "ORGANISM", 36, 49], ["blood", "ORGANISM_SUBSTANCE", 74, 79], ["rats", "ORGANISM", 105, 109], ["calcium", "SIMPLE_CHEMICAL", 144, 151], ["vessels", "MULTI-TISSUE_STRUCTURE", 164, 171], ["nitric oxide", "SIMPLE_CHEMICAL", 204, 216], ["inducible nitric oxide synthase", "GENE_OR_GENE_PRODUCT", 221, 252], ["myocardial", "MULTI-TISSUE_STRUCTURE", 269, 279], ["calcium channels", "PROTEIN", 144, 160], ["nitric oxide synthase", "PROTEIN", 231, 252], ["rats", "SPECIES", 105, 109], ["blood pressure", "TEST", 74, 88], ["hypertensive rats", "PROBLEM", 92, 109], ["calcium channels", "TREATMENT", 144, 160], ["the secretion of nitric oxide", "TREATMENT", 187, 216], ["inducible nitric oxide synthase", "TREATMENT", 221, 252], ["pressure", "OBSERVATION_MODIFIER", 80, 88], ["calcium channels", "OBSERVATION", 144, 160], ["vessels", "ANATOMY", 164, 171], ["myocardial", "ANATOMY", 269, 279], ["Water extractOther", "OBSERVATION", 280, 298]]], ["In addition to the pharmacological effects described above, Cassiae semen and its ingredients have other pharmacological effects, including estrogenic, anti-allergic, antigenotoxic, anti-aggregatory, antimutagenic and cardioprotective effects.", [["Cassiae", "ORGANISM", 60, 67], ["semen", "ORGANISM_SUBSTANCE", 68, 73], ["the pharmacological effects", "PROBLEM", 15, 42], ["Cassiae semen", "TREATMENT", 60, 73], ["estrogenic", "TREATMENT", 140, 150], ["anti-allergic", "TREATMENT", 152, 165], ["antigenotoxic", "TREATMENT", 167, 180], ["anti-aggregatory", "TREATMENT", 182, 198], ["antimutagenic", "TREATMENT", 200, 213], ["cardioprotective effects", "TREATMENT", 218, 242]]], ["Some of these effects are discussed briefly below.Improves myocardial Water extractThe estrogenic activity of C. obtusifolia seeds was evaluated by a recombinant yeast screening assay.", [["myocardial", "ANATOMY", 59, 69], ["myocardial", "MULTI-TISSUE_STRUCTURE", 59, 69], ["C. obtusifolia seeds", "ORGANISM", 110, 130], ["C. obtusifolia", "SPECIES", 110, 124], ["yeast", "SPECIES", 162, 167], ["C. obtusifolia", "SPECIES", 110, 124], ["yeast", "SPECIES", 162, 167], ["myocardial Water extract", "TREATMENT", 59, 83], ["C. obtusifolia seeds", "PROBLEM", 110, 130], ["a recombinant yeast screening assay", "TEST", 148, 183], ["myocardial", "ANATOMY", 59, 69], ["Water extract", "OBSERVATION", 70, 83], ["estrogenic", "OBSERVATION_MODIFIER", 87, 97], ["activity", "OBSERVATION_MODIFIER", 98, 106]]], ["The results revealed that 70% EtOH extracts of this drug exhibited estrogenic relative potency [half maximal effective concentration (EC 50 ) was 60.2 \u00b5g/ml) (105) .", [["extracts", "ANATOMY", 35, 43], ["EtOH", "CHEMICAL", 30, 34], ["EtOH", "CHEMICAL", 30, 34], ["EtOH", "SIMPLE_CHEMICAL", 30, 34], ["extracts", "ORGANISM_SUBSTANCE", 35, 43], ["this drug", "TREATMENT", 47, 56]]], ["Cassiaside C 2 (compound 66) isolated from C. obtusifolia seeds exhibited a potent anti-allergic activity by inhibiting the histamine release from mast cells induced by antigen-antibody reaction (19) .", [["mast cells", "ANATOMY", 147, 157], ["Cassiaside C 2 (compound 66", "CHEMICAL", 0, 27], ["histamine", "CHEMICAL", 124, 133], ["Cassiaside C 2", "CHEMICAL", 0, 14], ["histamine", "CHEMICAL", 124, 133], ["Cassiaside C 2", "SIMPLE_CHEMICAL", 0, 14], ["compound 66", "SIMPLE_CHEMICAL", 16, 27], ["C. obtusifolia", "ORGANISM", 43, 57], ["seeds", "ORGANISM", 58, 63], ["histamine", "SIMPLE_CHEMICAL", 124, 133], ["mast cells", "CELL", 147, 157], ["mast cells", "CELL_TYPE", 147, 157], ["C. obtusifolia", "SPECIES", 43, 57], ["C. obtusifolia", "SPECIES", 43, 57], ["Cassiaside C 2", "PROBLEM", 0, 14], ["C. obtusifolia seeds", "PROBLEM", 43, 63], ["a potent anti-allergic activity", "PROBLEM", 74, 105], ["the histamine release", "TREATMENT", 120, 141], ["mast cells", "PROBLEM", 147, 157], ["antigen-antibody reaction", "PROBLEM", 169, 194], ["potent", "OBSERVATION_MODIFIER", 76, 82], ["anti-allergic activity", "OBSERVATION", 83, 105], ["mast cells", "OBSERVATION", 147, 157]]], ["Furthermore, gluco-aurantioobtusin (compound 25) from C. obtusifolia seeds possessed potent inhibitory activities against arachidonic-acid-, ADP-and collagen-induced platelet aggregations (39).", [["platelet", "ANATOMY", 166, 174], ["gluco-aurantioobtusin", "CHEMICAL", 13, 34], ["compound 25", "CHEMICAL", 36, 47], ["arachidonic-acid", "CHEMICAL", 122, 138], ["ADP", "CHEMICAL", 141, 144], ["platelet aggregations", "DISEASE", 166, 187], ["gluco-aurantioobtusin", "CHEMICAL", 13, 34], ["arachidonic-acid", "CHEMICAL", 122, 138], ["ADP", "CHEMICAL", 141, 144], ["gluco-aurantioobtusin", "SIMPLE_CHEMICAL", 13, 34], ["compound 25", "SIMPLE_CHEMICAL", 36, 47], ["C. obtusifolia", "ORGANISM", 54, 68], ["seeds", "ORGANISM", 69, 74], ["arachidonic-acid", "SIMPLE_CHEMICAL", 122, 138], ["ADP", "SIMPLE_CHEMICAL", 141, 144], ["collagen", "GENE_OR_GENE_PRODUCT", 149, 157], ["platelet", "CELL", 166, 174], ["collagen", "PROTEIN", 149, 157], ["C. obtusifolia", "SPECIES", 54, 68], ["C. obtusifolia", "SPECIES", 54, 68], ["gluco", "TEST", 13, 18], ["C. obtusifolia seeds", "PROBLEM", 54, 74], ["arachidonic", "TEST", 122, 133], ["acid", "TEST", 134, 138], ["ADP", "TEST", 141, 144], ["platelet aggregations", "PROBLEM", 166, 187], ["platelet aggregations", "OBSERVATION", 166, 187]]], ["Wu and Yen (106) demonstrated that the water extract of C. tora seeds exhibited potential antigenotoxic activities against the dietary mutagens Glu-P-1 and TrpP-1 in the Ames test and the Comet assay.", [["Glu", "CHEMICAL", 144, 147], ["Glu", "CHEMICAL", 144, 147], ["C. tora seeds", "ORGANISM", 56, 69], ["Glu-P-1", "GENE_OR_GENE_PRODUCT", 144, 151], ["TrpP-1", "GENE_OR_GENE_PRODUCT", 156, 162], ["C. tora", "SPECIES", 56, 63], ["C. tora", "SPECIES", 56, 63], ["the water extract", "TREATMENT", 35, 52], ["C. tora seeds", "TREATMENT", 56, 69], ["the dietary mutagens Glu", "TEST", 123, 147], ["P", "TEST", 148, 149], ["TrpP", "TEST", 156, 160], ["the Comet assay", "TEST", 184, 199], ["antigenotoxic activities", "OBSERVATION", 90, 114]]], ["The potential mechanisms may be associated with neutralization of the reactive intermediate of Trp-P-1 and an antioxidant effect of the tested compounds (106) .", [["Trp-P-1", "CHEMICAL", 95, 102], ["Trp", "CHEMICAL", 95, 98], ["Trp-P-1", "GENE_OR_GENE_PRODUCT", 95, 102], ["may be associated with", "UNCERTAINTY", 25, 47], ["neutralization", "OBSERVATION", 48, 62], ["reactive", "OBSERVATION_MODIFIER", 70, 78], ["intermediate", "OBSERVATION_MODIFIER", 79, 91]]], ["Anthraquinone aglycones (compounds 2, 7 and 8) and naphthopyrone glycosides (compounds 49 and 52) from C. tora seeds exhibited significant antimutagenic activity in vitro.", [["Anthraquinone aglycones", "CHEMICAL", 0, 23], ["compounds 2, 7 and 8) and naphthopyrone glycosides", "CHEMICAL", 25, 75], ["compounds 49 and 52", "CHEMICAL", 77, 96], ["Anthraquinone aglycones", "CHEMICAL", 0, 23], ["naphthopyrone glycosides", "CHEMICAL", 51, 75], ["Anthraquinone aglycones", "SIMPLE_CHEMICAL", 0, 23], ["compounds 2, 7", "SIMPLE_CHEMICAL", 25, 39], ["naphthopyrone glycosides", "SIMPLE_CHEMICAL", 51, 75], ["C. tora seeds", "ORGANISM", 103, 116], ["C. tora", "SPECIES", 103, 110], ["C. tora", "SPECIES", 103, 110], ["Anthraquinone aglycones (compounds", "TREATMENT", 0, 34], ["naphthopyrone glycosides", "TREATMENT", 51, 75], ["significant", "OBSERVATION_MODIFIER", 127, 138], ["antimutagenic activity", "OBSERVATION", 139, 161]]], ["The mechanism associated with these compounds may be mediated via interactions with a microsomal activating system (14) .", [["microsomal", "ANATOMY", 86, 96], ["a microsomal activating system", "TREATMENT", 84, 114]]], ["Fu et al (107) reported that the water extract of Cassiae semen (10 mg/kg/day, for one week) effectively improved myocardial function, and attenuated myocardial ischemia and reperfusion-induced injury and apoptosis in diabetic animals, which is potentially attributable to the reduced plasma lipid levels and the triggered cell survival Akt and extracellular signal-regulated kinases 1/2 signaling.ConclusionsIn traditional Chinese medicine, Cassiae semen has long been used to clean the liver, brighten the eye, loosen the bowel to relieve constipation, and for the treatment of inflammation, photophobia, headaches, dizziness, hyperlipemia and Alzheimer's disease.", [["myocardial", "ANATOMY", 114, 124], ["myocardial", "ANATOMY", 150, 160], ["plasma", "ANATOMY", 285, 291], ["cell", "ANATOMY", 323, 327], ["semen", "ANATOMY", 450, 455], ["liver", "ANATOMY", 488, 493], ["eye", "ANATOMY", 508, 511], ["bowel", "ANATOMY", 524, 529], ["Cassiae", "CHEMICAL", 50, 57], ["myocardial ischemia", "DISEASE", 150, 169], ["diabetic", "DISEASE", 218, 226], ["constipation", "DISEASE", 541, 553], ["inflammation", "DISEASE", 580, 592], ["photophobia", "DISEASE", 594, 605], ["headaches", "DISEASE", 607, 616], ["dizziness", "DISEASE", 618, 627], ["hyperlipemia", "DISEASE", 629, 641], ["Alzheimer's disease", "DISEASE", 646, 665], ["Cassiae semen", "ORGANISM", 50, 63], ["myocardial", "MULTI-TISSUE_STRUCTURE", 114, 124], ["myocardial", "MULTI-TISSUE_STRUCTURE", 150, 160], ["plasma", "ORGANISM_SUBSTANCE", 285, 291], ["lipid", "SIMPLE_CHEMICAL", 292, 297], ["cell", "CELL", 323, 327], ["Akt", "GENE_OR_GENE_PRODUCT", 337, 340], ["extracellular signal-regulated kinases 1/2", "GENE_OR_GENE_PRODUCT", 345, 387], ["Cassiae", "ORGANISM", 442, 449], ["semen", "ORGANISM_SUBSTANCE", 450, 455], ["liver", "ORGAN", 488, 493], ["eye", "ORGAN", 508, 511], ["bowel", "ORGAN", 524, 529], ["Akt", "PROTEIN", 337, 340], ["extracellular signal-regulated kinases 1/2", "PROTEIN", 345, 387], ["Cassiae semen", "TREATMENT", 50, 63], ["attenuated myocardial ischemia", "PROBLEM", 139, 169], ["reperfusion-induced injury", "PROBLEM", 174, 200], ["apoptosis in diabetic animals", "PROBLEM", 205, 234], ["the reduced plasma lipid levels", "PROBLEM", 273, 304], ["the triggered cell survival", "TREATMENT", 309, 336], ["Akt", "TEST", 337, 340], ["extracellular signal", "TEST", 345, 365], ["traditional Chinese medicine", "TREATMENT", 412, 440], ["Cassiae semen", "TREATMENT", 442, 455], ["constipation", "PROBLEM", 541, 553], ["inflammation", "PROBLEM", 580, 592], ["photophobia", "PROBLEM", 594, 605], ["headaches", "PROBLEM", 607, 616], ["dizziness", "PROBLEM", 618, 627], ["hyperlipemia", "PROBLEM", 629, 641], ["Alzheimer's disease", "PROBLEM", 646, 665], ["myocardial function", "OBSERVATION", 114, 133], ["myocardial", "ANATOMY", 150, 160], ["ischemia", "OBSERVATION", 161, 169], ["reperfusion", "OBSERVATION_MODIFIER", 174, 185], ["injury", "OBSERVATION", 194, 200], ["cell survival", "OBSERVATION", 323, 336], ["extracellular signal", "OBSERVATION", 345, 365], ["liver", "ANATOMY", 488, 493], ["eye", "ANATOMY", 508, 511], ["bowel", "ANATOMY", 524, 529], ["inflammation", "OBSERVATION", 580, 592], ["hyperlipemia", "OBSERVATION", 629, 641], ["Alzheimer's", "OBSERVATION", 646, 657]]], ["In addition, Cassiae semen is commonly used in the composition of other herbs.", [["Cassiae semen", "TREATMENT", 13, 26]]], ["Although modern experiments have confirmed that this drug alone exhibits multiple pharmacological activities, it is important to investigate the molecular mechanisms of Cassiae semen combined with other herbs based on traditional uses.ConclusionsA number of studies have investigated the effective constituents of Cassiae semen from different batches and geographical areas.", [["semen", "ANATOMY", 322, 327], ["Cassiae", "ORGANISM", 169, 176], ["semen", "ORGANISM_SUBSTANCE", 177, 182], ["Cassiae", "ORGANISM", 314, 321], ["semen", "ORGANISM_SUBSTANCE", 322, 327], ["Cassiae semen", "TREATMENT", 169, 182], ["other herbs", "TREATMENT", 197, 208], ["studies", "TEST", 258, 265], ["Cassiae semen", "TREATMENT", 314, 327], ["geographical", "OBSERVATION_MODIFIER", 355, 367], ["areas", "OBSERVATION_MODIFIER", 368, 373]]], ["HPLC-fingerprint chromatography is a common method to compare the differences (108-111).", [["HPLC", "TEST", 0, 4], ["fingerprint chromatography", "TEST", 5, 31]]], ["Zhang et al (3) developed a sensitive and reliable ultra-high-performance liquid chromatography-electrospray ionization-tandem mass spectrometry (UHPLC-ESI-MS/MS) method to evaluate the quality of Cassiae semen through simultaneous determination of 13 components, providing a novel basis for the overall assessment of the quality of this plant.", [["semen", "ANATOMY", 205, 210], ["Cassiae", "ORGANISM", 197, 204], ["semen", "ORGANISM_SUBSTANCE", 205, 210], ["reliable ultra", "TEST", 42, 56], ["electrospray ionization", "TEST", 96, 119], ["tandem mass spectrometry", "TEST", 120, 144], ["UHPLC", "TEST", 146, 151], ["ESI", "TEST", 152, 155], ["the overall assessment", "TEST", 292, 314]]], ["In addition, a novel nonaqueous capillary electrophoresis method was used for the analysis of aurantio-obtusin, emodin and rhein in Cassiae semen with satisfactory results (112) .", [["semen", "ANATOMY", 140, 145], ["aurantio-obtusin", "CHEMICAL", 94, 110], ["emodin", "CHEMICAL", 112, 118], ["rhein", "CHEMICAL", 123, 128], ["aurantio-obtusin", "CHEMICAL", 94, 110], ["emodin", "CHEMICAL", 112, 118], ["rhein", "CHEMICAL", 123, 128], ["capillary", "TISSUE", 32, 41], ["aurantio-obtusin", "SIMPLE_CHEMICAL", 94, 110], ["emodin", "SIMPLE_CHEMICAL", 112, 118], ["rhein", "SIMPLE_CHEMICAL", 123, 128], ["Cassiae", "ORGANISM", 132, 139], ["semen", "ORGANISM_SUBSTANCE", 140, 145], ["a novel nonaqueous capillary electrophoresis method", "TREATMENT", 13, 64], ["the analysis", "TEST", 78, 90], ["aurantio", "TEST", 94, 102], ["obtusin", "TREATMENT", 103, 110], ["emodin", "TREATMENT", 112, 118]]], ["Yang et al (113) was the first to simultaneously determine 7 anthraquinones in rat plasma by UHPLC-MS/MS following oral administration of Cassiae semen extract.", [["plasma", "ANATOMY", 83, 89], ["oral", "ANATOMY", 115, 119], ["extract", "ANATOMY", 152, 159], ["anthraquinones", "CHEMICAL", 61, 75], ["UHPLC", "CHEMICAL", 93, 98], ["Cassiae semen extract", "CHEMICAL", 138, 159], ["anthraquinones", "CHEMICAL", 61, 75], ["anthraquinones", "SIMPLE_CHEMICAL", 61, 75], ["rat", "ORGANISM", 79, 82], ["plasma", "ORGANISM_SUBSTANCE", 83, 89], ["oral", "ORGANISM_SUBDIVISION", 115, 119], ["Cassiae", "ORGANISM", 138, 145], ["semen extract", "ORGANISM_SUBSTANCE", 146, 159], ["rat", "SPECIES", 79, 82], ["rat", "SPECIES", 79, 82], ["MS", "PROBLEM", 99, 101], ["MS", "PROBLEM", 102, 104], ["oral administration", "TREATMENT", 115, 134], ["Cassiae semen extract", "TREATMENT", 138, 159]]], ["Anthraquinones and naphthopyrones are considered to be the major constituents.", [["Anthraquinones", "CHEMICAL", 0, 14], ["naphthopyrones", "CHEMICAL", 19, 33], ["Anthraquinones", "CHEMICAL", 0, 14], ["naphthopyrones", "CHEMICAL", 19, 33], ["Anthraquinones", "SIMPLE_CHEMICAL", 0, 14], ["naphthopyrones", "SIMPLE_CHEMICAL", 19, 33], ["Anthraquinones", "TREATMENT", 0, 14], ["naphthopyrones", "TREATMENT", 19, 33]]], ["Therefore, characteristic compounds or a biological index should be established to evaluate the quality and ensure their clinical application is suitable.", [["a biological index", "TEST", 39, 57]]], ["In the Pharmacopoeia of the People's Republic of China, chrysophanol and aurantio-obtusin are used as the indicator compounds to characterize the quality of Cassiae semen with the minimum contents of 0.20 and 0.080%, respectively (1).ConclusionsA total of 79 compounds including anthraquinones, naphthopyrones and volatile oil have been isolated and identified from Cassiae semen (Table I; Figs.", [["semen", "ANATOMY", 165, 170], ["volatile oil", "ANATOMY", 314, 326], ["chrysophanol", "CHEMICAL", 56, 68], ["-obtusin", "CHEMICAL", 81, 89], ["anthraquinones", "CHEMICAL", 279, 293], ["naphthopyrones", "CHEMICAL", 295, 309], ["chrysophanol", "CHEMICAL", 56, 68], ["-obtusin", "CHEMICAL", 81, 89], ["anthraquinones", "CHEMICAL", 279, 293], ["naphthopyrones", "CHEMICAL", 295, 309], ["chrysophanol", "SIMPLE_CHEMICAL", 56, 68], ["aurantio-obtusin", "SIMPLE_CHEMICAL", 73, 89], ["Cassiae", "ORGANISM", 157, 164], ["semen", "ORGANISM_SUBSTANCE", 165, 170], ["anthraquinones", "SIMPLE_CHEMICAL", 279, 293], ["naphthopyrones", "SIMPLE_CHEMICAL", 295, 309], ["oil", "ORGANISM_SUBSTANCE", 323, 326], ["semen", "ORGANISM_SUBSTANCE", 374, 379], ["People", "SPECIES", 28, 34], ["chrysophanol and aurantio-obtusin", "TREATMENT", 56, 89], ["anthraquinones", "TREATMENT", 279, 293], ["naphthopyrones", "TREATMENT", 295, 309], ["volatile oil", "TREATMENT", 314, 326]]], ["It has also been suggested that certain efforts should be made to isolate and identify novel compounds from Cassiae semen, in order to strengthen its pharmacological profile to develop it further as a candidate for novel drug developments in the future.ConclusionsPharmacological studies have revealed that Cassiae semen possesses a variety of biological effects, including anti-hyperlipidemic, anti-diabetic, neuroprotective, hepatoprotective, antimicrobial, anti-oxidant and hypotensive activities (5, 90, 93, 114, 115) .", [["Cassiae", "CHEMICAL", 307, 314], ["hypotensive", "DISEASE", 477, 488], ["Cassiae", "ORGANISM", 108, 115], ["semen", "ORGANISM_SUBSTANCE", 116, 121], ["Cassiae semen", "ORGANISM", 307, 320], ["Cassiae semen", "TREATMENT", 108, 121], ["novel drug developments", "TREATMENT", 215, 238], ["Pharmacological studies", "TEST", 264, 287], ["Cassiae semen", "TREATMENT", 307, 320], ["anti-hyperlipidemic", "TREATMENT", 374, 393], ["anti-diabetic", "TREATMENT", 395, 408], ["neuroprotective", "TREATMENT", 410, 425], ["hepatoprotective", "TREATMENT", 427, 443], ["antimicrobial", "TREATMENT", 445, 458], ["anti-oxidant", "TREATMENT", 460, 472], ["hypotensive activities", "TEST", 477, 499]]], ["Extracts and compounds responsible for the pharmacological properties have also been determined, as presented in Table II .", [["Extracts", "ANATOMY", 0, 8], ["Extracts", "ORGANISM_SUBSTANCE", 0, 8]]], ["Although the pharmacological properties of certain traditional uses of Cassiae semen have been validated, these studies were primarily conducted in vitro (16, 116, 117) .", [["Cassiae", "ORGANISM", 71, 78], ["semen", "ORGANISM_SUBSTANCE", 79, 84], ["Cassiae semen", "TREATMENT", 71, 84], ["these studies", "TEST", 106, 119]]], ["Therefore, the effects of these compounds require verification in vivo.", [["these compounds", "TREATMENT", 26, 41]]], ["In addition, the association between structure and activity, and the potential synergistic action exerted by the bioactive compounds requires further elucidation.", [["activity", "OBSERVATION_MODIFIER", 51, 59], ["bioactive compounds", "OBSERVATION", 113, 132]]], ["It is anticipated that the comprehensive and current research on the pharmacological activities of extracts, as well as on active molecules isolated from Cassiae semen, provided in this review will inspire novel strategies in therapeutics for curing a number of different ailments.", [["extracts", "ANATOMY", 99, 107], ["semen", "ANATOMY", 162, 167], ["extracts", "ORGANISM_SUBSTANCE", 99, 107], ["Cassiae semen", "ORGANISM", 154, 167], ["Cassiae semen", "TREATMENT", 154, 167], ["novel strategies", "TREATMENT", 206, 222]]]], "PMC7114588": [["IntroductionOngoing surveillance of healthcare-associated infection (HCAI) is an essential component of hospital infection control programmes.", [["infection", "DISEASE", 58, 67], ["HCAI", "DISEASE", 69, 73], ["infection", "DISEASE", 113, 122], ["associated infection", "PROBLEM", 47, 67], ["hospital infection control programmes", "PROBLEM", 104, 141], ["infection", "OBSERVATION", 58, 67], ["essential", "OBSERVATION_MODIFIER", 81, 90], ["component", "OBSERVATION_MODIFIER", 91, 100], ["hospital infection", "OBSERVATION", 104, 122]]], ["The goals are to assess the burden of infectious diseases, identify important problems, monitor the efficacy of specific interventions and support rational hospital policies.1 The National Nosocomial Infections Surveillance System was established in the 1980s.", [["infectious diseases", "DISEASE", 38, 57], ["Nosocomial Infections", "DISEASE", 189, 210], ["infectious diseases", "PROBLEM", 38, 57], ["specific interventions", "TREATMENT", 112, 134], ["infectious", "OBSERVATION", 38, 48], ["Nosocomial", "OBSERVATION_MODIFIER", 189, 199], ["Infections", "OBSERVATION", 200, 210]]], ["HCAIs were reported to be significantly decreased in hospitals that adopted surveillance programmes.2, 3 Hospital-wide surveillance programmes are highly labour intensive and tend to divert resources needed to implement control measures and prevention activities.", [["HCAIs", "SIMPLE_CHEMICAL", 0, 5], ["surveillance programmes", "TREATMENT", 76, 99], ["control measures", "TREATMENT", 220, 236], ["significantly", "OBSERVATION_MODIFIER", 26, 39], ["decreased", "OBSERVATION_MODIFIER", 40, 49]]], ["Consequently, they are often of minimal interest to hospital policymakers except during major outbreaks such as severe acute respiratory syndrome (SARS).", [["acute respiratory syndrome", "DISEASE", 119, 145], ["SARS", "DISEASE", 147, 151], ["severe acute respiratory syndrome", "PROBLEM", 112, 145], ["severe", "OBSERVATION_MODIFIER", 112, 118], ["acute", "OBSERVATION_MODIFIER", 119, 124], ["respiratory syndrome", "OBSERVATION", 125, 145]]], ["It has become increasingly apparent that hospital support for surveillance programmes needs to be justified by improved outcomes.", [["hospital support", "TREATMENT", 41, 57], ["surveillance programmes", "TREATMENT", 62, 85]]], ["To accomplish these goals they must be closely linked to effective interventional strategies.IntroductionThe first infection prevention and control hospital-wide HCAI surveillance programme in Taiwan, based on international guidelines, was established at the National Taiwan University Hospital (NTUH) in 1981.", [["infection", "DISEASE", 115, 124], ["interventional strategies", "TREATMENT", 67, 92], ["The first infection prevention", "TREATMENT", 105, 135], ["infection", "OBSERVATION", 115, 124]]], ["A vigorous hospital-wide hand hygiene programme was initiated in 2004.", [["hand", "ANATOMY", 25, 29], ["hand", "ORGANISM_SUBDIVISION", 25, 29]]], ["This report describes the secular trends in HCAI at the NTUH during the past 27 years (1981\u20132007) according to site of infection, aetiological agents and control measures.Hospital setting ::: MethodsThe NTUH is a 2200-bedded teaching hospital located in Taipei, Taiwan.", [["HCAI", "DISEASE", 44, 48], ["infection", "DISEASE", 119, 128], ["infection", "PROBLEM", 119, 128], ["aetiological agents", "TREATMENT", 130, 149], ["control measures", "TREATMENT", 154, 170], ["Methods", "TREATMENT", 192, 199], ["infection", "OBSERVATION", 119, 128]]], ["There are 220 intensive care unit (ICU) beds, 1866 beds in other acute care units, and 160 beds in a psychiatric day care unit.", [["psychiatric", "DISEASE", 101, 112]]], ["Among the acute care units are the following beds: 700 on medical wards, 800 on surgical wards, 200 on paediatric wards, 130 on gynaecology wards, and 100 on oncology wards.", [["acute", "OBSERVATION_MODIFIER", 10, 15]]], ["There are 68 negative pressure isolation rooms.Infection prevention and control programme ::: MethodsThe NTUH Infection Control Team currently consists of 10 full-time infection control nurses (ICNs), two full-time technicians and is supervised by two infection disease physicians.", [["infection", "DISEASE", 168, 177], ["infection disease", "DISEASE", 252, 269], ["Infection prevention", "TREATMENT", 47, 67], ["Methods", "TREATMENT", 94, 101], ["The NTUH Infection Control", "TREATMENT", 101, 127], ["Infection", "OBSERVATION", 110, 119]]], ["Prospective, hospital-wide on-site surveillance of HCAI was conducted by weekly visits of ICNs to all patient units.", [["HCAI", "DISEASE", 51, 55], ["patient", "ORGANISM", 102, 109], ["patient", "SPECIES", 102, 109]]], ["Hospital charts were reviewed to identify patients with HCAIs according to definitions of the Centers for Disease Control and Prevention with the help of infectious disease physicians at weekly meetings.4, 5, 6 The data were collected on standardised data collection forms (Appendix 1) and incorporated into the computer database by manual entry.", [["HCAIs", "DISEASE", 56, 61], ["infectious disease", "DISEASE", 154, 172], ["patients", "ORGANISM", 42, 50], ["patients", "SPECIES", 42, 50], ["HCAIs", "TREATMENT", 56, 61], ["Disease Control", "TREATMENT", 106, 121], ["The data", "TEST", 211, 219], ["standardised data collection", "TEST", 238, 266]]], ["The unit-specific incidences of HCAI (episodes per 100 discharges) including overall and site-specific infection rates were analysed monthly and compared with historical data.", [["HCAI", "DISEASE", 32, 36], ["infection", "DISEASE", 103, 112], ["HCAI", "PROBLEM", 32, 36], ["specific infection rates", "PROBLEM", 94, 118], ["historical data", "TEST", 159, 174], ["infection", "OBSERVATION", 103, 112]]], ["Feedback was provided to each service to stimulate intervention measures.Infection prevention and control events and interventions ::: MethodsMultiple special infection prevention and control events and interventions occurred during the study period.", [["infection", "DISEASE", 159, 168], ["intervention measures", "TREATMENT", 51, 72], ["Infection prevention", "TREATMENT", 73, 93], ["MethodsMultiple special infection prevention", "TREATMENT", 135, 179], ["control events", "PROBLEM", 184, 198], ["interventions", "TREATMENT", 203, 216], ["the study", "TEST", 233, 242], ["infection", "OBSERVATION", 159, 168]]], ["Prevention and control measures for surgical site infection (SSI) included intensified surveillance of SSI with feedback to the surgeons during 1988\u20131990, monitoring the timing and choice of prophylactic antibiotics, reinforcement of aseptic procedures, amelioration and monitoring ventilation in the operation rooms since 1991, and enhanced environmental cleaning in 1992.", [["site", "ANATOMY", 45, 49], ["surgical site infection", "DISEASE", 36, 59], ["SSI", "DISEASE", 61, 64], ["control measures", "TREATMENT", 15, 31], ["surgical site infection", "PROBLEM", 36, 59], ["prophylactic antibiotics", "TREATMENT", 191, 215], ["aseptic procedures", "TREATMENT", 234, 252], ["amelioration", "TREATMENT", 254, 266], ["monitoring ventilation", "TREATMENT", 271, 293], ["aseptic", "OBSERVATION", 234, 241]]], ["Organism-specific isolation precautions for meticilllin-resistant Staphylococcus aureus (MRSA) were initiated in 1990 and this was augmented in 1993 for extensively drug-resistant Acinetobacter baumannii (XDRAB) in 2001 and SARS-specific precautions during March to June 2003.7, 8, 9 The infection control guideline for XDRAB requiring contact isolation (single room cohort) was introduced in 2001.", [["meticilllin", "CHEMICAL", 44, 55], ["Staphylococcus aureus", "DISEASE", 66, 87], ["MRSA", "CHEMICAL", 89, 93], ["SARS", "DISEASE", 224, 228], ["infection", "DISEASE", 288, 297], ["XDRAB", "CHEMICAL", 320, 325], ["meticilllin", "CHEMICAL", 44, 55], ["meticilllin-resistant Staphylococcus aureus", "ORGANISM", 44, 87], ["MRSA", "CANCER", 89, 93], ["Acinetobacter baumannii", "ORGANISM", 180, 203], ["Staphylococcus aureus", "SPECIES", 66, 87], ["MRSA", "SPECIES", 89, 93], ["Acinetobacter baumannii", "SPECIES", 180, 203], ["Staphylococcus aureus", "SPECIES", 66, 87], ["MRSA", "SPECIES", 89, 93], ["Acinetobacter baumannii", "SPECIES", 180, 203], ["Organism", "TEST", 0, 8], ["specific isolation precautions", "TREATMENT", 9, 39], ["meticilllin-resistant Staphylococcus aureus", "PROBLEM", 44, 87], ["MRSA", "PROBLEM", 89, 93], ["resistant Acinetobacter baumannii", "PROBLEM", 170, 203], ["The infection control guideline", "TREATMENT", 284, 315], ["contact isolation", "TREATMENT", 336, 353], ["Staphylococcus aureus", "OBSERVATION", 66, 87], ["Acinetobacter baumannii", "OBSERVATION", 180, 203], ["infection", "OBSERVATION", 288, 297]]], ["This was reinforced the following year by requiring ICNs to inform staff to isolate patients with XDRAB.", [["XDRAB", "DISEASE", 98, 103], ["patients", "ORGANISM", 84, 92], ["patients", "SPECIES", 84, 92], ["XDRAB", "TREATMENT", 98, 103]]], ["Hospital-wide surveillance of HCAIs was interrupted temporarily during the SARS epidemic because the ICNs were fully occupied with containing SARS.", [["HCAIs", "DISEASE", 30, 35], ["SARS", "DISEASE", 75, 79], ["SARS", "DISEASE", 142, 146], ["HCAIs", "CANCER", 30, 35], ["ICNs", "CANCER", 101, 105], ["the SARS epidemic", "PROBLEM", 71, 88]]], ["The infection prevention and control programme was upgraded in 2004 by implementing annual, intensive, project-based control programmes.", [["infection", "DISEASE", 4, 13], ["The infection prevention", "TREATMENT", 0, 24], ["project-based control programmes", "TREATMENT", 103, 135], ["infection", "OBSERVATION", 4, 13]]], ["The hospital-wide hand hygiene programme was instituted in April 2004 and has continued as an annual campaign.", [["hand", "ANATOMY", 18, 22], ["hand", "ORGANISM_SUBDIVISION", 18, 22]]], ["Targeted surveillance and control for device-associated infections in ICUs (e.g. urinary catheters, central venous catheters, and ventilators) and SSI for selected surgical procedures were initiated in 2000 and intensified since 2005.", [["urinary", "ANATOMY", 81, 88], ["central venous", "ANATOMY", 100, 114], ["infections", "DISEASE", 56, 66], ["urinary", "ORGANISM_SUBDIVISION", 81, 88], ["central venous catheters", "MULTI-TISSUE_STRUCTURE", 100, 124], ["Targeted surveillance", "TEST", 0, 21], ["device", "TREATMENT", 38, 44], ["associated infections", "PROBLEM", 45, 66], ["urinary catheters", "TREATMENT", 81, 98], ["central venous catheters", "TREATMENT", 100, 124], ["ventilators", "TREATMENT", 130, 141], ["SSI", "TREATMENT", 147, 150], ["selected surgical procedures", "TREATMENT", 155, 183], ["infections", "OBSERVATION", 56, 66], ["urinary catheters", "ANATOMY", 81, 98], ["central", "ANATOMY_MODIFIER", 100, 107], ["venous", "ANATOMY", 108, 114], ["catheters", "OBSERVATION", 115, 124]]], ["Data were analysed and compared with national and international data and feedback every quarter.Microbiological studies ::: MethodsCulture data were obtained from computer-generated reports issued by the hospital clinical microbiology laboratory.10 The in vitro susceptibility of Acinetobacter isolates was determined by disc diffusion method.8, 10 The following antibacterial agents were tested: cephalosporins (ceftazidime and cefepime), extended-spectrum penicillins (piperacillin-tazobactam), carbapenems (imipenem), aminoglycosides (gentamicin and amikacin), fluoroquinolones (ciprofloxacin), sulbactam and colistin.", [["cephalosporins", "CHEMICAL", 397, 411], ["ceftazidime", "CHEMICAL", 413, 424], ["cefepime", "CHEMICAL", 429, 437], ["penicillins", "CHEMICAL", 458, 469], ["piperacillin-tazobactam", "CHEMICAL", 471, 494], ["carbapenems", "CHEMICAL", 497, 508], ["imipenem", "CHEMICAL", 510, 518], ["aminoglycosides", "CHEMICAL", 521, 536], ["gentamicin", "CHEMICAL", 538, 548], ["amikacin", "CHEMICAL", 553, 561], ["fluoroquinolones", "CHEMICAL", 564, 580], ["ciprofloxacin", "CHEMICAL", 582, 595], ["sulbactam", "CHEMICAL", 598, 607], ["colistin", "CHEMICAL", 612, 620], ["cephalosporins", "CHEMICAL", 397, 411], ["ceftazidime", "CHEMICAL", 413, 424], ["cefepime", "CHEMICAL", 429, 437], ["penicillins", "CHEMICAL", 458, 469], ["piperacillin", "CHEMICAL", 471, 483], ["tazobactam", "CHEMICAL", 484, 494], ["carbapenems", "CHEMICAL", 497, 508], ["imipenem", "CHEMICAL", 510, 518], ["aminoglycosides", "CHEMICAL", 521, 536], ["gentamicin", "CHEMICAL", 538, 548], ["amikacin", "CHEMICAL", 553, 561], ["fluoroquinolones", "CHEMICAL", 564, 580], ["ciprofloxacin", "CHEMICAL", 582, 595], ["sulbactam", "CHEMICAL", 598, 607], ["colistin", "CHEMICAL", 612, 620], ["cephalosporins", "SIMPLE_CHEMICAL", 397, 411], ["ceftazidime", "SIMPLE_CHEMICAL", 413, 424], ["cefepime", "SIMPLE_CHEMICAL", 429, 437], ["extended-spectrum penicillins", "SIMPLE_CHEMICAL", 440, 469], ["piperacillin-tazobactam", "SIMPLE_CHEMICAL", 471, 494], ["carbapenems", "SIMPLE_CHEMICAL", 497, 508], ["imipenem", "SIMPLE_CHEMICAL", 510, 518], ["aminoglycosides", "SIMPLE_CHEMICAL", 521, 536], ["gentamicin", "SIMPLE_CHEMICAL", 538, 548], ["amikacin", "SIMPLE_CHEMICAL", 553, 561], ["fluoroquinolones", "SIMPLE_CHEMICAL", 564, 580], ["ciprofloxacin", "SIMPLE_CHEMICAL", 582, 595], ["sulbactam", "SIMPLE_CHEMICAL", 598, 607], ["colistin", "SIMPLE_CHEMICAL", 612, 620], ["Microbiological studies", "TEST", 96, 119], ["MethodsCulture data", "TEST", 124, 143], ["Acinetobacter isolates", "PROBLEM", 280, 302], ["disc diffusion method", "TEST", 321, 342], ["The following antibacterial agents", "TREATMENT", 349, 383], ["cephalosporins", "TREATMENT", 397, 411], ["ceftazidime", "TREATMENT", 413, 424], ["cefepime", "TREATMENT", 429, 437], ["extended-spectrum penicillins", "TREATMENT", 440, 469], ["piperacillin", "TREATMENT", 471, 483], ["tazobactam", "TREATMENT", 484, 494], ["carbapenems", "TREATMENT", 497, 508], ["imipenem", "TREATMENT", 510, 518], ["aminoglycosides", "TREATMENT", 521, 536], ["gentamicin", "TREATMENT", 538, 548], ["amikacin", "TREATMENT", 553, 561], ["fluoroquinolones", "TREATMENT", 564, 580], ["ciprofloxacin", "TREATMENT", 582, 595], ["sulbactam", "TREATMENT", 598, 607], ["colistin", "TREATMENT", 612, 620], ["Acinetobacter isolates", "OBSERVATION", 280, 302]]], ["In vitro susceptibility testing of colistin was begun in July 2006.", [["colistin", "CHEMICAL", 35, 43], ["colistin", "CHEMICAL", 35, 43], ["colistin", "SIMPLE_CHEMICAL", 35, 43], ["colistin", "TREATMENT", 35, 43]]], ["XDRAB was defined as A. baumannii isolates that were resistant to five or more classes of antibacterial agents.Statistical analysis ::: MethodsPoisson regression was used to model the secular trends of the annual incidence (episodes per 100 discharges) of HCAIs during 1981\u20132007.11 The Poisson regression model form is written aslog(Y)=\u03b20+\u03b21\u00d7time+log(PY)where Y is the number of HCAI cases at time t, PY is the number of patient-years discharged at time t, \u03b20 represents the baseline level of HCAI rate (HCAI rate in 1981), \u03b21 represents the annual change of HCAI, and \u2018time\u2019 indicates the linear trend of HCAI, denoted as time in year from 1981.", [["HCAIs", "DISEASE", 256, 261], ["1981\u20132007.11", "CHEMICAL", 269, 281], ["HCAI", "DISEASE", 379, 383], ["HCAI", "DISEASE", 606, 610], ["XDRAB", "GENE_OR_GENE_PRODUCT", 0, 5], ["A. baumannii", "ORGANISM", 21, 33], ["patient", "ORGANISM", 421, 428], ["A. baumannii", "SPECIES", 21, 33], ["patient", "SPECIES", 421, 428], ["A. baumannii", "SPECIES", 21, 33], ["A. baumannii isolates", "PROBLEM", 21, 42], ["antibacterial agents", "TREATMENT", 90, 110], ["MethodsPoisson regression", "TREATMENT", 136, 161], ["HCAI rate", "TEST", 493, 502], ["HCAI rate", "TEST", 504, 513], ["HCAI", "PROBLEM", 606, 610]]], ["Estimated average annual changes during 1981\u20132007 were calculated by (e\u03b21\u22121)\u00d7100%.", [["average", "OBSERVATION_MODIFIER", 10, 17]]], ["The negative binomial regression was applied while the number of HCAI cases was overdispersed, i.e. the variance was greater than the mean.12P< 0.05 was considered to be significant.", [["the variance", "TEST", 100, 112], ["negative", "OBSERVATION_MODIFIER", 4, 12], ["binomial regression", "OBSERVATION", 13, 32], ["greater", "OBSERVATION_MODIFIER", 117, 124], ["significant", "OBSERVATION_MODIFIER", 170, 181]]], ["Statistical analyses were performed using SAS 9.1.3 (SAS Institute, Cary, NC, USA).Secular trends in annual rates of overall infections ::: ResultsThe annual infection rates increased slowly (average 0.3% per year, range \u22120.1% to 0.7%, P= 0.16) during 1981\u20132007 and fluctuated around 4.5 episodes per 100 discharges (Figure 1B).", [["infections", "DISEASE", 125, 135], ["infection", "DISEASE", 158, 167], ["Statistical analyses", "TEST", 0, 20], ["SAS", "TEST", 42, 45], ["The annual infection rates", "TEST", 147, 173], ["P", "TEST", 236, 237], ["infections", "OBSERVATION", 125, 135], ["annual", "OBSERVATION_MODIFIER", 151, 157], ["infection", "OBSERVATION", 158, 167]]], ["The major exception was an abrupt increase during 1989\u20131990 in HCAI with microbiological documentation and those cases without (Figure 1C).", [["microbiological documentation", "TEST", 73, 102], ["abrupt", "OBSERVATION_MODIFIER", 27, 33], ["increase", "OBSERVATION_MODIFIER", 34, 42]]]], "55472016ad28c19e9c1857a30c156a26b26f602f": [["The incidence has been even higher in the Italian series, with up to 10% of infected patients in Lombardy developing ARDS (2) .", [["ARDS", "DISEASE", 117, 121], ["patients", "ORGANISM", 85, 93], ["patients", "SPECIES", 85, 93], ["ARDS", "PROBLEM", 117, 121], ["higher", "OBSERVATION_MODIFIER", 28, 34], ["ARDS", "OBSERVATION", 117, 121]]], ["It is likely that many American physicians will be called on to treat pneumonia, hypoxemic respiratory failure, and ARDS, regardless of their specialty.ACUTE RESPIRATORY DISTRESS SYNDROMEARDS is a life-threatening form of lung injury.", [["respiratory", "ANATOMY", 91, 102], ["lung", "ANATOMY", 222, 226], ["pneumonia", "DISEASE", 70, 79], ["hypoxemic respiratory failure", "DISEASE", 81, 110], ["ARDS", "DISEASE", 116, 120], ["lung injury", "DISEASE", 222, 233], ["lung", "ORGAN", 222, 226], ["pneumonia", "PROBLEM", 70, 79], ["hypoxemic respiratory failure", "PROBLEM", 81, 110], ["ARDS", "PROBLEM", 116, 120], ["ACUTE RESPIRATORY DISTRESS SYNDROMEARDS", "PROBLEM", 152, 191], ["lung injury", "PROBLEM", 222, 233], ["is likely", "UNCERTAINTY", 3, 12], ["pneumonia", "OBSERVATION", 70, 79], ["hypoxemic", "OBSERVATION_MODIFIER", 81, 90], ["respiratory failure", "OBSERVATION", 91, 110], ["ARDS", "OBSERVATION", 116, 120], ["RESPIRATORY", "ANATOMY", 158, 169], ["DISTRESS", "OBSERVATION", 170, 178], ["lung", "ANATOMY", 222, 226], ["injury", "OBSERVATION", 227, 233]]], ["This lung injury can be the result of primary pulmonary parenchymal injury such as pneumonia or aspiration or from a systemic process such as sepsis or trauma.ACUTE RESPIRATORY DISTRESS SYNDROMEIncreased capillary permeability leading to inflammation is the inciting factor for ARDS.", [["lung", "ANATOMY", 5, 9], ["pulmonary parenchymal", "ANATOMY", 46, 67], ["capillary", "ANATOMY", 204, 213], ["lung injury", "DISEASE", 5, 16], ["pulmonary parenchymal injury", "DISEASE", 46, 74], ["pneumonia", "DISEASE", 83, 92], ["sepsis", "DISEASE", 142, 148], ["trauma", "DISEASE", 152, 158], ["inflammation", "DISEASE", 238, 250], ["ARDS", "DISEASE", 278, 282], ["lung", "ORGAN", 5, 9], ["pulmonary parenchymal", "MULTI-TISSUE_STRUCTURE", 46, 67], ["capillary", "TISSUE", 204, 213], ["This lung injury", "PROBLEM", 0, 16], ["primary pulmonary parenchymal injury", "PROBLEM", 38, 74], ["pneumonia", "PROBLEM", 83, 92], ["aspiration", "PROBLEM", 96, 106], ["a systemic process", "PROBLEM", 115, 133], ["sepsis", "PROBLEM", 142, 148], ["trauma", "PROBLEM", 152, 158], ["ACUTE RESPIRATORY DISTRESS", "PROBLEM", 159, 185], ["capillary permeability", "PROBLEM", 204, 226], ["inflammation", "PROBLEM", 238, 250], ["ARDS", "PROBLEM", 278, 282], ["lung", "ANATOMY", 5, 9], ["injury", "OBSERVATION", 10, 16], ["can be the result of", "UNCERTAINTY", 17, 37], ["primary", "OBSERVATION_MODIFIER", 38, 45], ["pulmonary", "ANATOMY", 46, 55], ["parenchymal", "ANATOMY_MODIFIER", 56, 67], ["injury", "OBSERVATION", 68, 74], ["pneumonia", "OBSERVATION", 83, 92], ["aspiration", "OBSERVATION", 96, 106], ["systemic", "OBSERVATION_MODIFIER", 117, 125], ["process", "OBSERVATION", 126, 133], ["sepsis", "OBSERVATION", 142, 148], ["trauma", "OBSERVATION", 152, 158], ["RESPIRATORY", "ANATOMY", 165, 176], ["DISTRESS", "OBSERVATION", 177, 185], ["capillary permeability", "OBSERVATION", 204, 226], ["inflammation", "OBSERVATION", 238, 250], ["ARDS", "OBSERVATION", 278, 282]]], ["Damage to the capillary endothelium and alveolar epithelium results in protein accumulation within the alveoli, activation of proinflammatory cytokines, and then pulmonary fibrosis.", [["capillary endothelium", "ANATOMY", 14, 35], ["alveolar epithelium", "ANATOMY", 40, 59], ["alveoli", "ANATOMY", 103, 110], ["pulmonary", "ANATOMY", 162, 171], ["fibrosis", "DISEASE", 172, 180], ["capillary endothelium", "TISSUE", 14, 35], ["alveolar epithelium", "TISSUE", 40, 59], ["alveoli", "MULTI-TISSUE_STRUCTURE", 103, 110], ["pulmonary", "ORGAN", 162, 171], ["proinflammatory cytokines", "PROTEIN", 126, 151], ["the capillary endothelium", "TEST", 10, 35], ["alveolar epithelium", "PROBLEM", 40, 59], ["protein accumulation", "PROBLEM", 71, 91], ["proinflammatory cytokines", "PROBLEM", 126, 151], ["pulmonary fibrosis", "PROBLEM", 162, 180], ["capillary endothelium", "ANATOMY", 14, 35], ["alveolar", "ANATOMY_MODIFIER", 40, 48], ["epithelium", "ANATOMY_MODIFIER", 49, 59], ["protein accumulation", "OBSERVATION", 71, 91], ["alveoli", "ANATOMY", 103, 110], ["proinflammatory cytokines", "OBSERVATION", 126, 151], ["pulmonary", "ANATOMY", 162, 171], ["fibrosis", "OBSERVATION", 172, 180]]], ["This cascade leads to loss of functional lung tissue.", [["lung tissue", "ANATOMY", 41, 52], ["lung tissue", "TISSUE", 41, 52], ["This cascade", "TREATMENT", 0, 12], ["loss of functional lung tissue", "PROBLEM", 22, 52], ["loss", "OBSERVATION_MODIFIER", 22, 26], ["functional lung tissue", "OBSERVATION", 30, 52]]], ["Chest radiography demonstrates bilateral opacities.", [["opacities", "DISEASE", 41, 50], ["Chest radiography", "TEST", 0, 17], ["bilateral opacities", "PROBLEM", 31, 50], ["bilateral", "ANATOMY_MODIFIER", 31, 40], ["opacities", "OBSERVATION", 41, 50]]], ["As ARDS progresses, lung compliance decreases, hypoxemia ensues, and patients can progress to ventilator dependence (3, 4) .ACUTE RESPIRATORY DISTRESS SYNDROMEIn practice, ARDS is defined by the Berlin definition. blockade may also be considered (7).ACUTE RESPIRATORY DISTRESS SYNDROMEIt should be noted that mild ARDS may be managed with noninvasive forms of ventilation.", [["lung", "ANATOMY", 20, 24], ["ARDS", "DISEASE", 3, 7], ["hypoxemia", "DISEASE", 47, 56], ["ARDS", "DISEASE", 172, 176], ["ARDS", "DISEASE", 314, 318], ["lung", "ORGAN", 20, 24], ["patients", "ORGANISM", 69, 77], ["patients", "SPECIES", 69, 77], ["ARDS", "PROBLEM", 3, 7], ["lung compliance decreases", "PROBLEM", 20, 45], ["hypoxemia", "PROBLEM", 47, 56], ["ventilator dependence", "PROBLEM", 94, 115], ["ACUTE RESPIRATORY DISTRESS SYNDROMEIn practice", "PROBLEM", 124, 170], ["ARDS", "PROBLEM", 172, 176], ["blockade", "TREATMENT", 214, 222], ["ACUTE RESPIRATORY DISTRESS SYNDROMEIt", "PROBLEM", 250, 287], ["mild ARDS", "PROBLEM", 309, 318], ["noninvasive forms of ventilation", "TREATMENT", 339, 371], ["ARDS", "OBSERVATION", 3, 7], ["lung", "ANATOMY", 20, 24], ["compliance", "OBSERVATION", 25, 35], ["decreases", "OBSERVATION_MODIFIER", 36, 45], ["hypoxemia", "OBSERVATION", 47, 56], ["RESPIRATORY", "ANATOMY", 130, 141], ["DISTRESS", "OBSERVATION", 142, 150], ["ARDS", "OBSERVATION", 172, 176], ["may also be considered", "UNCERTAINTY", 223, 245], ["RESPIRATORY", "ANATOMY", 256, 267], ["DISTRESS", "OBSERVATION", 268, 276], ["mild", "OBSERVATION_MODIFIER", 309, 313], ["ARDS", "OBSERVATION", 314, 318]]], ["However, during the present pandemic, modifications to usual critical care may be necessary.", [["usual critical care", "TREATMENT", 55, 74]]], ["Given concern for viral transmission, current recommendations advise to 28 breaths/min); this may then be adjusted based on the patient's arterial pCO 2 ( Figure 1 ).ACUTE RESPIRATORY DISTRESS SYNDROMEAfter initial stabilization, it is critical to appropriately titrate settings to minimize ventilator-induced lung injury.", [["arterial", "ANATOMY", 138, 146], ["lung", "ANATOMY", 310, 314], ["lung injury", "DISEASE", 310, 321], ["patient", "ORGANISM", 128, 135], ["lung", "ORGAN", 310, 314], ["patient", "SPECIES", 128, 135], ["viral transmission", "PROBLEM", 18, 36], ["the patient's arterial pCO", "TEST", 124, 150], ["ACUTE RESPIRATORY DISTRESS", "PROBLEM", 166, 192], ["initial stabilization", "TREATMENT", 207, 228], ["ventilator", "TREATMENT", 291, 301], ["lung injury", "PROBLEM", 310, 321], ["RESPIRATORY", "ANATOMY", 172, 183], ["DISTRESS", "OBSERVATION", 184, 192], ["stabilization", "OBSERVATION", 215, 228], ["lung", "ANATOMY", 310, 314], ["injury", "OBSERVATION", 315, 321]]], ["One of the most common methods for doing this is careful monitoring of the plateau pressure ( Figure 2) .", [["careful monitoring", "TEST", 49, 67], ["the plateau pressure", "TEST", 71, 91]]], ["Although the peak inspiratory pressure represents the pressure to which the proximal large airways are exposed, the plateau pressure is representative of the pressure present in the alveoli at end inspiration, and thus is an indicator of transpulmonary pressure, lung overdistention, and ventilator-induced lung injury.", [["airways", "ANATOMY", 91, 98], ["alveoli", "ANATOMY", 182, 189], ["transpulmonary", "ANATOMY", 238, 252], ["lung", "ANATOMY", 263, 267], ["lung", "ANATOMY", 307, 311], ["lung injury", "DISEASE", 307, 318], ["airways", "MULTI-TISSUE_STRUCTURE", 91, 98], ["alveoli", "MULTI-TISSUE_STRUCTURE", 182, 189], ["lung", "ORGAN", 263, 267], ["lung", "ORGAN", 307, 311], ["the peak inspiratory pressure", "TEST", 9, 38], ["the pressure", "TEST", 50, 62], ["the plateau pressure", "TEST", 112, 132], ["transpulmonary pressure", "TEST", 238, 261], ["lung overdistention", "PROBLEM", 263, 282], ["ventilator", "TREATMENT", 288, 298], ["lung injury", "PROBLEM", 307, 318], ["peak", "OBSERVATION_MODIFIER", 13, 17], ["inspiratory pressure", "OBSERVATION", 18, 38], ["pressure", "OBSERVATION_MODIFIER", 54, 62], ["proximal", "ANATOMY_MODIFIER", 76, 84], ["large", "OBSERVATION_MODIFIER", 85, 90], ["airways", "ANATOMY", 91, 98], ["exposed", "OBSERVATION", 103, 110], ["plateau", "OBSERVATION_MODIFIER", 116, 123], ["pressure", "OBSERVATION_MODIFIER", 124, 132], ["pressure", "OBSERVATION_MODIFIER", 158, 166], ["alveoli", "ANATOMY_MODIFIER", 182, 189], ["transpulmonary pressure", "OBSERVATION", 238, 261], ["lung", "ANATOMY", 263, 267], ["overdistention", "OBSERVATION", 268, 282], ["lung", "ANATOMY", 307, 311], ["injury", "OBSERVATION", 312, 318]]], ["Plateau pressure is measured after a 0.5-to 1.0-s inspiratory pause maneuver.", [["Plateau pressure", "TEST", 0, 16], ["pressure", "OBSERVATION_MODIFIER", 8, 16]]], ["If the plateau pressure is >30 cm H 2 O, consider further reducing the delivered tidal volume.ACUTE RESPIRATORY DISTRESS SYNDROMEIt is also important to monitor the patient's driving pressure, or difference between the PEEP and plateau pressure, as increased driving pressures have been associated with higher mortality in ARDS (10).CONCLUSIONSWith a basic understanding of these fundamentals, it is possible for all cardiologists to provide safe and effective care for our patients with COVID-19.", [["ARDS", "DISEASE", 323, 327], ["H 2 O", "CHEMICAL", 34, 39], ["patient", "ORGANISM", 165, 172], ["patients", "ORGANISM", 474, 482], ["patient", "SPECIES", 165, 172], ["patients", "SPECIES", 474, 482], ["the plateau pressure", "TEST", 3, 23], ["further reducing the delivered tidal volume", "TREATMENT", 50, 93], ["ACUTE RESPIRATORY DISTRESS SYNDROMEIt", "PROBLEM", 94, 131], ["the patient's driving pressure", "TEST", 161, 191], ["the PEEP", "TEST", 215, 223], ["plateau pressure", "TEST", 228, 244], ["increased driving pressures", "PROBLEM", 249, 276], ["ARDS", "PROBLEM", 323, 327], ["COVID", "TEST", 488, 493], ["plateau", "OBSERVATION_MODIFIER", 7, 14], ["pressure", "OBSERVATION_MODIFIER", 15, 23], ["RESPIRATORY DISTRESS", "OBSERVATION", 100, 120], ["plateau pressure", "OBSERVATION", 228, 244], ["increased", "OBSERVATION_MODIFIER", 249, 258], ["driving pressures", "OBSERVATION", 259, 276], ["higher", "OBSERVATION_MODIFIER", 303, 309], ["mortality", "OBSERVATION_MODIFIER", 310, 319], ["ARDS", "OBSERVATION", 323, 327]]], ["One of the few bright spots in this pandemic has been the resurgence of interdisciplinary team-", [["few", "OBSERVATION_MODIFIER", 11, 14], ["bright", "OBSERVATION_MODIFIER", 15, 21], ["spots", "OBSERVATION", 22, 27]]]], "79979652a864cef3a41342ccb1add48e5ad0cf85": [["INTRODUCTIONGenetic material in plants is distributed into nucleus and the chloroplast and mitochondria in the cytoplasm.", [["nucleus", "ANATOMY", 59, 66], ["chloroplast", "ANATOMY", 75, 86], ["mitochondria", "ANATOMY", 91, 103], ["cytoplasm", "ANATOMY", 111, 120], ["nucleus", "CELLULAR_COMPONENT", 59, 66], ["chloroplast", "CELLULAR_COMPONENT", 75, 86], ["mitochondria", "CELLULAR_COMPONENT", 91, 103], ["cytoplasm", "ORGANISM_SUBSTANCE", 111, 120], ["INTRODUCTIONGenetic material", "TREATMENT", 0, 28], ["cytoplasm", "OBSERVATION_MODIFIER", 111, 120]]], ["The chloroplast is one of organelles known as plastids in plant cells and eukaryotic algae [3] .", [["chloroplast", "ANATOMY", 4, 15], ["organelles", "ANATOMY", 26, 36], ["plastids", "ANATOMY", 46, 54], ["cells", "ANATOMY", 64, 69], ["chloroplast", "CELLULAR_COMPONENT", 4, 15], ["organelles", "CELLULAR_COMPONENT", 26, 36], ["plastids", "CELLULAR_COMPONENT", 46, 54], ["plant cells", "CELL", 58, 69], ["plant cells", "CELL_TYPE", 58, 69], ["The chloroplast", "TREATMENT", 0, 15], ["plant cells", "OBSERVATION", 58, 69]]], ["According to Verhounig et al. [4] , plastids and mitochondria are derived from formerly free-living bacteria and have largely prokaryotic gene expression machinery.", [["plastids", "ANATOMY", 36, 44], ["mitochondria", "ANATOMY", 49, 61], ["plastids", "CELLULAR_COMPONENT", 36, 44], ["mitochondria", "CELLULAR_COMPONENT", 49, 61], ["plastids and mitochondria", "TREATMENT", 36, 61]]], ["The plastid (biosynthetic centre of the plant cell) carries out photosynthesis, in plant cells and eukaryotic algae, which provides the primary source of the world's food [3] .", [["cell", "ANATOMY", 46, 50], ["cells", "ANATOMY", 89, 94], ["algae", "ANATOMY", 110, 115], ["plastid", "CELLULAR_COMPONENT", 4, 11], ["plant cell", "CELL", 40, 50], ["plant cells", "CELL", 83, 94], ["eukaryotic algae", "CELL", 99, 115], ["plant cells", "CELL_TYPE", 83, 94], ["The plastid (biosynthetic centre of the plant cell", "TREATMENT", 0, 50], ["photosynthesis", "PROBLEM", 64, 78], ["plant cell", "OBSERVATION", 40, 50], ["plant cells", "OBSERVATION", 83, 94], ["eukaryotic algae", "OBSERVATION", 99, 115]]], ["There are other important activities that occur in plastids.", [["plastids", "ANATOMY", 51, 59], ["plastids", "CELLULAR_COMPONENT", 51, 59]]], ["These include sequestration of carbon, production of starch, evolution of oxygen, synthesis of amino acids, fatty acids, and pigments, and key aspects of sulfur and nitrogen metabolism [5] .", [["oxygen", "CHEMICAL", 74, 80], ["amino acids", "CHEMICAL", 95, 106], ["fatty acids", "CHEMICAL", 108, 119], ["sulfur", "CHEMICAL", 154, 160], ["nitrogen", "CHEMICAL", 165, 173], ["carbon", "CHEMICAL", 31, 37], ["oxygen", "CHEMICAL", 74, 80], ["amino acids", "CHEMICAL", 95, 106], ["fatty acids", "CHEMICAL", 108, 119], ["sulfur", "CHEMICAL", 154, 160], ["nitrogen", "CHEMICAL", 165, 173], ["carbon", "SIMPLE_CHEMICAL", 31, 37], ["starch", "SIMPLE_CHEMICAL", 53, 59], ["oxygen", "SIMPLE_CHEMICAL", 74, 80], ["amino acids", "AMINO_ACID", 95, 106], ["fatty acids", "SIMPLE_CHEMICAL", 108, 119], ["sulfur", "SIMPLE_CHEMICAL", 154, 160], ["nitrogen", "SIMPLE_CHEMICAL", 165, 173], ["carbon, production of starch", "TREATMENT", 31, 59], ["oxygen", "TREATMENT", 74, 80], ["synthesis of amino acids", "TREATMENT", 82, 106], ["fatty acids", "TEST", 108, 119], ["sulfur and nitrogen metabolism", "TREATMENT", 154, 184], ["sequestration", "OBSERVATION", 14, 27], ["carbon", "OBSERVATION_MODIFIER", 31, 37]]], ["In spite of the prokaryotic past of the plastids, their gene expression has very different regulatory mechanisms from those operating in bacteria [6] .", [["plastids", "ANATOMY", 40, 48], ["plastids", "CELLULAR_COMPONENT", 40, 48], ["the plastids", "PROBLEM", 36, 48], ["very different regulatory mechanisms", "PROBLEM", 76, 112]]], ["There are up to 300 plastids [7] in one plant cell.", [["cell", "ANATOMY", 46, 50], ["plant cell", "CELL", 40, 50], ["plant cell", "OBSERVATION", 40, 50]]], ["The plastid genome (plastome or plastid DNA, ptDNA), 1,000-10,000 copies per cell [8] , contrasts strikingly with the nuclear DNA.", [["plastid genome", "ANATOMY", 4, 18], ["cell", "ANATOMY", 77, 81], ["nuclear", "ANATOMY", 118, 125], ["plastid", "CELLULAR_COMPONENT", 4, 11], ["genome", "CELLULAR_COMPONENT", 12, 18], ["plastome", "CELLULAR_COMPONENT", 20, 28], ["plastid", "CELLULAR_COMPONENT", 32, 39], ["DNA", "CELLULAR_COMPONENT", 40, 43], ["nuclear", "CELLULAR_COMPONENT", 118, 125], ["DNA", "CELLULAR_COMPONENT", 126, 129], ["plastid genome", "DNA", 4, 18], ["plastome", "DNA", 20, 28], ["plastid DNA", "DNA", 32, 43], ["ptDNA", "DNA", 45, 50], ["nuclear DNA", "DNA", 118, 129], ["The plastid genome (plastome", "TREATMENT", 0, 28], ["plastid DNA", "TREATMENT", 32, 43], ["the nuclear DNA", "PROBLEM", 114, 129], ["plastid genome", "OBSERVATION", 4, 18], ["nuclear DNA", "ANATOMY", 118, 129]]], ["In most species, plastids are usually strictly maternally inherited [9] in most (80%) angiosperm plant species [10, 11] .", [["plastids", "ANATOMY", 17, 25], ["plastids", "CELLULAR_COMPONENT", 17, 25], ["angiosperm plant species", "PROBLEM", 86, 110], ["most species", "OBSERVATION_MODIFIER", 3, 15]]], ["It is also not influenced by polyploidy, gene duplication and recombination that are widespread features of the nuclear genomes of plants [12, 13] .", [["nuclear genomes", "ANATOMY", 112, 127], ["nuclear", "CELLULAR_COMPONENT", 112, 119], ["nuclear genomes", "DNA", 112, 127], ["polyploidy", "PROBLEM", 29, 39], ["gene duplication", "PROBLEM", 41, 57], ["polyploidy", "OBSERVATION", 29, 39], ["gene duplication", "OBSERVATION", 41, 57], ["widespread", "OBSERVATION_MODIFIER", 85, 95]]], ["Therefore, ptDNA varies little among angiosperms in terms of size, structure and gene content [14] .", [["ptDNA", "GENE_OR_GENE_PRODUCT", 11, 16], ["ptDNA", "PROTEIN", 11, 16], ["angiosperms", "OBSERVATION_MODIFIER", 37, 48], ["size", "OBSERVATION_MODIFIER", 61, 65], ["gene content", "OBSERVATION", 81, 93]]], ["Currently 170 DNA.", [["DNA", "CELLULAR_COMPONENT", 14, 17], ["170 DNA", "DNA", 10, 17]]], ["The authors, therefore, developed a simple and inexpensive method to obtain plastid DNA from grass species by modifying and extending protocols optimized for the use in eudicots.", [["DNA", "CELLULAR_COMPONENT", 84, 87], ["plastid DNA", "DNA", 76, 87], ["a simple and inexpensive method", "PROBLEM", 34, 65], ["plastid DNA", "PROBLEM", 76, 87], ["grass species", "PROBLEM", 93, 106], ["extending protocols", "TREATMENT", 124, 143], ["grass species", "OBSERVATION", 93, 106]]], ["Plastid engineering involves the targeting of foreign genes to the plastid's double-stranded circular DNA genome instead of chromosomal DNA [31] , and as a consequence the production of the foreign protein of interest (Fig. 1) .", [["chromosomal", "ANATOMY", 124, 135], ["plastid", "CELLULAR_COMPONENT", 67, 74], ["DNA", "CELLULAR_COMPONENT", 102, 105], ["chromosomal DNA", "CELLULAR_COMPONENT", 124, 139], ["foreign genes", "DNA", 46, 59], ["plastid's double-stranded circular DNA genome", "DNA", 67, 112], ["foreign protein", "PROTEIN", 190, 205], ["Plastid engineering", "TREATMENT", 0, 19], ["the plastid's double-stranded circular DNA genome", "TREATMENT", 63, 112], ["chromosomal DNA", "PROBLEM", 124, 139], ["foreign protein", "OBSERVATION", 190, 205]]], ["The advancement in the particle gun mediated transformation has enabled targeting the plastid genome for developing transgenic plants against many biotic (e.g. insects and pathogens) and abiotic stresses (e.g. drought and salinity), which reduce the plant productivity.", [["plastid", "CELLULAR_COMPONENT", 86, 93], ["plastid genome", "DNA", 86, 100], ["the plastid genome", "TREATMENT", 82, 100], ["developing transgenic plants", "PROBLEM", 105, 133], ["pathogens", "PROBLEM", 172, 181], ["abiotic stresses", "PROBLEM", 187, 203], ["the plant productivity", "PROBLEM", 246, 268], ["plastid genome", "OBSERVATION", 86, 100], ["abiotic stresses", "OBSERVATION", 187, 203], ["plant productivity", "OBSERVATION", 250, 268]]], ["Improving the quality of fruits has been another main target in plastid transformation [32] .INTRODUCTIONPlastid transformation was first achieved in a unicellular alga, Chlamydomonas reindhartii [33] .", [["fruits", "ANATOMY", 25, 31], ["alga", "ANATOMY", 164, 168], ["fruits", "ORGANISM_SUBDIVISION", 25, 31], ["plastid", "CELLULAR_COMPONENT", 64, 71], ["Chlamydomonas reindhartii", "ORGANISM", 170, 195], ["Chlamydomonas reindhartii", "SPECIES", 170, 195], ["Chlamydomonas reindhartii", "SPECIES", 170, 195], ["plastid transformation", "PROBLEM", 64, 86], ["main", "OBSERVATION_MODIFIER", 49, 53], ["target", "OBSERVATION_MODIFIER", 54, 60], ["plastid transformation", "OBSERVATION", 64, 86]]], ["In 1990, Sv\u00e1b et al. [34] reported the first successful chloroplast transformation of a higher plant (tobacco).", [["chloroplast", "ANATOMY", 56, 67], ["tobacco", "ORGANISM", 102, 109], ["tobacco", "SPECIES", 102, 109], ["tobacco", "SPECIES", 102, 109]]], ["This was followed by transformation of the plastid genome in tobacco by many researchers [35, 36] .", [["plastid", "CELLULAR_COMPONENT", 43, 50], ["tobacco", "ORGANISM", 61, 68], ["plastid genome", "DNA", 43, 57], ["tobacco", "SPECIES", 61, 68], ["tobacco", "SPECIES", 61, 68], ["plastid genome", "OBSERVATION", 43, 57]]], ["Recently, tobacco plastid has been engineered to express the E7 HPV type 16 protein, which is an attractive candidate for anticancer vaccine development [37] .", [["anticancer", "ANATOMY", 122, 132], ["tobacco", "ORGANISM", 10, 17], ["E7 HPV type 16", "ORGANISM", 61, 75], ["anticancer", "CANCER", 122, 132], ["E7 HPV type 16 protein", "PROTEIN", 61, 83], ["tobacco", "SPECIES", 10, 17], ["anticancer vaccine development", "TREATMENT", 122, 152]]], ["Similarly, a protocol for plastid transformation of an elite rapeseed cultivar (Brassica napus L.) has been developed [38] .", [["plastid", "CELLULAR_COMPONENT", 26, 33], ["Brassica napus L.", "ORGANISM", 80, 97], ["rapeseed", "SPECIES", 61, 69], ["Brassica napus", "SPECIES", 80, 94], ["L.", "SPECIES", 95, 97], ["rapeseed", "SPECIES", 61, 69], ["Brassica napus L.", "SPECIES", 80, 97], ["a protocol", "TREATMENT", 11, 21], ["plastid transformation", "PROBLEM", 26, 48], ["an elite rapeseed cultivar (Brassica napus L.", "PROBLEM", 52, 97], ["rapeseed cultivar", "OBSERVATION", 61, 78]]], ["Brassica napus - [132] Citrus sinensis 155,189 [133] Coffea arabica - [134] Cucumis sativus 155,293 [135] Daucus carota 155,911 [136] Ficus sp.INTRODUCTION- [137] Glycine max 152,218 [138] Gossypium barbadense 160,317 [139] Gossypium hirsutum 160,301 [140] Helianthus annuus 151,104 [141] Hordeum vulgare, Sorghum bicolor - [142] Lycopersicon esculentum 155,460 [21] Manihot esculenta - [143] Morus indica 156,599 [144] Musa acuminata - [145] Nicotiana tabacum 155,943 [146] Oryza sativa 134,551 [15] Oryza nivara 134,494 [16] Phaseolus vulgaris 150,285 [147] Saccharum officinarum 141,182 [18] Solanum tuberosu 155,298 [148] Spinacia oleracea 150,725 [149] Triticum aestivum 134,545 [19, 20] Vitis vinifera 160,928 [150] Zea mays 22,784 [17] Jatropha curcas 163,856 [151] Vigna radiata 151,271 [22] More recently, a method for plastid transformation in eggplant (Solanum melongena L.) has been reported with pPRV111A plastid expression vector carrying the aadA gene encoding aminoglycoside 300-adenylyltransferase [26] .", [["Brassica napus - [132] Citrus sinensis 155,189 [133] Coffea arabica - [134] Cucumis sativus 155,293", "CHEMICAL", 0, 99], ["[137] Glycine max 152,218 [138] Gossypium barbadense 160,317 [139] Gossypium hirsutum 160,301 [140] Helianthus annuus 151,104 [141] Hordeum vulgare, Sorghum bicolor - [142] Lycopersicon esculentum 155,460 [21] Manihot esculenta - [143] Morus indica 156,599 [144] Musa acuminata - [145] Nicotiana tabacum 155,943 [146] Oryza sativa 134,551 [15] Oryza nivara 134,494 [16] Phaseolus vulgaris 150,285 [147] Saccharum officinarum 141,182 [18] Solanum tuberosu 155,298 [148] Spinacia oleracea 150,725 [149] Triticum aestivum 134,545 [19, 20] Vitis vinifera 160,928 [150] Zea mays 22,784 [17] Jatropha curcas", "CHEMICAL", 157, 758], ["aminoglycoside 300-adenylyltransferase", "CHEMICAL", 976, 1014], ["aminoglycoside", "CHEMICAL", 976, 990], ["Brassica napus", "ORGANISM", 0, 14], ["Hordeum vulgare", "ORGANISM", 289, 304], ["Sorghum bicolor", "ORGANISM", 306, 321], ["- [142] Lycopersicon esculentum", "ORGANISM", 322, 353], ["Nicotiana tabacum", "ORGANISM", 443, 460], ["155,943 [146] Oryza sativa", "ORGANISM", 461, 487], ["Phaseolus vulgaris", "ORGANISM", 527, 545], ["Triticum aestivum", "ORGANISM", 658, 675], ["Vitis vinifera", "ORGANISM", 693, 707], ["Zea mays", "ORGANISM", 722, 730], ["plastid", "CELLULAR_COMPONENT", 828, 835], ["eggplant", "ORGANISM", 854, 862], ["Solanum melongena L.", "ORGANISM", 864, 884], ["pPRV111A", "GENE_OR_GENE_PRODUCT", 909, 917], ["aadA", "GENE_OR_GENE_PRODUCT", 957, 961], ["aminoglycoside 300-adenylyltransferase", "SIMPLE_CHEMICAL", 976, 1014], ["pPRV111A plastid expression vector", "DNA", 909, 943], ["aadA gene", "DNA", 957, 966], ["Brassica napus", "SPECIES", 0, 14], ["Citrus sinensis", "SPECIES", 23, 38], ["Coffea arabica", "SPECIES", 53, 67], ["Cucumis sativus", "SPECIES", 76, 91], ["Daucus carota", "SPECIES", 106, 119], ["Gossypium barbadense", "SPECIES", 189, 209], ["Gossypium hirsutum", "SPECIES", 224, 242], ["Helianthus annuus", "SPECIES", 257, 274], ["Hordeum vulgare", "SPECIES", 289, 304], ["Sorghum bicolor", "SPECIES", 306, 321], ["Lycopersicon esculentum", "SPECIES", 330, 353], ["Manihot esculenta", "SPECIES", 367, 384], ["Morus indica", "SPECIES", 393, 405], ["Musa acuminata", "SPECIES", 420, 434], ["Nicotiana tabacum", "SPECIES", 443, 460], ["Oryza sativa", "SPECIES", 475, 487], ["Oryza nivara", "SPECIES", 501, 513], ["Phaseolus vulgaris", "SPECIES", 527, 545], ["Saccharum officinarum", "SPECIES", 560, 581], ["Solanum tuberosu", "SPECIES", 595, 611], ["Spinacia oleracea", "SPECIES", 626, 643], ["Triticum aestivum", "SPECIES", 658, 675], ["Vitis vinifera", "SPECIES", 693, 707], ["Zea mays", "SPECIES", 722, 730], ["Jatropha curcas", "SPECIES", 743, 758], ["Vigna radiata", "SPECIES", 773, 786], ["eggplant", "SPECIES", 854, 862], ["Solanum melongena", "SPECIES", 864, 881], ["L.", "SPECIES", 882, 884], ["Brassica napus", "SPECIES", 0, 14], ["Citrus sinensis", "SPECIES", 23, 38], ["Coffea arabica", "SPECIES", 53, 67], ["Cucumis sativus", "SPECIES", 76, 91], ["Daucus carota", "SPECIES", 106, 119], ["Gossypium barbadense", "SPECIES", 189, 209], ["Gossypium hirsutum", "SPECIES", 224, 242], ["Helianthus annuus", "SPECIES", 257, 274], ["Hordeum vulgare", "SPECIES", 289, 304], ["Sorghum bicolor", "SPECIES", 306, 321], ["Lycopersicon esculentum", "SPECIES", 330, 353], ["Manihot esculenta", "SPECIES", 367, 384], ["Morus indica", "SPECIES", 393, 405], ["Nicotiana tabacum", "SPECIES", 443, 460], ["Oryza sativa", "SPECIES", 475, 487], ["Oryza nivara", "SPECIES", 501, 513], ["Phaseolus vulgaris", "SPECIES", 527, 545], ["Saccharum officinarum", "SPECIES", 560, 581], ["Solanum tuberosu", "SPECIES", 595, 611], ["Spinacia oleracea", "SPECIES", 626, 643], ["Triticum aestivum", "SPECIES", 658, 675], ["Vitis vinifera", "SPECIES", 693, 707], ["Zea mays", "SPECIES", 722, 730], ["Jatropha curcas", "SPECIES", 743, 758], ["Vigna radiata", "SPECIES", 773, 786], ["eggplant", "SPECIES", 854, 862], ["Solanum melongena L.", "SPECIES", 864, 884], ["Brassica napus", "TEST", 0, 14], ["Citrus sinensis", "TEST", 23, 38], ["Coffea arabica", "TEST", 53, 67], ["Cucumis sativus", "TEST", 76, 91], ["Glycine max", "TEST", 163, 174], ["Gossypium barbadense", "TEST", 189, 209], ["Helianthus annuus", "TEST", 257, 274], ["Sorghum bicolor", "TEST", 306, 321], ["Lycopersicon esculentum", "TEST", 330, 353], ["Manihot esculenta", "TEST", 367, 384], ["Morus indica", "TEST", 393, 405], ["Musa acuminata", "TEST", 420, 434], ["Nicotiana tabacum", "TEST", 443, 460], ["Oryza sativa", "TEST", 475, 487], ["Oryza nivara", "TEST", 501, 513], ["Phaseolus vulgaris", "TEST", 527, 545], ["Saccharum officinarum", "TEST", 560, 581], ["Solanum tuberosu", "TEST", 595, 611], ["Spinacia oleracea", "TEST", 626, 643], ["Triticum aestivum", "TEST", 658, 675], ["Vitis vinifera", "TEST", 693, 707], ["Zea mays", "TEST", 722, 730], ["Jatropha curcas", "TEST", 743, 758], ["Vigna radiata", "TEST", 773, 786], ["plastid transformation in eggplant (Solanum melongena L.", "TREATMENT", 828, 884], ["pPRV111A plastid expression vector", "TREATMENT", 909, 943], ["the aadA gene encoding aminoglycoside", "TREATMENT", 953, 990]]], ["The authors believe that this may open up exciting possibilities to introduce and express novel genes in the engineered plants via plastid transformation for agronomic or pharmaceutical traits.", [["plastid", "CELLULAR_COMPONENT", 131, 138], ["plastid transformation", "TREATMENT", 131, 153], ["agronomic or pharmaceutical traits", "PROBLEM", 158, 192]]], ["Up to date, plastid transformation has been extended to many other higher plants, such as Arabidopsis thaliana [39] , potato [40, 41] , tomato [1, 42] , Lesquerella fendleri, a kind of oilseed Brassicaceae [43] , oilseed rape, [38, 44] , petunia [45] , lettuce [46] , soybean [47] , cotton [48] , carrot [49] , rice [50] , poplar [51] , tobacco, [28, 52, 53] , mulberry , [54] and eggplant [26] (see review written by Wang et al. [3] ).INTRODUCTIONTwo interesting applications of plastid transformation were carried out by (i) [55] for the construction of a tobacco master line to improve Rubisco engineering in plastids, and (ii), [4] who explored the possibility of engineering riboswitches (natural RNA sensors that regulate gene expression in response to ligand binding) to function as translational regulators of gene and transgene expression in plastids.INTRODUCTIONThe dominant trait that attracted the most attention for plastid transformation has been herbicide tolerance [28, 35, 56, 57] .", [["plastids", "ANATOMY", 612, 620], ["plastids", "ANATOMY", 851, 859], ["potato [40, 41] , tomato [1, 42] , Lesquerella fendleri", "CHEMICAL", 118, 173], ["[38, 44] , petunia [45] , lettuce [46] , soybean [47] , cotton [48] , carrot [49] , rice [50] , poplar [51] , tobacco, [28, 52, 53] , mulberry", "CHEMICAL", 227, 369], ["herbicide", "CHEMICAL", 961, 970], ["plastid", "CELLULAR_COMPONENT", 12, 19], ["Arabidopsis thaliana", "ORGANISM", 90, 110], ["potato", "ORGANISM", 118, 124], ["tomato", "ORGANISM", 136, 142], ["[1, 42]", "SIMPLE_CHEMICAL", 143, 150], ["Lesquerella fendleri", "ORGANISM", 153, 173], ["oilseed Brassicaceae", "ORGANISM", 185, 205], ["oilseed rape", "ORGANISM", 213, 225], ["petunia", "ORGANISM", 238, 245], ["lettuce", "ORGANISM", 253, 260], ["soybean", "ORGANISM", 268, 275], ["carrot", "ORGANISM", 297, 303], ["rice", "ORGANISM", 311, 315], ["tobacco", "ORGANISM", 337, 344], ["plastid", "CELLULAR_COMPONENT", 480, 487], ["tobacco", "ORGANISM", 558, 565], ["Rubisco", "SIMPLE_CHEMICAL", 589, 596], ["plastids", "CELLULAR_COMPONENT", 612, 620], ["plastids", "CELLULAR_COMPONENT", 851, 859], ["plastid", "CELLULAR_COMPONENT", 929, 936], ["Rubisco", "PROTEIN", 589, 596], ["translational regulators", "PROTEIN", 790, 814], ["Arabidopsis thaliana", "SPECIES", 90, 110], ["potato", "SPECIES", 118, 124], ["tomato", "SPECIES", 136, 142], ["Lesquerella fendleri", "SPECIES", 153, 173], ["oilseed", "SPECIES", 185, 192], ["oilseed", "SPECIES", 213, 220], ["lettuce", "SPECIES", 253, 260], ["soybean", "SPECIES", 268, 275], ["carrot", "SPECIES", 297, 303], ["rice", "SPECIES", 311, 315], ["tobacco", "SPECIES", 337, 344], ["Arabidopsis thaliana", "SPECIES", 90, 110], ["potato", "SPECIES", 118, 124], ["tomato", "SPECIES", 136, 142], ["Lesquerella fendleri", "SPECIES", 153, 173], ["oilseed", "SPECIES", 185, 192], ["oilseed", "SPECIES", 213, 220], ["lettuce", "SPECIES", 253, 260], ["soybean", "SPECIES", 268, 275], ["rice", "SPECIES", 311, 315], ["tobacco", "SPECIES", 337, 344], ["tobacco", "SPECIES", 558, 565], ["plastid transformation", "PROBLEM", 12, 34], ["plastid transformation", "TREATMENT", 480, 502], ["engineering riboswitches (natural RNA sensors", "TREATMENT", 668, 713], ["The dominant trait", "PROBLEM", 872, 890], ["plastid transformation", "PROBLEM", 929, 951], ["plastid transformation", "OBSERVATION", 480, 502], ["dominant", "OBSERVATION_MODIFIER", 876, 884], ["trait", "OBSERVATION", 885, 890]]], ["Roudsari et al. [28] revealed the production of high level glyphosate tolerant plants (N. tabacum) through biolistic transformation of plastids by introduction of a mutated herbicide-tolerant gene coding for EPSP synthase.", [["plastids", "ANATOMY", 135, 143], ["glyphosate", "CHEMICAL", 59, 69], ["herbicide", "CHEMICAL", 173, 182], ["glyphosate", "CHEMICAL", 59, 69], ["N. tabacum", "ORGANISM", 87, 97], ["plastids", "CELLULAR_COMPONENT", 135, 143], ["EPSP synthase", "GENE_OR_GENE_PRODUCT", 208, 221], ["EPSP synthase", "PROTEIN", 208, 221], ["N. tabacum", "SPECIES", 87, 97], ["N. tabacum", "SPECIES", 87, 97], ["high level glyphosate tolerant plants", "PROBLEM", 48, 85], ["biolistic transformation of plastids", "TREATMENT", 107, 143], ["a mutated herbicide", "TREATMENT", 163, 182], ["EPSP synthase", "TREATMENT", 208, 221]]], ["Plastid transformation is routine, however, only in tobacco and the efficiency of transformation is much higher in tobacco than in other plants [58] .", [["tobacco", "ORGANISM", 52, 59], ["tobacco", "ORGANISM", 115, 122], ["tobacco", "SPECIES", 52, 59], ["tobacco", "SPECIES", 52, 59], ["tobacco", "SPECIES", 115, 122], ["Plastid transformation", "PROBLEM", 0, 22], ["transformation", "OBSERVATION", 8, 22]]], ["Lee et al. [50] discussed the major obstacles to the extension of plastid transformation technology to other crop plants which includes regeneration via somatic embryogenesis.ADVANTAGES OF PLASTID ENGINEERINGProduction of transgenic plants, at laboratory level or commercially, has traditionally been mainly through expression of transgenes in the nucleus [24, 25] .", [["nucleus", "ANATOMY", 348, 355], ["transgenic plants", "ORGANISM", 222, 239], ["nucleus", "CELLULAR_COMPONENT", 348, 355], ["plastid transformation technology", "TREATMENT", 66, 99], ["regeneration via somatic embryogenesis", "PROBLEM", 136, 174], ["transgenic plants", "TREATMENT", 222, 239], ["plastid transformation", "OBSERVATION", 66, 88], ["somatic embryogenesis", "OBSERVATION", 153, 174], ["PLASTID ENGINEERINGProduction", "OBSERVATION", 189, 218], ["transgenic plants", "OBSERVATION", 222, 239], ["nucleus", "ANATOMY", 348, 355]]], ["Among the ecological concerns raised about genetically engineered organisms is that transgenes could move (\"transgene flow\", the process of transgene movement by recurrent hybridisation) via pollen from the crop and into relatives growing in natural or semi-natural communities [59] .", [["genetically engineered organisms", "PROBLEM", 43, 75], ["recurrent hybridisation)", "PROBLEM", 162, 186]]], ["Such concerns have led to a new field of transgene containment [60, 61] .ADVANTAGES OF PLASTID ENGINEERINGSince plastids are inherited maternally in the majority of angiosperm species, they would therefore not be found in pollen grains of corps.", [["pollen grains", "ANATOMY", 222, 235], ["PLASTID ENGINEERINGSince plastids", "TREATMENT", 87, 120], ["angiosperm species", "PROBLEM", 165, 183], ["PLASTID ENGINEERINGSince", "OBSERVATION", 87, 111], ["angiosperm species", "OBSERVATION", 165, 183]]], ["Insertion of transgenes, therefore, into the plastid genome has the potential of preventing gene flow via pollen.", [["pollen", "ANATOMY", 106, 112], ["plastid", "CELLULAR_COMPONENT", 45, 52], ["transgenes", "DNA", 13, 23], ["plastid genome", "DNA", 45, 59], ["Insertion of transgenes", "TREATMENT", 0, 23], ["gene flow", "TREATMENT", 92, 101], ["transgenes", "OBSERVATION", 13, 23], ["plastid genome", "OBSERVATION", 45, 59], ["gene flow", "OBSERVATION", 92, 101]]], ["Hence, genes expressed in the plastome will not be transferred through pollination to weedy or wild relatives of the transgenic crop.", [["plastome", "ANATOMY", 30, 38], ["plastome", "CANCER", 30, 38]]], ["Bansal and Sharma, [62] believes that there is little risk of any transgene flow via pollen from transplastomic plants to the neighboring weedy or wild relatives since plastids are almost always maternally transferred to the next progeny.", [["plastids", "ANATOMY", 168, 176], ["plastids", "CELLULAR_COMPONENT", 168, 176]]], ["The authors suggested that plastid transformation could be a method of choice for generating improved transgenics in crops that grow along with their weedy or wild relatives in the same geographical region, such as rice, sorghum, cucurbits, solanaceous crops, Vigna and Cajanus species, and various Brassica crops.", [["plastid", "ANATOMY", 27, 34], ["plastid", "CELLULAR_COMPONENT", 27, 34], ["sorghum", "ORGANISM_SUBDIVISION", 221, 228], ["Vigna", "ORGANISM", 260, 265], ["Cajanus species", "ORGANISM", 270, 285], ["rice", "SPECIES", 215, 219], ["sorghum", "SPECIES", 221, 228], ["rice", "SPECIES", 215, 219], ["sorghum", "SPECIES", 221, 228], ["plastid transformation", "PROBLEM", 27, 49], ["rice, sorghum, cucurbits", "PROBLEM", 215, 239], ["solanaceous crops", "PROBLEM", 241, 258], ["Vigna and Cajanus species", "PROBLEM", 260, 285], ["plastid transformation", "OBSERVATION", 27, 49], ["solanaceous crops", "OBSERVATION", 241, 258], ["Cajanus species", "OBSERVATION", 270, 285]]], ["Therefore, the focus of many researchers has shifted to plastid engineering [26] , rather than nuclear transformation.", [["nuclear", "ANATOMY", 95, 102], ["plastid", "CELLULAR_COMPONENT", 56, 63], ["nuclear", "CELLULAR_COMPONENT", 95, 102], ["transformation", "OBSERVATION", 103, 117]]], ["Singh et al. 2010 [26] reported that engineering of the plastid genome is gaining momentum as an attractive alternative to nuclear transformation.ADVANTAGES OF PLASTID ENGINEERINGRuf et al. [60] believe that plastid transformation is considered as a superb tool for ensuring transgene containment and improving the biosafety of transgenic plants.", [["nuclear", "ANATOMY", 123, 130], ["plastid", "ANATOMY", 208, 215], ["plastid", "CELLULAR_COMPONENT", 56, 63], ["nuclear", "CELLULAR_COMPONENT", 123, 130], ["plastid", "CELLULAR_COMPONENT", 208, 215], ["plastid genome", "DNA", 56, 70], ["plastid transformation", "PROBLEM", 208, 230], ["transgene containment", "TREATMENT", 275, 296], ["plastid genome", "OBSERVATION", 56, 70], ["plastid transformation", "OBSERVATION", 208, 230]]], ["However, they pointed out that plastid transformation would only be effective as a biocontainment measure when applied on a landscape scale if it were combined additional mechanisms such as mitigating genes genetic use restriction technology, and/or male sterility [63] .", [["plastid", "CELLULAR_COMPONENT", 31, 38], ["plastid transformation", "PROBLEM", 31, 53], ["a biocontainment measure", "TREATMENT", 81, 105], ["a landscape scale", "TREATMENT", 122, 139], ["plastid transformation", "OBSERVATION", 31, 53]]], ["In a recent study, it has been demonstrated that the use of plastid transformation would provide an imperfect biocontainment for GM oilseed rape (Brassica napus L.) in the United Kingdom [64] .", [["GM", "CHEMICAL", 129, 131], ["plastid", "CELLULAR_COMPONENT", 60, 67], ["Brassica napus L.", "ORGANISM", 146, 163], ["oilseed", "SPECIES", 132, 139], ["Brassica napus", "SPECIES", 146, 160], ["L.", "SPECIES", 161, 163], ["oilseed", "SPECIES", 132, 139], ["Brassica napus L.", "SPECIES", 146, 163], ["a recent study", "TEST", 3, 17], ["plastid transformation", "TREATMENT", 60, 82]]], ["In another study, Allainguillaume et al. [65] revealed that chloroplast transformation may slow transgene recruitment in two settings, but actually accelerate transgene spread in a third.", [["chloroplast", "ANATOMY", 60, 71], ["chloroplast", "CELLULAR_COMPONENT", 60, 71], ["another study", "TEST", 3, 16], ["chloroplast transformation", "PROBLEM", 60, 86], ["slow transgene recruitment", "PROBLEM", 91, 117], ["chloroplast transformation", "OBSERVATION", 60, 86], ["may", "UNCERTAINTY", 87, 90], ["slow", "OBSERVATION_MODIFIER", 91, 95], ["transgene recruitment", "OBSERVATION", 96, 117], ["transgene spread", "OBSERVATION", 159, 175]]], ["Plastid transformation has become an attractive alternative to nuclear gene transformation due to several other advantages [3] .", [["nuclear", "ANATOMY", 63, 70], ["nuclear", "CELLULAR_COMPONENT", 63, 70], ["Plastid transformation", "PROBLEM", 0, 22], ["nuclear gene transformation", "PROBLEM", 63, 90]]], ["The high ploidy number of the plastid genome allows high levels (up to 1-40% of total protein) of protein expression or expression of the transgene [28] .", [["plastid genome", "ANATOMY", 30, 44], ["plastid", "CELLULAR_COMPONENT", 30, 37], ["plastid genome", "DNA", 30, 44], ["protein expression", "PROBLEM", 98, 116], ["high", "OBSERVATION_MODIFIER", 4, 8], ["ploidy", "OBSERVATION_MODIFIER", 9, 15], ["number", "OBSERVATION_MODIFIER", 16, 22], ["plastid genome", "OBSERVATION", 30, 44]]], ["Daniell et al. [66] and Hou et al. [44] reported that while nuclear transgenes typically result in 0.5 -3% of total proteins, concentration of proteins expressed by plastid transgenes is much higher; up to 18%.", [["nuclear", "ANATOMY", 60, 67], ["nuclear", "CELLULAR_COMPONENT", 60, 67], ["plastid", "CELLULAR_COMPONENT", 165, 172], ["plastid transgenes", "DNA", 165, 183], ["total proteins", "TEST", 110, 124], ["concentration of proteins", "PROBLEM", 126, 151], ["plastid transgenes", "TEST", 165, 183], ["plastid transgenes", "OBSERVATION", 165, 183], ["higher", "OBSERVATION_MODIFIER", 192, 198]]], ["The greater production of the expressed protein is possible because plastid transgenes are present as multiple copies per plant cell, and they are little affected by phenomena like pre-or post-transcriptional silencing.", [["cell", "ANATOMY", 128, 132], ["plastid", "CELLULAR_COMPONENT", 68, 75], ["cell", "CELL", 128, 132], ["plastid transgenes", "DNA", 68, 86], ["plastid transgenes", "PROBLEM", 68, 86], ["greater", "OBSERVATION_MODIFIER", 4, 11], ["production", "OBSERVATION_MODIFIER", 12, 22], ["plant cell", "OBSERVATION", 122, 132], ["post-transcriptional silencing", "OBSERVATION", 188, 218]]], ["Other advantages of plastid engineering are the capacity to express multiple genes from polycistronic messenger RNA (mRNA) [31] , and the absence of epigenetic effects and gene silencing [40] .ADVANTAGES OF PLASTID ENGINEERINGWang et al. [3] believe that transgene stacking in operons and a lack of epigenetic interference allowing stable transgene expression.", [["plastid", "CELLULAR_COMPONENT", 20, 27], ["polycistronic messenger RNA", "RNA", 88, 115], ["mRNA", "RNA", 117, 121], ["operons", "DNA", 277, 284], ["plastid engineering", "TREATMENT", 20, 39], ["the capacity", "PROBLEM", 44, 56], ["multiple genes from polycistronic messenger RNA", "PROBLEM", 68, 115], ["epigenetic effects and gene silencing", "PROBLEM", 149, 186], ["transgene stacking in operons", "TREATMENT", 255, 284], ["epigenetic interference", "PROBLEM", 299, 322], ["plastid engineering", "OBSERVATION", 20, 39], ["messenger RNA", "OBSERVATION", 102, 115]]], ["Added to that, plastid transformation is more environmental friendly than transformation of the nuclear DNA for plant engineering because it eliminates the possibility of toxic transgenic pollen to nontarget insects [67] .", [["nuclear", "ANATOMY", 96, 103], ["pollen", "ANATOMY", 188, 194], ["plastid", "CELLULAR_COMPONENT", 15, 22], ["nuclear", "CELLULAR_COMPONENT", 96, 103], ["DNA", "CELLULAR_COMPONENT", 104, 107], ["pollen", "DEVELOPING_ANATOMICAL_STRUCTURE", 188, 194], ["nuclear DNA", "DNA", 96, 107], ["plastid transformation", "PROBLEM", 15, 37], ["plant engineering", "TREATMENT", 112, 129], ["toxic transgenic pollen", "PROBLEM", 171, 194], ["plastid transformation", "OBSERVATION", 15, 37]]], ["Adverse effects of toxic proteins might be minimized by plastid compartmentalization but in case of nuclear transformation, toxic proteins accumulating within the cytosol might result in serious pleiotropic effects.", [["nuclear", "ANATOMY", 100, 107], ["cytosol", "ANATOMY", 163, 170], ["plastid", "CELLULAR_COMPONENT", 56, 63], ["nuclear", "CELLULAR_COMPONENT", 100, 107], ["cytosol", "CELLULAR_COMPONENT", 163, 170], ["toxic proteins", "PROTEIN", 19, 33], ["toxic proteins", "PROTEIN", 124, 138], ["toxic proteins", "PROBLEM", 19, 33], ["nuclear transformation", "PROBLEM", 100, 122], ["toxic proteins", "PROBLEM", 124, 138], ["serious pleiotropic effects", "PROBLEM", 187, 214], ["toxic proteins", "OBSERVATION", 19, 33], ["nuclear transformation", "OBSERVATION", 100, 122], ["serious", "OBSERVATION_MODIFIER", 187, 194]]], ["Further, the expression of the transgene in case of plastid transformation is more uniform compared to that of trangenes inserted into the nuclear genome.", [["plastid", "ANATOMY", 52, 59], ["nuclear genome", "ANATOMY", 139, 153], ["plastid", "CELLULAR_COMPONENT", 52, 59], ["trangenes", "GENE_OR_GENE_PRODUCT", 111, 120], ["nuclear", "CELLULAR_COMPONENT", 139, 146], ["trangenes", "DNA", 111, 120], ["nuclear genome", "DNA", 139, 153], ["plastid transformation", "PROBLEM", 52, 74], ["plastid transformation", "OBSERVATION", 52, 74], ["more uniform", "OBSERVATION_MODIFIER", 78, 90], ["nuclear genome", "ANATOMY", 139, 153]]], ["Although there is a major drawback in the engineering of plastid gene expression, which is the lack of tissue-specific developmentally regulated control mechanisms [3] , the many advantages of plastid engineering stated above attracted researchers to engineer the plastid genome to confer several useful agronomic traits, and hence the number of species whose plastome can be transformed continues to expand [68] .GENE DELIVERY INTO PLASTIDSGene delivery into the plastome was initially done by Agrobacterium mediated method [Block et al.1985 ] [69] .", [["tissue", "ANATOMY", 103, 109], ["plastid", "CELLULAR_COMPONENT", 57, 64], ["tissue", "TISSUE", 103, 109], ["plastid", "CELLULAR_COMPONENT", 193, 200], ["plastid", "CELLULAR_COMPONENT", 264, 271], ["plastome", "CANCER", 464, 472], ["plastid genome", "DNA", 264, 278], ["plastid gene expression", "TREATMENT", 57, 80], ["plastid engineering", "TREATMENT", 193, 212], ["GENE DELIVERY INTO PLASTIDSGene delivery", "TREATMENT", 414, 454], ["the plastome", "TREATMENT", 460, 472], ["plastid gene expression", "OBSERVATION", 57, 80]]], ["The discovery of biolistic DNA delivery led to plastid trans-formation via particle gun [Sanford 1990 ] [70] .", [["DNA", "CELLULAR_COMPONENT", 27, 30], ["biolistic DNA delivery", "TREATMENT", 17, 39], ["biolistic DNA", "OBSERVATION", 17, 30]]], ["In this method, the Escherichia coli plasmids contain a marker gene and the gene of interest is introduced into plastids.", [["plasmids", "ANATOMY", 37, 45], ["plastids", "ANATOMY", 112, 120], ["Escherichia coli", "ORGANISM", 20, 36], ["plastids", "CELLULAR_COMPONENT", 112, 120], ["Escherichia coli plasmids", "DNA", 20, 45], ["marker gene", "DNA", 56, 67], ["Escherichia coli", "SPECIES", 20, 36], ["Escherichia coli", "SPECIES", 20, 36], ["this method", "TREATMENT", 3, 14], ["the Escherichia coli plasmids", "TREATMENT", 16, 45], ["a marker gene", "TREATMENT", 54, 67], ["Escherichia coli plasmids", "OBSERVATION", 20, 45]]], ["The foreign genes are inserted into plasmid DNA by homologous recombination via the flanking sequences at the insertion site [66] .", [["plasmid", "CELLULAR_COMPONENT", 36, 43], ["DNA", "CELLULAR_COMPONENT", 44, 47], ["foreign genes", "DNA", 4, 17], ["plasmid DNA", "DNA", 36, 47], ["flanking sequences", "DNA", 84, 102], ["insertion site", "DNA", 110, 124], ["The foreign genes", "TREATMENT", 0, 17], ["plasmid DNA", "TREATMENT", 36, 47], ["foreign genes", "OBSERVATION", 4, 17]]], ["Polyethylene glycol (PEG) mediated transformation of plastids was also utilized [71, 72] .", [["plastids", "ANATOMY", 53, 61], ["Polyethylene glycol", "CHEMICAL", 0, 19], ["PEG", "CHEMICAL", 21, 24], ["Polyethylene glycol", "CHEMICAL", 0, 19], ["PEG", "CHEMICAL", 21, 24], ["Polyethylene glycol", "SIMPLE_CHEMICAL", 0, 19], ["PEG", "SIMPLE_CHEMICAL", 21, 24], ["plastids", "CELLULAR_COMPONENT", 53, 61], ["Polyethylene glycol (PEG) mediated transformation of plastids", "TREATMENT", 0, 61]]], ["PEG-mediated transformation of plastids requires enzymatically removing the cell wall to obtain protoplasts, then exposing the protoplasts to purified DNA in the presence of PEG.", [["plastids", "ANATOMY", 31, 39], ["cell wall", "ANATOMY", 76, 85], ["protoplasts", "ANATOMY", 96, 107], ["protoplasts", "ANATOMY", 127, 138], ["PEG", "CHEMICAL", 0, 3], ["PEG", "CHEMICAL", 174, 177], ["PEG", "CHEMICAL", 0, 3], ["PEG", "CHEMICAL", 174, 177], ["PEG", "SIMPLE_CHEMICAL", 0, 3], ["plastids", "CELLULAR_COMPONENT", 31, 39], ["cell wall", "CELLULAR_COMPONENT", 76, 85], ["protoplasts", "CELL", 96, 107], ["DNA", "CELLULAR_COMPONENT", 151, 154], ["PEG", "SIMPLE_CHEMICAL", 174, 177], ["PEG-mediated transformation of plastids", "TREATMENT", 0, 39], ["the cell wall", "TREATMENT", 72, 85], ["protoplasts", "TREATMENT", 96, 107], ["the protoplasts", "TREATMENT", 123, 138], ["PEG", "TREATMENT", 174, 177], ["plastids", "OBSERVATION", 31, 39], ["cell wall", "OBSERVATION", 76, 85], ["DNA", "OBSERVATION", 151, 154], ["PEG", "OBSERVATION", 174, 177]]], ["The protoplasts first shrink in the presence of PEG, then lyse due to disintegration of the cell membrane.", [["protoplasts", "ANATOMY", 4, 15], ["cell membrane", "ANATOMY", 92, 105], ["PEG", "CHEMICAL", 48, 51], ["PEG", "CHEMICAL", 48, 51], ["protoplasts", "CELL", 4, 15], ["PEG", "SIMPLE_CHEMICAL", 48, 51], ["cell membrane", "CELLULAR_COMPONENT", 92, 105], ["The protoplasts", "TREATMENT", 0, 15], ["PEG", "TREATMENT", 48, 51], ["disintegration of the cell membrane", "PROBLEM", 70, 105], ["shrink", "OBSERVATION_MODIFIER", 22, 28], ["PEG", "OBSERVATION", 48, 51], ["cell membrane", "OBSERVATION", 92, 105]]], ["Removing PEG before the membrane is irreversibly damaged reverses the process.", [["membrane", "ANATOMY", 24, 32], ["PEG", "CHEMICAL", 9, 12], ["PEG", "CHEMICAL", 9, 12], ["PEG", "SIMPLE_CHEMICAL", 9, 12], ["membrane", "CELLULAR_COMPONENT", 24, 32], ["PEG", "TREATMENT", 9, 12], ["the membrane", "TREATMENT", 20, 32], ["PEG", "OBSERVATION", 9, 12], ["irreversibly", "OBSERVATION_MODIFIER", 36, 48], ["damaged", "OBSERVATION", 49, 56]]], ["Biolistic delivery is the routine system for most laboratories, as manipulation of leaves, cotyledons, or cultured cells in tissue culture is a simple practice than the alternative PEG treatment of protoplasts [58] .", [["leaves", "ANATOMY", 83, 89], ["cotyledons", "ANATOMY", 91, 101], ["cells", "ANATOMY", 115, 120], ["tissue culture", "ANATOMY", 124, 138], ["protoplasts", "ANATOMY", 198, 209], ["PEG", "CHEMICAL", 181, 184], ["PEG", "CHEMICAL", 181, 184], ["leaves", "ORGANISM_SUBDIVISION", 83, 89], ["cotyledons", "DEVELOPING_ANATOMICAL_STRUCTURE", 91, 101], ["cells", "CELL", 115, 120], ["tissue", "TISSUE", 124, 130], ["PEG", "SIMPLE_CHEMICAL", 181, 184], ["cultured cells", "CELL_LINE", 106, 120], ["Biolistic delivery", "TREATMENT", 0, 18], ["most laboratories", "TEST", 45, 62], ["cotyledons", "TREATMENT", 91, 101], ["cultured cells", "PROBLEM", 106, 120], ["tissue culture", "TEST", 124, 138], ["the alternative PEG treatment of protoplasts", "TREATMENT", 165, 209]]], ["Recently, particle gun mediated plastid transformation has been demonstrated in rapeseed using cotyledons as explants [38] .GENE DELIVERY INTO PLASTIDSThe major difficulty in engineering plastid genome for production of transplastomic plants is in generating homoplasmic plants in which all the plastids are uniformly transformed, for that takes a long process of selection, thus hampering the production of genetically stable transplastomic plants (e.g. rice).", [["cotyledons", "ANATOMY", 95, 105], ["explants", "ANATOMY", 109, 117], ["plastids", "ANATOMY", 295, 303], ["plastid", "CELLULAR_COMPONENT", 32, 39], ["cotyledons", "ORGANISM_SUBDIVISION", 95, 105], ["plastid", "CELLULAR_COMPONENT", 187, 194], ["plastids", "CELLULAR_COMPONENT", 295, 303], ["rice", "ORGANISM_SUBDIVISION", 455, 459], ["plastid genome", "DNA", 187, 201], ["rice", "SPECIES", 455, 459], ["rapeseed", "SPECIES", 80, 88], ["rice", "SPECIES", 455, 459], ["particle gun mediated plastid transformation", "PROBLEM", 10, 54], ["transplastomic plants", "TREATMENT", 220, 241], ["plastid transformation", "OBSERVATION", 32, 54], ["plastid genome", "OBSERVATION", 187, 201], ["transplastomic plants", "OBSERVATION", 220, 241], ["homoplasmic plants", "OBSERVATION", 259, 277], ["stable", "OBSERVATION_MODIFIER", 420, 426]]], ["This is due to the presence of about 10-100 plastids, each of which has up to 100 copies of the plastid genome, in one cell, that does not allow achieving homoplastomic state [73] .", [["cell", "ANATOMY", 119, 123], ["plastid", "CELLULAR_COMPONENT", 96, 103], ["genome", "CELLULAR_COMPONENT", 104, 110], ["cell", "CELL", 119, 123], ["plastid genome", "DNA", 96, 110], ["plastid genome", "OBSERVATION", 96, 110], ["one cell", "OBSERVATION_MODIFIER", 115, 123]]], ["In 2005, however, Nguyen et al. [41] described the generation of homoplasmic plastid transformants of a commercial cultivar of potato (Solanum tuberosum L.) using two tobacco specific plastid transformation vectors, pZS197 (Prrn/aadA/psbA3 ) and pMSK18 (trc/gfp/Prrn/aadA/psbA3 ).", [["transformants", "ANATOMY", 85, 98], ["plastid transformants", "CELL", 77, 98], ["potato", "ORGANISM", 127, 133], ["Solanum tuberosum L.", "ORGANISM", 135, 155], ["tobacco", "ORGANISM", 167, 174], ["pZS197", "GENE_OR_GENE_PRODUCT", 216, 222], ["Prrn", "GENE_OR_GENE_PRODUCT", 224, 228], ["aadA", "GENE_OR_GENE_PRODUCT", 229, 233], ["psbA3", "GENE_OR_GENE_PRODUCT", 234, 239], ["pMSK18", "GENE_OR_GENE_PRODUCT", 246, 252], ["trc", "GENE_OR_GENE_PRODUCT", 254, 257], ["gfp", "GENE_OR_GENE_PRODUCT", 258, 261], ["Prrn", "GENE_OR_GENE_PRODUCT", 262, 266], ["aadA", "GENE_OR_GENE_PRODUCT", 267, 271], ["psbA3", "GENE_OR_GENE_PRODUCT", 272, 277], ["plastid transformation vectors", "DNA", 184, 214], ["pZS197", "DNA", 216, 222], ["Prrn", "DNA", 224, 228], ["aadA", "DNA", 229, 233], ["psbA3", "DNA", 234, 239], ["pMSK18", "DNA", 246, 252], ["trc", "DNA", 254, 257], ["gfp", "DNA", 258, 261], ["Prrn", "DNA", 262, 266], ["aadA", "DNA", 267, 271], ["psbA3", "DNA", 272, 277], ["potato", "SPECIES", 127, 133], ["Solanum tuberosum", "SPECIES", 135, 152], ["L.", "SPECIES", 153, 155], ["potato", "SPECIES", 127, 133], ["Solanum tuberosum L.", "SPECIES", 135, 155], ["tobacco", "SPECIES", 167, 174], ["homoplasmic plastid transformants", "TREATMENT", 65, 98], ["a commercial cultivar of potato (Solanum tuberosum L.", "TREATMENT", 102, 155], ["plastid transformation vectors", "TREATMENT", 184, 214], ["pMSK18", "TREATMENT", 246, 252], ["plastid transformation", "OBSERVATION", 184, 206]]], ["Similarly, Liu et al. [74] were able to develop homoplasmic fertile plants of Brassica oleracea L. var. capitata L. (cabbage).", [["Brassica oleracea L. var.", "CHEMICAL", 78, 103], ["Brassica oleracea", "ORGANISM", 78, 95], ["L.", "ORGANISM", 96, 98], ["var.", "ORGANISM", 99, 103], ["capitata L.", "ORGANISM", 104, 115], ["cabbage", "ORGANISM_SUBDIVISION", 117, 124], ["Brassica oleracea", "SPECIES", 78, 95], ["L. var.", "SPECIES", 96, 103], ["capitata L.", "SPECIES", 104, 115], ["cabbage", "SPECIES", 117, 124], ["Brassica oleracea L. var.", "SPECIES", 78, 103], ["capitata", "SPECIES", 104, 112], ["cabbage", "SPECIES", 117, 124], ["homoplasmic fertile plants", "PROBLEM", 48, 74]]], ["Among other higher plants of which fertile homoplasmic plants with genetically modified plastid genomes have be been produced are Nicotiana tabacum (tobacco), Nicotiana plumbaginifolia (texmex tobacco), Solanum lycopersicum (tomato), Glycine max (soybean), Lesquerella fendleri (bladderpod), Gossypium hirsutum (cotton), Petunia hybrida (petunia), and Lactuca sativa (lettuce) [68] .", [["Nicotiana tabacum", "ORGANISM", 130, 147], ["tobacco", "ORGANISM", 149, 156], ["Nicotiana plumbaginifolia", "ORGANISM", 159, 184], ["texmex tobacco", "ORGANISM", 186, 200], ["Solanum lycopersicum", "ORGANISM", 203, 223], ["tomato)", "ORGANISM", 225, 232], ["Glycine max", "ORGANISM", 234, 245], ["soybean)", "ORGANISM", 247, 255], ["Lesquerella fendleri", "ORGANISM", 257, 277], ["bladderpod)", "ORGANISM", 279, 290], ["Gossypium hirsutum", "ORGANISM", 292, 310], ["cotton)", "ORGANISM", 312, 319], ["Petunia hybrida", "ORGANISM", 321, 336], ["petunia)", "ORGANISM", 338, 346], ["Lactuca sativa", "ORGANISM", 352, 366], ["lettuce", "ORGANISM_SUBDIVISION", 368, 375], ["genetically modified plastid genomes", "DNA", 67, 103], ["Nicotiana tabacum", "SPECIES", 130, 147], ["tobacco", "SPECIES", 149, 156], ["Nicotiana plumbaginifolia", "SPECIES", 159, 184], ["tobacco", "SPECIES", 193, 200], ["Solanum lycopersicum", "SPECIES", 203, 223], ["tomato", "SPECIES", 225, 231], ["Glycine max", "SPECIES", 234, 245], ["soybean", "SPECIES", 247, 254], ["Lesquerella fendleri", "SPECIES", 257, 277], ["bladderpod", "SPECIES", 279, 289], ["Gossypium hirsutum", "SPECIES", 292, 310], ["cotton", "SPECIES", 312, 318], ["Petunia hybrida", "SPECIES", 321, 336], ["petunia", "SPECIES", 338, 345], ["Lactuca sativa", "SPECIES", 352, 366], ["Nicotiana tabacum", "SPECIES", 130, 147], ["tobacco", "SPECIES", 149, 156], ["Nicotiana plumbaginifolia", "SPECIES", 159, 184], ["tobacco", "SPECIES", 193, 200], ["Solanum lycopersicum", "SPECIES", 203, 223], ["tomato", "SPECIES", 225, 231], ["Glycine max", "SPECIES", 234, 245], ["soybean", "SPECIES", 247, 254], ["Lesquerella fendleri", "SPECIES", 257, 277], ["Gossypium hirsutum", "SPECIES", 292, 310], ["cotton", "SPECIES", 312, 318], ["Petunia hybrida", "SPECIES", 321, 336], ["Lactuca sativa", "SPECIES", 352, 366], ["fertile homoplasmic plants", "PROBLEM", 35, 61], ["genetically modified plastid genomes", "TREATMENT", 67, 103], ["Nicotiana plumbaginifolia (texmex tobacco", "TREATMENT", 159, 200], ["Solanum lycopersicum (tomato)", "TREATMENT", 203, 232], ["Glycine max (soybean)", "TREATMENT", 234, 255], ["Lesquerella fendleri (bladderpod)", "TREATMENT", 257, 290], ["Gossypium hirsutum (cotton)", "TREATMENT", 292, 319], ["Petunia hybrida (petunia", "PROBLEM", 321, 345], ["Nicotiana tabacum", "OBSERVATION", 130, 147], ["Petunia hybrida", "OBSERVATION", 321, 336]]], ["The amino glycoside 3adenylyltransferase (aadA) gene, which confers dual resistance to spectinomycin-streptomycin antibiotics, is still the selectable marker that is routinely used efficiently for plastid transformation [58, 75, 76] .", [["amino glycoside", "CHEMICAL", 4, 19], ["spectinomycin", "CHEMICAL", 87, 100], ["streptomycin", "CHEMICAL", 101, 113], ["amino glycoside", "CHEMICAL", 4, 19], ["spectinomycin", "CHEMICAL", 87, 100], ["streptomycin", "CHEMICAL", 101, 113], ["amino glycoside 3adenylyltransferase", "GENE_OR_GENE_PRODUCT", 4, 40], ["aadA", "GENE_OR_GENE_PRODUCT", 42, 46], ["spectinomycin-streptomycin antibiotics", "SIMPLE_CHEMICAL", 87, 125], ["plastid", "CELLULAR_COMPONENT", 197, 204], ["amino glycoside 3adenylyltransferase (aadA) gene", "DNA", 4, 52], ["The amino glycoside 3adenylyltransferase (aadA) gene", "TREATMENT", 0, 52], ["spectinomycin", "TREATMENT", 87, 100], ["streptomycin antibiotics", "TREATMENT", 101, 125], ["plastid transformation", "PROBLEM", 197, 219]]], ["Since the antibiotic resistant genes used in transformation are not desirable in the final products, different strategies have been developed to eliminate the necessity of using such selectable markers [56, 77] .IMPROVEMENT OF SOME AGRONOMIC TRAITS BY PLASTID ENGINEERINGApel & Bock, [42] demonstrated the potential of plastids genome engineering for the nutritional enhancement of food crops when they enhanced carotenoid biosynthesis in transplastomic tomatoes by induced lycopene-to-provitamin A conversion.", [["tomatoes", "ANATOMY", 454, 462], ["carotenoid", "CHEMICAL", 412, 422], ["lycopene", "CHEMICAL", 474, 482], ["provitamin A", "CHEMICAL", 486, 498], ["lycopene", "CHEMICAL", 474, 482], ["provitamin A", "CHEMICAL", 486, 498], ["carotenoid", "SIMPLE_CHEMICAL", 412, 422], ["tomatoes", "ORGANISM_SUBDIVISION", 454, 462], ["lycopene", "SIMPLE_CHEMICAL", 474, 482], ["provitamin A", "SIMPLE_CHEMICAL", 486, 498], ["antibiotic resistant genes", "DNA", 10, 36], ["tomatoes", "SPECIES", 454, 462], ["the antibiotic resistant genes", "TREATMENT", 6, 36], ["such selectable markers", "TEST", 178, 201], ["plastids genome engineering", "TREATMENT", 319, 346], ["transplastomic tomatoes", "TREATMENT", 439, 462], ["provitamin A conversion", "TREATMENT", 486, 509], ["SOME", "OBSERVATION_MODIFIER", 227, 231], ["AGRONOMIC TRAITS", "OBSERVATION", 232, 248], ["plastids genome", "OBSERVATION", 319, 334]]], ["The transplastomic technology could also be useful for engineering agronomic traits including phytoremediation [78] reversible male sterility [79] , and toler-ance/resistance of stresses such as diseases, drought, insect pests, salinity and freezing that can severely limit plant growth and development [3] .IMPROVEMENT OF SOME AGRONOMIC TRAITS BY PLASTID ENGINEERINGSince plastids are transferred mostly through the \"maternal inheritance\" as identical copies, and hence a female plant transfers identical copies to all the seeds it produces without changes from one generation to the next, an important promise for applying plastid transformation for industry is the stable passing on to the next generation of the foreign DNA [80] .", [["plastid", "CELLULAR_COMPONENT", 625, 632], ["DNA", "CELLULAR_COMPONENT", 724, 727], ["The transplastomic technology", "TREATMENT", 0, 29], ["reversible male sterility", "PROBLEM", 116, 141], ["diseases", "PROBLEM", 195, 203], ["SOME AGRONOMIC TRAITS", "PROBLEM", 323, 344], ["applying plastid transformation", "TREATMENT", 616, 647], ["the foreign DNA", "PROBLEM", 712, 727], ["SOME", "OBSERVATION_MODIFIER", 323, 327], ["AGRONOMIC TRAITS", "OBSERVATION", 328, 344], ["PLASTID ENGINEERINGSince plastids", "OBSERVATION", 348, 381], ["stable", "OBSERVATION_MODIFIER", 668, 674]]], ["Therefore, the plastid genome has also been utilized for metabolic pathway engineering and in the field of molecular farming (the production of drugs and chemicals through engineered crops) [27, 68] for the expression and production of biomaterials and biopharmaceuticals in plants, human therapeutic proteins, and vaccines for use in humans or animals (reviewed in [26, 27, 50] .", [["plastid", "CELLULAR_COMPONENT", 15, 22], ["human", "ORGANISM", 283, 288], ["humans", "ORGANISM", 335, 341], ["plastid genome", "DNA", 15, 29], ["human therapeutic proteins", "PROTEIN", 283, 309], ["human", "SPECIES", 283, 288], ["humans", "SPECIES", 335, 341], ["human", "SPECIES", 283, 288], ["humans", "SPECIES", 335, 341], ["the plastid genome", "TREATMENT", 11, 29], ["metabolic pathway engineering", "TREATMENT", 57, 86], ["drugs", "TREATMENT", 144, 149], ["biomaterials and biopharmaceuticals", "TREATMENT", 236, 271], ["human therapeutic proteins", "TREATMENT", 283, 309], ["vaccines", "TREATMENT", 315, 323], ["plastid genome", "OBSERVATION", 15, 29]]], ["Singh et al. [26] believe that for such applications, plastid transformation technology offers solutions to the ecological and technical problems associated with conventional transgenic technologies such as outcrossing and transgene silencing.Insect ResistanceTransformation of the nuclear genome of plants with genes (e.g. Bt genes) to confer insect resistance gives very low levels of expression unless extensive modifications are carried.", [["nuclear", "ANATOMY", 282, 289], ["plastid", "CELLULAR_COMPONENT", 54, 61], ["nuclear", "CELLULAR_COMPONENT", 282, 289], ["Bt", "GENE_OR_GENE_PRODUCT", 324, 326], ["nuclear genome", "DNA", 282, 296], ["Bt genes", "DNA", 324, 332], ["plastid transformation technology", "TREATMENT", 54, 87], ["conventional transgenic technologies", "TREATMENT", 162, 198], ["outcrossing and transgene silencing", "TREATMENT", 207, 242]]], ["Whereas, introduction of the same genes into the plastid genome results in high levels of toxin accumulation as the plastid genome is bacterial in origin [81] .", [["plastid", "CELLULAR_COMPONENT", 49, 56], ["toxin", "GENE_OR_GENE_PRODUCT", 90, 95], ["plastid", "CELLULAR_COMPONENT", 116, 123], ["plastid genome", "DNA", 49, 63], ["toxin", "PROTEIN", 90, 95], ["plastid genome", "DNA", 116, 130], ["toxin accumulation", "PROBLEM", 90, 108], ["high levels", "OBSERVATION_MODIFIER", 75, 86], ["plastid genome", "OBSERVATION", 116, 130], ["bacterial", "OBSERVATION_MODIFIER", 134, 143]]], ["Therefore, the insect resistance genes were investigated for high-level expression from the plastid genome [3] .", [["plastid", "CELLULAR_COMPONENT", 92, 99], ["insect resistance genes", "DNA", 15, 38], ["plastid genome", "DNA", 92, 106], ["the insect resistance genes", "PROBLEM", 11, 38], ["high-level expression", "PROBLEM", 61, 82], ["plastid genome", "OBSERVATION", 92, 106]]], ["Hence, when insect resistance genes are expressed into the plastid genome, leaves of these transplastomic plants proved highly toxic to herbivorous insect larvae.Insect ResistanceOne of the major advantages of introducing the Bt toxin into the plastid genome is the high levels of toxin accumulation (3% -5% of total leaf protein as compared to > 0.2% of total soluble protein through nuclear genome transformation) [82] .", [["plastid genome", "ANATOMY", 59, 73], ["leaves", "ANATOMY", 75, 81], ["plastid genome", "ANATOMY", 244, 258], ["leaf", "ANATOMY", 317, 321], ["nuclear", "ANATOMY", 385, 392], ["plastid genome", "CELLULAR_COMPONENT", 59, 73], ["transplastomic plants", "ORGANISM", 91, 112], ["insect", "ORGANISM", 148, 154], ["larvae", "DEVELOPING_ANATOMICAL_STRUCTURE", 155, 161], ["Bt toxin", "GENE_OR_GENE_PRODUCT", 226, 234], ["plastid", "CELLULAR_COMPONENT", 244, 251], ["toxin", "SIMPLE_CHEMICAL", 281, 286], ["leaf", "ORGAN", 317, 321], ["nuclear", "CELLULAR_COMPONENT", 385, 392], ["insect resistance genes", "DNA", 12, 35], ["plastid genome", "DNA", 59, 73], ["Bt toxin", "PROTEIN", 226, 234], ["plastid genome", "DNA", 244, 258], ["toxin", "PROTEIN", 281, 286], ["soluble protein", "PROTEIN", 361, 376], ["Bt", "SPECIES", 226, 228], ["these transplastomic plants", "TREATMENT", 85, 112], ["the Bt toxin", "TREATMENT", 222, 234], ["toxin accumulation", "PROBLEM", 281, 299], ["total leaf protein", "TEST", 311, 329], ["total soluble protein", "TREATMENT", 355, 376], ["plastid genome", "OBSERVATION", 59, 73], ["plastid genome", "OBSERVATION", 244, 258]]], ["Achievement of stable transformation of the plastid genome and transforming plastids in species other than tobacco (Nicotiana tabacum) are some of the hurdles for widespread adaptation of this technique [81] .", [["plastid", "CELLULAR_COMPONENT", 44, 51], ["plastids", "CELLULAR_COMPONENT", 76, 84], ["tobacco", "ORGANISM", 107, 114], ["Nicotiana tabacum", "ORGANISM", 116, 133], ["plastid genome", "DNA", 44, 58], ["tobacco", "SPECIES", 107, 114], ["Nicotiana tabacum", "SPECIES", 116, 133], ["tobacco", "SPECIES", 107, 114], ["Nicotiana tabacum", "SPECIES", 116, 133], ["the plastid genome", "PROBLEM", 40, 58], ["transforming plastids in species", "PROBLEM", 63, 95], ["Nicotiana tabacum)", "TREATMENT", 116, 134], ["this technique", "TREATMENT", 188, 202], ["stable", "OBSERVATION_MODIFIER", 15, 21], ["transformation", "OBSERVATION", 22, 36], ["plastid genome", "OBSERVATION", 44, 58]]], ["Despite of overwhelming odds, many attempts have been made to produce transplastomic plants expressing Bt toxin for increased resistance against insect pests.", [["insect pests", "DISEASE", 145, 157], ["Bt toxin", "GENE_OR_GENE_PRODUCT", 103, 111], ["Bt toxin", "PROTEIN", 103, 111], ["Bt", "SPECIES", 103, 105], ["transplastomic plants", "TREATMENT", 70, 91], ["Bt toxin", "TREATMENT", 103, 111], ["increased resistance against insect pests", "PROBLEM", 116, 157]]], ["[83] generated soybean plastid transformants expressing Bacillus thuringiensis Cry1Ab protoxin.", [["transformants", "ANATOMY", 31, 44], ["soybean", "ORGANISM", 15, 22], ["transformants", "CELL", 31, 44], ["Bacillus thuringiensis Cry1Ab", "ORGANISM", 56, 85], ["protoxin", "GENE_OR_GENE_PRODUCT", 86, 94], ["Bacillus thuringiensis Cry1Ab protoxin", "PROTEIN", 56, 94], ["soybean", "SPECIES", 15, 22], ["Bacillus thuringiensis Cry1Ab", "SPECIES", 56, 85], ["soybean", "SPECIES", 15, 22], ["Bacillus thuringiensis", "SPECIES", 56, 78], ["soybean plastid transformants", "TREATMENT", 15, 44], ["Bacillus thuringiensis Cry1Ab protoxin", "PROBLEM", 56, 94]]], ["Similarly, Chakrabarti et al. [84] reported the control of potato tuber moth (Phthorimaea operculella) by incorporating a truncated Bacillus thuringiensis cry9Aa2 gene in the plastid genome.", [["plastid genome", "ANATOMY", 175, 189], ["potato", "ORGANISM", 59, 65], ["tuber moth", "ORGANISM", 66, 76], ["Phthorimaea operculella", "ORGANISM", 78, 101], ["Bacillus thuringiensis", "ORGANISM", 132, 154], ["cry9Aa2", "GENE_OR_GENE_PRODUCT", 155, 162], ["plastid", "CELLULAR_COMPONENT", 175, 182], ["truncated Bacillus thuringiensis cry9Aa2 gene", "DNA", 122, 167], ["plastid genome", "DNA", 175, 189], ["potato", "SPECIES", 59, 65], ["Phthorimaea operculella", "SPECIES", 78, 101], ["Bacillus thuringiensis cry9Aa2", "SPECIES", 132, 162], ["potato tuber moth", "SPECIES", 59, 76], ["Phthorimaea operculella", "SPECIES", 78, 101], ["Bacillus thuringiensis", "SPECIES", 132, 154], ["potato tuber moth (Phthorimaea operculella", "TREATMENT", 59, 101], ["a truncated Bacillus thuringiensis", "PROBLEM", 120, 154], ["plastid genome", "OBSERVATION", 175, 189]]], ["The authors observed high-level expression (about 10% of total soluble protein) of the cry gene from the plastid genome which resulted in severe growth retardation.Insect ResistanceOver-expression of the cry2Aa2 operon in plastids was proved effective in allowing a broad-spectrum of protection against a range of pests [81] .", [["plastid genome", "ANATOMY", 105, 119], ["plastids", "ANATOMY", 222, 230], ["growth retardation", "DISEASE", 145, 163], ["cry", "GENE_OR_GENE_PRODUCT", 87, 90], ["plastid", "CELLULAR_COMPONENT", 105, 112], ["cry2Aa2", "GENE_OR_GENE_PRODUCT", 204, 211], ["plastids", "CELLULAR_COMPONENT", 222, 230], ["soluble protein", "PROTEIN", 63, 78], ["cry gene", "DNA", 87, 95], ["plastid genome", "DNA", 105, 119], ["cry2Aa2 operon", "DNA", 204, 218], ["total soluble protein", "TREATMENT", 57, 78], ["the plastid genome", "PROBLEM", 101, 119], ["severe growth retardation", "PROBLEM", 138, 163], ["the cry2Aa2 operon", "TREATMENT", 200, 218], ["high", "OBSERVATION_MODIFIER", 21, 25], ["plastid genome", "OBSERVATION", 105, 119], ["severe", "OBSERVATION_MODIFIER", 138, 144], ["growth retardation", "OBSERVATION", 145, 163]]], ["In cabbage, the cry1Ab gene was also successfully transferred into the plastid genome [85] .", [["cabbage", "ORGANISM_SUBDIVISION", 3, 10], ["cry1Ab", "GENE_OR_GENE_PRODUCT", 16, 22], ["plastid", "CELLULAR_COMPONENT", 71, 78], ["cry1Ab gene", "DNA", 16, 27], ["plastid genome", "DNA", 71, 85], ["cabbage", "SPECIES", 3, 10], ["cabbage", "SPECIES", 3, 10], ["the cry1Ab gene", "TREATMENT", 12, 27]]], ["Expression of cry1Ab protein was detected in the range of 4.8-11.1% of total soluble protein in transgenic mature leaves of the two species.", [["leaves", "ANATOMY", 114, 120], ["cry1Ab", "GENE_OR_GENE_PRODUCT", 14, 20], ["cry1Ab protein", "PROTEIN", 14, 28], ["soluble protein", "PROTEIN", 77, 92], ["cry1Ab protein", "TEST", 14, 28], ["total soluble protein", "TEST", 71, 92]]], ["Insecticidal effects on Plutella xylostella were also demonstrated in cry1Ab transformed cabbage.", [["cabbage", "ANATOMY", 89, 96], ["Plutella xylostella", "ORGANISM", 24, 43], ["Plutella xylostella", "SPECIES", 24, 43], ["cabbage", "SPECIES", 89, 96], ["Plutella xylostella", "SPECIES", 24, 43], ["cabbage", "SPECIES", 89, 96], ["Insecticidal effects on Plutella xylostella", "PROBLEM", 0, 43]]], ["In an attempt to increase insect resistance in trans-genic rice plants, a synthetic truncated cry1Ac gene was linked to the rice rbcS promoter and its transit peptide sequence (tp) for plastid-targeted expression [86] .", [["cry1Ac", "GENE_OR_GENE_PRODUCT", 94, 100], ["rbcS", "GENE_OR_GENE_PRODUCT", 129, 133], ["plastid", "CELLULAR_COMPONENT", 185, 192], ["synthetic truncated cry1Ac gene", "DNA", 74, 105], ["rice rbcS promoter", "DNA", 124, 142], ["transit peptide sequence", "DNA", 151, 175], ["rice", "SPECIES", 59, 63], ["rice", "SPECIES", 124, 128], ["rice", "SPECIES", 59, 63], ["rice", "SPECIES", 124, 128], ["trans-genic rice plants", "TREATMENT", 47, 70], ["a synthetic truncated cry1Ac gene", "TREATMENT", 72, 105], ["the rice rbcS promoter", "TREATMENT", 120, 142], ["its transit peptide sequence", "TEST", 147, 175]]], ["Use of the rbcS-tp sequence increased the cry1Ac transcript and protein levels by 25-and 100-fold, respectively, with the accumulated protein in plastids comprising up to 2% of the total soluble proteins.", [["plastids", "ANATOMY", 145, 153], ["rbcS", "GENE_OR_GENE_PRODUCT", 11, 15], ["cry1Ac", "GENE_OR_GENE_PRODUCT", 42, 48], ["plastids", "CELLULAR_COMPONENT", 145, 153], ["rbcS", "PROTEIN", 11, 15], ["tp sequence", "DNA", 16, 27], ["soluble proteins", "PROTEIN", 187, 203], ["the rbcS-tp sequence", "TEST", 7, 27], ["the cry1Ac transcript", "TEST", 38, 59], ["protein levels", "TEST", 64, 78], ["the accumulated protein in plastids", "PROBLEM", 118, 153], ["the total soluble proteins", "TEST", 177, 203], ["protein", "OBSERVATION", 134, 141]]], ["The high level of cry1Ac expression resulted in high levels of plant resistance to three common rice pests, rice leaf folder, rice green caterpillar, and rice skipper, as evidenced by insect feeding assays.", [["leaf", "ANATOMY", 113, 117], ["rice leaf folder, rice green caterpillar", "CHEMICAL", 108, 148], ["cry1Ac", "GENE_OR_GENE_PRODUCT", 18, 24], ["leaf", "ORGANISM_SUBDIVISION", 113, 117], ["cry1Ac", "PROTEIN", 18, 24], ["rice", "SPECIES", 96, 100], ["rice", "SPECIES", 108, 112], ["rice", "SPECIES", 126, 130], ["rice", "SPECIES", 154, 158], ["rice", "SPECIES", 96, 100], ["rice", "SPECIES", 108, 112], ["rice green caterpillar", "SPECIES", 126, 148], ["rice", "SPECIES", 154, 158], ["high", "OBSERVATION_MODIFIER", 4, 8], ["plant resistance", "OBSERVATION", 63, 79], ["green caterpillar", "OBSERVATION", 131, 148]]], ["It was concluded that targeting of cry1Ac protein to the plastid using the rbcS:tp system confers a high level of plant protection to insects.", [["cry1Ac", "GENE_OR_GENE_PRODUCT", 35, 41], ["plastid", "CELLULAR_COMPONENT", 57, 64], ["rbcS", "GENE_OR_GENE_PRODUCT", 75, 79], ["tp", "GENE_OR_GENE_PRODUCT", 80, 82], ["cry1Ac protein", "PROTEIN", 35, 49], ["rbcS:tp", "PROTEIN", 75, 82], ["cry1Ac protein", "PROBLEM", 35, 49], ["tp system", "TREATMENT", 80, 89], ["plant protection", "TREATMENT", 114, 130], ["plant protection", "OBSERVATION", 114, 130]]], ["Several other cry proteins have also been expressed in plastids of tobacco [83, 84, 87, 88] and rice [50] (see Table 2 ).Disease ResistancePlastid engineering offers a new and effective option in development of plant varieties which are resistant to various bacterial and fungal diseases.", [["plastids", "ANATOMY", 55, 63], ["bacterial and fungal diseases", "DISEASE", 258, 287], ["plastids", "CELLULAR_COMPONENT", 55, 63], ["tobacco", "ORGANISM", 67, 74], ["cry proteins", "PROTEIN", 14, 26], ["tobacco", "SPECIES", 67, 74], ["rice", "SPECIES", 96, 100], ["tobacco", "SPECIES", 67, 74], ["rice", "SPECIES", 96, 100], ["Several other cry proteins", "PROBLEM", 0, 26], ["Disease", "PROBLEM", 121, 128], ["plant varieties", "PROBLEM", 211, 226], ["various bacterial and fungal diseases", "PROBLEM", 250, 287], ["new", "OBSERVATION_MODIFIER", 168, 171], ["plant varieties", "OBSERVATION", 211, 226], ["bacterial", "OBSERVATION_MODIFIER", 258, 267], ["fungal diseases", "OBSERVATION", 272, 287]]], ["In tobacco, introduction of MSI-99 gene, an antimicrobial peptide, into plastids resulted in transplastomic plants resistant to fungal pathogen Colletotrichum destructive [89] .", [["plastids", "ANATOMY", 72, 80], ["MSI-99", "CHEMICAL", 28, 34], ["tobacco", "ORGANISM", 3, 10], ["MSI-99", "GENE_OR_GENE_PRODUCT", 28, 34], ["MSI-99 gene", "DNA", 28, 39], ["tobacco", "SPECIES", 3, 10], ["tobacco", "SPECIES", 3, 10], ["MSI", "TEST", 28, 31], ["an antimicrobial peptide", "TREATMENT", 41, 65], ["transplastomic plants", "PROBLEM", 93, 114], ["fungal pathogen Colletotrichum destructive", "PROBLEM", 128, 170], ["fungal", "OBSERVATION_MODIFIER", 128, 134], ["pathogen", "OBSERVATION_MODIFIER", 135, 143], ["Colletotrichum", "OBSERVATION_MODIFIER", 144, 158], ["destructive", "OBSERVATION_MODIFIER", 159, 170]]], ["The plastids expressed MSI-99 at high levels and showed 88% (T1) and 96% (T2) inhibition of growth against Pseudomonas syringe, which is a major plant pathogen.", [["plastids", "ANATOMY", 4, 12], ["plastids", "CELLULAR_COMPONENT", 4, 12], ["MSI-99", "CELL", 23, 29], ["Pseudomonas syringe", "ORGANISM", 107, 126], ["Pseudomonas syringe", "SPECIES", 107, 126], ["The plastids expressed MSI", "TEST", 0, 26], ["Pseudomonas syringe", "PROBLEM", 107, 126], ["a major plant pathogen", "PROBLEM", 137, 159], ["plant pathogen", "OBSERVATION", 145, 159]]], ["In another study, Agrobacterium mediated transformation was used to develop tobacco plants carrying argK gene, which encodes ROCT [90] .", [["Agrobacterium", "CHEMICAL", 18, 31], ["tobacco", "ORGANISM", 76, 83], ["argK", "GENE_OR_GENE_PRODUCT", 100, 104], ["argK gene", "DNA", 100, 109], ["tobacco", "SPECIES", 76, 83], ["another study", "TEST", 3, 16], ["Agrobacterium mediated transformation", "PROBLEM", 18, 55]]], ["Since OCT in plant cells is produced in the plastid, argK was fused to the plastid transit sequence of the pea rubisco small subunit (rbcS) gene for localized expression of the enzyme.", [["cells", "ANATOMY", 19, 24], ["plant cells", "CELL", 13, 24], ["plastid", "CELLULAR_COMPONENT", 44, 51], ["argK", "GENE_OR_GENE_PRODUCT", 53, 57], ["plastid", "CELLULAR_COMPONENT", 75, 82], ["pea rubisco small subunit", "GENE_OR_GENE_PRODUCT", 107, 132], ["rbcS", "GENE_OR_GENE_PRODUCT", 134, 138], ["OCT", "PROTEIN", 6, 9], ["plant cells", "CELL_TYPE", 13, 24], ["plastid", "DNA", 44, 51], ["argK", "DNA", 53, 57], ["plastid transit sequence", "DNA", 75, 99], ["pea rubisco small subunit (rbcS) gene", "DNA", 107, 144], ["enzyme", "PROTEIN", 177, 183], ["the plastid transit sequence", "TEST", 71, 99], ["the pea rubisco small subunit (rbcS)", "TREATMENT", 103, 139], ["the enzyme", "TEST", 173, 183], ["plant cells", "OBSERVATION", 13, 24], ["pea rubisco", "OBSERVATION", 107, 118]]], ["The ROCT enzyme produced by the transgenic tobacco showed greater resistance (83-100%) to phaseolotoxin compared to the wild-type OCT (0-22%).", [["phaseolotoxin", "CHEMICAL", 90, 103], ["phaseolotoxin", "CHEMICAL", 90, 103], ["ROCT enzyme", "GENE_OR_GENE_PRODUCT", 4, 15], ["tobacco", "ORGANISM", 43, 50], ["phaseolotoxin", "GENE_OR_GENE_PRODUCT", 90, 103], ["ROCT enzyme", "PROTEIN", 4, 15], ["tobacco", "SPECIES", 43, 50], ["tobacco", "SPECIES", 43, 50], ["The ROCT enzyme", "TEST", 0, 15], ["phaseolotoxin", "TEST", 90, 103], ["greater resistance", "OBSERVATION", 58, 76]]], ["When phaseolotoxin was applied exogenously to the leaves of plants, chlorosis was observed in 100% of wildtype tobacco, but not seen in the leaves of the transgenic tobacco plants carrying the argK gene from P. syringae pv. phaseolicola.", [["leaves", "ANATOMY", 50, 56], ["leaves", "ANATOMY", 140, 146], ["phaseolotoxin", "CHEMICAL", 5, 18], ["chlorosis", "DISEASE", 68, 77], ["phaseolotoxin", "CHEMICAL", 5, 18], ["phaseolotoxin", "GENE_OR_GENE_PRODUCT", 5, 18], ["tobacco", "ORGANISM", 111, 118], ["tobacco", "ORGANISM", 165, 172], ["argK", "GENE_OR_GENE_PRODUCT", 193, 197], ["P. syringae pv", "ORGANISM", 208, 222], ["phaseolicola", "ORGANISM", 224, 236], ["argK gene", "DNA", 193, 202], ["tobacco", "SPECIES", 111, 118], ["tobacco", "SPECIES", 165, 172], ["P. syringae", "SPECIES", 208, 219], ["phaseolicola", "SPECIES", 224, 236], ["tobacco", "SPECIES", 111, 118], ["tobacco", "SPECIES", 165, 172], ["P. syringae", "SPECIES", 208, 219], ["phaseolicola", "SPECIES", 224, 236], ["phaseolotoxin", "TREATMENT", 5, 18], ["chlorosis", "PROBLEM", 68, 77], ["chlorosis", "OBSERVATION", 68, 77]]], ["Transgenic tobacco plants that constitutively expressed both entC and pmsB in the plastid have also been reported [91] where transformation was accomplished through biolistic methods.", [["tobacco", "ORGANISM", 11, 18], ["entC", "GENE_OR_GENE_PRODUCT", 61, 65], ["pmsB", "GENE_OR_GENE_PRODUCT", 70, 74], ["plastid", "CELLULAR_COMPONENT", 82, 89], ["entC", "PROTEIN", 61, 65], ["pmsB", "PROTEIN", 70, 74], ["tobacco", "SPECIES", 11, 18], ["tobacco", "SPECIES", 11, 18]]], ["The transgenic tobacco plants expressing these bacterial genes showed accumulation of salicylic acid that were up to 1000 times higher than that observed in wild-type tobacco.", [["salicylic acid", "CHEMICAL", 86, 100], ["salicylic acid", "CHEMICAL", 86, 100], ["tobacco", "ORGANISM", 15, 22], ["plants", "ORGANISM", 23, 29], ["salicylic acid", "SIMPLE_CHEMICAL", 86, 100], ["tobacco", "ORGANISM", 167, 174], ["bacterial genes", "DNA", 47, 62], ["tobacco", "SPECIES", 15, 22], ["tobacco", "SPECIES", 167, 174], ["tobacco", "SPECIES", 15, 22], ["tobacco", "SPECIES", 167, 174], ["The transgenic tobacco plants", "TREATMENT", 0, 29], ["these bacterial genes", "PROBLEM", 41, 62], ["accumulation of salicylic acid", "PROBLEM", 70, 100], ["transgenic", "OBSERVATION_MODIFIER", 4, 14], ["tobacco plants", "OBSERVATION", 15, 29], ["salicylic acid", "OBSERVATION", 86, 100]]], ["When challenged with the fungus Oidium lycopersicon, the transgenic tobacco plants showed increased levels of resistance compared to the wildtype plants.", [["Oidium lycopersicon", "ORGANISM", 32, 51], ["tobacco", "ORGANISM", 68, 75], ["tobacco", "SPECIES", 68, 75], ["Oidium lycopersicon", "SPECIES", 32, 51], ["tobacco", "SPECIES", 68, 75], ["increased levels of resistance", "PROBLEM", 90, 120], ["increased", "OBSERVATION_MODIFIER", 90, 99]]], ["It was revealed that the transgenic plants generated did not show any adverse effects due to the high level expression of salicylic acid.", [["salicylic acid", "CHEMICAL", 122, 136], ["salicylic acid", "CHEMICAL", 122, 136], ["salicylic acid", "SIMPLE_CHEMICAL", 122, 136], ["the transgenic plants", "PROBLEM", 21, 42], ["any adverse effects", "PROBLEM", 66, 85], ["salicylic acid", "TREATMENT", 122, 136], ["salicylic acid", "OBSERVATION", 122, 136]]], ["Thus gene transfer in plastids can provide a significant protection from various bacterial and fungal diseases.Drought and Salinity ToleranceTransgenes that confer tolerance to abiotic stress may permanently transfer from transgenic crops to the nuclear genome of their weedy relatives which may result in drought tolerant superweeds [92] when the gene is inserted into the nuclear genome and the transgenic plant outcross with relative weeds.", [["plastids", "ANATOMY", 22, 30], ["nuclear genome", "ANATOMY", 246, 260], ["nuclear genome", "ANATOMY", 374, 388], ["bacterial and fungal diseases", "DISEASE", 81, 110], ["Drought", "DISEASE", 111, 118], ["Salinity", "CHEMICAL", 123, 131], ["plastids", "CELLULAR_COMPONENT", 22, 30], ["nuclear", "CELLULAR_COMPONENT", 246, 253], ["nuclear", "CELLULAR_COMPONENT", 374, 381], ["nuclear genome", "DNA", 246, 260], ["nuclear genome", "DNA", 374, 388], ["a significant protection", "TREATMENT", 43, 67], ["various bacterial and fungal diseases", "PROBLEM", 73, 110], ["abiotic stress", "PROBLEM", 177, 191], ["bacterial", "OBSERVATION_MODIFIER", 81, 90], ["fungal diseases", "OBSERVATION", 95, 110], ["Salinity Tolerance", "OBSERVATION", 123, 141]]], ["There is a great potential, therefore, for the genetic manipulation of key enzymes involved in stress metabolism in plants within plastids.", [["plastids", "ANATOMY", 130, 138], ["plastids", "CELLULAR_COMPONENT", 130, 138], ["key enzymes", "TEST", 71, 82], ["stress metabolism in plants within plastids", "PROBLEM", 95, 138], ["great potential", "OBSERVATION_MODIFIER", 11, 26], ["stress metabolism", "OBSERVATION", 95, 112]]], ["Because plastid genomes of major crops including cotton and soybean have been Nicotiana tabacum nptII [153] Nicotiana tabacum uidA [154] Nicotiana tabacum Human somatotropin (hST) [155] Nicotiana tabacum cry [88] Nicotiana tabacum cry9Aa2 [84] Nicotiana tabacum Bar & aadA [156] Nicotiana tabacum Cor 15a-FAD7 [157] Nicotiana tabacum rbcL [55] Nicotiana tabacum DXR [158] Nicotiana tabacum aadA & gfp [60] Nicotiana tabacum Delta(9) desaturase [159] Nicotiana tabacum AsA2 [160] Nicotiana tabacum PhaG & PhaC [161] Nicotiana tabacum gfp [4] Nicotiana tabacum A1AT [162] Arabidopsis thaliana aadA [39] Solanum tuberosum aadA & gfp [40] Oryza sativa aadA & gfp [50] Solanum lycopersicon aadA [1] Solanum lycopersicon Lyc [42] Brassica napus aadA & cry1Aa10 [44] Brassica napus aadA [38] Lesquerella fendleri aadA & gfp [43] Daucus carota dehydrogenase (badh) [48] Gossypium hirsutum aphA-6 [49] Glycine max aadA [47] Petunia hybrida aadA & gusA [45] Lactuca sativa gfp [46] Brassica oleracea gus & aadA [163] Lettuce gfp [164] Populus alba gfp [51] Brassica oleracea aadA & uidA [74] Beta vulgaris aadA & uidA [165] Crocus sativus CstLcyB1& CstLcyB2a [166] Solanum melongena aadA [26] Arabidopsis thaliana pre-Tic40-His [167] Zea mays ManA [168] successfully transformed, this offers an exciting new approach to create transgenic plants with abiotic stress tolerance [93] .", [["DXR", "CHEMICAL", 362, 365], ["aphA-6 [49] Glycine max aadA", "CHEMICAL", 881, 909], ["cotton", "ORGANISM_SUBDIVISION", 49, 55], ["soybean", "ORGANISM_SUBDIVISION", 60, 67], ["Nicotiana tabacum", "ORGANISM", 78, 95], ["nptII [153] Nicotiana tabacum", "ORGANISM", 96, 125], ["uidA [154] Nicotiana tabacum", "ORGANISM", 126, 154], ["Human", "ORGANISM", 155, 160], ["somatotropin", "GENE_OR_GENE_PRODUCT", 161, 173], ["Nicotiana tabacum", "ORGANISM", 186, 203], ["Nicotiana tabacum", "ORGANISM", 213, 230], ["Nicotiana tabacum", "ORGANISM", 244, 261], ["Nicotiana tabacum", "ORGANISM", 279, 296], ["Nicotiana tabacum", "ORGANISM", 316, 333], ["Nicotiana tabacum", "ORGANISM", 344, 361], ["Nicotiana tabacum", "ORGANISM", 372, 389], ["Nicotiana tabacum", "ORGANISM", 406, 423], ["Delta(9) desaturase", "GENE_OR_GENE_PRODUCT", 424, 443], ["Nicotiana tabacum", "ORGANISM", 450, 467], ["Nicotiana tabacum", "ORGANISM", 479, 496], ["PhaC [161] Nicotiana tabacum", "ORGANISM", 504, 532], ["gfp", "ORGANISM", 533, 536], ["Nicotiana tabacum", "ORGANISM", 541, 558], ["A1AT", "GENE_OR_GENE_PRODUCT", 559, 563], ["Solanum", "ORGANISM", 601, 608], ["tuberosum", "ORGANISM", 609, 618], ["gfp [40] Oryza sativa", "ORGANISM", 626, 647], ["Solanum", "ORGANISM", 664, 671], ["Solanum", "ORGANISM", 694, 701], ["Brassica napus", "ORGANISM", 724, 738], ["Brassica napus", "ORGANISM", 760, 774], ["Petunia", "ORGANISM", 915, 922], ["gusA [45] Lactuca sativa", "ORGANISM", 938, 962], ["gfp", "ORGANISM", 963, 966], ["Brassica oleracea", "ORGANISM", 1047, 1064], ["uidA", "GENE_OR_GENE_PRODUCT", 1072, 1076], ["plastid genomes", "DNA", 8, 23], ["gfp [60] Nicotiana tabacum Delta(9) desaturase", "PROTEIN", 397, 443], ["gfp [43] Daucus carota dehydrogenase", "PROTEIN", 813, 849], ["badh", "PROTEIN", 851, 855], ["aadA & gusA [45] Lactuca sativa gfp [46] Brassica oleracea gus & aadA [163] Lettuce gfp [164] Populus alba gfp [51] Brassica oleracea aadA & uidA [74] Beta vulgaris aadA", "DNA", 931, 1100], ["cotton", "SPECIES", 49, 55], ["soybean", "SPECIES", 60, 67], ["Nicotiana tabacum", "SPECIES", 78, 95], ["Nicotiana tabacum", "SPECIES", 108, 125], ["Nicotiana tabacum", "SPECIES", 137, 154], ["Human", "SPECIES", 155, 160], ["Nicotiana tabacum", "SPECIES", 186, 203], ["Nicotiana tabacum", "SPECIES", 213, 230], ["Nicotiana tabacum", "SPECIES", 244, 261], ["Nicotiana tabacum", "SPECIES", 279, 296], ["Nicotiana tabacum", "SPECIES", 316, 333], ["Nicotiana tabacum", "SPECIES", 344, 361], ["Nicotiana tabacum", "SPECIES", 372, 389], ["Nicotiana tabacum", "SPECIES", 406, 423], ["Nicotiana tabacum", "SPECIES", 450, 467], ["Nicotiana tabacum", "SPECIES", 479, 496], ["Nicotiana tabacum", "SPECIES", 515, 532], ["Nicotiana tabacum", "SPECIES", 541, 558], ["Arabidopsis thaliana", "SPECIES", 570, 590], ["Solanum tuberosum", "SPECIES", 601, 618], ["Oryza sativa", "SPECIES", 635, 647], ["Solanum lycopersicon", "SPECIES", 664, 684], ["Solanum lycopersicon", "SPECIES", 694, 714], ["Brassica napus", "SPECIES", 724, 738], ["Brassica napus", "SPECIES", 760, 774], ["Lesquerella fendleri", "SPECIES", 785, 805], ["Daucus carota", "SPECIES", 822, 835], ["Gossypium hirsutum", "SPECIES", 862, 880], ["Glycine max", "SPECIES", 893, 904], ["Petunia hybrida", "SPECIES", 915, 930], ["Lactuca sativa", "SPECIES", 948, 962], ["Brassica oleracea", "SPECIES", 972, 989], ["Populus alba", "SPECIES", 1025, 1037], ["Brassica oleracea", "SPECIES", 1047, 1064], ["Beta vulgaris", "SPECIES", 1082, 1095], ["Crocus sativus", "SPECIES", 1114, 1128], ["Solanum melongena", "SPECIES", 1155, 1172], ["Arabidopsis thaliana", "SPECIES", 1183, 1203], ["Zea mays", "SPECIES", 1224, 1232], ["cotton", "SPECIES", 49, 55], ["soybean", "SPECIES", 60, 67], ["Nicotiana tabacum", "SPECIES", 78, 95], ["Nicotiana tabacum", "SPECIES", 108, 125], ["Nicotiana tabacum", "SPECIES", 137, 154], ["Nicotiana tabacum", "SPECIES", 186, 203], ["Nicotiana tabacum", "SPECIES", 213, 230], ["Nicotiana tabacum", "SPECIES", 244, 261], ["Nicotiana tabacum", "SPECIES", 279, 296], ["Nicotiana tabacum", "SPECIES", 316, 333], ["Nicotiana tabacum", "SPECIES", 344, 361], ["Nicotiana tabacum", "SPECIES", 372, 389], ["Nicotiana tabacum", "SPECIES", 406, 423], ["Nicotiana tabacum", "SPECIES", 450, 467], ["Nicotiana tabacum", "SPECIES", 479, 496], ["Nicotiana tabacum", "SPECIES", 515, 532], ["Nicotiana tabacum", "SPECIES", 541, 558], ["Arabidopsis thaliana", "SPECIES", 570, 590], ["Solanum tuberosum", "SPECIES", 601, 618], ["Oryza sativa", "SPECIES", 635, 647], ["Solanum lycopersicon", "SPECIES", 664, 684], ["Solanum lycopersicon", "SPECIES", 694, 714], ["Brassica napus aadA & cry1Aa10", "SPECIES", 724, 754], ["Brassica napus", "SPECIES", 760, 774], ["Lesquerella fendleri", "SPECIES", 785, 805], ["Daucus carota", "SPECIES", 822, 835], ["Gossypium hirsutum", "SPECIES", 862, 880], ["Petunia hybrida", "SPECIES", 915, 930], ["Lactuca sativa", "SPECIES", 948, 962], ["Brassica oleracea", "SPECIES", 972, 989], ["Populus alba", "SPECIES", 1025, 1037], ["Brassica oleracea", "SPECIES", 1047, 1064], ["Beta vulgaris", "SPECIES", 1082, 1095], ["Crocus sativus", "SPECIES", 1114, 1128], ["Solanum melongena", "SPECIES", 1155, 1172], ["Arabidopsis thaliana", "SPECIES", 1183, 1203], ["Zea mays", "SPECIES", 1224, 1232], ["cotton and soybean", "TREATMENT", 49, 67], ["Nicotiana tabacum nptII", "TREATMENT", 78, 101], ["Nicotiana tabacum uidA", "TREATMENT", 108, 130], ["Nicotiana tabacum Human somatotropin (hST)", "TREATMENT", 137, 179], ["Nicotiana tabacum rbcL", "TREATMENT", 316, 338], ["Nicotiana tabacum DXR", "TREATMENT", 344, 365], ["Nicotiana tabacum aadA", "TREATMENT", 372, 394], ["Nicotiana tabacum Delta", "TEST", 406, 429], ["desaturase", "TEST", 433, 443], ["Nicotiana tabacum AsA2", "TREATMENT", 450, 472], ["Nicotiana tabacum gfp", "TREATMENT", 515, 536], ["Arabidopsis thaliana aadA", "TREATMENT", 570, 595], ["Solanum tuberosum aadA", "TREATMENT", 601, 623], ["Solanum lycopersicon aadA", "TREATMENT", 664, 689], ["Solanum lycopersicon Lyc", "TREATMENT", 694, 718], ["Brassica napus aadA", "TEST", 760, 779], ["Lesquerella fendleri aadA", "TREATMENT", 785, 810], ["Daucus carota dehydrogenase", "TEST", 822, 849], ["Gossypium hirsutum aphA", "TEST", 862, 885], ["Glycine max aadA", "TEST", 893, 909], ["Lactuca sativa gfp", "TEST", 948, 966], ["Brassica oleracea gus", "TEST", 972, 993], ["Lettuce gfp", "TEST", 1007, 1018], ["Populus alba gfp", "TEST", 1025, 1041], ["Brassica oleracea aadA", "TEST", 1047, 1069], ["uidA", "TEST", 1072, 1076], ["Beta vulgaris aadA", "TEST", 1082, 1100], ["CstLcyB2a", "TEST", 1139, 1148], ["Solanum melongena aadA", "TREATMENT", 1155, 1177], ["abiotic stress tolerance", "PROBLEM", 1340, 1364]]], ["Therefore, the authors believe that there appears to be tremendous potential for increasing tolerance in plants to a number of stresses by expression of appropriate genes within plastids due to the maternal inheritance of transgenes that confer tolerance to abiotic stress.", [["plastids", "ANATOMY", 178, 186], ["plastids", "CELLULAR_COMPONENT", 178, 186], ["increasing tolerance in plants", "PROBLEM", 81, 111], ["abiotic stress", "PROBLEM", 258, 272], ["appears to be", "UNCERTAINTY", 42, 55], ["tremendous", "OBSERVATION_MODIFIER", 56, 66]]], ["Plastid engineering had been successfully applied for the development of plants with tolerance to salt, drought [94] and low temperature [reviewed in 3].", [["salt", "SIMPLE_CHEMICAL", 98, 102], ["Plastid engineering", "TREATMENT", 0, 19], ["low temperature", "PROBLEM", 121, 136]]], ["Djilianov et al. [95] demonstrated that enhanced tolerance to abiotic stresses has been achieved when the gene was directed to plastid genome.Drought and Salinity ToleranceAmong many strategies used for development of abiotic stress tolerance in plants, the over-expression of compatible osmolytes like glycinebetaine was found to be successful [24] .", [["Drought", "DISEASE", 142, 149], ["Salinity", "CHEMICAL", 154, 162], ["glycinebetaine", "CHEMICAL", 303, 317], ["glycinebetaine", "CHEMICAL", 303, 317], ["plastid", "CELLULAR_COMPONENT", 127, 134], ["genome", "CELLULAR_COMPONENT", 135, 141], ["osmolytes", "SIMPLE_CHEMICAL", 288, 297], ["glycinebetaine", "SIMPLE_CHEMICAL", 303, 317], ["plastid genome", "DNA", 127, 141], ["abiotic stresses", "PROBLEM", 62, 78], ["abiotic stress tolerance", "PROBLEM", 218, 242], ["compatible osmolytes", "PROBLEM", 277, 297], ["glycinebetaine", "TREATMENT", 303, 317], ["abiotic stresses", "OBSERVATION", 62, 78], ["plastid genome", "OBSERVATION", 127, 141], ["Salinity Tolerance", "OBSERVATION", 154, 172]]], ["Initial attempts for producing transplastomic plants through the introduction of CMO (Choline monooxygenase) and betaine aldehyde dehydrogenase (BADH) pathway were made in tobacco.", [["CMO", "CHEMICAL", 81, 84], ["Choline", "CHEMICAL", 86, 93], ["betaine aldehyde", "CHEMICAL", 113, 129], ["CMO", "CHEMICAL", 81, 84], ["Choline", "CHEMICAL", 86, 93], ["betaine aldehyde", "CHEMICAL", 113, 129], ["CMO", "SIMPLE_CHEMICAL", 81, 84], ["Choline monooxygenase", "GENE_OR_GENE_PRODUCT", 86, 107], ["betaine aldehyde dehydrogenase", "GENE_OR_GENE_PRODUCT", 113, 143], ["BADH", "SIMPLE_CHEMICAL", 145, 149], ["tobacco", "ORGANISM", 172, 179], ["CMO", "PROTEIN", 81, 84], ["Choline monooxygenase", "PROTEIN", 86, 107], ["betaine aldehyde dehydrogenase", "PROTEIN", 113, 143], ["BADH", "PROTEIN", 145, 149], ["tobacco", "SPECIES", 172, 179], ["tobacco", "SPECIES", 172, 179], ["producing transplastomic plants", "TREATMENT", 21, 52], ["CMO (Choline monooxygenase)", "TREATMENT", 81, 108], ["betaine aldehyde dehydrogenase", "TREATMENT", 113, 143]]], ["Tobacco plants were transformed with cDNA for BADH from spinach (Spinacia oleracea) and sugar beet (Beta vulgaris) under the control of CaMV 35 S promoter.", [["BADH", "CHEMICAL", 46, 50], ["Tobacco", "ORGANISM", 0, 7], ["BADH", "GENE_OR_GENE_PRODUCT", 46, 50], ["spinach", "ORGANISM_SUBDIVISION", 56, 63], ["Spinacia oleracea", "ORGANISM", 65, 82], ["sugar beet", "ORGANISM", 88, 98], ["Beta vulgaris", "ORGANISM", 100, 113], ["CaMV 35 S", "GENE_OR_GENE_PRODUCT", 136, 145], ["cDNA", "DNA", 37, 41], ["BADH", "PROTEIN", 46, 50], ["CaMV 35 S promoter", "DNA", 136, 154], ["spinach", "SPECIES", 56, 63], ["Spinacia oleracea", "SPECIES", 65, 82], ["Beta vulgaris", "SPECIES", 100, 113], ["Spinacia oleracea", "SPECIES", 65, 82], ["beet", "SPECIES", 94, 98], ["Beta vulgaris", "SPECIES", 100, 113], ["CaMV", "SPECIES", 136, 140], ["BADH", "PROBLEM", 46, 50], ["spinach (Spinacia oleracea", "TREATMENT", 56, 82], ["sugar beet (Beta vulgaris)", "TREATMENT", 88, 114], ["CaMV 35 S promoter", "TREATMENT", 136, 154]]], ["The BADH was produced in plastids of tobacco.", [["plastids", "ANATOMY", 25, 33], ["BADH", "CHEMICAL", 4, 8], ["BADH", "GENE_OR_GENE_PRODUCT", 4, 8], ["tobacco", "ORGANISM", 37, 44], ["BADH", "PROTEIN", 4, 8], ["tobacco", "SPECIES", 37, 44], ["tobacco", "SPECIES", 37, 44], ["plastids of tobacco", "OBSERVATION", 25, 44]]], ["Betaine aldehyde was converted to betaine by BADH, thus conferring resistance to betaine aldehyde.", [["Betaine aldehyde", "CHEMICAL", 0, 16], ["betaine", "CHEMICAL", 34, 41], ["BADH", "CHEMICAL", 45, 49], ["betaine aldehyde", "CHEMICAL", 81, 97], ["Betaine aldehyde", "CHEMICAL", 0, 16], ["betaine", "CHEMICAL", 34, 41], ["betaine aldehyde", "CHEMICAL", 81, 97], ["Betaine aldehyde", "SIMPLE_CHEMICAL", 0, 16], ["betaine", "SIMPLE_CHEMICAL", 34, 41], ["BADH", "SIMPLE_CHEMICAL", 45, 49], ["betaine aldehyde", "SIMPLE_CHEMICAL", 81, 97], ["Betaine aldehyde", "TREATMENT", 0, 16], ["betaine aldehyde", "TREATMENT", 81, 97], ["betaine aldehyde", "OBSERVATION", 81, 97]]], ["In another attempt, cDNA for choline monooxygenase from Spinacia oleracea was introduced into tobacco and the enzyme thus synthesized was transported to its functional place i.e., plastids.", [["plastids", "ANATOMY", 180, 188], ["choline", "CHEMICAL", 29, 36], ["Spinacia oleracea", "CHEMICAL", 56, 73], ["choline", "CHEMICAL", 29, 36], ["choline monooxygenase", "GENE_OR_GENE_PRODUCT", 29, 50], ["Spinacia oleracea", "ORGANISM", 56, 73], ["tobacco", "ORGANISM", 94, 101], ["plastids", "CELLULAR_COMPONENT", 180, 188], ["cDNA", "DNA", 20, 24], ["choline monooxygenase", "PROTEIN", 29, 50], ["Spinacia oleracea", "SPECIES", 56, 73], ["tobacco", "SPECIES", 94, 101], ["Spinacia oleracea", "SPECIES", 56, 73], ["tobacco", "SPECIES", 94, 101], ["choline monooxygenase", "TREATMENT", 29, 50], ["Spinacia oleracea", "TREATMENT", 56, 73], ["the enzyme", "TEST", 106, 116]]], ["But the leaves of tobacco accumulated betaine at a very low concentration i.e., 10-100 folds lower [96] .", [["leaves", "ANATOMY", 8, 14], ["betaine", "CHEMICAL", 38, 45], ["betaine", "CHEMICAL", 38, 45], ["tobacco", "ORGANISM", 18, 25], ["betaine", "SIMPLE_CHEMICAL", 38, 45], ["tobacco", "SPECIES", 18, 25], ["tobacco", "SPECIES", 18, 25], ["tobacco accumulated", "OBSERVATION", 18, 37]]], ["The reason for insufficient synthesis of betaine most probably was the absence of engineered BADH activity in plastids.", [["plastids", "ANATOMY", 110, 118], ["betaine", "CHEMICAL", 41, 48], ["betaine", "CHEMICAL", 41, 48], ["betaine", "SIMPLE_CHEMICAL", 41, 48], ["BADH", "GENE_OR_GENE_PRODUCT", 93, 97], ["plastids", "CELLULAR_COMPONENT", 110, 118], ["BADH", "PROTEIN", 93, 97], ["insufficient synthesis of betaine", "PROBLEM", 15, 48], ["BADH activity", "OBSERVATION", 93, 106]]], ["Therefore, both CMO and BADH need to be present in the plastids for efficient synthesis of betaine in transgenic plants which do not accumulate glycinebetaine.", [["plastids", "ANATOMY", 55, 63], ["CMO", "CHEMICAL", 16, 19], ["BADH", "CHEMICAL", 24, 28], ["betaine", "CHEMICAL", 91, 98], ["glycinebetaine", "CHEMICAL", 144, 158], ["betaine", "CHEMICAL", 91, 98], ["glycinebetaine", "CHEMICAL", 144, 158], ["CMO", "SIMPLE_CHEMICAL", 16, 19], ["BADH", "SIMPLE_CHEMICAL", 24, 28], ["plastids", "CELLULAR_COMPONENT", 55, 63], ["betaine", "SIMPLE_CHEMICAL", 91, 98], ["transgenic plants", "ORGANISM", 102, 119], ["glycinebetaine", "SIMPLE_CHEMICAL", 144, 158], ["BADH", "TREATMENT", 24, 28], ["efficient synthesis of betaine in transgenic plants", "TREATMENT", 68, 119]]], ["In carrot (Daucus carota), homoplasmic transgenic plants exhibiting high levels of salt tolerance were regenerated from bombarded cell cultures via somatic embryogenesis [48] .", [["cell cultures", "ANATOMY", 130, 143], ["carrot", "ORGANISM_SUBDIVISION", 3, 9], ["Daucus carota", "ORGANISM", 11, 24], ["salt", "SIMPLE_CHEMICAL", 83, 87], ["cell cultures", "CELL", 130, 143], ["bombarded cell cultures", "CELL_LINE", 120, 143], ["carrot", "SPECIES", 3, 9], ["Daucus carota", "SPECIES", 11, 24], ["carrot", "SPECIES", 3, 9], ["Daucus carota", "SPECIES", 11, 24], ["homoplasmic transgenic plants", "PROBLEM", 27, 56], ["high levels of salt tolerance", "PROBLEM", 68, 97], ["bombarded cell cultures", "TEST", 120, 143], ["somatic embryogenesis", "PROBLEM", 148, 169], ["Daucus carota", "OBSERVATION", 11, 24]]], ["BADH enzyme activity was enhanced 8-fold in transgenic carrot cell cultures, grew 7-fold more, and accumulated 50-to 54-fold more betaine than untransformed cells grown in liquid medium containing 100 mM NaCl.", [["cell cultures", "ANATOMY", 62, 75], ["cells", "ANATOMY", 157, 162], ["betaine", "CHEMICAL", 130, 137], ["NaCl", "CHEMICAL", 204, 208], ["betaine", "CHEMICAL", 130, 137], ["NaCl", "CHEMICAL", 204, 208], ["BADH", "GENE_OR_GENE_PRODUCT", 0, 4], ["carrot cell cultures", "CELL", 55, 75], ["betaine", "SIMPLE_CHEMICAL", 130, 137], ["cells", "CELL", 157, 162], ["BADH", "PROTEIN", 0, 4], ["transgenic carrot cell cultures", "CELL_LINE", 44, 75], ["untransformed cells", "CELL_LINE", 143, 162], ["BADH enzyme activity", "TEST", 0, 20], ["transgenic carrot cell cultures", "TEST", 44, 75], ["untransformed cells", "PROBLEM", 143, 162], ["activity", "OBSERVATION_MODIFIER", 12, 20], ["carrot cell cultures", "OBSERVATION", 55, 75]]], ["Transgenic carrot plants expressing BADH grew in the presence of high concentrations of NaCl (up to 400 mM), the highest level of salt tolerance reported so far among genetically modified crop plants.", [["BADH", "CHEMICAL", 36, 40], ["NaCl", "CHEMICAL", 88, 92], ["NaCl", "CHEMICAL", 88, 92], ["carrot plants", "ORGANISM", 11, 24], ["BADH", "GENE_OR_GENE_PRODUCT", 36, 40], ["NaCl", "SIMPLE_CHEMICAL", 88, 92], ["salt", "SIMPLE_CHEMICAL", 130, 134], ["BADH", "PROTEIN", 36, 40], ["carrot", "SPECIES", 11, 17], ["carrot", "SPECIES", 11, 17], ["high concentrations of NaCl", "PROBLEM", 65, 92], ["salt tolerance", "PROBLEM", 130, 144], ["carrot plants", "OBSERVATION", 11, 24], ["high", "OBSERVATION_MODIFIER", 65, 69], ["concentrations", "OBSERVATION_MODIFIER", 70, 84], ["salt tolerance", "OBSERVATION", 130, 144], ["crop plants", "OBSERVATION", 188, 199]]], ["Further, a gene for CMO, cloned from spinach (Spinacia oleracea) was introduced into rice through Agrobacterium mediated transformation.", [["CMO", "CHEMICAL", 20, 23], ["CMO", "GENE_OR_GENE_PRODUCT", 20, 23], ["spinach (", "ORGANISM", 37, 46], ["Spinacia oleracea", "ORGANISM", 46, 63], ["rice", "ORGANISM", 85, 89], ["CMO", "DNA", 20, 23], ["spinach", "SPECIES", 37, 44], ["Spinacia oleracea", "SPECIES", 46, 63], ["rice", "SPECIES", 85, 89], ["spinach", "SPECIES", 37, 44], ["Spinacia oleracea", "SPECIES", 46, 63], ["rice", "SPECIES", 85, 89], ["spinach (Spinacia oleracea)", "TREATMENT", 37, 64]]], ["The level of glycinebetaine in rice was low to the expectations.", [["glycinebetaine", "CHEMICAL", 13, 27], ["glycinebetaine", "CHEMICAL", 13, 27], ["glycinebetaine", "SIMPLE_CHEMICAL", 13, 27], ["rice", "ORGANISM", 31, 35], ["rice", "SPECIES", 31, 35], ["rice", "SPECIES", 31, 35], ["glycinebetaine", "TREATMENT", 13, 27]]], ["The author has given several reasons for the low productivity of rice and low glycinebetaine accumulation.", [["glycinebetaine", "CHEMICAL", 78, 92], ["glycinebetaine", "CHEMICAL", 78, 92], ["glycinebetaine", "SIMPLE_CHEMICAL", 78, 92], ["rice", "SPECIES", 65, 69], ["rice", "SPECIES", 65, 69], ["the low productivity of rice", "PROBLEM", 41, 69], ["low glycinebetaine accumulation", "PROBLEM", 74, 105], ["low glycinebetaine", "OBSERVATION_MODIFIER", 74, 92]]], ["Firstly, the position of spinach CMO and endogenous BADH might be different and secondly the catalytic activity of spinach CMO in rice plants might be lower than it was in spinach [97] .", [["CMO", "CHEMICAL", 123, 126], ["spinach CMO", "GENE_OR_GENE_PRODUCT", 25, 36], ["BADH", "GENE_OR_GENE_PRODUCT", 52, 56], ["spinach CMO", "ORGANISM", 115, 126], ["rice plants", "ORGANISM", 130, 141], ["spinach CMO", "PROTEIN", 25, 36], ["endogenous BADH", "PROTEIN", 41, 56], ["rice", "SPECIES", 130, 134], ["rice", "SPECIES", 130, 134], ["spinach CMO", "TREATMENT", 25, 36]]], ["Transplastomic plants constitutively expressing BvCMO under the control of the ribosomal RNA operon promoter and a synthetic T7 gene G10 leader were able to accumulate glycinebetaine in leaves, roots and seeds, and exhibited improved tolerance to toxic level of choline and to salt/drought stress when compared to wild type plants.", [["ribosomal", "ANATOMY", 79, 88], ["leaves", "ANATOMY", 186, 192], ["roots", "ANATOMY", 194, 199], ["seeds", "ANATOMY", 204, 209], ["glycinebetaine", "CHEMICAL", 168, 182], ["choline", "CHEMICAL", 262, 269], ["salt", "CHEMICAL", 277, 281], ["glycinebetaine", "CHEMICAL", 168, 182], ["choline", "CHEMICAL", 262, 269], ["BvCMO", "GENE_OR_GENE_PRODUCT", 48, 53], ["ribosomal", "CELLULAR_COMPONENT", 79, 88], ["glycinebetaine", "SIMPLE_CHEMICAL", 168, 182], ["roots", "ORGAN", 194, 199], ["choline", "SIMPLE_CHEMICAL", 262, 269], ["salt", "SIMPLE_CHEMICAL", 277, 281], ["BvCMO", "PROTEIN", 48, 53], ["ribosomal RNA operon promoter", "DNA", 79, 108], ["synthetic T7 gene G10 leader", "DNA", 115, 143], ["Transplastomic plants", "TREATMENT", 0, 21], ["the ribosomal RNA operon promoter", "TREATMENT", 75, 108], ["a synthetic T7 gene G10 leader", "TREATMENT", 113, 143]]], ["Transplastomic plants showed higher net photosynthetic rate and apparent quantum yield of photosynthesis in the presence of 150 mM NaCl [98] .", [["NaCl", "CHEMICAL", 131, 135], ["NaCl", "CHEMICAL", 131, 135], ["Transplastomic plants", "TREATMENT", 0, 21], ["higher net photosynthetic rate", "PROBLEM", 29, 59], ["photosynthesis", "TREATMENT", 90, 104], ["higher", "OBSERVATION_MODIFIER", 29, 35], ["net", "OBSERVATION_MODIFIER", 36, 39], ["photosynthetic rate", "OBSERVATION", 40, 59]]], ["Thus, it can be concluded that glycinebetaine has a role as compatible solute and its engineering into non-accumulations will be a success only if both CMO and BADH pathways are introduced and if the localization of both CMO and BADH is in plastids.", [["plastids", "ANATOMY", 240, 248], ["glycinebetaine", "CHEMICAL", 31, 45], ["BADH", "CHEMICAL", 229, 233], ["glycinebetaine", "CHEMICAL", 31, 45], ["glycinebetaine", "SIMPLE_CHEMICAL", 31, 45], ["CMO", "GENE_OR_GENE_PRODUCT", 152, 155], ["BADH", "GENE_OR_GENE_PRODUCT", 160, 164], ["CMO", "GENE_OR_GENE_PRODUCT", 221, 224], ["BADH", "GENE_OR_GENE_PRODUCT", 229, 233], ["plastids", "CELLULAR_COMPONENT", 240, 248], ["CMO", "PROTEIN", 221, 224], ["BADH", "PROTEIN", 229, 233], ["glycinebetaine", "TREATMENT", 31, 45]]], ["Very recently, George et al. [99] demonstrated how a chloroplastlocalized and auxin-induced glutathione S-transferase from phreatophyte Prosopis juliflora conferred drought tolerance on tobacco.", [["auxin", "CHEMICAL", 78, 83], ["glutathione", "CHEMICAL", 92, 103], ["auxin", "CHEMICAL", 78, 83], ["glutathione", "CHEMICAL", 92, 103], ["S", "CHEMICAL", 104, 105], ["auxin", "SIMPLE_CHEMICAL", 78, 83], ["glutathione S-transferase", "SIMPLE_CHEMICAL", 92, 117], ["phreatophyte Prosopis juliflora", "ORGANISM", 123, 154], ["tobacco", "ORGANISM", 186, 193], ["glutathione S-transferase", "PROTEIN", 92, 117], ["Prosopis juliflora", "SPECIES", 136, 154], ["tobacco", "SPECIES", 186, 193], ["Prosopis juliflora", "SPECIES", 136, 154], ["tobacco", "SPECIES", 186, 193], ["a chloroplastlocalized and auxin-induced glutathione S-transferase", "TREATMENT", 51, 117]]], ["For more examples of conferring tolerance to abiotic stress to plants via plastid engineering, see review by [3] .PRODUCTION OF BIOPHARMACEUTICALS AND VACCINES IN PLANTSMulesky et al. [100] pointed out two reasons that make using crops to produce drugs interesting for industry.", [["abiotic stress", "PROBLEM", 45, 59], ["plastid engineering", "TREATMENT", 74, 93], ["BIOPHARMACEUTICALS", "OBSERVATION_MODIFIER", 128, 146]]], ["These are (i) crops can be employed more efficiently in this process than animals or bacteria, with a larger output achieved with fewer resources, and (ii) the oral delivery of the drugs produced to people and animals is easier.", [["oral", "ANATOMY", 160, 164], ["oral", "ORGANISM_SUBDIVISION", 160, 164], ["people", "ORGANISM", 199, 205], ["people", "SPECIES", 199, 205], ["bacteria", "PROBLEM", 85, 93], ["a larger output", "PROBLEM", 100, 115], ["the drugs", "TREATMENT", 177, 186]]], ["A third reason is the high-level production of antigens for use as vaccines and their tests for immunological efficacy in animal studies [3] .", [["antigens", "PROTEIN", 47, 55], ["vaccines", "TREATMENT", 67, 75], ["their tests", "TEST", 80, 91], ["immunological efficacy", "PROBLEM", 96, 118], ["animal studies", "TEST", 122, 136]]], ["The hyper-expression of vaccine antigens or therapeutic proteins in transgenic chloroplasts (leaves) or chromoplasts (fruits/roots) and antibiotic-free selection systems available in plastid transformation systems made possible the oral delivery of vaccine antigens against cholera, tetanus, anthrax, plague, and canine parvovirus, [101] [102] [103] [104] and reviews of [102, 105, 3 and 106] explained why plastid engineering can be regarded as an attractive strategy and environmentally friendly approach for the production of vaccines, therapeutic proteins, and biomaterials, and provided some examples.", [["chloroplasts", "ANATOMY", 79, 91], ["leaves", "ANATOMY", 93, 99], ["chromoplasts", "ANATOMY", 104, 116], ["fruits", "ANATOMY", 118, 124], ["roots", "ANATOMY", 125, 130], ["oral", "ANATOMY", 232, 236], ["cholera", "DISEASE", 274, 281], ["tetanus", "DISEASE", 283, 290], ["anthrax", "DISEASE", 292, 299], ["plague", "DISEASE", 301, 307], ["canine parvovirus", "DISEASE", 313, 330], ["transgenic chloroplasts", "ORGANISM", 68, 91], ["leaves", "ORGANISM_SUBDIVISION", 93, 99], ["fruits", "ORGANISM_SUBDIVISION", 118, 124], ["roots", "ORGAN", 125, 130], ["oral", "ORGANISM_SUBDIVISION", 232, 236], ["canine parvovirus", "ORGANISM", 313, 330], ["plastid", "CELLULAR_COMPONENT", 407, 414], ["vaccine antigens", "PROTEIN", 24, 40], ["therapeutic proteins", "PROTEIN", 44, 64], ["canine parvovirus", "SPECIES", 313, 330], ["canine parvovirus", "SPECIES", 313, 330], ["The hyper-expression of vaccine antigens", "TREATMENT", 0, 40], ["therapeutic proteins", "TREATMENT", 44, 64], ["transgenic chloroplasts", "TREATMENT", 68, 91], ["chromoplasts (fruits/roots", "TREATMENT", 104, 130], ["antibiotic", "TREATMENT", 136, 146], ["free selection systems", "TREATMENT", 147, 169], ["plastid transformation systems", "TREATMENT", 183, 213], ["the oral delivery of vaccine antigens", "TREATMENT", 228, 265], ["cholera", "PROBLEM", 274, 281], ["plastid engineering", "TREATMENT", 407, 426], ["the production of vaccines", "TREATMENT", 511, 537], ["therapeutic proteins", "TREATMENT", 539, 559], ["biomaterials", "TREATMENT", 565, 577]]], ["Kumar & Daniell [107] described various techniques for creating plastid transgenic plants and their biochemical and molecular characterization.", [["various techniques", "TREATMENT", 32, 50], ["creating plastid transgenic plants", "TREATMENT", 55, 89], ["transgenic plants", "OBSERVATION", 72, 89]]], ["They also provided suitable examples for application of chloroplast genetic engineering in human medicine.PRODUCTION OF BIOPHARMACEUTICALS AND VACCINES IN PLANTSWang et al. [3] also discussed applying plastid transformation for metabolic pathway engineering in plants, the production of biopharmaceuticals, and marker gene excision system and how plastid transformation can be applied to study RNA editing.", [["human", "ORGANISM", 91, 96], ["plastid", "CELLULAR_COMPONENT", 347, 354], ["human", "SPECIES", 91, 96], ["human", "SPECIES", 91, 96], ["chloroplast genetic engineering", "TREATMENT", 56, 87], ["human medicine", "TREATMENT", 91, 105], ["plastid transformation", "TREATMENT", 201, 223], ["metabolic pathway engineering", "TREATMENT", 228, 257], ["biopharmaceuticals", "TREATMENT", 287, 305], ["marker gene excision system", "TREATMENT", 311, 338], ["plastid transformation", "TREATMENT", 347, 369], ["BIOPHARMACEUTICALS", "OBSERVATION_MODIFIER", 120, 138]]], ["Similarly, Hefferon [67] , considers plastid engineering as a valuable tool that gives enormous promise for the production of biopharmaceuticals and vaccines, because higher level of the protein expressed by the transgene inserted into the plastid genome can be achieved.", [["Hefferon", "CHEMICAL", 11, 19], ["plastid", "CELLULAR_COMPONENT", 240, 247], ["plastid genome", "DNA", 240, 254], ["plastid engineering", "TREATMENT", 37, 56], ["the production of biopharmaceuticals", "TREATMENT", 108, 144], ["vaccines", "TREATMENT", 149, 157], ["plastid genome", "OBSERVATION", 240, 254]]], ["Many vaccine antigens, which played a key role for the prevention of infectious diseases, and biopharmaceutical proteins, have been expressed at high levels via the chloroplast genome [108] and they proved to be functional using in vitro assays in cell cultures.", [["cell cultures", "ANATOMY", 248, 261], ["infectious diseases", "DISEASE", 69, 88], ["chloroplast", "CELLULAR_COMPONENT", 165, 176], ["cell cultures", "CELL", 248, 261], ["vaccine antigens", "PROTEIN", 5, 21], ["biopharmaceutical proteins", "PROTEIN", 94, 120], ["chloroplast genome", "DNA", 165, 183], ["cell cultures", "CELL_LINE", 248, 261], ["Many vaccine antigens", "TREATMENT", 0, 21], ["infectious diseases", "PROBLEM", 69, 88], ["biopharmaceutical proteins", "TREATMENT", 94, 120], ["the chloroplast genome", "TREATMENT", 161, 183], ["cell cultures", "TEST", 248, 261], ["infectious", "OBSERVATION", 69, 79]]], ["[109] stated that production of therapeutic proteins in plastids eliminates the expensive fermentation technology, and that the oral delivery of plastid-derived therapeutic proteins eliminates cold storage, cold transportation, expensive purification steps, and delivery via sterile needles, and hence decrease their cost.", [["plastids", "ANATOMY", 56, 64], ["oral", "ANATOMY", 128, 132], ["plastids", "CELLULAR_COMPONENT", 56, 64], ["oral", "ORGANISM_SUBDIVISION", 128, 132], ["therapeutic proteins", "PROTEIN", 32, 52], ["therapeutic proteins in plastids", "PROBLEM", 32, 64], ["the oral delivery of plastid", "TREATMENT", 124, 152], ["therapeutic proteins", "TREATMENT", 161, 181], ["cold transportation", "TREATMENT", 207, 226], ["expensive purification steps", "TREATMENT", 228, 256], ["delivery via sterile needles", "TREATMENT", 262, 290]]], ["The main goal for applications of plastid transformation by the biotech industry is molecular pharming, and food production is considered as only a secondary target [80] .PRODUCTION OF BIOPHARMACEUTICALS AND VACCINES IN PLANTSTo create an edible vaccine, selected desired genes should be introduced into plants and then inducing these altered plants to manufacture the encoded proteins.", [["plastid", "CELLULAR_COMPONENT", 34, 41], ["encoded proteins", "PROTEIN", 369, 385], ["plastid transformation", "TREATMENT", 34, 56], ["VACCINES", "TREATMENT", 208, 216], ["an edible vaccine", "TREATMENT", 236, 253], ["these altered plants", "PROBLEM", 329, 349], ["main", "OBSERVATION_MODIFIER", 4, 8], ["plastid transformation", "OBSERVATION", 34, 56], ["BIOPHARMACEUTICALS", "OBSERVATION", 185, 203]]], ["Like conventional subunit vaccines, edible vaccines are composed of antigenic proteins and are devoid of pathogenic genes.", [["antigenic proteins", "PROTEIN", 68, 86], ["pathogenic genes", "DNA", 105, 121], ["conventional subunit vaccines", "TREATMENT", 5, 34], ["edible vaccines", "TREATMENT", 36, 51], ["antigenic proteins", "TREATMENT", 68, 86], ["pathogenic genes", "PROBLEM", 105, 121], ["pathogenic genes", "OBSERVATION", 105, 121]]], ["Plastids of green plants as bioreactors for the production of vaccines and biopharmaceuticals are of great potential as indicated from a number of published studies [110] [111] [112] [113] [114] .", [["[110] [111] [112] [113] [114]", "SIMPLE_CHEMICAL", 165, 194], ["green plants", "TREATMENT", 12, 24], ["bioreactors", "TREATMENT", 28, 39], ["the production of vaccines", "TREATMENT", 44, 70], ["biopharmaceuticals", "TREATMENT", 75, 93], ["green plants", "OBSERVATION", 12, 24]]], ["The significance of using plants as production platforms for pharmaceuticals is due to the low production and delivery costs, easy scale-up and high safety standards regarding less risk of product contamination with human pathogen [27] .", [["human", "ORGANISM", 216, 221], ["human", "SPECIES", 216, 221], ["human", "SPECIES", 216, 221], ["pharmaceuticals", "TREATMENT", 61, 76], ["the low production", "PROBLEM", 87, 105], ["delivery costs", "TREATMENT", 110, 124], ["easy scale", "TEST", 126, 136]]], ["Keeping in view the high efficiency of plastids to express foreign genes, it is meaningful to explore this property of plastids for the production of proteinaceous pharmaceuticals, such as antigens, antibodies and antimicrobials.", [["plastids", "ANATOMY", 39, 47], ["plastids", "ANATOMY", 119, 127], ["plastids", "CELLULAR_COMPONENT", 39, 47], ["plastids", "CELLULAR_COMPONENT", 119, 127], ["foreign genes", "DNA", 59, 72], ["antigens", "PROTEIN", 189, 197], ["antibodies", "PROTEIN", 199, 209], ["foreign genes", "PROBLEM", 59, 72], ["proteinaceous pharmaceuticals", "TREATMENT", 150, 179], ["antibodies", "TREATMENT", 199, 209], ["antimicrobials", "TREATMENT", 214, 228], ["high efficiency", "OBSERVATION_MODIFIER", 20, 35], ["foreign genes", "OBSERVATION", 59, 72], ["proteinaceous pharmaceuticals", "OBSERVATION", 150, 179]]], ["The candidate subunit vaccine against Clostridium tetani, causing tetanus was the first plastid-produced antigen that proved to be immunologically active in experimental animals [111] .", [["Clostridium tetani", "DISEASE", 38, 56], ["tetanus", "DISEASE", 66, 73], ["Clostridium tetani", "ORGANISM", 38, 56], ["Clostridium tetani", "SPECIES", 38, 56], ["Clostridium tetani", "SPECIES", 38, 56], ["The candidate subunit vaccine", "TREATMENT", 0, 29], ["Clostridium tetani", "PROBLEM", 38, 56], ["tetanus", "PROBLEM", 66, 73]]], ["In this initial attempt, fragment C of the tetanus toxin (TetC), a non-toxic protein fragment, was expressed from the tobacco plastid genome which resulted in high levels of antigen protein expression (30% of the plant's total soluble protein (TSP)).", [["TetC", "CHEMICAL", 58, 62], ["tetanus toxin", "GENE_OR_GENE_PRODUCT", 43, 56], ["TetC", "GENE_OR_GENE_PRODUCT", 58, 62], ["tobacco", "ORGANISM", 118, 125], ["TSP", "GENE_OR_GENE_PRODUCT", 244, 247], ["fragment C", "PROTEIN", 25, 35], ["tetanus toxin", "PROTEIN", 43, 56], ["TetC", "PROTEIN", 58, 62], ["non-toxic protein fragment", "PROTEIN", 67, 93], ["tobacco plastid genome", "DNA", 118, 140], ["antigen protein", "PROTEIN", 174, 189], ["plant's total soluble protein", "PROTEIN", 213, 242], ["TSP", "PROTEIN", 244, 247], ["tobacco", "SPECIES", 118, 125], ["tobacco", "SPECIES", 118, 125], ["fragment C of the tetanus toxin", "PROBLEM", 25, 56], ["a non-toxic protein fragment", "PROBLEM", 65, 93], ["high levels of antigen protein expression", "PROBLEM", 159, 200], ["non-toxic", "OBSERVATION_MODIFIER", 67, 76], ["protein fragment", "OBSERVATION", 77, 93], ["tobacco", "OBSERVATION", 118, 125], ["plastid genome", "OBSERVATION", 126, 140], ["high levels", "OBSERVATION_MODIFIER", 159, 170]]], ["Anthrax is an acute infectious disease caused by the spore-forming bacterium Bacillus anthracis.", [["Anthrax", "DISEASE", 0, 7], ["Bacillus anthracis", "ORGANISM", 77, 95], ["Bacillus anthracis", "SPECIES", 77, 95], ["Bacillus anthracis", "SPECIES", 77, 95], ["Anthrax", "PROBLEM", 0, 7], ["an acute infectious disease", "PROBLEM", 11, 38], ["the spore-forming bacterium Bacillus anthracis", "PROBLEM", 49, 95], ["acute", "OBSERVATION_MODIFIER", 14, 19], ["infectious", "OBSERVATION", 20, 30], ["bacterium Bacillus anthracis", "OBSERVATION", 67, 95]]], ["Significant development has been achieved towards the production of plastid-based vaccine for this infectious disease.", [["infectious disease", "DISEASE", 99, 117], ["plastid", "CELLULAR_COMPONENT", 68, 75], ["plastid-based vaccine", "TREATMENT", 68, 89], ["this infectious disease", "PROBLEM", 94, 117], ["infectious", "OBSERVATION", 99, 109]]], ["Expression (14% of the plants TSP) of the pagA gene encoding the protective antigen (PA) from the tobacco plastid genome gave rise to stable antigen protein [112, 113] .", [["TSP", "GENE_OR_GENE_PRODUCT", 30, 33], ["pagA", "GENE_OR_GENE_PRODUCT", 42, 46], ["protective antigen", "GENE_OR_GENE_PRODUCT", 65, 83], ["PA", "GENE_OR_GENE_PRODUCT", 85, 87], ["tobacco", "ORGANISM", 98, 105], ["TSP", "PROTEIN", 30, 33], ["pagA gene", "DNA", 42, 51], ["protective antigen", "PROTEIN", 65, 83], ["PA", "PROTEIN", 85, 87], ["tobacco plastid genome", "DNA", 98, 120], ["antigen protein", "PROTEIN", 141, 156], ["tobacco", "SPECIES", 98, 105], ["tobacco", "SPECIES", 98, 105], ["the plants TSP", "TREATMENT", 19, 33], ["the pagA gene", "TREATMENT", 38, 51]]], ["The plastid-derived PA was equally effective in cytotoxicity assays as the bacterial protein produced in B. anthracis.", [["plastid", "CELLULAR_COMPONENT", 4, 11], ["PA", "GENE_OR_GENE_PRODUCT", 20, 22], ["B. anthracis", "ORGANISM", 105, 117], ["bacterial protein", "PROTEIN", 75, 92], ["B. anthracis", "SPECIES", 105, 117], ["B. anthracis", "SPECIES", 105, 117], ["cytotoxicity assays", "TEST", 48, 67], ["the bacterial protein", "TEST", 71, 92], ["bacterial protein", "OBSERVATION", 75, 92]]], ["The potential of plastid transformation as an alternative tool to produce high levels of HIV-1 Nef and p24 antigens in plant cells have been also demonstrated [115] .", [["plant cells", "ANATOMY", 119, 130], ["plastid", "CELLULAR_COMPONENT", 17, 24], ["HIV-1", "ORGANISM", 89, 94], ["Nef", "GENE_OR_GENE_PRODUCT", 95, 98], ["p24 antigens", "GENE_OR_GENE_PRODUCT", 103, 115], ["plant cells", "CELL", 119, 130], ["HIV-1 Nef", "PROTEIN", 89, 98], ["p24 antigens", "PROTEIN", 103, 115], ["plant cells", "CELL_TYPE", 119, 130], ["HIV-1", "SPECIES", 89, 94], ["HIV-1", "SPECIES", 89, 94], ["plastid transformation", "PROBLEM", 17, 39], ["high levels of HIV", "PROBLEM", 74, 92], ["p24 antigens in plant cells", "PROBLEM", 103, 130], ["potential of", "UNCERTAINTY", 4, 16], ["plastid transformation", "OBSERVATION", 17, 39], ["plant cells", "OBSERVATION", 119, 130]]], ["Different constructs were designed to express the p27 Nef protein either alone or as p24-Nef or Nef-p24 fusion proteins.", [["p27 Nef", "GENE_OR_GENE_PRODUCT", 50, 57], ["p24-Nef", "GENE_OR_GENE_PRODUCT", 85, 92], ["Nef", "GENE_OR_GENE_PRODUCT", 96, 99], ["p24", "GENE_OR_GENE_PRODUCT", 100, 103], ["p27 Nef protein", "PROTEIN", 50, 65], ["p24", "PROTEIN", 85, 88], ["Nef", "PROTEIN", 89, 92], ["Nef", "PROTEIN", 96, 99], ["p24 fusion proteins", "PROTEIN", 100, 119], ["the p27 Nef protein", "TREATMENT", 46, 65], ["p24", "TEST", 85, 88], ["Nef-p24 fusion proteins", "TREATMENT", 96, 119], ["p24 fusion", "OBSERVATION", 100, 110]]], ["All constructs were utilized to transform tobacco (cv.", [["tobacco", "ORGANISM", 42, 49], ["tobacco", "SPECIES", 42, 49], ["tobacco", "SPECIES", 42, 49], ["cv", "SPECIES", 51, 53]]], ["Petite Havana) plastids and the transplastomic lines.", [["plastids", "ANATOMY", 15, 23], ["transplastomic lines", "ANATOMY", 32, 52], ["transplastomic lines", "CELL", 32, 52], ["transplastomic lines", "CELL_LINE", 32, 52], ["the transplastomic lines", "TREATMENT", 28, 52], ["transplastomic lines", "OBSERVATION", 32, 52]]], ["Analysis of p24-Nef and Nefp24 fusion proteins showed that both can be expressed to relatively high levels in plastids.", [["plastids", "ANATOMY", 110, 118], ["p24", "GENE_OR_GENE_PRODUCT", 12, 15], ["Nef", "GENE_OR_GENE_PRODUCT", 16, 19], ["Nefp24", "GENE_OR_GENE_PRODUCT", 24, 30], ["plastids", "CELLULAR_COMPONENT", 110, 118], ["p24", "PROTEIN", 12, 15], ["Nef", "PROTEIN", 16, 19], ["Nefp24 fusion proteins", "PROTEIN", 24, 46], ["Analysis", "TEST", 0, 8], ["p24", "TEST", 12, 15], ["Nef", "TEST", 16, 19], ["Nefp24 fusion proteins", "TEST", 24, 46]]], ["As the best results in terms of protein expression levels were obtained with the p24-Nef fusion protein, the correspondent gene was cloned in a new expression vector.", [["p24", "GENE_OR_GENE_PRODUCT", 81, 84], ["Nef", "GENE_OR_GENE_PRODUCT", 85, 88], ["p24", "PROTEIN", 81, 84], ["Nef fusion protein", "PROTEIN", 85, 103], ["correspondent gene", "DNA", 109, 127], ["protein expression levels", "TEST", 32, 57], ["the p24-Nef fusion protein", "TREATMENT", 77, 103]]], ["This construct was introduced into the tobacco and tomato plastid genomes.", [["tobacco", "ORGANISM", 39, 46], ["tomato", "ORGANISM", 51, 57], ["tobacco and tomato plastid genomes", "DNA", 39, 73], ["tobacco", "SPECIES", 39, 46], ["tomato", "SPECIES", 51, 57], ["tobacco", "SPECIES", 39, 46], ["tomato", "SPECIES", 51, 57], ["plastid genomes", "OBSERVATION", 58, 73]]], ["Transplastomic tobacco and tomato plants were analyzed and protein accumulation was found to be close to 40% of the leaf's total protein.", [["leaf", "ANATOMY", 116, 120], ["tobacco", "ORGANISM", 15, 22], ["tomato", "ORGANISM", 27, 33], ["leaf", "ORGAN", 116, 120], ["leaf's total protein", "PROTEIN", 116, 136], ["tobacco", "SPECIES", 15, 22], ["tomato", "SPECIES", 27, 33], ["tobacco", "SPECIES", 15, 22], ["tomato", "SPECIES", 27, 33], ["tomato plants", "TREATMENT", 27, 40], ["protein accumulation", "PROBLEM", 59, 79]]], ["Transcript and protein accumulation were analyzed in different ripening stage of tomato fruit and green tomatoes accumulated the fusion protein to 2.5% of the TSP [115] .", [["fruit", "ANATOMY", 88, 93], ["tomatoes", "ANATOMY", 104, 112], ["tomato", "ORGANISM", 81, 87], ["fruit", "ORGANISM_SUBDIVISION", 88, 93], ["tomatoes", "ORGANISM_SUBDIVISION", 104, 112], ["fusion protein", "PROTEIN", 129, 143], ["tomato", "SPECIES", 81, 87], ["tomato", "SPECIES", 81, 87], ["Transcript and protein accumulation", "PROBLEM", 0, 35], ["tomato fruit", "PROBLEM", 81, 93], ["green tomatoes", "PROBLEM", 98, 112], ["the fusion protein", "TEST", 125, 143], ["the TSP", "TEST", 155, 162], ["tomato fruit", "OBSERVATION", 81, 93]]], ["Recently, a strategy for plastid production of antibiotics against pneumonia Streptococcus pneumonia has been outlined [116] .", [["pneumonia", "DISEASE", 67, 76], ["Streptococcus pneumonia", "DISEASE", 77, 100], ["Streptococcus pneumonia", "SPECIES", 77, 100], ["a strategy", "TREATMENT", 10, 20], ["plastid production of antibiotics", "TREATMENT", 25, 58], ["pneumonia", "PROBLEM", 67, 76], ["Streptococcus pneumonia", "PROBLEM", 77, 100], ["pneumonia", "OBSERVATION", 91, 100]]], ["The authors describe it as a new technique for high level expression (to up to 30% of the plant's TSP) of antmicrobial proteins that are toxic to E. coli.", [["TSP", "GENE_OR_GENE_PRODUCT", 98, 101], ["antmicrobial proteins", "GENE_OR_GENE_PRODUCT", 106, 127], ["E. coli", "ORGANISM", 146, 153], ["TSP", "PROTEIN", 98, 101], ["antmicrobial proteins", "PROTEIN", 106, 127], ["E. coli", "SPECIES", 146, 153], ["E. coli", "SPECIES", 146, 153], ["a new technique", "TREATMENT", 27, 42], ["high level expression", "PROBLEM", 47, 68], ["antmicrobial proteins", "PROBLEM", 106, 127], ["toxic to E. coli", "PROBLEM", 137, 153], ["E. coli", "OBSERVATION", 146, 153]]], ["It was also shown that the plastid-produced antibiotics efficiently kill pathogenic strains of Streptococcus pneumoniae, the causative agent of pneumonia, thus providing a promising strategy for the production of next-generation antibiotics in plants.", [["Streptococcus pneumoniae", "DISEASE", 95, 119], ["pneumonia", "DISEASE", 144, 153], ["plastid", "CELLULAR_COMPONENT", 27, 34], ["Streptococcus pneumoniae", "ORGANISM", 95, 119], ["Streptococcus pneumoniae", "SPECIES", 95, 119], ["Streptococcus pneumoniae", "SPECIES", 95, 119], ["the plastid", "TREATMENT", 23, 34], ["antibiotics", "TREATMENT", 44, 55], ["Streptococcus pneumoniae", "PROBLEM", 95, 119], ["pneumonia", "PROBLEM", 144, 153], ["a promising strategy", "TREATMENT", 170, 190], ["next-generation antibiotics", "TREATMENT", 213, 240], ["Streptococcus pneumoniae", "OBSERVATION", 95, 119], ["pneumonia", "OBSERVATION", 144, 153]]], ["In 2007, Chebolu and Daniell [117] achieved a stable expression of Gal/GalNAc lectin of Entamoeba histolytica in transgenic chloroplasts and immunogenicity in mice towards vaccine development for amoebiasis.", [["chloroplasts", "ANATOMY", 124, 136], ["amoebiasis", "DISEASE", 196, 206], ["GalNAc", "CHEMICAL", 71, 77], ["Gal/GalNAc lectin", "GENE_OR_GENE_PRODUCT", 67, 84], ["Entamoeba histolytica", "ORGANISM", 88, 109], ["mice", "ORGANISM", 159, 163], ["Gal/GalNAc lectin", "PROTEIN", 67, 84], ["Entamoeba histolytica", "SPECIES", 88, 109], ["mice", "SPECIES", 159, 163], ["Entamoeba histolytica", "SPECIES", 88, 109], ["mice", "SPECIES", 159, 163], ["Gal/GalNAc lectin", "TREATMENT", 67, 84], ["Entamoeba histolytica", "PROBLEM", 88, 109], ["transgenic chloroplasts", "TREATMENT", 113, 136], ["immunogenicity in mice towards vaccine", "TREATMENT", 141, 179], ["amoebiasis", "PROBLEM", 196, 206], ["amoebiasis", "OBSERVATION", 196, 206]]], ["Shao et al. [118] reported the expression of the structural protein E2 of classical swine fever virus (CSFV), which has been shown to carry critical epitopes CFSV E2 gene in tobacco chloroplasts.", [["chloroplasts", "ANATOMY", 182, 194], ["E2", "CHEMICAL", 68, 70], ["swine fever", "DISEASE", 84, 95], ["E2", "CHEMICAL", 163, 165], ["E2", "GENE_OR_GENE_PRODUCT", 68, 70], ["classical swine fever virus", "ORGANISM", 74, 101], ["CSFV", "ORGANISM", 103, 107], ["CFSV E2", "GENE_OR_GENE_PRODUCT", 158, 165], ["tobacco", "ORGANISM", 174, 181], ["structural protein E2", "PROTEIN", 49, 70], ["CFSV E2 gene", "DNA", 158, 170], ["swine fever virus", "SPECIES", 84, 101], ["tobacco", "SPECIES", 174, 181], ["classical swine fever virus", "SPECIES", 74, 101], ["CSFV", "SPECIES", 103, 107], ["tobacco", "SPECIES", 174, 181], ["classical swine fever virus (CSFV)", "PROBLEM", 74, 108]]], ["In another study on tobacco, plastid transformation of the high-biomass tobacco variety has been assessed by McCabe et al. [119] as a production platform for the human immunodeficiency virus type 1 (HIV-1) p24 antigen.", [["human immunodeficiency virus", "DISEASE", 162, 190], ["tobacco", "ORGANISM", 20, 27], ["plastid", "CELLULAR_COMPONENT", 29, 36], ["tobacco", "ORGANISM", 72, 79], ["human immunodeficiency virus type 1", "ORGANISM", 162, 197], ["HIV-1", "ORGANISM", 199, 204], ["p24 antigen", "GENE_OR_GENE_PRODUCT", 206, 217], ["human immunodeficiency virus type 1 (HIV-1) p24 antigen", "PROTEIN", 162, 217], ["tobacco", "SPECIES", 20, 27], ["tobacco", "SPECIES", 72, 79], ["human immunodeficiency virus type 1", "SPECIES", 162, 197], ["HIV-1", "SPECIES", 199, 204], ["tobacco", "SPECIES", 20, 27], ["tobacco", "SPECIES", 72, 79], ["human immunodeficiency virus type 1", "SPECIES", 162, 197], ["HIV-1", "SPECIES", 199, 204], ["plastid transformation", "PROBLEM", 29, 51], ["a production platform", "TEST", 132, 153], ["the human immunodeficiency virus type", "TEST", 158, 195], ["HIV", "TEST", 199, 202], ["p24 antigen", "TEST", 206, 217], ["plastid transformation", "OBSERVATION", 29, 51]]], ["Similarly, Meyers et al. 2008 [120] revealed the usefulness of plastid signal peptides in enhancing the production of recombinant proteins meant for use as vaccines.", [["recombinant proteins", "PROTEIN", 118, 138], ["plastid signal peptides", "PROBLEM", 63, 86], ["recombinant proteins", "TREATMENT", 118, 138], ["vaccines", "TREATMENT", 156, 164]]], ["Transgenic plastids were also proved efficient for high-yield production of the vaccinia virus envelope protein A27L in plant cellsdagger by Rigano et al. [121] , who revealed that chloroplasts are an attractive production vehicle for the expression of OPV subunit vaccines.", [["plastids", "ANATOMY", 11, 19], ["chloroplasts", "ANATOMY", 181, 193], ["vaccinia virus", "ORGANISM", 80, 94], ["chloroplasts", "CELLULAR_COMPONENT", 181, 193], ["vaccinia virus envelope protein A27L", "PROTEIN", 80, 116], ["vaccinia virus", "SPECIES", 80, 94], ["Transgenic plastids", "TREATMENT", 0, 19], ["the vaccinia virus envelope protein", "TREATMENT", 76, 111], ["OPV subunit vaccines", "TREATMENT", 253, 273]]], ["Very recently, Youm et al. [122] were able to produce the human beta-site APP cleaving enzyme (BACE) via transformation of tobacco plastids.", [["human", "ORGANISM", 58, 63], ["beta-site APP cleaving enzyme", "GENE_OR_GENE_PRODUCT", 64, 93], ["BACE", "GENE_OR_GENE_PRODUCT", 95, 99], ["tobacco", "ORGANISM", 123, 130], ["human beta-site APP cleaving enzyme", "PROTEIN", 58, 93], ["BACE", "PROTEIN", 95, 99], ["human", "SPECIES", 58, 63], ["human", "SPECIES", 58, 63], ["tobacco", "SPECIES", 123, 130], ["the human beta", "TREATMENT", 54, 68], ["tobacco plastids", "OBSERVATION", 123, 139]]], ["The authors argued that the successful production of plastid-based BACE protein has the potential for developing a plant-based vaccine against Alzheimer disease.", [["Alzheimer disease", "DISEASE", 143, 160], ["plastid", "CELLULAR_COMPONENT", 53, 60], ["BACE", "GENE_OR_GENE_PRODUCT", 67, 71], ["BACE protein", "PROTEIN", 67, 79], ["plastid-based BACE protein", "TREATMENT", 53, 79], ["a plant-based vaccine", "TREATMENT", 113, 134], ["Alzheimer disease", "PROBLEM", 143, 160]]], ["Because recombinant extra domain A from fibronectin (EDA) could be used as an adjuvant for vaccine development, [104] aimed to express EDA from the tobacco plastome as a promising strategy in molecular farming.", [["extra domain A", "GENE_OR_GENE_PRODUCT", 20, 34], ["fibronectin", "GENE_OR_GENE_PRODUCT", 40, 51], ["EDA", "GENE_OR_GENE_PRODUCT", 53, 56], ["EDA", "GENE_OR_GENE_PRODUCT", 135, 138], ["tobacco", "ORGANISM", 148, 155], ["recombinant extra domain A", "PROTEIN", 8, 34], ["fibronectin", "PROTEIN", 40, 51], ["EDA", "PROTEIN", 53, 56], ["EDA", "PROTEIN", 135, 138], ["tobacco", "SPECIES", 148, 155], ["tobacco", "SPECIES", 148, 155], ["fibronectin (EDA)", "TREATMENT", 40, 57], ["an adjuvant for vaccine development", "TREATMENT", 75, 110]]], ["Tobacco plastids transformation was also evaluated by Lentz et al. [123] for the production of a highly immunogenic epitope containing amino acid residues 135-160 of the structural protein VP1 of the foot and mouth disease virus (FMDV).", [["foot", "ANATOMY", 200, 204], ["amino acid residues 135-160", "CHEMICAL", 135, 162], ["foot and mouth disease", "DISEASE", 200, 222], ["amino acid", "CHEMICAL", 135, 145], ["Tobacco", "ORGANISM", 0, 7], ["amino acid", "AMINO_ACID", 135, 145], ["foot and mouth disease virus", "ORGANISM", 200, 228], ["FMDV", "ORGANISM", 230, 234], ["amino acid residues 135-160", "PROTEIN", 135, 162], ["structural protein VP1", "PROTEIN", 170, 192], ["foot and mouth disease virus", "SPECIES", 200, 228], ["FMDV", "SPECIES", 230, 234], ["foot and mouth disease virus", "SPECIES", 200, 228], ["FMDV", "SPECIES", 230, 234], ["a highly immunogenic epitope", "TREATMENT", 95, 123], ["amino acid residues", "TEST", 135, 154], ["mouth disease virus", "PROBLEM", 209, 228], ["foot", "ANATOMY", 200, 204], ["mouth", "ANATOMY", 209, 214]]], ["The authors concluded that this technology allows the production of large quantities of immunogenic proteins.PRODUCTION OF BIOPHARMACEUTICALS AND VACCINES IN PLANTSIn spite of this huge success in applying plastid engineering for molecular pharming, Ho & Cummins [73] referred to several risks of plastid engineering in producing GM pharmaceuticals that are associated with its advantages.", [["GM", "CHEMICAL", 330, 332], ["immunogenic proteins", "PROTEIN", 88, 108], ["immunogenic proteins", "PROBLEM", 88, 108], ["plastid engineering", "TREATMENT", 297, 316], ["large", "OBSERVATION_MODIFIER", 68, 73], ["BIOPHARMACEUTICALS", "OBSERVATION", 123, 141]]], ["Other valuable reviews are available on (a) generation of plants with transgenic plastids, summary of our current understanding of the transformation process and highlights on selected applications of transplastomic technologies in basic and applied research [124] , (b) Progress in expressing proteins that are biomedically relevant, in engineering metabolic pathways, and in manipulating photosynthesis and agronomic traits and the problems of implementing the technology in crops [125] , (c) plastid transformation in higher plants [56] , (d) the characteristics, applications of chloroplast genetic engineering and its promising prospects, [126] , (e) Engineering the chloroplast genome [127] (f) exciting developments in this field and offers directions for further research and development, [128] (g) the expression of resistance traits, the production of biopharmaceuticals and metabolic pathway engineering in plants [27] , (h) chloroplasts as bioreactors, and whether we can replace plants with plants [129] , (i) how plastid transformation played an important role in understanding the RNA editing [3] and (j) comparison of opportunities and challenges between nuclear and plastid genetic engineering of plants [130] .CONCLUSIONSUp to date, many transgenes have been successfully introduced into the plastid genome of model plant tobacco and many other important crop plants for various agronomic traits.", [["plastids", "ANATOMY", 81, 89], ["chloroplasts", "ANATOMY", 936, 948], ["nuclear", "ANATOMY", 1171, 1178], ["plastid", "CELLULAR_COMPONENT", 495, 502], ["plastid", "CELLULAR_COMPONENT", 1027, 1034], ["nuclear", "CELLULAR_COMPONENT", 1171, 1178], ["plastid", "CELLULAR_COMPONENT", 1183, 1190], ["plastid", "CELLULAR_COMPONENT", 1310, 1317], ["tobacco", "ORGANISM", 1340, 1347], ["chloroplast genome", "DNA", 672, 690], ["plastid genome", "DNA", 1310, 1324], ["tobacco", "SPECIES", 1340, 1347], ["tobacco", "SPECIES", 1340, 1347], ["transgenic plastids", "TREATMENT", 70, 89], ["the transformation process", "PROBLEM", 131, 157], ["transplastomic technologies", "TREATMENT", 201, 228], ["plastid transformation", "PROBLEM", 495, 517], ["chloroplast genetic engineering", "TREATMENT", 583, 614], ["resistance traits", "PROBLEM", 825, 842], ["the production of biopharmaceuticals", "TREATMENT", 844, 880], ["plastid transformation", "PROBLEM", 1027, 1049], ["various agronomic traits", "PROBLEM", 1389, 1413], ["plastid genome", "OBSERVATION", 1310, 1324], ["plant tobacco", "OBSERVATION", 1334, 1347]]], ["Initially, this technology was limited to model plant species, but now it has been extended to some other important crops.", [["model plant species", "PROBLEM", 42, 61], ["plant species", "OBSERVATION", 48, 61]]], ["Still there are many agronomically important cereals crops in which plastid engineering has not yet been standardized.", [["cereals crops", "OBSERVATION", 45, 58]]], ["Plastid transformation has been proved to result in high levels of transgene expression.", [["Plastid transformation", "PROBLEM", 0, 22], ["transgene expression", "OBSERVATION", 67, 87]]], ["It has also provided a baseline for production of proteinaceous pharmaceuticals, such as antigens, antibodies and antimicrobials in a cost effective manner.", [["antigens", "PROTEIN", 89, 97], ["antibodies", "PROTEIN", 99, 109], ["proteinaceous pharmaceuticals", "TREATMENT", 50, 79], ["antibodies", "TREATMENT", 99, 109], ["antimicrobials", "TREATMENT", 114, 128], ["proteinaceous pharmaceuticals", "OBSERVATION", 50, 79]]], ["Bock [27] believes that a great progress has been achieved over years in investigating the mechanisms that govern transgene expression from the plastid genome and in using this technology for biotechnological applications.", [["plastid", "CELLULAR_COMPONENT", 144, 151], ["plastid genome", "DNA", 144, 158], ["this technology", "TREATMENT", 172, 187], ["biotechnological applications", "TREATMENT", 192, 221], ["plastid genome", "OBSERVATION", 144, 158]]], ["We agree with the author that \"the routine use of plastid engineering in biotechnology is still a long way off, but would surely benefit the humanity in the near future\".", [["plastid engineering", "TREATMENT", 50, 69]]], ["There is no doubt that plastid engineering holds a great potential in plant biotechnology; but like every new technology, there are some challenges which need to be addressed before its widespread adoption.", [["plastid", "CELLULAR_COMPONENT", 23, 30], ["no doubt", "UNCERTAINTY", 9, 17]]], ["Among other important factors to be solved are the protein purification and expression level control.", [["the protein purification", "TREATMENT", 47, 71], ["expression level control", "TREATMENT", 76, 100]]]], "PMC7313529": [["INTRODUCTIONNon-infectious uveitis (NIU)is a group of sight-threatening inflammatory diseases, sometimes associated with systemic inflammatory disorders.", [["infectious uveitis", "DISEASE", 16, 34], ["NIU", "DISEASE", 36, 39], ["inflammatory disorders", "DISEASE", 130, 152], ["infectious uveitis", "PROBLEM", 16, 34], ["threatening inflammatory diseases", "PROBLEM", 60, 93], ["systemic inflammatory disorders", "PROBLEM", 121, 152], ["infectious", "OBSERVATION_MODIFIER", 16, 26], ["uveitis", "OBSERVATION", 27, 34], ["threatening", "OBSERVATION_MODIFIER", 60, 71], ["inflammatory diseases", "OBSERVATION", 72, 93], ["sometimes associated with", "UNCERTAINTY", 95, 120], ["systemic", "OBSERVATION_MODIFIER", 121, 129], ["inflammatory", "OBSERVATION", 130, 142]]], ["Immunomodulatory therapy (IMT) is often considered for systemic treatment of NIU, and commonly selected drugs include corticosteroids (topical, peribulbar, intravitreal, oral and intravenous), with conventional immunosuppressive agents or biologics used when long-term treatment is required and a corticosteroid-sparing approach is necessary.1 2 It is well known that one of the most important concerns related to IMT is the increased risk of infections, as these drugs act by limiting the patient\u2019s immune responses.3", [["oral", "ANATOMY", 170, 174], ["intravenous", "ANATOMY", 179, 190], ["NIU", "DISEASE", 77, 80], ["IMT", "DISEASE", 414, 417], ["infections", "DISEASE", 443, 453], ["corticosteroids", "CHEMICAL", 118, 133], ["corticosteroids", "SIMPLE_CHEMICAL", 118, 133], ["oral", "ORGANISM_SUBDIVISION", 170, 174], ["intravenous", "IMMATERIAL_ANATOMICAL_ENTITY", 179, 190], ["patient", "ORGANISM", 490, 497], ["patient", "SPECIES", 490, 497], ["Immunomodulatory therapy", "TREATMENT", 0, 24], ["systemic treatment of NIU", "TREATMENT", 55, 80], ["commonly selected drugs", "TREATMENT", 86, 109], ["corticosteroids", "TREATMENT", 118, 133], ["topical", "TREATMENT", 135, 142], ["peribulbar", "TREATMENT", 144, 154], ["intravitreal", "TREATMENT", 156, 168], ["oral and intravenous)", "TREATMENT", 170, 191], ["conventional immunosuppressive agents", "TREATMENT", 198, 235], ["biologics", "TREATMENT", 239, 248], ["long-term treatment", "TREATMENT", 259, 278], ["a corticosteroid-sparing approach", "TREATMENT", 295, 328], ["infections", "PROBLEM", 443, 453], ["these drugs", "TREATMENT", 458, 469], ["increased", "OBSERVATION_MODIFIER", 425, 434], ["infections", "OBSERVATION", 443, 453]]]], "PMC7289727": [], "b7fc5c5fef346ba27de4322e673bd64e30d9320c": [["advantage of learning through trial and error without physically harming a patient.", [["patient", "ORGANISM", 75, 82], ["patient", "SPECIES", 75, 82]]]]}